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SUMMARY 
Exploring The Structure And Function Of Bacterial Cytosine Specific DNA 
Methyltransferases Using Site-directed Mutagenesis 
Submitted to 
The University of Sheffield 
For the degree of 
Doctor of Philosophy 
Qaiser Iftikhar Sheikh 
Point mutations were engineered into the sequence of the multispecific DNA 
methyltransferase (Mtase) M. SPRI in motif IX, in order to mimic the corresponding 
motif IX of mono-specific Mtase. A similar approach was adopted to modify the 
sequence of the monospecific enzyme M. HhaI in motifs IX and X based on the 
available structure and as a consequence the enzyme regained methylation potential. 
It was thought that these changes might be sufficient to enable functional exchange 
of the target recognition domains (TRDs) between a mono- and a multispecific 
enzyme. However, insertion of various segments of TRD region from M. SPRI into 
the M. HhaI was not successful (Chapter 4). To establish whether mono- and 
multispecific Mtases are incompatible in terms of sequence exchanges, a systematic 
"swapping" of motifs was carried out (Chapter 5). These experiments suggested that 
there are some enzyme-specific structural interactions between different subunits 
within each class of Mtases. 
In second half of this thesis a bacterial two-hybrid system based on the reversible 
assembly of an engineered form of M. SPRI was developed (Chapter 6). However the 
Mtase protein does not assemble into an active species until a DNA segment 
encoding a leucine zipper motif is fused to each of the two halves. Co-transformation 
of E. coli with the plasmids expressing the C-terminal and N-terminal domains 
respectively resulted in the abolition of colonies on double antibiotic plates, when an 
mcr strain was used as host. 
High performance liquid chromatography was used to estimate the extent of 
modification of plasmids indirectly. The extent of methylation at specific sequences 
within a plasmid molecule was readily detected by the corresponding differential 
susceptibility to digestion by specific restriction enzymes. Using this approach it 
proved possible to detect different levels of activity produced by wild type and 
mutant recombinant DNA Methyltransferases with sensitivity and in a semi 
quantitative manner. 
In order to analyse the biochemical properties of Mtase, I have developed an in vitro 
translation-modification assay. Binary studies with the mutants (from Chapter 3 and 
5) showed that there were no detectable sequence-specific recognition differences 
between these enzymes. Taken together, these results suggest that motif IX plays a 
role in general stabilisation of the enzyme core structure and has a less significant 
role in DNA recognition. 
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CHAPTER ONE 
INTRODUCTION 
1.1: DNA methylation 
In all cells, nitrogenous bases that are strung together with sugars and phosphate 
molecules as polymers of nucleic acids (Figure 1.1) form the genetic material, which 
provides the information specifying all of the proteins necessary for life. The goal of 
understanding how each individual gene directs the formation and properties of cells 
irrespective of their origin remains one of the major challenges of science. The 
information obtained from recombinant DNA technology has already formed the 
basis for a new industry: biotechnology, and for new advances in medical treatment, 
particularly gene therapy and in the field of chemical diagnostics. However, a 
comprehensive understanding of information flow in biological systems at the 
molecular level remains a challenge for molecular biologists. The availability of 
sequence specific restriction enzymes and Methyltransferases (Mtases) was one of 
the key elements that led to the rapid developments in molecular biology (Sambrook 
et al., 1989; Cheng, 1995). 
Proteins and RNA are the working molecules of a cell, which carry out the program 
of activities encoded by genes. Some proteins build the structure of the cell, while 
others process materials by catalysing chemical reactions. For example, the 
enzymatic processes that are responsible for authentic bacterial replication include 
polymerisation, a range of base modification and DNA hydrolysis: specific enzymes 
or more often multiprotein enzyme complexes carry out each type of reaction. 
Modification enzymes protect a bacterium's own DNA from endonuclease-mediated 
hydrolysis or cleavage, by modifying it at or near each potential cleavage site. 
Modification enzymes typically add a methyl group to one or two bases usually 
within the restriction site at a specific nucleotide sequence. The DNA of most 
organisms contains one or more minor bases. Minor modified bases are not 
introduced as DNA is synthesised, but are produced after replication by modification 
of specific nucleotides already present in duplex DNA (Adams, 1990). DNA Mtases 
catalyse the addition of a methyl group to one nucleotide in each strand of the 
recognition sequence. DNA Mtases are classified on the basis of their ability to 
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Figure 1.1: (a) Four major bases found in nucleic acids: Uracil is restricted to RNA while thymine is 
generally confined to DNA. (b) The regular hydrogen bonded base pairs found in DNA. (c) The 
polynucleotide arrangement of bases in a single strand of DNA showing the polar nature of the 
polymer with its sugar-phosphate backbone. dR represents 2'-deoxyribose. 
CHAPTER ONE 
modify bases in the DNA. Based on the chemical nature of modification of 
nucleotides, DNA Mtases fall into three classes (Wilson and Murray, 1991) each 
involving the transfer of a methyl group from S-adenosylmethionine (SAM) to one 
nucleotide in each strand of the recognition sequence. SAM invariably serves as the 
methyl group donor in the DNA Mtase reaction and is thus an essential cofactor for 
methylation. The commonest base 5-methylcytosine (C5-mC), was discovered by 
Hotchkiss in 1948 as a "fifth base" in DNA (Razin et al., 1984). N6-methyladenine 
(N6-mA) and N4-methylcytosine (N4-mC) are also found, but are low in abundance 
by comparison. Therefore a total of three different modifications are produced by the 
action of DNA Mtases. 
1. N6-methyl adenine (N6-mA) 
2. N4-methylcytosine (N4-mC) 
3.5-methylcytosine (C5-mC) 
HNI SCH3 Hý ýCH3 NN NH2 
NN 
CH , ' ri 
ý NN Oý 0 AN 
OL 
L 
0. 
L 
Two classes methylate exocyclic nitrogen and form either N6-methyladenine, or N4- 
methylcytosine. Exocyclic Mtases, which catalyse the conversion of adenine to N6- 
methyladenine (e. g. M. TaqI) and cytosine to N4-methylcytosine (e. g. M. PvuII), have 
only been isolated from prokaryotes to date (Kumar et al., 1994). The third class of 
C5 Mtases modifies a ring carbon and forms 5-methylcytosine (e. g. M. HhaI, 
M. HaeIII, M. MspI). The structural explanations have been published regarding the 
mode of DNA recognition by all three modifying activities e. g. M. TagI (Labahn et 
al., 1994; Goedecke et al., 2001), M. Pvu1I (Gong et al., 1997) and 5-methylcytosine 
M. HhaI (Cheng et al., 1993) M. HaeIII (Reinisch et al., 1995). The cloning and 
characterization of modification genes has progressed at a remarkable rate. More 
than 300 putative Mtases have been cloned and sequenced (Roberts and Macelis, 
1999) (see REBASE database at http: //rebase. neb. com/rebase/rebase. html for 
complete listing available electronically). C5 Mtases, that form the basis of this 
study, transfer a methyl group from SAM to the 5-position of cytosine within a range 
of short DNA recognition sites (e. g. GCGC for M. HhaI, GGCC for M. HaeIII and 
CCGG for M. MspI). 
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When a methyl group is present at a specific position the cognate restriction 
endonuclease (Enase) is prevented from cutting the DNA. Together with the 
restriction Enase the methylating enzyme forms a Restriction-Modification (R-M) 
system that protects the host DNA while it destroys foreign DNA. Mostly in R-M 
systems the two activities are separate, however in some systems the two activities 
are combined in a single multisubunit enzyme (Wilson & Murray, 1991). 
1.2: Restriction And Modification (R-M) 
The phenomenon of restriction and modification (R-M) of bacterial viruses was first 
described fifty years ago (Luria and Human, 1952 and Bertani and Weigle in 1953) 
also reviewed by Heitman, (1993). Bertani and Weigle (1953) observed that stocks 
of ?, phage prepared from E. coli strain C grew poorly when propagated on a different 
strain, K-12. Rare phage that escaped this effect grew with equal efficiency on either 
host. They coined the term "restriction" to describe this observation. Specific 
enzymes that catalyse the hydrolysis of specific DNA sequences form the basis of 
this underlying phenomenon of restriction (Arber, 1979). These enzymes are referred 
to as restriction Enases. Most restriction enzymes cleave unmethylated DNA and are 
blocked by modified DNA. In 1964 Gold and Hurwitz proposed that a DNA Mtase 
was responsible for the phenomenon of modification in E. coll. Mtase recognises and 
methylate the same DNA sequence to protect the host chromosome from Enase 
action. Resistance to restriction occurs when the Mtase modifies each phage borne 
recognition site prior to Enase action. Kuehnlein in 1969 isolated the enzyme from E. 
coil that was responsible for methylation of DNA and the enzyme was finally 
purified in 1972 (Kuehnlein and Arber, 1972). The molecular explanation has now 
become apparent: all restriction-modification systems include two opposing 
sequence specific enzymatic activities: (for a review, see Wilson and Murray, 1991, 
Bickle and Kruger, 1993) an Enase and a DNA Mtase. Enases and Mtases from the 
same system recognise the same sequences and are referred to as cognate enzymes. 
1.2.1: NOMENCLATURE AND PROPERTIES OF R-M SYSTEM 
Several kinds of RM enzymes have been discovered (Wilson and Murray, 1991). 
They appear to perform equivalent jobs but in opposing ways. More than two dozen 
bacterial and archaeal genomes have been completely sequenced within last 5 years 
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which has revealed a remarkable fact: >80% of the genomes appear to have at least 
one R-M system and most of these genomes appear to contain multiple R-M systems 
(Kong et al. 2000). The genes for restriction and modification enzymes appear to be 
closely linked. Escherichia cola K-12 contain at least four restriction systems to 
monitor the "origin" of invading DNA and determine its fate (Bickle and Kruger, 
1993). 
Bacterial restriction and modification (R-M) systems are traditionally divided into 
three classes, designated as type I, II and III on the basis of enzyme subunit 
composition, co-factor requirements, recognition sequence symmetry, cleavage 
position and reaction products (Wilson and Murray, 1991). 
1.2.1.1: Type I 
Type I restriction modification enzymes are the most complex and least diverse types 
known. Members of this group have similar enzymatic subunits, but different 
specificity subunits. The main enzyme comprises the products of the hsdS, hsdM, and 
hsdR genes (hsd for host specificity for DNA). The three polypeptide chains termed 
Restriction (R), Modification (M), & Specificity (S) and the resulting pentameric 
(R2M2S) multifunctional enzyme complexes catalyse both Enase and Mtase 
reactions. These complexes cleave at random sites distant from the site of recognition 
and cleavage, hydrolyse ATP, and are inactive after a single round of DNA scission. 
The recognition sequences are asymmetric and bipartite; they comprise two sub- 
sequences, three and four bp in length, separated by six to eight non-specific bp. The 
S subunit determines specificity for both restriction and modification. These types of 
restriction enzymes have been found in E. coli, Citrobacter and Salmonella and have 
been grouped into three families. 
1) IA (e. g. EcoKI) 2) IB (e. g. EcoAI) 3) IC (e. g. EcoR124I) 
1.2.1.2: Type II 
Type II R-M enzymes are the simplest and appear to be more common than the type 
III and I. Type II restriction and modification enzymes possess separate target 
recognition domains (TRD). The specificities of cognate enzymes are the same. Type 
II R-M enzymes possess varied specificities. Type II Enases and Mtases act 
independently and have simple requirements. The Enases require Mg+2 and the 
Mtases require SAM. Cleavage by type II Enases occurs symmetrically within the 
4 
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recognition sequence. A Type II recognition sequence is essentially a symmetric 
sequence consisting of up to eight base pairs (bp). 
1.2.1.3: Type Its 
Some Type II enzymes have been further sub classified as Type Its because of their 
asymmetric recognition sequence: these enzymes usually cleave at some distance 
from the recognition sequence e. g. Fokl. The Type Its R-M enzymes also have 
separate Enases and Mtases: their target sites, however, are asymmetric, non- 
palindromic sequences. The endonucleolytic scission catalyzed by type Its Enases 
occurs at enzyme specific locations within 20 bp outside of the target sequence (only 
one active site is involved). Methylation of the two complementary, but non-identical 
target sequences require usually two different Mtases: one for each strand of the 
target. 
1.2.1.4: Type III 
The enzymes typical of this class are multi-subunit structures with the capacity to 
mediate both modification and restriction. SAM serves as the methyl group donor 
and is also required for cleavage by the complex. Adenine (specifically at N) is the 
only base that is known to be methylated by these enzymes. 
Roberts, (personal communication) has proposed a new nomenclature for 
RM enzymes with some modifications to overcome several problems and limitations 
with the present system of nomenclature that cannot easily be fixed. In his proposal 
the original subdivisions of Type I, II and III were maintained with subdivisions 
within each major category to reflect either biochemical or sequence characteristics 
as outlined in table 1.1. 
1.2.1.5: Genetics of R-M systems 
The modification (M) and specificity (S) genes in type I enzymes are transcribed as a 
single operon and the restriction (R) gene is transcribed separately but in the same 
direction. However, in type II systems the R and M genes are linked. Sometimes the 
R gene precedes M; at other times the M gene precedes R and in several systems the 
genes have opposite orientations: some transcription units diverge while others 
converge. Type III R and M gene are transcribed as a single operon in the same 
5 
CHAPTER ONE 
RM Definition Example 
Nomenclature 
Type I IA Contain R, M and S sub units, require ATP for their action MpuUI 
and cleave at random positions away from the recognition 
sequence. 
II S Recognise asymmetric sequences and cleave away from the Hphl 
recognition sequence. 
II T Resemble Type IIs, but are composed of heterodimeric BsrBI 
subunits. 
II B Cleave on both sides of the recognition sequence BcgI 
Type II II E Interact with two copies of their recognition sequence, one EcoRII 
being the actual target of cleavage, the other being the 
allosteric effector. 
II F Interact with and cleave two copies of their recognition Sf11 
sequence but otherwise have the appearance of being 
normal. 
II G Stimulated by SAM and have both R and M domains within Eco571 
a single polypeptide but otherwise resemble Type 11. 
II D Recognise methylated DNA and cleave specifically. DpnI 
II M Cleave methylated DNA but without the clean recognition McrBC 
specificity of IID. 
II H These are halfway between Type I and 11 in their genetic Ahdl 
makeup, but look like Type II if only the enzymatic activity 
is considered 
II X This is for oddballs that may ultimately need a separate 
category 
Type III Contain two subunits for restriction and modification, EcoPI 
require ATP for cleavage, cleave at a specific distance away 
from their recognition sequence and are easily recognised 
because of their apparent similarity at the sequence level. 
Table 1.1: The three types of RM system (I, II, and III) with definition of each 
subdivision illustrated with an example for each. Roberts proposed nomenclature 
(personal communication). 
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orientation (Wilson, 1991). The general properties and the gene organisation of R-M 
systems are summarised in table 1.2. 
1.2.1.6: Solitary Methylation by commonly used strains of E. coli 
A biological function of post-replicative DNA methylation is observed in common 
strains of E. coll. Most laboratory strains of E. cola contain three site specific DNA 
Mtases. Cells contain enzymes that methylate DNA, e. g. Dam, Dcm and EcoKI 
Mtases. 
The Dam Mtase (encoded by the dam gene) transfers a methyl group from SAM to 
the N6 position of the adenine residue in the sequence "GATC". Several restriction 
sites contain this sequence (or part of it followed by nucleotides to complete 
"GATC") and therefore are unable to restrict Dam modified DNA. There are about 
16 restriction sites that are blocked by Dam methylation and common examples are 
XbaI, NruI and Bcll. When it is necessary to cleave plasmid DNA containing these 
sequences which are blocked by Dam methylation, the DNA must be prepared from 
strains of E. coli that are dam (New England Biolabs Catalogue, 2000, Sambrook et 
al., 1989). 
The Dcm Mtase (encoded by the dem gene) methylates the internal cytosine residues 
in the sequence CCAGG and CCTGG at the C5 position (-I site per 512 bp) in DNA 
of random sequence (New England Biolabs Catalogue, 2000, Sambrook et al., 1989). 
There are about 20 restriction sites which are blocked by Dcm methylation, and 
therefore it is essential to prepare the plasmid DNA in a dem strain of E. coil. The 
common examples of restriction sites that can be blocked in this way are Stul and 
AIwNI. 
M. EcoKI (the EcoKI Mtase) modifies adenine residues in the sequences 
AAC(N6)GTGC and GCAC(N6)GTT. EcoKI sites are much less common than Dam 
or Dcm sites in a random DNA sequence. However, it has also been pointed out that 
DNA isolated from E. coil is not always methylated to the same extent. Few 
examples exists that these sites are not blocked by Dam or Dem Mtase (New 
England Biolabs Catalogue, 2000). 
The other reason to consider these Mtases is that the modification state of the 
plasmid DNA can affect the frequency of transformation in special situations. For 
example, when Dam-modified plasmid DNA is introduced into dam- E. cola, it has 
been shown that replication initiation is suppressed when plasmid DNA is 
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hemimethylated at Dam sites (Russell and Zinder, 1987). Dam-modified plasmids 
therefore replicate once in dam cells, and are unable to replicate again. The 
phenomenon of poor transformation of other bacterial strains may be due to the 
presence of a modification-dependent restriction system. See below for a detailed 
discussion on this topic. 
1.2.1.7: Solitary Restriction of methylated DNA by commonly used E. coli 
In addition to the capacity to protect DNA against cleavage by restriction Enases, E. 
coli has several mechanisms for identifying foreign DNA and destroying it. 
Methylation can also provide a signal for the restriction of foreign DNA. In this case, 
foreign DNA is acted on because it does contain methylated bases in a particular 
sequence, rather than because it does not. These systems only restrict modified DNA 
substrates. DNA is protected by the absence of particular modified sequences 
(Raleigh, 1992). At least four mechanistically distinct classes of modification- 
dependent restriction system are known. The first and best known of these is DpnI 
from Streptococcus pneumoniae (previously called Diplococcus pneumoniae) (Lacks 
and Greenberg, 1977). The Dpnl Enase is encoded by one gene, and will cleave 
DNA with the appropriate modified base, N6-methyladenine, in its recognition 
sequence. Three mechanistically distinct sequence-specific, modification-dependent 
systems McrA, McrBC and Mrr have been identified in E. coli K12 (reviewed by 
Raleigh, 1992; Bickle and Kruger, 1993). Several prokaryotic restriction Enases have 
been identified (reviewed by Noyer-Weidner and Trautner, 1993) which cleave DNA 
invading a cell provided it is methylated at specific DNA sequences. It is evident that 
cells encoding this type of restriction activity must not methylate such sequences, 
and to this end such Enases are solitary enzymes. Such systems also have practical 
significance since cells harbouring such restriction activities display restriction in 
vivo when DNA (e. g. plasmid DNA) transforms the cell. 
The observation that Mtase encoding genes could not be cloned in some E. coli 
strains led to the discovery of two E. coli K12 restriction systems directed against 
methylated DNA: Mcr (Modified Cytosine Restriction) and Mrr (Modified adenine 
Recognition and Restriction) (Raleigh and Wilson 1986; Heitman and Model 1987; 
Raleigh 1987; Waite-Rees et al. 1991; Raleigh 1992). 
The Mrr system was discovered due to an observed activity that cut DNA that had 
been methylated by the HhaII or PslI Mtase, both of which methylate adenosyl 
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residues to form N6-mA in specific sequences (Heitman and Model, 1987). Later it 
was found that some sequences containing 5mC are also restricted and this has been 
referred to as McrF restriction (Kelleher and Raleigh, 1991; Waite-Rees et al., 1991). 
Mfr is the only system known to specifically hydrolyse DNA containing either 
methyladenine or 5-methylcytosine in particular sequences (de Bruijn et al., 1998). 
The Mcr phenotype was the first restriction system reported (Luria and Human, 
1952) and RgIA and RgIB were the original name given to this phenomenon (Raleigh 
et al., 1989). In the 1980s, the Rgl systems were rediscovered in the course of 
cloning experiments (Raleigh and Wilson, 1986; Noyer-Weidner et al., 1986). It was 
subsequently shown that the two Mcr phenotypes, McrA and McrBC were identical 
to RgIA and Rg1B respectively (Raleigh et al., 1991). McrA is specified by a single 
gene and restricts DNA with modified cytosine (hydroxymethylcytosine or 
methylcytosine) followed by guanine in vivo. 
McrBC is the most extensively characterised of the modification dependent systems 
in E. coli, (reviewed by Raleigh, 1992). Like McrA, it acts on DNA containing 
modified cytosine (5-hydroxymethylcytosine or N4-methylcytosine). This system 
acts as a multi-subunit nucleotide-dependent Enase. Unlike other nucleotide- 
dependent nucleases, it displays an absolute requirement for GTP rather than ATP. 
Restriction activity requires the products of two genes mcrB and mcrC that express 
three proteins for activity both in vivo and in vitro. 
The mcrB gene produces two gene products. The complete mcrB open reading frame 
produces a 51-kDa protein (McrBL) and a 33-kDa protein (McrBs). The smaller 
McrB polypeptide is produced from an in-frame, internal translation start site in the 
mcrB gene. The McrBs sequence is identical to that of MCrBL except that it lacks 161 
amino acids present at the N-terminus of the latter protein. It has been suggested that 
McrBL is the DNA binding restriction subunit. The function of McrBs was unknown 
and challenging since it is produced in frame with McrBL. There was speculation that 
it played a role in the modulation of McrBC restriction. The first experiments 
published suggested that McrBs was necessary for stabilization of the McrBC 
restriction complex in vivo (Beary et al., 1997). It has also been suggested that the 
role of McrBs is to modulate McrBC activity by binding to McrC (Panne et al., 
1998). 
The mcrC gene product, a single protein (39 kDa), is thought to be a specificity 
subunit and contains a leucine heptad repeat (leucine zipper) and a cationic region 
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that could play a role in protein-protein interaction and affords less specificity to the 
mcrB gene products (Ross, et al., 1987, Raleigh, 1992, Beary, et al., 1997). 
1.3: DNA Methyltransferases (Mtases) 
DNA Mtases are found in a wide variety of Prokaryotes and Eukaryotes. The 
widespread presence of methylated bases in DNA of different organisms, the 
sequence specificity of various Mtases and the even distribution of the methylated 
bases along the chromosomes strongly suggest that modified bases in DNA are 
biologically significant. Several kinds of R-M systems have been discovered. They 
appear to perform equivalent biological functions but in different ways (Wilson, 
1991). Although in general the biological significance of methylated bases in DNA is 
still unresolved, a number of recent experiments strongly suggest that DNA 
methylation is involved in major biological processes some of which are described 
below. 
1.3.1: DNA METHYLATION IN PROKARYOTES 
In prokaryotes, Mtases have most often been identified as elements of restriction 
modification systems in which they act to protect DNA from cleavage by the 
corresponding Enases. DNA methylation is the modification product, which is found 
in almost all bacteria, and seems to protect cells from foreign DNA molecules, 
particularly viruses. Hence, the main function of methylation in prokaryotes is to 
give protection to cells from viral infection; it primarily serves as an "immune 
response" to phage infection. Enases digest foreign DNA that enters the cell, thereby 
protecting the cell from genetic subversion. 
The biological role of R-M systems was recently a subject of considerable debate. 
Whilst it has been suggested that they provide a bacterium with a primitive immune 
system to combat phage infection, more recently it has been reported that R-M genes 
may be selfish (Naito et al., 1995; Naito et al., 1998). 
As discussed above, many R-M systems have been demonstrated to restrict phage 
growth. However, for most R-M systems this property has not been tested due to the 
difficulties of working with unusual bacteria, which may or may not have 
characterised phage. It is certainly true that a large number of R-M systems do not 
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restrict phage growth when expressed in E. coli, even though in several cases the 
enzymes are sufficiently well expressed (Heitman, 1993). 
Where as the Enase activity of a R-M system cannot usually exist in a cell in the 
absence of its cognate Mtase activity, since this would lead to suicidal degradation of 
the cell's DNA, the reciprocal situation, the solitary existence of a Mtase, is often 
encountered. Moreover, although the genes for restriction and modification systems 
appear to be closely linked (Wilson, 1991) sequence comparisons of a large 
collection of different cloned R-M systems reveal limited sequence homologies 
(Wilson and Murray, 1991; Wilson, 1991; Heitman, 1993). With the exception of 
type I R-M systems (see below), which share considerable homology within, but not 
between families, there has been little homology identified between Enases of 
different sources. In contrast, Mtases share a limited degree of homology that is 
related to enzymatic constraints rather than being a reflection of common origin 
(Wilson and Murray, 1991). Even in cases of isoschizomeric R-M systems, which 
recognise and cleave identical DNA sequences, the vast majority shares no 
homology between Enases. 
Considering this information, the emerging view is that sequence-specific Enases and 
DNA Mtases arose independently in evolution to serve functions other than R-M or 
at least other than the `cellular defence' hypothesis (Heitman, 1993). This model, 
which envisages the pairing of independent enzymes and the subsequent tailoring of 
Enase and Mtase specificities, is perhaps even more plausible in the light of work by 
Naito et al. (1995). Here plasmids carrying gene pairs encoding type II R-M systems 
(see below) were shown to have increased stability in E. coll. The descendants of 
cells that had lost these genes appeared unable to modify a sufficient number of 
recognition sites in their chromosomes to protect them from lethal attack by the 
remaining Enase molecules. The authors suggest that the enforced retention and 
functional integrity of such systems on plasmids, is as a result of the R-M systems 
behaving as a `selfish' unit, which enforces its retention in hosts whose 
chromosome(s) bear the specific sites it recognises. 
As an explanation for the widespread occurrence, diversity and specificity of R-M 
systems, such a `selfish gene' or `selfish symbiont' hypothesis would seem as 
plausible as the `cellular defence' hypothesis. Both hypotheses are consistent with 
the findings outlined above, that R-M genes are tightly linked and widely distributed. 
However, the diversity and high degree of specialisation in sequence recognition, in 
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particular the existence of `rare cutters' (e. g. Enases which have long recognition 
sequences, which are unlikely to be present in many bacterial viruses) is more 
consistent with a selfish gene hypothesis than one of cellular defence. This idea has 
been tested in type I R-M genes encoding EcoKI and has been shown that type I 
genes are not `selfish' (O'Neil et al., 1997). Clearly more experiments are required to 
resolve these issues. 
1.3.2: DNA METHYLATION IN EUKARYOTES 
DNA methylation in eukaryotes appears to have a different and more diverse role 
than in prokaryotes, and is implicated in the control of several cellular processes. 
However this study is concerned exclusively with the properties of two prokaryotic 
Mtases and therefore the functions of methylation in eukaryotes is briefly reviewed. 
Several excellent reviews are available on this subject (Mostoslavsky and Bergman, 
1997; Colot and Rossingol, 1999; Hsieh, 2000; Robertson and Wolffe, 2000: 
Robertson and Jones, 2000). 
Most eukaryotic DNA Mtases are -1600 amino acids long, single subunit enzymes 
that preferentially methylate hemimethylated DNA (Bestor et al., 1988). The N- 
terminal two third of the protein is considered the regulatory domain and the C- 
terminus is the catalytic domain. They have much smaller target recognition 
sequences than the bacterial enzymes (Adam, 1990). In vertebrates methylation of 
cytosines takes place when the cytosine residue is followed by a guanosine (CpG). In 
plants, methylcytosine occurs both in symmetrical and sequences, CpG and CpNpG, 
and in non-symmetrical sequences, for example, CpApTp and CpTpT. The relative 
importance of symmetric and asymmetric methylation in regulating gene expression 
is unknown but as methylation at symmetric sequences can be transmitted through 
cycles of DNA replication, it seems likely that methylation of these sequences will 
play an integral role in regulating gene expression (reviewed by Finnegan et al., 
2000). The CpG Mtases found in higher eukaryote is not known to be involved in 
restriction and modification. The patterns of CpG methylation are heritable, tissue 
specific, correlate with gene expression and also play role in differentiation. Studies 
have shown that cytosine methylation regulates the activity of a gene. Methylation of 
cytosine residues in higher eukaryotes appears to be involved in the control of gene 
expression and has been implicated in gene regulatory processes such as 
transcription, tissue specific expression, and genomic imprinting (Adams, 1995). 
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In eukaryotes, methylcytosine is made enzymatically after DNA is replicated, and 
about 5 percent of the cytosines in mammalian DNA are converted to 5- 
methylcytosine. Eukaryotic DNA Mtases were believed to have possible alternative 
functions such as regulation of gene expression (Wilson, 1991, Wilson and Murray, 
1991). It has now become clear that DNA methylation is involved in a diverse range 
of cellular processes and there is a wider acceptance that DNA methylation plays a 
variety of roles in different cancer types and probably at different stages of 
oncogenesis (Laird and Jaenisch, 1996). Methylation of DNA is important in many 
organisms and is essential in mammals. In eukaryotes, methylation is the only known 
covalent modification of DNA. At least in mammals it is absolutely essential (Li et 
al., 1992). There have been many suggestions as to how DNA methylation 
contributes to the differential expression of genes (Gilbert, 1994). The methylation of 
promoter sequences contributes to the temporal and spatial regulation of these genes 
encoding tissue-specific proteins. This has been intensively studied in vertebrates. 
DNA methylation is also thought to be responsible for the continued repression of 
the genes on one of the two X chromosome in each female mammalian cell. In many 
cases the methyl group tags a gene, thereby silencing its expression and an 
unnecessary protein product is not prod-aced in a particular cell (Razin, 1998). Work 
on animals, plants and fungi leaves little doubt that gene silencing is a major 
biological consequence of DNA methylation (Colot and Rossingol, 1999). 
Experiments indicate that gene silencing by methylation involves the generation of a 
chromatin structure (Razin, 1998). Normally, a methyl-binding protein binds to 
methylated CpG units and brings together histone deacetylases and the co-repressor 
protein mSin3A. This complex contributes to the formation of repressive chromatin 
states and the deacetylation of histones. As a result, transcription machinery cannot 
bind to DNA, and the protein cannot be translated (Wolffe, 1998). 
In prokaryotes, the methyltransferases are simpler and lack regulatory N-terminal 
domain compared to mammalian Mtase Dnmtl. The C-terminal domain of Dnmtl is 
clearly related to the prokaryotic C5-Mtases, since it harbours a set of ten motifs that 
are involved in the catalytic reaction and whose sequence is shared with over 100 
prokaryotic Mtases (Margot et al., 2000). Recently a proven connection has been 
made between DNA methylation and development in eukaryotic cells: the first 
human diseases caused by defects in the DNA methylation machinery have been 
reported such as "Rett Syndrome" (Amir et al., 1999) and "ICF Syndrome (Xu et al., 
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1999; Hansen et al., 1999) (reviewed by Robertson and Wolffe 2000). These studies 
linked the observed methylation defect in ICF syndrome to mutations in the 
DNMT3B gene. Although no "hot spot" has been identified and many of the 
mutations are heterozygous, all seem to affect the carboxy-terminal catalytic domain 
of DNMT3B. 
1.3.3: MONO AND MULTISPECIFIC DNA Mtases 
Most Mtases recognise a single DNA sequence (Wilson and Murray, 1991), 
however, multispecific C5 DNA Mtases are known that methylate several unrelated 
sequences (Tran-Betcke et al., 1986). The major difference between the mono- and 
multispecific Mtases occurs in the variable region between motifs VIII and IX. The 
region is 80-120 amino acids in the monospecific Mtases and 175-268 amino acids in 
the multispecific Mtases (Wilson and Murray, 1991; Trautner et al., 1996). 
Multispecific Mtases possess a sequentially arranged, interchangeable region that can 
recognise up to 5 target DNA sequences (Behrens et al., 1987; Wilke et al., 1988; 
Lange et al., 1991; Walter et al., 1992; Schumann et al., 1996; Trautner et al., 1996; 
Lange et al., 1996). See section 1.3.5 for the detailed discussion regarding the 
variable region. 
1.3.4: THE CONSERVED MOTIFS OF C5-DNA Mtase 
Comparative analysis has shown that these proteins share an ordered set of ten 
sequence motifs, which alternate with non-conserved regions. All ten motifs can be 
identified in the majority of the known sequences, including the C-terminal 500 
amino acids of the eukaryotic CpG Mtases (Bestor et al., 1988; Lauster et al., 1989). 
In the original analysis of thirteen C5 Mtases (Posfai et al., 1989), five motifs were 
considered highly conserved (I, IV, VI, VIII, and X), and the remaining five, 
moderately conserved. However, when 44 Mtases were compared, it was shown that 
motif IX is also highly conserved and resulted in the inclusion of motif IX with in the 
highly conserved set (Kumar et al., 1994) (Figures 1.2 and Figure 1.3). The motifs 
may be of use in identifying putative Mtases among protein sequences of unknown 
function (Posfai et al., 1989). A few sequences have been detected in which 
unambiguous assignments for some of the motifs are not possible. These motifs (II, 
III, IX, X) are either more tolerant to sequence variation or are nonessential for 
function in some of the proteins (Kumar et al., 1994). The largest non-conserved or 
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Figure 1.2 Diagrammatic representation showing the alignment of motifs of 44 C5-Mtases. 
The six highly conserved motifs are coloured (red-motif I, yellow-motif IV, green-motif VI, cyan- 
motif VIII, magenta-motif IX, dark blue-motif X). Where boxes are missing, the motifs could not be 
equivocally assigned. Gaps are placed arbitrarily to allow alignment of motifs (Kumar et al., 1994). 
Motif I (F X(-, XC) Motif IV (P('Q) 
M. HgaI-1 GLSLFS SAG IFEYF DFLIASPP CQGMSVAGK 
M. HgaI-2 AMSLFSSAGIGELD KFLLATPP CQGLSSVGR 
M. SPRI VMSLFSGIGAFEAA DLLVGGSP CQSFSVAGH 
Dcm FIDLFAGIGGIRRG DVLLAGFP CQPFS LAG V 
M. EcORII FIDLFAGIGGIRXG DVLLAGFP CQPFS LAG V 
M. HaeIII LISLFSGAGGLDLG DGIIGGPP CQSWSEGGS 
M. MspI FIDLFSGIGGIRQS DILCAGFP CQPFSHIGK 
M. HpaII FIDLFAGIGGFRIA DILCAGFP CQAFSIAGK 
M. Hhal FIDLFAGIGGFRLA DILCAGFP CQAFSISG !C 
M. AquI LISLFSGAG GMD IG DLVIGGPP CQSFSLAGK 
M. SssI VFEAFAGIGAQRKA DLLTYSFP CQDLSQQGI 
Mouse TLDVFSGCGGLSEG EMLCGGPP CQGFSGMNR 
'Y27M. SpOI VLELYSGIGGMHYA CKLWTMSP SCQPFTRIGN 
14 27 73 
89 
Motif VI (F V) Motif VIII (QXRXR) 
M. HgaI-1 PAYILIE II VPFL 
M. Hgal-2 LDFILIENVPFL 
M. SPRI PRFFVFE IT VKGL 
Dcm PAMFVLE 11 VKGL 
M. EcORII PAIFVLE 11 VRNL 
M. HaeIII PIFFLAE I] VKGM 
M. MspI TPVLFLENVPGL 
M. Hpal IPKAFFLENVKGL 
M. HhaI PKVVFME IT VKNF 
M. AquI PKCFVME 11 VEGM 
M. Sssl PKYLLME 11 VGAL 
Mouse PRFFLLE II VRNF 
'PM. SpoI PEYILIE 11 VQGF 
113 124 
LDAADYGTPQRRKRAIIR 
LNAEDYGICQ8RPRAIIA 
LNSKFFNVPQNRERLYII 
IID GEH FLPQHRERIVLV 
VIDGAHFLPQHRERIVLV 
LNANDYGVAQDRERVFYI 
LDASHFGIPQERERFYLV 
VNAENFGVPQNRERIYIV 
LNALDYGIPQERERIYMI 
LNAADFGVPQFRERVFIV 
LNAADFGSSQARRRVEMI 
LQAGQYGVAQTRRRAIIL 
LSPNQFNIPN8R8RWYGL 
152 169 
Motif IX (RXXXXXEXXR) 
M. HgaI-1 RVLSVLELMPLTGLP 
M. HgaI-2 RVLSLLETFIVSSID 
M. SPRI F. RLTPLECFiLQAFD 
Dcm RRLYPRECAFLMGFE 
M. Ec0RII PRLYPRECAPLMGFE 
M. HaeI II RRLTVRECAPVQGFP 
M. MapI RLLTTNECKAIMGFP 
M. HpaII RKMTPREWAFLQGFP 
M. HhaI RKLHPRECA F' VHGYP 
M. AgUI PMLTVRELACLQTFP 
M. Ss$I RRMNSDETFLYIGFD 
Mouse RVVSVRECAiSQGFP 
Y'M. SpOI RY FTARE VAF LN GF P 
272 286 
Motif X (G N) 
RQIIGECIPP 
RTIIGEAIPP 
YKQAGNSITV 
YRQFGNSVVV 
YRQFGNSVVV 
YKMIGNAVPV 
YRQMGNSVVV 
YKQFGNSVAV 
YKQFGNSVVI 
FGQVGNAVPP 
IFVCGN8I8V 
HRQVGNAVPP 
YRLLGNSINV 
299 308 
Figure 1.3: Diagram showing a comparison of the 6 most highly conserved motifs among 13 type U C5 
Mtases. Among these enzymes, the seven bacterial C5 Mtases (Dcm, M. EcoRll, M. Haelll, M. Mspl, 
M. Hpall, M. Hhal and M. AquI) conform well to the consensus. M. Hgal-I and M. HgaI-2 are shown as 
examples of bacterial C5 hemi-methyltransferases. The M. Sss1 is from the mycoplasm, Spiroplasma, the 
mouse sequence represents a eukaryotic Mtase and M. SPRI is a multispecific phage C5 Mtase. The amino 
acid numbering shown is from the M. Hhal sequence and thick coloured line represents (red-motif I, yellow- 
motif IV, green-motif VI, cyan-motif VIII, magenta-motif IX, dark blue-motif X). Residues, which with one 
or two exceptions, are invariably conserved are shown in red. Data taken from Wilson (1992) and Cheng et 
al. (1993). Sequence alignment of prokaryotic and eukaryotic Mtases are given separately in Appendices. 
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'variable' region lies between motifs VIII and IX and often varies greatly in size. Part 
of the variable region, which is responsible for target DNA recognition, is called the 
Target Recognition Domain (TRD) (Figure 1.4) that has been well defined in 
multispecific Mtases (Lange et al., 1991; Walter et al., 1992; Trautner et al., 1996; 
Lange et al., 1996). The sequential order of the motifs appears to be important, since 
no deviation is seen in the 45 sequences examined (Kumar et al., 1994) (Figures 1.2). 
However, when M. BssHII was compared with other C5-Mtases, it was found that 
motifs IX and X precede motif I in the amino acid sequence. Thus, the M. BssHII 
contains a circular permutation of the C5-Mtase motifs (Xu et al., 1997) and the 
TRD is located at a non-canonical position at its N-terminus (Sethmann et al. 1999). 
1.3.5: THE VARIABLE REGION AND TARGET RECOGNITION DOMAINS 
(TRD) 
It is now well established that the variable region of Mtases is responsible for the 
selection of DNA sequences to be methylated (Balganesh et al., 1987; Wilke et al., 
1988; Trautner et al., 1988; Klima3auskas et al., 1991; Mi and Roberts, 1992). Many 
authors have reported that short segments of variable regions, could be implicated in 
specific DNA interactions (Trautner et al., 1980; Buhk et al., 1984; Balganesh et al., 
1987; Wilke et al., 1988). It has also been recognised that in monospecific Mtases it 
is a smaller part of the variable region that is responsible for the DNA sequence 
recognition (Figure 1.4). Structural analysis of M. HhaI (Cheng et al., 1993) have 
described that a stretch of 22 amino acids in (amino acid numbers 231-253) 
constitute TRD of this enzyme. The variable region, previously identified as being 
the essential component of target recognition by multispecific C5-Mtases, was shown 
to possesses three sequence elements: (i) a region of 71 amino acids at the N- 
terminus of the variable region, which is very similar among the multispecific 
Mtases; (ii) the mostly dissimilar TRDs; and (iii) minor `linker' sequences (Trautner 
et al., 1996). 
It has been revealed that towards the C-terminus of the variable region of multi 
specific Mtases, there are ensembles of individual target recognition domains 
(TRDs), which are for example, composed of 39 (TRD EcoRII), 38 (TRD Mspl) and 
40 (TRD Hae1II) amino acids in M. SPRI (Trautner et al., 1996) (Figures 1.4). 
It has been found that a point mutation in the variable region is capable of abolishing 
single target specificity in a multispecific Mtase, while leaving the others intact. By 
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Figure 1.4: General architecture of mono- and multi-specific methyltransferases. The arrangement 
of motifs and conservation of amino acid sequence among C5 Mtases are illustrated. Six highly 
conserved motifs with their consensus sequence are shown. The motifs are coloured as (red-motif 1, 
yellow-motif IV, green-motif VI, cyan-motif VIII, magenta-motif IX, dark blue-motif X). Target 
recognition sequences for Mtases SPRI and Hhal have been shown with the cytosine to be methylated 
underlined. Data taken from Adams, 1995. 
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mapping these mutations as well as determining the specificity of chimaeric 
multispecific Mtases, Trautner's group was able to define and eventually swap TRDs 
within the variable region (Balganesh et al., 1987; Wilke et al., 1988; Trautner et al., 
1988; Walter et al., 1992; Trautner et al., 1996). 
TRDs of different multispecific enzymes with equivalent specificities have the same 
size and differ from each other by a few amino acids. TRDs do not overlap but may 
be separated by a third element, which takes the form of short "linker" sequences 
often found between the TRDs (Trautner et al., 1996). Walter et al., (1992) have 
shown that the activity of individual TRDs does not depends on a functionally active 
state of the neighbouring ones. In spite of their flexibility, multi-specific Mtases 
could not be endowed with novel specificities by integration of putative TRDs of 
mono-specific Mtases, pointing to a fundamental difference between multi- and 
mono-specific Mtases in the way their core and TRD sequence interact (Walter et al., 
1992). Sequence alignment of the TRD regions of Mtase from different sources, has 
revealed that regions of homology in the TL dipeptide exist within this region, 
suggesting that target recognition in some cases is performed by virtually identical 
sequences. An assessment of conservation level of this TL dipeptide in the variable 
region of C5-Mtases has recently been described as 85-90% out of 79 bacterial 
sequences analysed (Vilkaitis et al., 2000). 
1.3.6: THE DOMAINS OF C5 Mtase AND MONOMER STRUCTURE OF 
M. HhaI 
M. HhaI is one of the smallest C5-Mtases containing 327 amino acids (molecular 
mass 37 kDa) that recognises the 5'-GCGC-3' sequence in double-stranded DNA and 
methylates the first cytosine of the recognition sequence. The crystal structure of 
M. HhaI has dimensions of 40 x 50 x 60 A which is folded into two parts, a large 
domain and a small domain which are connected by a hinge region (Cheng et al., 
1993; Kumar et al., 1994) (Figure 1.5). 
The large domain contains a core beta sheet with six strands (five shown in ribbons, 
Figure 1.6). Four of the strands are parallel to one another, and the remaining two 
strands form a hairpin beta sheet turn at one end of the four parallel strands. The core 
beta sheet complex is sandwiched between two alpha helices and two alpha helices 
plus one beta strand. There is also an alpha helix that lies in front of the beta sheet 
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Figure 1.5: Schematic drawing of secondary structural elements of M. HhaI in relation to the ten 
conserved motifs. The large (amino acids 1-93 and amino acids 304-327) and small (amino acids 194- 
275) domains are marked. Rectangles indicate a-helices (lettered) and arrows indicate ß-strands 
(numbered). Conserved or functionally important amino acids are circled. Cofactor S-adenosyl-L- 
methionine (SAM) binding site with its interactions with the protein is also shown. The thick dashed 
lines indicate hydrophobic interactions, and the thin dashed Imes indicate electrostatic interactions or 
hydrogen bonds. The colours of various motifs are shown as (red-motif I, yellow-motif IV, green-motif 
VI, cyan-motif VIII, magenta-motif IX, dark blue-motif X). (Figure adapted from Cheng et al., 1993) 
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core. The large domain contains all or parts of ten of the conserved motifs found in 
C5 Mtases (Cheng et al. 1993) (Figure 1.6). 
The small domain contains seven beta strands. Five beta strands are configured in an 
anti-parallel formation and are arranged in a circular formation that resembles a 
pinwheel. There are two strands above and below the anti-parallel group, orientated 
in opposite directions (Cheng et al. 1993) (Figure 1.6). 
The hinge region is composed of an alpha-beta-alpha structure that connects the large 
and small domains. The hinge region is comprised of parts of conserved motifs IX 
and X. The first half of motif IX is in the small domain, and provides much of the 
structural backbone for the small domain. The second half of motif X is located in 
the large domain (Cheng et al. 1993). 
The amino acid sequences between motifs VIII and IX "the variable region" have the 
greatest heterogeneity in size, sequence, and composition among family members 
(Cheng et al. 1993). The variable region spans the entire length of the HhaI molecule 
and folds to form the majority of the small domain. There is a pronounced cleft 
between the large domain and small domain. This cleft is capable of binding double- 
stranded B-DNA (Figure 1.5 and Figure 1.6). There is a small sub-region within the 
variable region that is responsible for sequence specific recognition and target base 
selection. The target recognition domains are located on the side of the cleft in the 
small domain and directly interact with the major groove of the DNA molecule 
(Cheng et al. 1993). 
The catalytic domain is a mixed alpha beta structure which consists of about two 
thirds of the protein's amino acids from the N-terminus and an additional a-helix 
from the C-termial (Cheng, 1995). It encompasses motifs I-VIII and the last half of 
motif X, incorporating amino acids 1-193 and 304-327 of the M. HhaI sequence 
(Figure 1.5). The invariant Pro-Cys dipeptide, containing the catalytic Cys 81 (in 
motif IV) is situated on a large flexible loop (catalytic loop) that "hovers" over the 
cleft. 
1.3.7: THE THREE DIMENSIONAL STRUCTURE OF C5 Mtases 
The crystal structure of binary M. HhaI-SAM (Cheng et al., 1993), ternary M. HhaI- 
SAH-DNA (Klimagauskas et al., 1994) and M. HaellI-DNA (Reinisch et al., 1995) 
complexes has revealed the function of both the conserved motifs and the variable 
region (reviewed by Cheng, 1995). Since all C5 Mtases have a common structural 
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A: 
B: 
Figure 1.6: Ribbon diagram showing the domain organisation and DNA binding region of M. HhaL 
(A) The structure of M. Hhal (PDB code, 1 MHY). SAM is shown as ball and stick model. (B) The 
structure of M. Hhal (PDB code, I MHT) illustrate the front and side view with the DNA as ball and stick 
model, showing the DNA binding cleft which is large enough to accommodate the DNA (Cheng et al., 
1993). The motifs are coloured as (red-motif I, yellow-motif IV, green-motif VI, cyan-motif VIII, 
magenta-motif IX, dark blue-motif X). The large and small domain are circled green. The image was 
created by Dr. Matthew J. Conroy. The figure was produced using Molscript (Kraulis (1991) J. Appl. 
Cryst. 24 946-950) and Raster3D, (Merritt & Murphy (1994) Acta Cryst. D50 869-873). 
Small domain 
CHAPTERONE 
framework, the information obtained from these structures is likely to be very similar 
for the entire family of enzymes. The structure of M. HhaI-SAM has provided an 
opportunity to view the secondary structures of the conserved motifs as well as their 
interactions with each other and the rest of the protein. M. HhaI contacts six 
phosphates on the methylated strand and four phosphates are in contact with the 
protein on the complementary strand, spread out over ten residues (Figure 1.6 and 
Figure 1.7). Most of the intermolecular interactions involve direct contacts, but also 
include one base specific and one phosphate contact that is bridged by water 
molecules. One of these interactions involves Thr 250, which is a preferred residue 
used to anchor the alignments of putative TRDs (Lauster et al., 1989; Cheng and 
Blumenthal, 1996). This residue makes Van der Waals contacts with the flipped out 
cytosine and the adjacent, 5', guanine base. The side chain hydroxyl group forms a 
hydrogen bond with a water molecule through which it contacts the phosphate of the 
same guanine base (Figure 1.7). 
1.3.8: THE MECHANISM OF BASE FLIPPING AND THE METHYL 
TRANSFER REACTION 
Proteins bind to DNA either to control transcription and replication, or to catalyse 
any chemical reactions on the DNA. Accessibility of proteins that need to interact 
with the bases and to perform chemistry on those bases was not clear until recently. 
Base flipping is the phenomenon whereby a base in normal B-DNA is swung 
completely out of the helix into an extra helical position to bring the target base close 
to the active site. There are two C5 Mtases whose complex with cognate DNA has 
been studied by X-ray crystallography which have provided a dramatic visual 
demonstration of base flipping. The structure of the M. Hhal complex revealed that 
the enzyme employs base flipping, a previously unknown mechanism, to access the 
target cytosine (Klimasauskas et al., 1994). The structure of the M. HaeIII-DNA 
complex showed that this enzyme also flips the target base (Reinisch et al., 1995). 
Since then, the structures of a number of other protein-nucleic acid complexes that 
share this feature have been reported in many systems where enzymes need to gain 
access to a DNA base to catalyse chemical reaction on it (Roberts and Cheng, 1998). 
Two theories explain the mechanism of base flipping: "Active or Passive" (O'Gara et 
al., 1998). "Active" base flipping suggests a process in which the base is first pushed 
out of the helix by appropriate amino acid(s) on the protein and then pulled into the 
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Figure 1.7: Schematic representation showing the specific base and phosphate contacts between 
M. Hhal and DNA. 
The DNA is represented as a cylindrical projection. The recognition bases and contacted phosphates are 
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through main chain atoms with a dashed line. The symbol (W) indicates the water-mediated contacts. 
(Diagram adapted from Klimagauskas, et al., 1994) 
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active site pocket of the enzyme where it remains trapped during the reaction. In the 
context of M. HhaI the "push" required could be supplied by the side chain of Gln 
237, which penetrates into the DNA duplex and occupies the space left by the flipped 
nucleotide. The "Passive" theory suggests that during the normal "breathing" of 
DNA, the bases naturally spend some time in an extra-helical or spontaneously 
flipped-out position, or series of such positions, and it is this transient conformation 
in DNA that is recognised and caught by the protein (O'Gara et al., 1998). The 
structure of M. HhaI complexed with substrates containing mismatches at the target 
base has been determined which provided an insight into the mechanism of base 
flipping (Figure 1.8). It has been proposed that, if the process involves the protein 
pushing the base out of the helix, then the push must take place not on the base, but 
rather on the sugar-phosphate backbone. Thus rotation of the DNA backbone is 
probably the key to base flipping (O'Gara et al., 1998). 
From studies of bacterial Mtases, the catalytic pathway to cytosine methylation is 
understood in some detail. The cytosine to be methylated forms a covalent link with 
a cysteine in conserved region IV. As this position in the cytosine ring is not readily 
accessible in duplex DNA, the enzyme has to catalyse a massive disruption of the 
DNA double helix with the cytosine being first flipped through about 180° out of the 
duplex and then rotated by 65°. This facilitates intimate contact with the protein; a 
section of which "wriggles" into the DNA duplex to fill the gap left by the cytosine 
in M. HhaI (Klima§auskas et al., 1994). Covalent cytosine-cysteine bond formation 
activates the 5-position of the cytosine, which now accepts a methyl group from 
SAM which binds to the enzyme through interactions with conserved residues 
phenylalanine, leucine, glutamate, aspartate and tryptophan that stack against the 
adenine ring of SAM; the whole forms a pocket using parts of motifs I-V and X. 
Finally the product S-adenosyl homocysteine (SAH), is released and the covalent 
cytosine: cysteine bond is broken with concomitant release of the DNA from the 
enzyme. In this complex, un-stacking the substrate cytosine does not greatly perturb 
the nearby DNA structure, and a side chain from the enzyme fills most of the cavity 
left by the absent base. On the other hand the extrusion of the cytosine in M. HaeIII 
differs from M. HhaI in the mode of recognition. In the former case the bases in the 
recognition sequence undergo an extensive local rearrangement in their base pairing 
(Reinisch et al., 1995). These bases are unstacked and a gap of 8A is formed in the 
DNA for the extrusion of cytosine. However, it seems likely that the features of this 
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Figure 1.8: Structure of M. HhaI-DNA-AdoHcy complex (3MHT) illustrates 
the position of Thr-250 (space fill, green and red) relative to DNA (yellow 
sticks) and AdoHcy (red sticks) and the rest of the protein (shown as ribbons). 
Flipped out base is also shown. (Adapted from Vilkaitis et al. 2000) 
CHAPTER ONE 
class of enzymes for cytosine methylation are broadly conserved (Reinisch et al., 
1995). 
1.3.9: THE MECHANISM OF ACTION OF DNA METHYLATION 
The classical mechanism proposed for enzyme mediated C5 DNA methylation 
involves the formation of a resonance-stabilised carbanion at C5 of cytosine as a 
consequence of nucleophilic attack at C6 by the protein (Santi et al., 1983). A 
protein-DNA complex is formed by this covalent catalysis and therefore the C5- 
carbanion is available to attack at the methyl group of SAM. Following methyl 
group transfer, abstraction of the C5 proton would restore the C5-C6 double bond 
and allow release of the covalent intermediate as a free enzyme by a-elimination. 
Successful attempts have been made to trap the intermediates formed by replacing 
the hydrogen atom at C5 position with a fluorine atom (Osterman et al., 1988). 
Evidence in support of this catalytic mechanism comes from the use of C5 Mtase 
mechanistic based inhibitors such as 5-azadeoxycytidine (5-azaC) and 5- 
fluorodeoxycytidine (5-FdC). In 5-azaC, the carbon atom at the 5 position of the 
r 
cytosine ring is replaced with a nitrogen atom, while in 5-FdC, the proton at C5 is 
replaced with a fluorine atom. When incorporated into DNA in place of the target 
cytosine, such substituted nucleotides cause an irreversible complex formation 
between the Mtase and the DNA (Santi et al., 1984; Friedman, 1985; Osterman et al., 
1988; Chen et al., 1991). Direct support for this mechanism has also been provided 
by the isolation and characterisation of covalent intermediates formed by M HaeIII 
(Chen et al., 1991), M. EcoRII (Friedman and Ansari, 1992), and human DNA Mtase 
(Smith et al., 1992). Chen et al., (1993) proposed a revised mechanism for 
enzymatic DNA methylation (Figure 1.9), and demonstrated that covalent addition of 
the active site Cys residue is dispensable for sequence specific DNA binding. 
1.4: Aims Of The Thesis 
DNA Mtase with varying sequence specificities provides an excellent model system 
for understanding the molecular mechanism of specific DNA recognition. Sequence 
comparisons of cloned genes and crystal structures of monospecific Mtases have 
clearly defined the functions of various conserved motifs. However, it has been 
revealed that although the conserved motifs are clearly similar but they are different 
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in their target recognition domain. This could be explained with the assumption that 
each DNA Mtase has different recognition sequence while the similarity in catalytic 
unit is due to same mode of action and function of every Mtase. 
Our focus of attention is variation in the TRD region and comparison between multi 
and monospecific Mtases. There are more subtle differences in the conserved motif 
IX that are essential for specificity swapping in monospecific Mtases but not in 
multispecific Mtases. I aim to address whether the conserved motifs are also critical 
for the observed incompatibility of TRDs between mono and multispecific Mtase 
enzyme. Based on the knowledge from a range of mutagenesis experiments we also 
aim to set out development of new techniques for the study of Protein-DNA 
interactions of Mtases in particular and other proteins in general. Development of a 
novel technique for the study of protein-protein interactions using the detailed 
information of the structure function relationship of M. SPRI is also an achievement 
in this regard. 
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CHAPTER TWO 
MATERIALS AND METHODS 
2.1: Materials 
2.1.1: CHEMICALS, ENZYMES AND REAGENTS 
Molecular biology grade or highest quality material and reagents were used 
for the experiments and purchased from Sigma, BDH and Fisons unless otherwise 
stated. Enzymes for use in general DNA manipulations were from New England 
Biolabs (N. E. B. ), MBI Fermentas or Promega. Water was either glass distilled or 
purified by the MilliQ system (Millipore) and used after autoclaving at standard 
conditions. Oxoid and Difco Laboratories supplied growth media compounds for the 
culture of Escherichia coli (E. Coli). DNA Markers (1 kb ladder and 100 bp ladder) 
were obtained from MBI Fermentas and broad-range molecular weight marker for 
protein electrophoresis was from N. E. B. All other enzymes, chemicals and reagents 
were purchased from the sources listed in Table 2.1. 
2.1.2: STANDARD BUFFERS AND SOLUTIONS 
Following chemicals, buffers and reagents were prepared in the lab according to their 
composition given in the Table 2.2 in MilliQ water unless specified. 
2.1.3: EQUIPMENT 
The equipment used during the course of this study and their suppliers are listed in 
the Table 2.3. 
2.1.4: BACTERIAL STRAINS 
The Escherichia coli (E. coh) bacterial strains used as hosts in the experiments, their 
genotypes and suppliers are described in Table 2.4. 
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Table 2.1: List of chemicals and their suppliers 
Reagent Supplier 
30% Acrylamide / Bisacrylamide (29: 1) BIO-RAD 
Agarose Boehringer Mannheim 
Antibiotics: 
Am icillin/Chloram henicol/Kenam cif 
Sigma 
BIO-RAD protein assay kit BIO-RAD 
dNTPs Promega 
Dpn I NEB 
Gene-Clean kit Bio-101 Inc. 
Glutathione agarose beads Sigma 
Isopropylthio-ß-D-Galactoside (IPTG) Melford 
JetsorbT'Agel extraction kit Genomed Inc. 
Lysozyme Sigma 
(3-[N-Morpholino] propane sulfonic acid) MOPS Sigma 
MobiSpin columns Mo Bi Tec 
Pfu DNA polymerase Stratagene 
Phenol pre equilibrated with Tris pH8.0 Sigma 
Polaroid 667 film Polaroid Ltd 
T4 DNA ligase MBI Fermentas 
S-adenosyl-L-methionine (SAM) NEB 
Taq DNA polymerase Promega 
Taq DyedeoxyTM Terminator Cycle sequencing kit Applied Biosystems Inc. 
Triethylammonium acetate (TEAA) Transgenomic 
Tetracycline Sigma 
TNT T7 Quick Coupled Transcription/Translation 
kit 
Promega 
Vent DNA Polymerase NEB 
Wizard® plus miniprep DNA purification system Promega 
X-Gal (5-Bromo-4-Chloro-3-indolyl-ß-D- 
Galactoside) 
Melford 
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Table 2.2: Composition of buffers/reagents used in this study 
Buffer Composition 
Ammonium Per Sulphate 10% in MilliQ Water 
(APS) 
Ampicillin Stock 20 mg/ml in water, working concentration 200 µg/ml 
Binding buffer l OX 500 mM Tris-HC1(pH 7.4), 500 mM NaCl, 100 mM EDTA 
(pH 8.0), 50 mM 2-mercaptoethanol 
Chloramphenicol Stock 34 mg/ml in Ethanol, working concentration 50 µg/ml 
Coomassie Brilliant Blue 230 ml methanol (46%), 230 ml water (46%), 40 ml acetic 
Stain acid (8%) and 2g Coomassie Brilliant Blue R250 for a total 
of 500 ml 
Destainer 300 ml methanol (30%), 100 ml acetic acid (10%) and 600 
ml water (60%) for one litre 
Ethylene Diamine Tetra 0.5 M (pH 8.0) 
Acetic Acid (EDTA) 
Ethidium Bromide Stock solution 10 mg/ml in water, Working solution 0.5 
µg/ml 
Gel loading Buffer 0.25% (w/v) Bromophenol Blue and 50% (v/v) Glycerol 
Glutathione Elution 10 mM reduced Glutathione, 50 mM Tris-HC1(pH 8.0) 
Buffer 
IPTG 100 mM, working concentration 1 mM, 
Kanamycin Stock 10 mg/ml in water, working concentration 50 µg/m1 
LA medium 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl 
and 1.5% (w/v) agar 
LB medium 1% (w/v) Tryptone, 0.5% (w/v) yeast extract, 1% (w/v) 
NaCl. 
Loading dye solution 0.2% Bromophenol blue, 0.2% Xylene cyanol, 60% 
Glycerol and 60 mM EDTA 
NEM 10 mM (N-Ethylmaleimide) 
PBS (l OX) 1400 mM NaCl (8.8168), 27 mM KCI (2.0128 g), 100 mM 
Na2HPO4 (14.196 g), 18 mM KH2PO4 (2.4642 g) (pH 7.3) 
Phenyl Methyl Sulfonyl- 20 mM in Isopropanol 
Fluoride (PMSF) 
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RF1 100 mM RbCI, 50 mM MnC12.4H20,30 mM K acetate (pH 
7.5), 10 mM CaC12. H2O and 15% Glycerol (w/v), final pH 
(5.8) adjusted using 1M acetic acid. Sterilized by filtration 
through 0.22 µ membrane 
RF2 10 mM RbCl, 75 mM CaC12.2H20,10 mM MOPS and 15% 
Glycerol (w/v), final pH (6.8) adjusted using 10 M NaOH. 
Sterilized by filtration through 0.22 t membrane 
SDS Resolving Gel Buffer 375 mM Tris-HCI, 0.1% SDS (pH 8.8) 
SDS Sample Buffer 1X 500 mM Tris-HCI (pH 6.8), 10% (v/v) Glycerol, 10% (w/v) 
SDS, 5% (v/v) 2-Mercaptoethanol, 
0.005% (v/v) Bromophenol Blue 
SDS Stacking Gel Buffer 125 mM Tris, 0.1% SDS (pH 6.8) 
STE 1X 10mM Tris-HC1(pH 8.0), 1mM EDTA (pH 8.0), 
100mM NaCl 
Tetracycline Stock 10 mg/ml in Ethanol, working concentration 50 µg/ml 
Tris-Acetate-EDTA Prepared as a 50X stock concentrate: 242g Tris base, 57.1 ml 
(TAE) 50X Glacial acetic acid and 100 ml 0.5 M EDTA (pH 8.0) per 
litre water 
(TAE) 1X = 40 mM Tris-acetate and 1 mM EDTA (pH 8.0) 
Tris-EDTA (TE) 1X 10 mM Tris-HCl (pH 8.0) and 1 mM EDTA (pH 8.0) 
X-Gal 20 mg/ml in N, N-Dimethylformamide (DMF) in glass bottle 
Buffer A for Wave 0.1 M TEAA (pH 7.4) 
Buffer B for Wave 0.1 M TEAA (pH 7.4), 25% Acetonitrile (CH3CN) 
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Table 2.3: List of equipment used in this study 
Equipment and Model Manufacturer 
Balance 0-100 g model AJ 100 
0-800g model K7 
Mettler 
Biacore 2000 BIACORE 
Biacore chips (SA and CM5) BIACORE 
Camera, Polaroid DS 34 camera Polaroid 
Centrifuges: 
a) J2 
b) Centaur 2, Minorcentaur and Microcentaur 
Beckman 
MSE 
DNAsep® Cartridge Transgenomic Inc. Omaha 
Gel Drier: Model 583 slab drier BIO-RAD 
Heating blocks Dri-Block DB1 Techne 
Horizontal slab gel (mini- and wide mini-subcell) BIO-RAD 
Incubator Model S. I. 60 Stuart Scientific. 
PC Scanner Flatbed Scanjet-4C Hewlett-Packard 
pH meter with Tris Electrode Denver Instruments Denver Basic 
Pipettes (P20, P200 and P 1000 µL) Gilson 
Power supplies Model 200/20 BIO-RAD 
Sonicator, Soniprep 350 M. S. E 
Spectrophotometer Lambda 12 Perkin Elmer 
Thermal cycler GeneE (Programmable) Techne 
UV Transilluminator, Model TM40 Genetic Research Instruments 
Ltd. 
Vacuum Dryers Hetovac VR-I rotary evaporator Heto-Intermed. 
Vertical slab gel: Mini Protean II BIO-RAD 
Water baths Grant Instruments, Cambridge 
WAVET"' DHPLC System Transgenomic Inc. 
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Table 2.4: Genotypes of E. coli strains used during the course of study 
Strain Genotype Source 
BL21 (DE3) IT om T hsdSe rB mB dem al (DE3) Nova en 
DH5a F lendAl hsdR17 (re mx+) gin V44 thi-1 NEB catalogue 
recAl gyrA (Na! ) relAl d(lacIZYA- 
ar F U169 deoR 0dlacd acZ MI S 
DH5aMCR F mcrA d(mrr-hsd RMS-mcrBC) Gibco BRL, Life 
((80dlacZdM1 S) d(IacZYA-argF) U169 technologies 
deoR recAl endAl phoA supE44 ?. thi-1 catalogue. 
gyrA96 relAI 
GM2163 IT ara-14 leuB6 fhuA31 lacYl tsx78 gin V44 NEB catalogue 
ga1K2 gal T22 mcrA dem-6 hisG4 rfbDl 
rpsL136 dam13:: Tn9 xylA5 mtl-1 thi 1 
mcrBI hsdR2 
INVaF endAl recAl hsdRl7(rK-mK+) supE44 A- Invitrogen Catalogue 
thi-1 gyrA re/Al 0801acZ A M15 d (lacZYA- 
ar F deoR+ F' 
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2.1.5: PLASMIDS AND GENES 
Cloning vectors used during the course of study for this work are listed in the Table 
2.5 with their brief characteristics and their source. The plasmid DNAs were stored 
in MIIIQ water at 20°C, or maintained in the appropriate bacterial strain and kept at 
-70°C. 
The multi-specific Mtase gene M. SPRI was a generous gift from Professor T. A. 
Trautner (Berlin, Germany) and was used as the starting point for the all M. SPRI 
related studies. The gene encoding mono-specific Mtase gene M. HhaI was obtained 
from Dr. G. Wilson (New England Biolabs). 
2.2: Methods 
2.2.1: MANIPULATION OF BACTERIA 
2.2.1.1: Growth of Bacterial Strains 
All strains were grown using standard liquid culture Luria-Bertani (LB) medium and 
maintained on LA plates and, if appropriate, supplemented with antibiotic(s). 
2.2.1.2: Storage of Bacterial Strains 
Strains of E. coli were stored in glycerol (long term storage). Glycerol cultures of E. 
coli were prepared by adding 0.80 ml of a fresh culture to 0.2 ml of sterile 100% 
glycerol in a sterile 1.5 ml micro-centrifuge tube. The tubes were vortexed until the 
contents were homogenous and were then flash frozen and stored at -70°C until 
required. Bacteria were recovered by scraping the surface of the frozen glycerol with 
a sterile loop and streaked onto LB-agar plate. The tube was returned to the freezer 
before thawing had occurred. The plates were incubated at 37°C overnight for the 
growth and isolation of a single colony. 
2.2.1.3: Preparation of Competent Cells 
Competent cells and subsequent transformation of plasmid DNA was carried out by a 
method as described by Hanahan, 1985. This is a less time consuming method, and 
involves the preparation of frozen competent cells stored at -70° C. 
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Table 2.5: Plasmids acquired for use during this study 
Plasmid Characteristics Source 
pACYC184 This plasmid has a different origin of Chang and 
replication derived from pl5A1 allowing it to Cohen, 1978. 
be maintained in other transformants with Transgenomic 
ColEl origin of replication for the expression Ltd. formerly 
of two recombinant proteins simultaneously. Kramei Biotech. 
pBR322 General purpose cloning vector New England 
Biolabs 
pET14b, E. coli inducible expression vector; containing Novagen 
pET22b 6 histidine and T7 promoter 
pGEX-KG E. coli inducible expression vector; having Guan and Dixon, 
GST gene 1991. 
Pharmacia 
Biotech 
pLITMUS28, E. coif inducible expression vector containing New England 
pLITMUS38 both lac promoter and T7 promoter Biolabs 
pUC18, General purpose cloning vectors New England 
pUC19 Biolabs 
pUC4K The pUC4K plasmid contains an Pharmacia 
aminoglicoside-3'phosphotransferase gene Biotech 
from Tn903. This gene confers resistance to 
Kanamycin in a wide variety of hosts and can 
be excised as a restriction size-mobilizing 
element (RSM). 
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25m1 of LB media in a 250m1 conical flask was inoculated with a 250µ1 of overnight 
culture of the E. coli strain and growth was allowed to proceed at 37°C until the 
OD595 was approximately 0.4-0.6. Cells were harvested at 3,000 rpm in a M. S. E. 
Centaur-2 centrifuge for 10 minutes. Cell pellets were gently re-suspended in 8m1 
RF1 solution and incubated for 15 minutes on ice. Cells were harvested again and 
cell pellets re-suspended in 2ml RF2 solution followed by a 15-minute incubation on 
ice. Aliquots (l00µ1) of cells were added to micro-centrifuge tubes and flash frozen 
on liquid nitrogen before being stored at -70°C, where cells remained stable for 
approximately 6 months. The RbC12 method of making competent cells has an 
advantage that a large number of such cells can be prepared on one occasion, and 
then aliquots stored at -70°C and used for transformation for many months. 
DH5aMCR strain of E. coli was used as host strain for usual transformations unless 
otherwise stated. 
2.2.1.4: Transformation of E. coli 
Frozen competent cells were thawed on ice and DNA was added (for plasmid 
miniprep the volume used was usually 1µl, while ligation mixture it was 
approximately up to 1 Opl). The cells were then incubated on ice for 20 minutes, heat- 
shocked at 42°C for 90 seconds and incubated on ice for a further 3 minutes. LB 
media (400µl) was added followed by a 60-minute incubation at 37°C with 
occasional shaking. 200 pl cells were then spread onto plates with a sterile spreader 
and the plates were incubated overnight. 
2.2.2: PLASMID DNA ISOLATION FROM E. COLI & QUANTIFICATION 
2.2.2.1: Small scale DNA preparation (miniprep) 
WizardTM Mini-preps system by Promega was used for small-scale preparation of 
plasmid DNA. This system is a modification of the alkaline lysis method. Cells 
harbouring the plasmid were grown overnight from a single colony in 4-10 ml LB 
with the appropriate antibiotic. The culture was centrifuged and the cell pellet was 
used to prepare the DNA. The cells were lysed and the DNA was allowed to bind 
with resin in a mini column. The DNA was then purified first by washing with 
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ethanol, and was eluted from the mini column in 50-100 [d of 1X TE buffer or 
MilliQ water. 
The kit was purchased from Promega and was used as described in the 
manufacturer's instructions. Sufficient plasmid of good quality can be purified from 
3-ml overnight culture and can be used directly for DNA sequencing and restriction 
digestion experiments without any further manipulation. 
2.2.2.2: Medium scale DNA preparation (midiprep) 
For large scale plasmid DNA purification, cells harbouring the plasmid were grown 
in 25-50 ml of LB with the appropriate antibiotic overnight, and plasmid DNA was 
then purified using QIAGEN® columns. DNA was separated from the lysate with a 
DNA-binding anion exchange column and then eluted in a high salt buffer. The DNA 
was precipitated with isopropanol, and washed with 70% ethanol to remove the salt, 
recentrifuged and dried under vacuum for 10 minutes and resuspended in 1X TE or 
Mil iQ water. 
Columns and buffers were purchased from QIAGEN® and used according to the 
manufacturer's instructions (except for an increase in the time of centrifugation in 
most steps). QIAGEN® kit produces a good yield and high quality pure DNA. 
2.2.2.3: Spectrophotometric Quantification 
The concentration of oligodeoxynucleotides was determined using the equation: 
A260 /E = Concentration (mM) 
Where: 
A260 = absorbance at 260nm 
E= the sum of all the mM extinction coefficients of the 
nucleotides present (ncdATP + ncdTTP + ncdGTP + ncdCTP) 
Where n= number of bases present 
The mM extinction coefficients for the nucleotides are as follows: 
c dATP = 15.20 
c dTTP = 8.40 
c dGTP = 12.01 
c dCTP = 7.05 
The absorbance at 260nm was performed using a spectrophotometer in 1 ml-quartz 
cuvettes. The path length was 1 cm in all cases. The concentrations of 
oligodeoxynucleotide were calculated by measuring the absorbance of a 500 fold 
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diluted sample at 260 nm and assuming that an absorbance reading of 1 corresponds 
to 33µg/ml single stranded oligodeoxynucleotide. 
The concentrations of single stranded DNA were determined by reading the 
absorbance of samples at 260 nm. An OD260 of 1 corresponds to a concentration of 
33 pg/ml for double stranded DNA. However, for miniprep and midiprep DNA the 
following method was used. 
2.2.2.4: Ethidium Bromide Fluorescence Quantification 
A more approximate determination of plasmid DNA concentration was obtained by 
running an appropriate amount of DNA in 1% agarose gel alongside a standard DNA 
marker (Figure 2.1 and Appendix I). After ethidium bromide staining, samples were 
visualized under UV and the approximate concentrations were determined by visual 
comparison between the unknown samples and standards. 
This technique was also adopted when the vector and insert fragments were 
recovered from the agarose gel and kept for ligation reaction in varying proportion. 
2.2.3: DNA MANIPULATION TECHNIQUES 
2.2.3.1: Deproteination of DNA Samples 
Proteins were removed from DNA samples by phenol/chloroform extraction. Phenol 
and other organic solvents are used which precipitate the protein but leave the 
nucleic acids (DNA and RNA) in aqueous solution. Phenol pre-equilibrated with Tris 
pH 8.0 was mixed with chloroform and isoamyl alcohol (25: 24: 1 respectively) as 
described by Sambrook et al. (1989). The solution was stored in the dark at 4°C. An 
equal volume of phenol: chloroform: isoamyl alcohol (25: 24: 1) was added to the 
DNA solution, mixed by vortexing and then centrifuged at 13,000 rpm for 5 minutes. 
The precipitated protein molecules were left as a white coagulant mass at the 
interface between the aqueous and organic layers. The upper aqueous phase was 
transferred to another tube, with care taken not to disturb the aqueous/organic phase 
interface where the proteins are partitioned. If required, residual traces of 
phenol/chloroform/isoamyl alcohol were removed by the addition of an equal 
volume of diethyl ether, vortexing and centrifugation in a micro-centrifuge at 13,000 
rpm for 1 minute. The upper ether layer was removed and discarded and traces of 
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Fragment Base Pairs DNA mass 
1 10,000 20 ng 
2 8,000 24 ng 
4 6,000 30 ng 
5 5,000 30 ng 
6 4,000 40 ng 
7 3,500 51 ng 
8 3,000 154.5 ng 
9 2,500 33.5 ng 
10 2,000 35 ng 
11 1,500 24.5 ng 
12 1,000 10 ng 
12 750 16.5 ng 
13 500 14.5 ng 
14 250 16.5 ng 
Frag ment Base Pairs DNA Mass 
1 1,500 46 ng 
2 1,200 37 ng 
3 1,000 91 ng 
4 900 27 ng 
5 800 24 ng 
6 700 21 ng 
7 600 18 ng 
8 500 91 ng 
9 400 37 ng 
10 300 27 ng 
11 200 24 ng 
12 100 55 ng 
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Figure 2.1: Electrophoretic molecular weight standards for DNA fragments separated on agarose. 
(a) GeneRulerTM Ikb DNA Ladder (MBI) (14 fragments) with 0.5µg loading on 1.0% agarose gel and the 
(b) 100 bp ladder (MBI) (12 fragments) analysed on 1.8 % agarose gel. The approximate DNA mass has 
also been tabulated above for each fragment. (Data adapted from MBI Fermentas, 1999 Catalogue). 
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ether removed by gentle aspiration. The DNA was then concentrated by ethanol 
precipitation as described in the next section. 
2.2.3.2: Ethanol Precipitation of DNA 
DNA was precipitated by the addition of 1/10 volume of 3M potassium acetate 
solution pH 4.8 and 3 volumes of -20°C absolute ethanol. The solution was vortexed, 
incubated at -20°C for 20-30 minutes and then centrifuged in a bench-top micro- 
centrifuge at 13,000 rpm for 15 minutes. The pellet was washed in 70% (v/v) ethanol 
and spun again for 5 minutes. The pellet was dried under vacuum for 5 minutes and 
then dissolved in an appropriate volume of TE buffer or MilEQ water. 
2.2.3.3: Restriction Enzyme Digestion of DNA 
Plasmids, DNA fragments and oligodeoxynucleotides were specifically cleaved 
using the appropriate restriction Enase(s). Standard digestion of DNA (0.1-2µg) was 
carried out in a total volume of 20-50µl with 5-10 units of restriction Enase(s) (one 
unit of restriction enzyme activity being defined as the amount of enzyme required to 
digest 1µg of ? DNA to completion in 1 hour at 37°C). Buffer was added to a final 
concentration of IX according to manufacturer's recommendations. 
Digestion reactions were incubated at 37°C for 2-6 hours unless otherwise stated. 
When digests requiring two enzymes with different buffer preferences were carried 
out, either, 
1. Using activity tables supplied by the manufacturers to decide the most 
suitable buffer and the amount of enzymes to be used for the double 
digestion, or 
2. Sequentially, upon completion of the first digest, the digestion mixture was 
diluted to a volume of 200µ1 with Mi11iQ water and extracted 3 times with 
phenol / chloroform / isoamyl alcohol and the digested DNA precipitated by 
ethanol. Once resuspended, the DNA was subjected to further restriction 
analysis. 
2.2.3.4: Recovery of DNA through Agarose gel 
DNA fragments were recovered from agarose gel slices using a JetsorbTM gel 
extraction kit (Genomed Inc. ). The DNA is adsorbed onto the glass beads and 
washed repeatedly before being eluted by incubation in 1X TE or MilliQ water. The 
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recommended protocol from the manufacturer was observed to carry out the 
procedure. 
2.2.3.5: Filling in Recessed 3'-ends 
The Klenow fragment is the large fragment of DNA polymerase I. It carries the 5'-3' 
polymerase and the 3'-5' exonuclease activities of intact DNA polymerase I, but lacks 
the 5'-3' exonuclease activity of the native enzyme. The enzyme catalyse the addition 
of mononucleotides from deoxynucleoside-5'-triphosphates to the 3'-hydroxyl 
terminus of template DNA. This property is used to synthesize DNA complementary 
to single-stranded DNA templates. Klenow enzyme was used to convert the 3'- 
recessed ends of restricted DNA fragments to blunt ends by a fill-in process. 
2.2.3.6: Annealing of Oligodeoxynucleotides 
Complementary oligodeoxynucleotides were annealed by mixing equimolar 
concentrations of each oligodeoxynucleotide together and incubating at 95°C for 10 
minutes and allowing to cool slowly to room temperature. Annealed 
oligodeoxynucleotides were then used as linker for ligation in plasmid. 
2.2.3.7: DNA Ligation 
DNA fragments or oligodeoxynucleotides (inserts) were ligated into plasmid vectors 
(containing compatible cohesive termini) using the reaction catalysed by 
bacteriophage T4 DNA ligase (as described in Sambrook et al., 1989). Ligations 
were performed in 20µl volumes using an approximate molar ratio of 1: 1 and 1: 3 
(plasmid DNA: insert DNA). Buffer, which was supplied by the manufacturer, was 
added to a final concentration of 1X. Finally T4 DNA ligase was added and the 
reaction was incubated at room temperature for 2-3 hours or at 16°C for 4-6 hours. 
2.2.4: GEL ELECTROPHORESIS 
2.2.4.1: Agarose Gel Electrophoresis of DNA fragments 
DNA fragments were separated by agarose gel electrophoresis through 0.8-1.5% 
agarose gels run in IX TAE buffer for 1 hour at 100V. Samples were run on either 
mini sub-cell (50ml (1X TAE) gel solution) with 8 lanes or on larger (100m1 (IX 
TAE gel solution) wide mini sub-cells where 15-20 lanes were available. A sixth 
volume of loading dye solution was added to each sample prior to loading onto the 
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gel. Following electrophoresis, the gels were stained for 10-15 minutes in a solution 
of ethidium bromide (0.5 µg/ml). DNA was visualized by illuminating with UV light 
on a transilluminator at 302 nm. The sizes of DNA fragments were estimated by 
comparison to Gene RulerTM 1 kb DNA ladder or Gene RulerTM 100 bp DNA ladder 
run on the same gel. Photographs of the gels were taken using a Polaroid DS-34 
direct screen instant camera with an orange filter and Polaroid 667 film. Photographs 
were then scanned into a PC and the image files stored on floppy disc. 
2.2.4.2: Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Protein expression and purification were analyzed by the SDS-PAGE method 
described in Sambrook et al (1989). Protein samples were denatured by boiling for 
10 minutes at 100°C with one half volume of 1X SDS loading buffer. 
Electrophoresis was carried out under denaturing conditions on 10% polyacrylamide 
gels with 4.5% stacking gels. In order to prepare a 10% gel, 5m1 of acrylamide- 
bisacrylamide (29% - 1%), 3.75 nil 4X resolving gel buffer, 6ml dH2O, l00pl 10% 
ammonium persulphate and 20 µl TEMED were mixed and poured. Propane-l-ol 
was layered on top of the gel. Once set, propane- l-ol was removed and the stacking 
gel (2.25m1 acrylamide-bisacrylamide 29% - 1%, 3.75 ml stacking gel buffer, 9 ml 
dH2O, 120 µl 10% ammonium persulphate and 30 µl TEMED) was poured. 
Electrophoresis was carried out at 100V through the stacking gel and 120V through 
the resolving gel in 1X SDS running buffer (5 mM Tris-HCI pH 8.3,38 mM glycine 
and 0.1% (w/v) SDS). Gels were stained with Coommassie Brilliant Blue R (46% 
methanol, 46% dH2O, 3% acetic acid and 3g Coommassie Blue R250) for 30 minutes 
to 1 hour and then destained in 30% methanol, 10% acetic acid and 60% dH2O. 
Broad range molecular marker was run on gels alongside the protein samples to 
enable their sizes to be determined (Figure 2.2 and Appendix II). 
2.2.5: POLYMERASE CHAIN REACTION (PCR) 
DNA segments can be hugely amplified using the polymerase chain reaction (PCR). 
It has an elegant simplicity. Two synthetic oligonucleotides are synthesized, each 
complementary to sequences on opposite strands of the target DNA at position just 
beyond the ends of segment to be amplified. The oligonucleotides serve as 
replication primers, with the 3' ends oriented towards each other and positioned to 
prime DNA synthesis across the desired DNA segment. The DNA segment to be 
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Fragment Protein Source Calculated 
MW (Da) 
1 Myosin rabbit muscle 212,000 
2 MBP-ß-galactosidase E. coli 158,194 
3 ß-galactosidase E. coli 116,351 
4 Phosphorylase b rabbit muscle 97,184 
5 Serum albumin bovine 66,409 
6 Glutamic dehydrogenase bovine liver 55,561 
7 MBP2 E. coli 42,710 
8 Lactose dehydrogenase porcine muscle 36,487 
9 Triose phosphate isomerase rabbit muscle 26,625 
10 Trypsin inhibitor soybean (20,040-20,167) 
11 Lysozyme chicken egg white 14,313 
12 Aprotinin bovine lung 6,517 
13 Insulin A, B chain bovine pancreas (2,340-3,400) 
I 
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Figure 2.2: Protein broad range marker. It is a mixture of purified proteins with known amino acid 
sequences. They are resolved to 13 sharp bands when analysed by SDS-PAGE and stained with 
Coomassie Blue R-250. Protein bands numbered 1-10 are visible in this gel. Two bands (BSA, MW 
66.4 kDa and triphosphate isomerase, MW 26.6 kDA) are at double intensity to serve as reference 
point. MBP is abbreviation for maltose binding protein (Data adapted from NEB, 1999 Catalogue). 
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amplified is heated briefly to denature it and then cooled in the presence of large 
excess of the synthetic oligonucleotide primers. In the presence of four dNTPs and 
heat-stable DNA polymerase, the primed DNA segment is replicated selectively. The 
cycle of heating, cooling and replication is repeated 25-30 times in an automated 
thermal cycler, amplifying the DNA segment flanked by the primers until it can be 
readily analysed and/or cloned. 
2.2.5.1: Standard polymerase chain reaction (PCR) 
Taq DNA polymerase was used to catalyse the reaction with the buffer (10 X PCR 
buffer) provided by the supplier. Ultra-pure dNTPs were stored as a mixture of all 
four at a concentration of 5 mM at -20°C and were used at a final concentration of 
0.2 mM. Primers were stored at -20°C as 5 µM stocks and were used at a 
concentration of 0.2 µM. A DNA template concentration of 10 ng / µl was generally 
employed. The reaction was set up as follows: 
The reagents were mixed at the concentration described in a thin-walled 0.5 ml 
micro-centrifuge tube prior to addition of the polymerase in a final volume of 49 µl. 
1 µ1(2U) of the polymerase enzyme was added and the contents were mixed gently. 
The thermal cycler program used consisted of a denaturation step at 94°C for 45 
seconds, a high thermal ramp (40°C/minute) to 46-50°C (depending on the primer 
length), 1 minute annealing, a rapid thermal ramp to 72°C, extension at 72°C, for 1 
minute and then a rapid thermal ramp to 94°C. The reaction was allowed to proceed 
for 25-30 cycles. The concentration of the amplified DNA was analysed on agarose 
gel. If required the PCR product was cut and recovered from the gel as described 
earlier section 2.2.3. 
2.2.5.2: PCR for Site Directed Mutagenesis (SDM) 
Site-directed mutagenesis (SDM) can be used to alter the gene coding for a protein 
and thus to make point mutations, switch amino acids and delete or insert single or 
multiple amino acids (Stratagene, 1997). The method of site-directed mutagenesis 
used here employs about 50-100 ng of double-stranded DNA (plasmid) and equal 
amount (100-125 ng) of two complementary synthetic oligonucleotide primers 
containing the desired mutation in the middle flanked by 10-15 bases on each side. 
The following criteria were observed for the design of primers. 
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a) Both the mutagenic primers contained the desired mutations and would 
anneal to the same sequence on opposite strand of the plasmid. 
b) Primers were between 25 and 45 bases in length, and the melting temperature 
(Tm) of the primers was -40°C above the extension temperature of 68°C. 
The formula used for calculating the (T. ) of primers was: 
T. = 81.5 + 0.41 (% GC) - 675/N -% mismatch. 
Where N is the primer length in base pairs. 
c) The desired mutation (deletion or insertion) was in the middle of the primers 
with 10-15 bases of correct sequence on both sides. 
d) The primers ideally had a minimum GC content of 50% and terminated in 
one or more G or C bases. 
The primers synthesis is explained in the following section. The other components 
were as described in the manufacturer's protocol. The recommended thermal cycling 
program for site-directed mutagenesis is as follows: 
" Rapid thermal ramp to 96°C 
" 96°C for 30 seconds 
" Rapid thermal ramp to 55°C 
" 55°C for 60 seconds 
" Rapid thermal ramp to 68°C 
" 68°C for 15-20 minutes (depending on the product size) 
All these steps were repeated for 18 cycles in Progene Techne thermocycler with a 
heated lid. 
The oligonucleotide primers, each complementary to opposite strands of the vector 
are then extended during temperature cycling by Pfu DNA polymerase. On 
incorporation of the oligonucleotide primers, a mutated plasmid containing staggered 
nicks is generated. After temperature cycling, the product is treated with Dpnl. The 
Dpnl restriction endonuclease (target sequence 5'-GATC-3') is used to digest the 
parental DNA template leaving behind mutagenised DNA synthesized by PCR. Since 
template DNA used was isolated from most E. cola strains is dam methylated, it is 
susceptible to Dpnl digestion, which is specific for methylated and hemimethylated 
DNA. 30 µl of the PCR product (after Dpnl digestion) was normally run on agarose 
gel to check if the reaction has worked. The nicked vector DNA incorporating the 
desired mutation(s) is then used to transform E. cola DH5aMCR. Colonies arising as 
a result of transformation were screened for the presence of desired mutation in their 
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DNA by restriction digestion. Sequencing was also carried out for selected mutants 
especially when multiple mutants were generated. 
2.2.6: DNA SYNTHESIS 
The chemical synthesis of oligonucleotides with a known sequence has paved the 
way for many biochemical advances, and had a powerful impact on all areas of 
molecular biology. In this study oligodeoxynucleotides were used as primers for the 
amplification of DNA and for site directed mutagenesis by polymerase chain reaction 
(PCR). Oligodeoxynucleotides were synthesized by Paul Brown using a 381A DNA 
Synthesizer (Applied Biosystem) using the standard phosphoramidate method 
followed by deprotection in 30% ammonia overnight. Oligodeoxynucleotides were 
ethanol precipitated and resuspended in Mi1liQ water and quantified using the 
spectrophotometric method described in section 2.2.2.3. 
2.2.7: DNA SEQUENCING 
A DNA molecule's most important property is its nucleotide sequence. Automated 
DNA sequencing uses a variation of Sanger's sequencing method in which the 
dideoxynucleotides used for each reaction labelled with a differently coloured 
fluorescent tag. The DNA to be sequenced is used as the template strand in a DNA 
polymerase reaction, and a short primer is annealed to it. The 3'-hydroxyl group of 
the primer reacts with incoming deoxynucleoside triphosphate (dNTP) to form a new 
phosphodiester bond. The Sanger sequencing procedure uses dideoxynucleoside 
triphosphate (ddNTP) analogs to interrupt DNA synthesis. When a ddNTP is inserted 
in place of a dNTP, strand elongation is halted because the ddNTP lacks the 
necessary 3'-hydroxyl group. By addition of small amounts of each ddNTPs over 
dNTPs, there exist a probability of acquiring at least one ddNTP at some point during 
synthesis and the strand synthesis will be prematurely terminated. The resulting 
solution contains a mixture of different-sized labelled fragments, which are then 
separated by electrophoresis; the colour associated with each peak is detected using a 
laser beam. The DNA sequence is read by determining the sequence of colours in the 
peaks as they pass the detector. 
Polymerase chain reaction (PCR) sequencing was carried out as described below. 
Template DNA was isolated from E. coli and purified using a Wizard@ column as 
described in section in 2.2.2. Cycle sequencing reactions were performed using the 
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Taq Dyedeoxy Terminator Cycle sequencing kit as described in the manufacturer's 
protocols using 0.2-0.5 µg template DNA and 3.2 pmol of oligodeoxynucleotide 
primer. 
The recommended thermal cycling programme that was used was: 
" Rapid thermal ramp to 96°C 
" 96°C for 30 seconds 
" Rapid thermal ramp to 50°C 
" 50°C for 15 seconds 
" Rapid thermal ramp to 60°C 
" 60°C for 4 minutes. 
All these steps were repeated for 25 cycles in a Progene Techne thermocycler with a 
heated lid. 
The extension products were concentrated using sodium acetate and ethanol 
precipitation as described in the manufacturer protocols. Samples were dried under 
vacuum. The Biomolecular Synthesis Laboratory in the Krebs Institute at Sheffield 
carried out the DNA sequencing on an Applied Biosystems 373A DNA sequencer 
and nucleotide-sequencing data was obtained as a computer file. The sequencing 
facility of Lark Technologies was also utilized in some cases. 
2.2.8: IN VIVO PROTEIN EXPRESSION 
2.2.8.1: Cell Growth and Induction 
Small scale inductions for initial screening of protein expression were performed by 
inoculating 5 ml of LB media with 200 pl of an overnight culture of which had been 
inoculated from a colony on agar plate. For large-scale inductions, 30 ml of media 
was inoculated with a colony and grown overnight. This was then used to inoculate 
500 ml-1L of fresh media. The protein was expressed in E. coli cells, which were 
induced by the addition of IPTG to actively growing cells in LB at an OD600 of 0.6-1. 
Incubation was continued for a further 4-6 hours for M. HhaI and overnight for 
M. SPRI. The induction conditions varied depending on the vector and strain being 
used and it was found that bacterial strain of E. coli GM2163 was the best for 
expression of M. SPRI as well as for M. HhaI expression when the vector used was 
pGEX-KG (personal communication, Adel AlGhanim and Dr. Mun Sen Kan). 
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2.2.8.2: Cell Harvesting and Lysis 
Small-scale cultures (up to 5ml) were harvested by centrifugation at 13,000 rpm for 5 
minutes in a micro centrifuge. Cell pellets were resuspended in 200 µl of PBS Buffer 
1X containing EDTA 1mM, PMSF 0.2 µM, Lysozyme 1mg/ml and DTT 0.05 mM. 
Cells were kept on ice for 15-20 minutes before sonication at a full setting for 2x 5 
seconds bursts. Insoluble protein was separated from soluble protein by 
centrifugation at 13,000 rpm for 10 minutes in a micro-centrifuge at 4°C. The 
insoluble pellet was resuspended in 200 µl of PBS Buffer. 
Larger volume cultures (200 ml) were harvested by centrifugation at 5,000 rpm for 
10 minutes at 4°C in a Sorvall RC5 or Beckman J2 centrifuge. Cell pellets were 
washed and resuspended in 2ml of PBS Buffer containing PMSF, EDTA, DTT and 
lysozyme as above. The cell pellets were kept on ice for 30 minutes followed by 
sonication on ice using five 10-second bursts at full setting. Soluble and insoluble 
fractions were separated by centrifugation at 12,000 rpm for 20 minutes at 4°C in a 
Sorvall RC5 or Beckman J2 centrifuge. 7-10 µl volumes of each soluble and 
insoluble sample were subjected for SDS-PAGE analysis. 
2.2.8.3: Protein Purification by Glutathione Affinity Chromatography 
Recombinant proteins were expressed as in-frame fusions with GST using the 
pGEX-2T vector (Pharmacia) and were purified by glutathione affinity 
chromatography (Smith and Johnson, 1988; Frangioni and Neel, 1993). Purification 
of the protein from 500 ml induced cultures was carried out as follows: The 
sonicated cell extract containing the soluble fusion protein in 10 ml Buffer X /1% 
TritonX-100 was gently shaken at 4°C for 30 minutes with 1 ml of glutathione 
agarose beads (pre-washed with three 10 ml volumes of Buffer X) in a 15 ml Sterilin 
tube. The Sterilin tubes were briefly spun (10-20 seconds) in a M. S. E. micro- 
centrifuge to collect the agarose beads. The supernatant was removed and the beads 
were resuspended in 1 nil of Buffer X and transferred to a 50 ml Falcon tube. The 
beads were washed three times with 50 ml volumes of Buffer X, the beads being 
pelleted after each wash by centrifugation for 3 minutes in a M. S. E. centaur2 
centrifuge at 4°C. Following a further 50 ml wash with 50 mM Tris-HC1 pH 8.0, and 
recentrifugation, beads were resuspended in 2 ml of 50mM Tris-HCI pH 8.0 and 
applied to a 2.5 ml disposable plastic column (Pierce and Warriner). Bound protein 
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was eluted at 4°C with 3 washes of 1 bed volume of freshly prepared 50 mM Tris- 
HCl pH 8.0 containing 10 mM reduced glutathione. Aliquots of from each elution 
(20 µl) were analyzed by SDS-PAGE (see Section 2.2.4.2) to ascertain purity. 15% 
(w/v) glycerol was added to each elution sample and 100 µl aliquots were stored at - 
70°C. Modifications to the basic purification procedure are detailed in the text. 
2.2.8.4: Concentration of Purified Protein 
The protein samples were concentrated either by reverse dialysis against PEG or by 
centrifugation in the centricon microconcentrator. For reverse dialysis method, 
samples were placed in dialysis tubing, laid on a tray and covered in solid PEG (MW 
15,000-20,000) for 1-2 hours. For the second method, samples were centrifuged in a 
centricon concentrator at 3000 rpm for 30-90 min. 
2.2.8.5: Protein Quantification 
Protein concentration was determined using the method of Bradford (1976) and the 
Bio-Rad protein assay kit. A standard curve was prepared using bovine serum 
albumin (BSA) supplied by the manufacturer and the concentration of the unknown 
protein sample was determined from this. All protein samples were assayed in 1 ml 
disposable plastic cuvettes using a spectrophotometer at 595 nm. 
2.2.9: IN VITRO PROTEIN EXPRESSION 
Coupled transcription-translation in the prokaryotic cell free system manufactured by 
Promega was used to express proteins from the wild type and mutant constructs. The 
reaction components in a 0.5 ml micro centrifuge tube were as follows. 
T7 S30 extract for Circular DNA 15 µl 
S30 Premix without amino acids 20 µl 
Amino Acid mixture 5 µl 
Rnasin ® Ribonuclease Inhibitor (40 units/ µl) 1 µl 
DNA Template (mal µg) x µl 
Nuclease-Free Water to a final volume 50 µl y µl 
Total = 50 µl 
The lysate was gently mixed by pipetting and then centrifuged briefly where 
necessary to return the reaction contents to the bottom of the tubes. The micro- 
centrifuges tubes were then incubated for 90-120 minutes at 37°C. A control 
experiment was also carried out using luciferase control DNA. The results of 
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translation were analyzed using an in vitro DNA Methyltransferase activity assay and 
by using Biacore as described (see section 2.2.11). 
2.2.10: DETERMINATION OF 5-METHYLCYTOSINE IN DNA SAMPLES 
Methods already in practice for the determination of 5-methylcytosine (m5C) are 
Maxam Gilbert sequencing and sodium bisulfite treatment methods. 
2.2.10.1: Maxam-Gilbert sequencing 
Maxam-Gilbert procedure of nucleotide sequencing can differentiate modified m5C 
and normal C and is a standard way to check methylated cytosine (Ohmori et al., 
1978; Maxam and Gilbert, 1980). 
2.2.10.2: Sodium bisulfite treatment 
The bisulfite genomic sequencing technique has gained a wider acceptance for the 
generation of DNA methylation maps with single base resolution. The method is 
based on the selective deamination of cytosine to uracil (and subsequent conversion 
to thymine via PCR), whereas 5-methylcytosine residues remain unchanged. 
Sequencing of the PCR amplified DNA can detect the sites at which the cytosine is 
methylated (Frommer et al., 1992; Feil et al., 1994; Xiong and Laird, 1997). 
2.2.11: DNA METHYLTRANSFERASE ACTIVITY ASSAY 
The activity of the encoded protein by the cloned wild type and mutant 
methyltransferases were analysed by the methods as described below. 
2.2.11.1: In vivo Mcr restriction assay 
This procedure is based on the exclusion of certain modified forms of DNA from 
Escherichia coil strains harbouring the mcr genes (Raleigh and Wilson, 1986). 
Plasmids carrying methyltransferase genes transformed into mcrA+BC+ strains of E. 
coil (like DH5a or INVa F) will result in the form of no colonies. It has been 
anticipated that Mcr assays would be the most sensitive, because of the continuous 
production of methylated DNA, which should constantly provide new targets for the 
mcr systems. However, (Mi and Roberts, 1992) suggest that testing plasmid 
sensitivity to restriction enzyme is preferable. 
43 
CHAPTER TWO 
2.2.11.2: In vivo DNA Methyltransferase Activity Assay (Sensitivity to 
Restriction Endonuclease) 
The evaluation of the activity of a C5 Mtase involves digestion of DNA extracted 
from the cells containing the Mtase, with a restriction endonuclease. For example 
when a plasmid carries a DNA Mtase gene, that plasmid is fully methylated at the 
sites on the plasmid that are recognized by the enzyme. This phenomenon facilitates 
the analysis of active and inactive mutant enzymes e. g. pGEX-KG-2T carrying the 
M. SPRI gene has 21 Mspl, 23 HaeIII and 11 EcoRII recognition sites. All sites are 
protected from restriction digestion by these restriction enzymes when the plasmid is 
recovered from the cells. Similarly M. HhaI can methylate all of its recognition sites 
and therefore Hhal cannot restrict the plasmid. However, certain mutant gene 
carrying plasmids are no longer resistant to cleavage and show smaller fragments 
when subjected to restriction digestion by any of these enzymes. Therefore, making 
it qualitatively possible to analyse the activity check for the cloned gene. The 
digestion profile is then checked by agarose gel electrophoresis. However when site- 
specific mutagenesis was carried out at various locations in the M. HhaI or M. SPRI 
gene, the activity of encoded protein was altered and various different levels of 
methylation was observed during this study which were difficult to analyse on the 
agarose gel. 
To establish various levels of methylation potential for an accurate digestion profile I 
have analysed the restricted fragments by a more sensitive technique by using 
DHPLC. 
2.2.12: DNA FRAGMENT SEPARATION WITH THE DIIPLC (WAVE TM 
SYSTEM 
2.2.12.1: Introduction 
Although the WAVETM system works like high performance/pressure liquid 
chromatography (HPLC), there are two important factors, which make it unique, and 
they are: 
a) Buffers used in combination with Ion pairing reagent(s) 
b) The DNAsep® column 
DNA molecules carry a negative charge due to their phosphate backbone. Long DNA 
fragments carry more net negative charges than shorter DNA fragments. The 
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stationary phase of the DNAsep® cartridge in the WAVETM instrument is electrically 
neutral and hydrophobic, and therefore DNA fragments themselves cannot be 
absorbed to the column. An ion-pairing reagent, triethylammonium acetate (TEAA), 
is needed as a bridging molecule to help the adsorption of DNA onto the column. 
The sizing of DNA fragments is based on the conversion of the hydrophobic 
stationary phase of the column into a dynamic ion-exchanger by adsorption of 
TEAA, which acts as a bridge between the fragments and the column. The positively 
charged ammonium ion of TEAA interacts with the negatively charged phosphate 
ions of DNA. The alkyl chains of the TEAA molecule interact with the hydrophobic 
surface of the column and therefore the longer DNA fragments will be adsorbed 
more strongly to the column than the shorter fragments. This interaction is reduced 
with the increase of the amount of acetonitrile in buffers AB, which are used as 
mobile phase in the system. This means that the separation on the WAVETM is size 
dependent and not sequence dependent. 
Optimization of column and buffer gradient 
In order to calibrate the DNAsep column, standard DNA markers such as pUC 18 
HaeIII digest and the GeneRulerTM 100 bp DNA ladder were used for separation by 
DHPLC. These fragments were separated according to their sizes by DHPLC. The 
gradient of buffers for DHPLC was optimized so that in most of the cases the largest 
fragment is eluted within 14 minutes and any uncut DNA (protected due to 
methylation) will be eluted at the end of the chromatogram with the acetonitrile 
washing of the column. The conditions for separation of DNA fragments on the 
DHPLC were optimized and used throughout (shown in Table 2.6). 2.5 µg of the 
each marker DNA was injected onto a preparative column (Transgenomic) and the 
retention time obtained for each standard DNA fragments is also tabulated (Table 
2.7). 
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Table 2.6: The gradient of buffers used for DHPLC. 
Time (min) %Buffer A 
(0.1 M TEAA) 
%Buffer B 
(0.1 M TEAA + 
25%AC 
Flow Rate ml/min Temperature °C 
0.0 65.0 35.0 0.75 50 
2.0 45.0 55.0 
10.0 35.0 65.0 
12.0 35.0 65.0 
17.0 28.0 72.0 
18.0 28.0 72.0 
19.0 0.0 100.0 
20.0 0.0 100.0 
21.0 65.0 35.0 
Table 2.7: Size of DNA marker fragments and their retention time 
Size of DNA (in base pairs) Retention time (in minutes) 
1 80 4.39 
2 100 4.82 
3 102 4.87 
4 174 6.29 
5 200 6.89 
6 257 8.37 
7 267 8.65 
8 298 9.36 
9 300 9.29 
10 400 11.12 
11 434 11.78 
12 458 12.15 
13 500 12.17 
14 587 13.57 
15 600 13.18 
16 700 13.87 
17 800 14.75 
18 900 15.89 
19 1000 16.58 
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2.2.12.2: Experimental procedure using DHPLC (WaveTM system) 
After overnight growth at 37°C, plasmids were purified using a Wizard Plus 
Minipreps kit (Promega) and then analysed by restriction digestion and separation of 
DNA fragments by DHPLC. The WaveTM system workstation handles complete 
DNA fragment analysis. The WaveTM built-in auto sampler injects the restricted 
DNA samples into DNAsep® column and a high-resolution micro-pellicular matrix 
rapidly separates DNA fragments (see above). The gradient of buffer A and B was 
used as shown in Table 2.6. The UV detector was set to 260 nm wavelength and all 
the DNA separations were carried out at 50°C with a flow rate of 0.75 ml per minute. 
Data obtained was analyzed using Hitachi model D-7000 Chromatography Data 
Station Software and Transgenomic Wave viewer software. 
2.2.13: IN VITRO DNA METHYLTRANSFERASE ACTIVITY ASSAY 
A) The activity of in vivo expressed and purified protein was checked by methylation 
of 1 µg of bacteriophage ? DNA, in the presence of excess of S-adenosyl-L- 
methionine (SAM). Reaction was carried out in a final volume of 20 µl with 2 µ1 of 
SAM (1 mM), 2 µ1 (10X) Mtase buffer (50 mM NaCl, 50 mM Tris-HCl pH 7.5,10 
mM EDTA, 1 mM DTT &5 mM ß-mercaptoethanol) and the protein sample. The 
mixture was incubated at 37°C for one hour. The reaction was stopped by adding 2 pl 
of 10 mM N-ethylmaleimide (NEM). 
Each reaction mixture was then subjected to digestion with 10 units of HaeI1I (in 
case of M. SPRI) and Hhal in case of M. HhaI protein. The volume of reaction 
mixture is increased up to 30 µl with appropriate restriction enzyme buffer and water. 
The mixture was further kept for one hour at 37°C before loading the samples onto a 
1% agarose gel. A control experiment was also carried out in parallel using 
commercially available respective Mtase. 
B) The activity of in vitro protein was checked first by binding the protein with 
glutathione agarose beads. Freshly prepared 20-25 µ1 beads (bed volume 10 pl) were 
used to bind with 10 pl in vitro translated mixture and kept for binding for some time 
at 4°C and then washed once with 1X Mtase buffer to remove unbound proteins from 
the beads. The beads were then mixed with S-adenosyl-L-methionine (SAM), 600 ng 
X DNA and Mtase buffer for incubation at 37°C for 1 hour. The mixture was 
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centrifuged to recover the supernatant in a separate tube before the reaction was 
stopped by adding 2 t1 of 10 mM NEM. Each reaction mixture was then subjected to 
restriction analysis and run on a 1% agarose gel. 
2.2.14: EXPERIMENTAL PROCEDURE USING SURFACE PLASMON 
RESONANCE (SPR) (QUANTIFICATION AND BINDING ASSAYS ON 
BIACORE) 
A BlAcore instrument (BlAcore 2000) was used with two sensor chips (both 
research grade) for the biochemical analysis of in vitro-translated products of wild 
type and mutant methyltransferases. 
The BlAcore chips that were used were: 
" SA (pre-coated with streptavidin) and 
9 CM5 (pre-coated with carbo)y-methyl dextran) 
BBS BIA buffer from BlAcore was used for running the samples and all experiments 
were carried out at 25°C. 
2.2.14.1: Immobilization of Biotinylated Oligonucleotides 
5'-biotinylated oligonucleotide solution were quantified spectrophotometrically and 
100 nM solutions were prepared by diluting the oligonucleotide in the appropriate 
running buffer. The BlAcore, sensor chip SA was first washed 3X using 0.1 M 
NaOH. The biotinylated oligonucleotide was then passed over the streptavidin sensor 
chip surface at a flow rate of 10 µl/min, until the desired level was achieved. 
2.2.14.2: Immobilization of anti-GST 
The GST capture kit from BlAcore was used for high affinity capture of the GST 
fusion protein on the surface of a CM5 chip. Carboxyl groups on the matrix of CM5 
chip were activated to form active esters by passing 30 µl 1: 1 mixture of 100mM N- 
hydroxysuccinimide (NHS) and 400 mM N-ethyl-N'(dimethylaminopropyl) 
carbodiimide (EDC) at a flow rate of 5 gl/min. The active ester groups react 
spontaneously with amine groups on the ligand. The diluted goat anti-GST antibody 
30 µg/ml in coupling solution (10 mM Sodium Acetate) (3 µl anti-GST + 77 µl 
Coupling solution) was passed over CM5 chip for immobilization by activated esters. 
After ligand coupling with matrix a solution of 1M-ethanolamine hydrochloride (pH 
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8.5) is added to deactivate remaining active esters. CM5 chip was now used for 
standard curve formation and quantification of unknown samples. 
2.2.14.3: Protein DNA Interactions 
Various wild type and mutant plasmids DNA were used to produce protein using 
Promega's T7 S30 extract System for circular DNA. This method was chosen simply 
because it reduces the time required to obtain in vitro translation results and it was 
easy to handle many samples at one time. In vitro translated products were first used 
for site-directed immobilization of fusion proteins through capture on immobilized 
anti-GST, for quantification. A positive control in this case was a standard 
recombinant GST fusion protein, which allowed for its quantification. Then the 
diluted in vitro products with running buffer were used for kinetic analysis of the 
protein-DNA interaction using a constant flow rate at 20 µl/minute. Bound protein 
was eluted from the DNA using a short pulse of 1M NaCl. This regeneration 
procedure did not alter to any measurable extent the ability of the immobilized DNA 
to bind protein in subsequent cycles. All analysis on the sensogram data was 
performed using the BlAevaluation software. 
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CHAPTER THREE 
REDESIGNING OF MOTIF IX OF MONOSPECIFIC 
Mtase M. HhaI 
3.1: M. SPRI multi-specific Mtase 
3.1.1: INTRODUCTION 
A number of bacteriophages from a variety of phylogenetically different hosts 
encode type II Mtases that recognise targets similar to those of the restriction 
modification (RM) system of the host that they infect. SPR is a Bacillus subtilus 
phage, which encodes a `multispecific' Mtase, which has the capacity to methylate 
several different DNA target sequences (Trautner et al., 1980; Buhk et al., 1984; 
Wilke et al., 1988). One of these multiple specificities may be identical to the RM 
system present in the bacterial host lysogenised by the bacteriophage. 
M. SPRI is a type II multispecific Mtase that catalyses the transfer of a methyl group 
from SAM to the C5 position of the underlined cytosine within the nucleotide 
sequences CCA/TGG (EcoRII), CCGG (Mspl) and GGCC (HaeIII). The three 
recognition sequences for M. SPRI are due to the activity of TRDs E, M and H, 
which are present in the order shown (Trautner et al., 1980; Behrens et al., 1983; 
Tran-Betcke et al., 1986; Wilke et al., 1988; Trautner et al., 1996). The TRDs of 
multispecific Mtases are structurally and functionally independent (Walter et al., 
1992). The gene coding for the sequence-specific DNA Mtase of the Bacillus 
subtilus phage SPR has been cloned from a genomic library of Bacillus subtilus 
phage DNA (Behrens et al., 1983) and its nucleotide sequence determined (Buhk et 
al., and Posfai et al., 1984). The DNA sequence of M. SPRI is shown in Figure 3.1 
and is from the GenBankTM/EMBL Data bank with the accession number X01670. 
The M. SPRI gene encodes a 49.8 kDa protein that shows a primary structure typical 
of a C5 Mtase (Tran-Betcke et al., 1986; Lauster et al., 1989; Posfai et al., 1989; 
Wilson and Murray, 1991; Kumar et al., 1994). 
The gene encoding M. SPRI was obtained from Professor T. Trautner (Berlin) and 
was sub-cloned into pGEX-KG by Dr. Alan Whitmarsh. In order to expedite a 
mutational analysis of M. SPRI, a set of unique restriction sites were introduced 
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1 ATG GGT AAA CTA CGT GTA ATG AGT CTT TTT AGT GGG ATC GGT GGA TTT 
MGRLRVMSLFSGIGGF 
49 CAA GCT GCA CTA AGA AAC ATT GGG GTT GGT TAT GAG CTG GTT GGT TTT 
EAALRNIGVGYELVGF 
97 AGT GAG ATT GAT AAA TAT GCC GTC AAA TCT TTT TGT GCA ATT CAC AAC 
SEIDKYAVKSFCAIHN 
145 GTT GAT GAG CAA TTA AAT TTT GGA GAT GTA AGC AAG ATT GAT AAG AAA 
VDEQLNFGDVSKIDKK 
193 AAA CTA CCT GAA TTT GAT ATC TTA GTT GGA GGA TCT CCT TGT CAA AGC 
KLPEFDILVGGSPCQS 
241 TTT AGT GTA GCC GGC CAT CGA AAG GGA TTT GAA GAT ACA AGA GGG ACA 
FSVAGHRKGFEDTRGT 
289 TTG TTT TTT CAA TAC GTT GAG ACT CTT AAG GAA AAG : ... LFFQYVETLKEKQPKF 
337 -. 
FVFENVKGLINHDKGN 
385 ACA TTA AAT GTT ATG GCT GAA GCT TTC AGT GAA GTT GGG TAC AGA ATT 
TLNVMAEAFSEVGYRI 
433 GAT CTA GAG CTC 
DLELLNSKFFNVPQNR 
481 AGA GAA GAT TTA ATT AAA AAT GAA 
ERLYIIGIREDLIKNE 
529 GAA TGG TCT TTG GAT TTT AAA AGA AAG GAT ATA CTT CAA AAA GGG AAA 
EWSLDFKRKDILQKGK 
577 CAG AGA TTG GTA GAA TTA GAT ATT AAA AGC TTT AAT TTT AGA TGG ACA 
QRLVELDIKSFNFRWT 
625 GCT CAA TCG GCT GCT ACG AAG AGG CTA AAA GAT TTA TTA GAA GAA TAC 
AQSAATKRLKDLLEEY 
673 GTT GAT GAA AAG TAC TAC TTG AAT GAA GAT AAA ACA AAC AGT TTG ATC 
VDEKYYLNEDKTNSLI 
721 AAA GAG TTG TCT ACA AGT CGA CTT AAT GAA AAT CTT ACT GTT GAG CAA 
KELSTSRLNENLTVEQ 
769 GTA GGT AAC ATT AAT CCC TCT GGT AAT GGA ATG AAT GGA AAT GTT TAT 
VGNINPSGNGMNGNVY 
817 AAT TCA TCT GGA TTA AGC CCC ACA ATT ACC ACT AAT AAA GGA GAG GGA 
NSSGLSPTITTNKGEG 
865 CTG AAA ATT GCA GTT GAG TAC TCC AGA AAA AGC GGG CTT GGA CGA GAA 
LKIAVEYSRKSGLGRE 
913 CTT GCT GTA TCT CAT ACG CTT TCT GCT TCT GAC TGG AGA GGA TTG AAT 
LAVSHTLSASDWRGLN 
961 AGG AAC CAA AAA CAA AAT GCA GTT GTT GAG GTA AGG CCA GTA TTA ACC 
RNQKQNAVVEVRPVLT 
1009 CCA GAA AGG GGG GAG AAG CGA CAA AAT GGA AGA AGA TTT AAA GAT GAC 
PERGEKRQNGRRFKDD 
1057 GGT GAA CCA GCA TTT ACA GTA AAC ACA ATT GAC AGA CAC GGG GTA GCG 
GEPAFTVNTIDRHGVA 
1105 GTT GGA GAG TAT CCA AAA TAC AGA ATT AGA AGA TTA ACA CCG TTA GAC, 
VGEYPKYRIRRLTPLE 
1153 TGC TTT AGG CTA CAG GCT TTT GAT GAC GAA GAT TTT GAA AAA GCT TTT 
CFRLQAFDDEDFEKAF 
1201 GCT GCG GGA ATA AGT AAC TCA CAA TTA TAT AAG CAA GCC GGT AAT TCA 
AAGISNSQLYKQAGNS 
1249 ATT ACT GTA ACT GTG CTT GAG TCA ATA TTC AAG GAA TTA ATA CAT ACA 
ITVTVLESIFKELIHT 
1297 TAC GTT AAT AAA GAA TCT GAA TAA 
YVNKESE Stop 
Figure 3.1: Nucleotide and amino acid sequences of M. SPRI. The amino acids present in the six 
highly conserved motifs of C5-Mtases are coloured as follows: Motif I (red), motif IV (brown), motif 
VI (green), motif VIII (light blue), motif IX (pink) and motif X (dark blue). The TRD region between 
motif VIII and IX is shown with underlined amino acids. Data from GenBankTM/EMBL Data Bank: 
accession number K02124/X01670. 
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which would not lead to a change in the enzyme's primary structure. To achieve this, 
four sets of oligonucleotides were designed (Figure 3.2) for the sequential 
replacement of the 3' end of the gene, carrying unique restriction sites that are not 
present in the starting plasmid pGEXKG-SPR. These linker duplex oligos were 
annealed and ligated sequentially into pLitmus 28 and were subsequently transferred 
to pGEXKG-SPR by exchanging the original Munl/Xhol fragment. The construct is 
named pQIS 6 (Figure 3.3). The presence of the newly inserted DNA was also 
confirmed by nucleotide sequence analysis. The protein encoded by construct pQIS 6 
was active and the plasmid preparation of pQIS 6 showed resistance to cleavage by 
Mspl and HaeIII. 
Although the gene is expressed as a GST fusion protein, it has been observed that a 
small C-terminal moiety is partially removed by in vivo proteolysis (personal 
communication from Adel Al-Ghanim). In order to facilitate purification of the intact 
fusion protein an oligonucleotide duplex encoding six histidines was introduced at 
the 3' end of the gene before the stop codon. Two complementary 
oligodeoxynucleotides were designed in order to produce cohesive ends for Ndel (see 
below). This annealed synthetic duplex, NIS 7/NIS 8, carries six histidine codons 
along with a new restriction site, Xbal, for diagnostic purposes (see below). A two 
base pair overhang (TA) has been introduced at both ends, and after insertion of the 
linker at the Ndel site in pQIS 6a unique Nde1 site was introduced into the plasmid. 
The last two bases after the Xbal site in the linker has been changed from CA to TC 
and therefore the linker can be ligated with any Ndel digested overhang but will not 
be cleaved by Ndel after ligation. 
Sequence of oligos for the 6X histidine codon insertion into the M. SPRI gene 
Top oligo NIS 7: 5'-TATGTTAATAAAGAATCTGAACATCATCATCATCATCATTAATCTAGATc-3' 
Bottom oligo NIS 8: 5'-TAGATCTAGATTAATGATGATGATGATGATGTTCAGATTCTTTATTAACA-3' 
NIS7/NIS8 linker duplex with Ndel site overhang: 
Xba[ 
5'-TAT GTTAATAAAGAATCTGAACATCATCATCATCATCATTAATCTAGATC-3' 
3-' ACAATTATTTCTTAGACTTGTAGTAGTAGTAGTAGTAATTAGATCTAGAT-5' 
His His His His His His Stop 
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Linker 1 
MunI EcoRI XbaI Xhoi 
5'--AATTGACAGACACGGGGTAGCGGTTGGAGAGTATCCAAAATACAGAATTCTCTAGAC--3' 
3'--CTGTCTGTGCCCCATCGCCAACCTCTCATAGGTTTTATGTCTTAAGAGATCTGAGCT--5' 
Oligo Linker I=Q1 T/Q IB duplex 
Linker 2 
ECORI Stuf Xhoi 
AATTCGAAGATTAACACCGTTAGAGTGCTTTAGGCTACAGGCTTTTGATGACGAAGATTTCGAAAAGGCCTC-3' 
3'-GCTTCTAATTGTGGCAATCTCACGAAATCCGATGTCCGAAAACTACTGCTTCTAAAGCTTTTCCGGAGAGCT-5' 
Oligo Linker 2= Q2T/Q2B duplex 
Linker 3 
Stuff BspDI/ClaI Xhoi 
5' CCTTTGCTGCGGGAATAAGTAACTCACAGTTGTACAAGCAAGCCGGTAATTCAATTACTGTAACTGTGCTTGAATCGATC-3' 
3'-GGAAACGACGCCCTTATTCATTGAGTGTCAACATGTTCGTTCGGCCATTAAGTTAATGACATTGACACGAACTTAGCTAGAGCT-3' 
Oligo Linker 3= Q3T/Q3B duplex 
Linker 4 
BspDI/C1aI Ndel Xhoi 
5'-CGATATTCAAGGAATTAATACATACATATGTTAATAAAGAATCTGAATAAC-3' 
3'-TATAAGTTCCTTAATTATGTATGTATACAATTATTTCTTAGACTTATTGAGCT-5' 
Oligo Linker 4= Q4T/Q4B duplex 
Oligo linker 1 Oligo linker 2 Oligo linker 3 Oligo linker 4 
Muni EcoRI SfuI Ndel XhoI 
M. SPRI motif IX and X 
(239 bp) 
Figure 3.2: A set of four Oligonucleotide linkers 1-4 used for cloning and introduction of 
new restriction sites into the gene for M. SPR Oligonucleotides are shown with their 
complementary oligonucleotides as duplex. The new restriction sites are shown in bold. The 
sticky or blunt-ended restriction sites used for cloning are shown in red. A general map of the 
linker regions relative to the original M. SPRI gene is shown at the bottom. (Map size of linkers 
are not shown according to scale). 
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The wild type M. SPRI gene cloned in pGEXKG-SPR with the new restriction sites, 
(pQIS 6) (see above) was cleaved with Mel and the resultant 6327 bp fragment was 
purified after gel electrophoresis. In order to inhibit the religation of vector, 5' 
terminal phosphates were removed using calf intestinal phosphatase (CIP). CIP 
treated and purified DNA was ligated with the NIS 7/ NIS 8 linker duplex. A 
construct pQIS 7 was finally made which encoded an active Mtase. Restriction 
digestion with Xbal confirmed the presence of an insert carrying six histidine codons 
(Figure 3.3). Nucleotide sequencing of the final construct pQIS 7 also confirmed that 
it contain the newly introduced sites and six histidine codons. Part of the 
chromatograms showing sequencing results in the motif IX and X of M. SPRI is 
shown in Figure 3.4. 
3.1.2: STRUCTURAL FLEXIBILITY 
Proteins show remarkably high tolerance to point mutations (Matthews, 1987). This 
is due to the high plasticity of protein structures in which only a limited subset of 
amino acids is critical for folding, stability and activity. The tertiary structure of 
some proteins can permit the incorporation of additional amino acids into a regular 
structural element without causing structural perturbations as long as the vital 
internal interactions are preserved (Heinz et al., 1994). 
Multi-specific Mtases, such as M. SPRI and M. BssHII, recognise several different 
DNA sequences and possess two to five TRDs. Each TRD recognises a unique 
sequence of bases but utilises the same catalytic site for the methyl transfer reaction. 
Multi-specific Mtase genes can also accommodate DNA of non-Mtase origin within 
the coding section of the TRDs without loss of enzyme activity (Walter et al., 1992). 
This remarkable plasticity suggests that the enzyme core sequences preceding or 
following the TRD form separable functional domains (Walter et al., 1992). It has 
been shown that the domain in the SPR Mtase, determining CCGG methylation, can 
be deleted without affecting the capacity of the mutant enzyme to methylate other 
target sequences (Wilke et al., 1988). Matin (2000) have modified the variable region 
of M. SPRI thereby producing a novel method for the detection and characterisation 
of nonsense mutations. 
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Muni Slut Xhol 
---> mai 
laclq 
GS Bam 
pGEXKG-SPR 
6277 bps SPR 
ml 
Xhol 
EcoRI Ndel 
Reconstructed M. SPR motif IX and X 
(239 bp) 
123 MI M 
559 bp 
Gel 2 
MunI Xhol 
Replacement o motif IX-X M. SPR motif IX and X 
(239 bp) 
GST 
laclq 
pQIS 6 
6277 bps SPR 
I'Xhol 
Amp NM' 
XhoI 
6X His dines 
Val 
Ndel Ndel 
NIS7/NIS8 linker 
kb 
GS BamHI 
aclq 
pQIS 7 Sp 6327 bps 
Figure 3.3: Schematic representation showing the construction of pQIS 6& pQIS 7. The newly 
introduced restriction sites are shown in plasmids pQIS 6 and pQIS 7. Gel 1 shows restriction 
analysis of pQIS 6, Lane 1: Sall/Ndel digest (559,5718 bp) 2: Stul cut (linear 6277 bp) 3: Munl/Xhol 
digest (239,6038 bp) Ml: 100 bp DNA ladder M: GeneRulerTM 1 kb DNA ladder. Gel 2 shows 
methylation status and restriction analysis of pQIS 7. Lane M: GeneRulerTM 1 kb DNA ladder. 1: 
pQIS 7 Mspl digest 2: pQIS 7 HaeIII digest. 3: EcoRI cut (linear 6327 bp) 4: MunI cut (linear 6327 
bp) 5: XbaI cut (linear 6327 bp). (For markers fragment sizes, see Chapter 2). 
Gel 1 
M12345 
(A) 
(B) EcoRI 
Muni 
rA.. 
.. TACA. 
IG AAT 
Lys Tyr Arg Ile 
(C) 
GATTTCGA. AA 1A GGCC TI TTGCTGCGGG 'Z+. 
Asp Phe Glu Lys Ala Phe Ala Ala Gly 
GAA: GATTAAC%,. CCG 
Arg Arg Leu Thr Pro 
Figure 3.4: Part of the DNA sequencing analysis for wild type M. SPRI gene (pQIS 7) after 
introduction of new restriction sites and insertion of codons for six histidines. Data shows the 
presence of the Muni restriction site (panel A), EcoRl site (panel B), Stul site (panel C), Ndel site 
(panel D), codons for six histidines, stop codon followed by Xbal site (panel E), and Xhol site (panel F). 
(D) Ndel 
GAATTATACATACAT AT G 
IT 
TAATAA. 
Glu Leu Ile His Thr Tyr Val Asn Lys 
_ 
flC"'J LL'fJ 
: 1' - 
-' 
(E) Xbal 
CATCATCATCA. TC. TCATT : +. ATCTAGü. T 
His His His His His His stop 
(F) 
Figure 3.4: Part of the DNA sequencing analysis for wild type M. SPRI gene (pQIS 7) after 
introduction of new restriction sites and insertion of codons for six histidines. Data shows the 
presence of the MunI restriction site (panel A), EcoRI site (panel B), Stul site (panel C), Ndel site 
(panel D), codons for six histidines, stop codon followed by Xbal site (panel E), and Xhol site (panel F). 
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3.1.3: MOTIF IX MODIFICATION IN M. SPRI GENE 
The determination of the 3D structure of M. Hhal revealed a two-domain 
organisation of this typical mono-specific Mtase. This structure confirmed many of 
the predictions made by (Behrens et al., 1987; Wilke et al., 1988; Posfai et al., 1989; 
Walter et al., 1992). 
Mutagenesis studies by Trautner (1988) have established that motif IX is the "core 
structure", i. e. the region needed for the methylation reaction. The conserved motif 
IX of C5-MTases has the consensus sequence RXXXXXEXXR (where X may be 
any amino acid). The sequences obtained from Genbank for several multi-specific 
DNA-Mtases contain similar sequences in this region (Figure 3.5) with the exception 
of M. BssHII, which possesses unusual target recognition properties (Schumann et 
al., 1996) and also exists in an isoform (Sethmann et al., 1999). We have also 
calculated the percentage conservation of M. SPRI and M. HhaI at each amino acid 
level present in motif IX (Table 3.1). M. SPRI differs only at amino acid position 
numbers 379 and 386 compared to the other members of the same family (Figure 
3.5). In general, the sequence of M. SPRI shows that there is some room for 
flexibility: Arg at position 379 can be accommodated instead of Lys (Figure 3.5). 
Similarly, Phe at position 386 in place of Trp in other multi-specific Mtases also 
suggests some flexibility in the structure (Figure 3.5). 
In order to understand more fully the relationship between mono-specific and multi- 
specific Mtases the following are three possible experimental approaches that I have 
considered. 
i) Alteration of the sequences of motif IX of M. SPRI to conform to other 
multi-specific Mtases. This involves mutation of Phenylalanine (F) 386 to 
Tryptophan (W) and Arginine (R) 379 to Lysine (K). 
ii) Alterations to motif IX of M. SPRI towards the sequences of mono-specific 
Mtases. 
iii) Finally it may be interesting to see whether random mutagenesis of the 
region-encoding motif IX can generate proteins with novel sequences that 
retain activity. 
Trautner et al., 1988 has carried out random mutagenesis of M. SPRI and found all 
the mutants in motif IX and X belongs to class I mutants in which the general 
methylation capacity of the Mtases is reduced or destroyed. Therefore a rational 
approach for mutagenesis was chosen instead of a random mutagenesis technique. It 
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Position ofA. A of SPR 378 80 84 86 90 92 95 
1. M. SPRI RRLTPLECFRLQAFDDED 
2. M. pIIs RKLTPLECWRLQAFDEED 
3. M. 021 RRLTPLECWRLQAFDEED 
4. M. ý3TII RRLSPLECWRLQAFDDED 
S. M. BssHII RRFTVRECLRIQSVPDWY 
Consensus IRER 
Decreasing KWAD 
Order WWW R F/L SP 
Position ofA. A ofSPR 378 80 84 86 9 
M. SPR 
M. AluI 
M. AquI 
M. BanI 
M. BepI 
M. BspRI 
M. BsuFI 
M. clam 
M. DdeI 
M. DsaV 
M. EcoRII 
M. HaeIII 
M. HgaI 
M. HhaI 
M. HpaII 
M. MspI 
M. Mth TI 
M. Ngoi 
M. Ngo V 
M. cp3TII 
M. SinI 
IHPFEDRMLTVRE 
VQNNVPRRITPRE 
I 
GKEHL 
ESPKP 
GRETL 
Genbank Accession number 
X02124 
X05242 
M72412 
M13488 
X90873 
95 Genbank Accession number 
;D K02124 
qF Z11841 
)W M28051 
DF D00704 
DY X13555 
WY X15758 
DF X51515 
PG X13330 
TY Y00449 
SF U10528 
VD X05050 
FI M24625 
NW D90363 
SY J02677 
SY X51322 
DF X14191 
DF M97222 
NF U42459 
DF U43735 
TY X80202 
EW J03391 
Figure 3.5: Comparison of sequence of amino acids in and around motif IX among 5 multispecific 
and 20 monospecific methyltransferases. All these enzymes conform well to the consensus sequence 
(shown in red) except M. Bepl (Brevibacterium epidermidis) and M. Sinl (Salmonella infantis). Among 
these enzymes, only one is (multispecific Mtase SPR), whereas M. Hgal is a bacterial C5 
hemimethyltransferase. The consensus sequence is shown in red. The amino acids shown at the bottom of 
alignment at position 379,386,390, and 392 of M. SPRI is the sequence in decreasing order of 
conservation at these positions. 
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was decided to mutate the SPR motif IX at three different positions. Three amino 
acids positioned at 386,390 and 392 were replaced with the most frequently found 
amino acids present in monospecific Mtases, as shown in Figure 3.5. 
When 20 mono-specific Mtases of different origins were compared with respect to 
motif IX, it was observed that this region is not as stringently conserved as that in the 
multi-specific Mtases. Additionally these Mtases show a lower degree of primary 
structure conservation than multi-specific enzymes. Mono-specific Mtases usually 
have an alanine at position 386 whereas at position 390 and 392 the most commonly 
found amino acids are glycine and proline (Figure 3.5, Table 3.1). Therefore, we 
opted to alter M. SPRI by introducing these amino acids and to examine the effects of 
these changes upon the activity of the mutant Mtases. Overviews of the mutations 
generated in this experiment are shown in figure 3.5 (a). The figures for the 
schematic representation of formation of mutants were collectively placed at the end 
of the chapter. 
3.1.4: MUTAGENESIS OF WILD TYPE MOTIF IX OF M. SPRI TOWARDS 
M. HhaI 
The oligonucleotides were designed for these three mutations (Phe 386 Ala, Ala 390 
Gly and Asp 392 Pro) by site directed mutagenesis and were synthesised by the 
central facility of the department. 
3.1.4.1: Phe 386 Ala mutagenesis in wild type M. SPRI 
Primer/oligonucleotide NIS 9 and NIS 10 were designed to mutate Phe 386 to Ala of 
M. SPRI, and the duplex also carries a new FspI site for diagnostic purposes. The 
NIS 9/NIS10 duplex oligonucleotide: 
Fspl 
5'-CCGTTAGAGTGCGCAAGGCTACAGGC-3' 
3'-GGCAATCTCACGCGTTCCGATGTCCG-5' 
PLECARLQ 
NIS 9: 5'-CCGTTAGAGTGCGCAAGGCTACAGGC-3' 
NIS10: 5'-GCCTGTAGCCTTGCGCACTCTAACGG-3' 
codons changed are underlined and the new FspI restriction site is shown in red. 
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Amino Acid Residues 
with numbers 
Percentage Conservation 
within their group 
Amino acids within 4.0 A 
vicinity in M. Hhal 
M. SPR M. HhaI Multispecific 
Mtases 
Monospecific 
Mtases 
R378 R272 100 100 Y265, V2o2, V267, E278, L196 
R379 K273 40 15 D2o8 
L38o L274 80 65 T262, Y299 
T381 H275 80 5 R277, E278, C279 
P382 P276 80 35 E278, C279, A28o 
L383 R277 80 75 1-1275, Y289, C279, A280,8281 
E384 E278 100 100 H275, P276, R272, L196, L197, 
A28o, 8281, V282 
C385 C279 100 50 H275, P276, R277, T262, Y299, 
R281, V282, M283 
F386 A28o 20 75 P276, R277, E278, V282, M283, 
G284, Y285 
R387 R281 100 95 8277, E278, C279, D287, L195, 
M283,6284 
L388 V282 80 10 E278, C279, A280, G284,1159, 
Q161, 
Q389 M283 100 20 C279, A280, R281, Q161, F302, 
Y285,1308, 
A390 G284 80 70 A28o, R281, V282, MI 
F391 Y285 80 5 A280, M283, G23, S305 
D392 P286 80 95 MI, S288, Y289 
D393 D287 60 55 R281, Y289 
E394 S288 80 20 P286 
D395 Y289 80 40 P286, D287, N52, L21, R277 
Table 3.1: Motif IX Residues of M. SPR & M. HhaI, percentage conservation, and 
M. HhaI interaction with other amino acids. The amino acids shown in red are 
conserved. The percentage similarity was calculated on the basis of Figure 3.5. 
Similar amino acids in M. SPR and M. HhaI are shown blue. 
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Wild type M. SPRI 
pGEXKG-SPR 7 
Wild type M. SPRI 
Active 
GST fused at N-terminus 
pQIS 6 
Wild type M. SPRI 
Active 
GST fused at N-terminus with new restriction sites 
pQIS 7 
Wild type M. SPRI 
Active 
GST fused at N-terminus with new restriction sites and a 6x his tag at the C-terminus 
pQIS 8 
F 386 A 
Partially active 
Fspl site introduced 
pQJs9 
A390G 
Active 
Confirmed by sequencing 
pQis 10 
D392P 
Active 
Confirmed by sequencing 
Key: 
Plasmid Number 
Mutational Position 
Methylation Activity 
Diagnostic Site Introduced 
Figure 3.5 (a): An overview of the formation of mutants of M. SPRI. Wild type M. SPRI in this figure 
already carries GST fusion at its N-terminus and a six histidine tag at the C-terminus (page 51-52) and 
figure 3.3. 
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3.1.4.2: Ala 390 Gly mutagenesis in wild type M. SPRI 
It was not possible in this case to introduce a diagnostic site for the Ala 390 Gly 
mutation. The sequences of the primers/oligonucleotides designed for the Ala 390 to 
Gly mutation were NIS 11 and NIS 12 as shown below. The mutated bases are 
shown in blue. 
NIS 11/NISI2 duplex oligonucleotide: 
5'-GCTTTAGGCTACAGGGTTTTGATGACGAAG-3' 
3'-CGAAATCCGATGTCCCAAAACTACTGCTTC-5' 
FRLQGFDDE 
NISII: 5'-GCTTTAGGCTACAGGGTTTTGATGACGAAG-3' 
NIS12: 5'-CTTCGTCATCAAAACCCTGTAGCCTAAAGC-3' 
3.1.4.3: Asp 392 Pro mutagenesis in wild type M. SPRI 
The primers used for the introduction of the third mutation in M. SPRI, Asp 392 Pro 
were NIS 13 and NIS 14. The sequences are shown below with the changes 
underlined and in blue. 
NIS 13/NIS14 duplex oligonucleotide: 
5'-GGCTACAGGCTTTTCCGGACGAAGATTTTG-3' 
3'-CCGATGTCCGAAAAGGCCTGCTTCTAAAAC-5' 
LQAFPDEDF 
NIS13: 5'-GGCTACAGGCTTTTCCGGACGAAGATTTTG-3' 
NIS14: 5'-CAAAATCTTCGTCCGGAAAAGCCTGTAGCC-3' 
Site-directed mutagenesis was carried out to generate each mutation separately using 
the construct pQIS 7 (which encodes wild-type M. SPRI) as a template and the newly 
synthesized mutated plasmids are sketched in Figure 3.6. 
The first mutant was identified by the presence of a new FspI site. The original wild 
type sequence of M. SPRI contains two FspI sites whereas the construct pQIS 8 when 
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digested with FspI gave three fragments of size 2738,2380, and 1209 bps as shown 
in Figure 3.6. The other mutants were identified using DNA sequencing. The 
complete sequences of the mutant plasmids pQIS 8, pQIS 9, and pQIS10 contained 
only the desired mutations in motif IX (Figure 3.7). Part of the sequencing analysis 
data, which confirm the formation of mutants, is shown in Figure 3.8. 
3.1.5: IN VIVO PLASMID RESTRICTION PROTECTION ASSAY 
In order to determine the effect of the three mutations upon the activity of M. SPRI, a 
plasmid protection assay was performed. This involves assessing the sensitivity of 
the plasmid to restriction with MspI and HaeIII endonuclease. As described earlier 
(Chapter Two, section 2.2.11.2), modification of DNA sequence by a DNA Mtase 
results in the resistance of that sequence to cleavage by the cognate endonuclease. If 
the cloned Mtase gene is active, all Mspl, HaeIII and EcoRII sites on the plasmid 
DNA will be methylated and therefore will be refractory to cleavage. In contrast an 
inactive Mtase would be signified by digested plasmid DNA following analysis by 
agarose gel electrophoresis. 
Plasmid DNA isolated from E. coli cultures was subjected to restriction using an 
excess of enzyme MspI. It was found that the pQIS 8 (which encodes for Phe 386 
Ala in M. SPRI) was not fully protected (See lane 1, Gel 2 of Figure 3.6). Another 
batch of plasmid was made from an overnight culture (originally the plasmid was 
obtained from a six hour culture) that showed the DNA to be fully protected against 
Mspl and HaeIII digestion. Further experiments on pQIS 8 revealed that if the 
culture was grown overnight either at room temperature or at 37°C, fully protected 
DNA was produced. It was therefore concluded from these experiments that Phe 386 
Ala mutant of M. SPRI encoded by pQIS 8, had not lost its ability to methylate DNA 
completely, but needed an extended growth time for complete activity of the protein 
to be expressed. This suggests that the mutant is catalytically or structurally 
compromised. Such mutants are often referred to as partially active, owing to the 
reduced or incomplete plasmid methylation that is observed in vivo (Wilke et al., 
1988; Vilkaitis et al., 2000; Matin, 2000). Therefore, when a restriction digestion of 
the plasmid encoding a Mtase gene shows this kind of pattern, it will be referred to as 
"partially active" throughout this study. 
The mutants Ala 390 Gly and Asp 392 Pro were fully protected and not digested by 
MspI and HaeIII restriction digestion and therefore produced a fully active enzyme, 
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Construct Mutation Amino Acid Sequence Activi a 
370 380 390 
pQIS7 W/T M. SPRI GEYPKYRIRRLTPLECFRLQAFDDED + 
pQIS8 F386A GEYPKYRIRRLTPLECARLQAFDDED +/- 
pQIS9 A390G GEYPKYRIRRLTPLECFRLQGFDDED + 
pQIS10 D392P GEYPKYRIRRLTPLECFRLQAFPDED + 
Figure 3.7: Amino acid sequence of Motif IX from wild type and mutant of M. SPRI. The 
amino acids shown in red are conserved motif IX residues. The mutated amino acids are shown in 
blue. The amino acids residues number are shown on the top. 
a: Activity shown on the right panel of diagram = Full protection (+), partial protection (+/-) 
(A 
(B 
Figure 3.8: Part of the DNA sequencing analysis of plasmids pQIS 8 and pQIS 9. (A) Data confirms 
the formation of construct pQIS 8, which encodes for the Phe 386 Ala mutation in M. SPRI and (B) the formation of construct pQIS 9 which encodes for the Ala 390 Gly mutation in M. SPRI. 
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in spite of the changes to the amino acid sequence (See lane 2 and 3 of Gel 2 in 
Figure 3.6). 
3.1.6: PROTEIN EXPRESSION AND PURIFICATION OF WILD TYPE AND 
MUTANT PHE 386 ALA M. SPRI 
Plasmids pQIS 7 (wild type M. SPRI) and pQIS 8 (mutant Phe 386 Ala of M. SPRI) 
were used for expression of the corresponding proteins in E. coli GM2163, for 
biochemical characterisation purposes. The proteins were expressed and analysed by 
SDS polyacrylamide gel electrophoresis (PAGE) and were purified as shown in 
Figure 3.9. 
The M. SPRI polypeptide is 50 kDa. However when it is fused to GST, it has a 
combined molecular weight of 76 kDa. SDS-PAGE analysis (Figure 3.9) of the 
expressed fusion protein showed that the major induced species was of this 
molecular weight. The fusion protein was purified to greater than 90% purity, as 
assessed using a Coomassie stained gel. The yield was estimated to be -40 µg of 
protein after purification from a 50 ml culture (see Chapter two, section 2.2.8). 
3.1.7: PLASMID PROTECTION ASSAY USING THE WILD TYPE AND 
MUTANT PHE 386 ALA M. SPRI PURIFIED FROM BACTERIA 
3.1.7.1: Dose response 
Purified enzymes were assayed for their in vitro DNA methylation activity. This 
assay is an in vitro mimic of biological restriction and modification, and involves 
pre-incubation of DNA with the Mtase enzyme in the presence of the methyl donor 
SAM, prior to addition of the cognate restriction enzyme (usually in excess). If the 
recombinant protein is active, DNA will be methylated and will therefore be resistant 
to digestion with HaeIII. Bacteriophage lambda DNA was used as substrate in a 
parallel set of reactions. (Lambda DNA contains 328 MspI and 149 HaeIII 
recognition sites). In order to establish the dose response, varying amounts of 
recombinant wild type and Phe 386 Ala mutant M. SPRI were used in a protection 
assay carried out on X DNA. The recombinant wild type and mutant Phe 386 Ala 
Mtases were incubated at 37°C with 1 µg bacteriophage X DNA in Mtase buffer (50 
mM Tris-HCI, pH 7.5,25°C, 50 mM NaCI, 10 mM EDTA, 1 mM DTT) 
supplemented with 100 µM SAM to give a final reaction volume of 20 µl. This 
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pQIS 7 
M1234 
66 kDa 
two 
ý--ýrYrr 
pQIS8 
Figure 3.9: SDS PAGE showing the protein expression and purification after expression pf 
plasmids pQIS 7 (wild type M. SPRI), and pQIS 8 (mutant F 386 A of M. SI'RI). The proteins 
were over-expressed, purified and analysed on 10% SI)S-polyacrylamide gels. M: Broad range 
protein molecular weight marker; 1: 8 µl of Soluble traction; 2: 8 µl of Insoluble fraction; 3,4: 
Samples from the first and second elution fractions (6 µl containing 240 ng and 120 ng respectively); 
M: Broad range protein molecular weight marker; 5: 8 µl Soluble fraction; 6: 8 µl Insoluble 
fraction; 7,8: Sample from the of first and second elution fractions (6 pl containing 300 ng and 150 
ng respectively). The gel was developed with coommassie blue stain followed by destaining. 
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incubation initiated the required methylation reactions. The reactions were stopped 
with 1 mM N-Ethylmaleimide (NEM -a modification reagent specific for cysteine 
residues in proteins) after one hour. An additional step of heat inactivation at 65°C 
for 20 minutes was carried out to completely inactivate the enzyme. lOX HaeIII 
buffer and HaeIII restriction enzyme were added to the reaction mixtures, which 
were incubated at 37°C for one hour. At the end of the reaction, the products were 
analysed on a 1% agarose gel to assess the degree of protection. Figure 3.10 shows 
the pattern of protection of ? DNA for recombinant pQIS 7 (wild type SPR) and 
pQIS 8 (Phe 386 Ala mutant). Full methylation protection was observed with 5µl of 
enzyme (Figure 3.10). 
Mtase activity was quantified as follows: 1.0 Unit recombinant SPR Mtase (M. SPRI) 
is the amount of enzyme required to fully methylate 1.0 µg X DNA within 60 
minutes in a 20 µl reaction volume at 37°C. The M. SPRI concentration varied from 
batch to batch of protein preparation. In the experiment discussed (and as shown in 
Figure 3.10) 1.0 unit was equal to 200 ng (at a concentration of 40 ng / µl) of purified 
wild type M. SPRI. Under these conditions the mutant Phe 386 Ala offered no 
protection against restriction (compare lanes 6 and 13 in Figure 3.10). 
3.1.7.2: Time course assay 
As observed from the in vivo protection assays, the recombinant mutant Phe 386 Ala 
was found to be active when the culture had been grown overnight. It was decided to 
carry out a time course methylation protection assay with both the wild type and 
mutant proteins. Equimolar concentrations of proteins were added to 1 µg 
bacteriophage ? DNA in Mtase buffer (50 mM Tris-HC1, pH 7.5,25°C, 50 mM 
NaCl, 10 mM EDTA, 1 mM DTT) supplemented with 100 µM SAM. The reaction 
mixtures were incubated for 30,60,90,120,150,300 minutes and overnight to 
initiate DNA methylation. Reactions were terminated with 1 mM NEM followed by 
a heat inactivation step at 65°C for 20 minutes. HaeIII buffer and restriction enzyme 
were added and the mixture incubated at 37°C for one hour. All the samples were 
analysed on a 1% agarose gel (Figure 3.11). As expected the wild type M. SPRI was 
fully functional, methylating 1 DNA and rendering it fully refractory to HaeIII. On 
the other hand the Phe 386 Ala mutant was only active after a prolonged incubation 
(compare lane 3 and 8, Figure 3.11). After 30 minutes, the wild type enzyme had 
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pQIS 7 pQIS 8 
Figure 3.10: An experiment to show the methylation "dose response" of M. SPRI enzymes, using 
an assay for the protection of X DNA followed by restriction digestion with Huelll. 
All the contents of the reaction tubes were analysed on a 1% gel. The reaction tubes were set up as 
follows. 
Lane 1: 1 tg X DNA only (no protein and no Haelll) 
Lane 8: 1 tg k DNA + HaelI I (no protein) 
Other lanes contain I pg X DNA, Haelll and M. SPRI enzymes. 
Lanes 2-7 = wild type M. SPRI 
Lanes 9-14 = mutant M. SPRI 
Lanes 2,9 =8 ng M. SPRI 
Lanes 3,10 = 20 ng M. SPRI 
Lanes 4,11 = 40 ng M. SPRI 
Lanes 5,12 = 80 ng M. SPRI 
Lanes 6,13 = 200 ng M. SPRI 
Lanes 7,14 = 400 ng M. SPRI 
12i15678 11 ') 111 11 12 1ý II 
pQIS 8 pQIS 7 
Fully methylated DNA 
Unmethylated DNA 
Figure 3.11: Time course protection assay for pQIS 7 (wild type M. SPR) and pQIS 8 (mutant F 
386 A) using I µg lambda DNA and (200 ng) of purified protein for methylation followed by 
restriction digestion with HaelIl. Lane 1-7: 30,60,90,120,150,300 minutes and overnight 
incubation of ?. DNA with mutant F 386 A (pQIS 8) protein. M: GeneRuler I'M 1 kb DNA ladder. Lane 
8-9: 30 minutes and overnight incubation of ?. DNA with wild type M. SPR (pQIS 7) protein. (All other 
reaction tubes between these timings have same digestion profile as lane 9). 
1234567M89 
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fully methylated the substrate, while the mutant enzyme at the same concentration 
took more than 4X longer to complete the reaction. Reactions of less than 60 minutes 
were not sufficient for this mutant to methylate all HaeIII sites in phage X DNA. 
Methylation protection was first observed after 90 minutes incubation and therefore 
compared to the wild type there is a significant delay in methylation with the mutant 
Mtase. The reactions of 90 and 120 minutes incubation for mutant Phe 386 Ala were 
comparable with 30 minutes incubation of wild type protein (Figure 3.11). All the 
remaining time course assay reactions for wild type M. SPRI were constant and 
showed full protection (not shown in figure). 
3.2: M. HhaI mono-specific Mtase 
3.2.1: INTRODUCTION 
The gene encoding the C5-cytosine Mtase (M. HhaI, EC 2.1.1.37) from Haemophilus 
heaemolyticus, is encoded by 981 bp and was originally isolated from a library of 
plasmid clones carrying HindIII digested DNA fragments (Caserta et al., 1987). 
M. HhaI is one of the smallest of the C5-Mtases, containing 327 amino acids and 
having a molecular weight of 37 kDa. Recombinants carrying the M. HhaI gene from 
the library were isolated and then cloned into plasmid pNW2801 for analysis. The 
full DNA sequence and translation product is shown in Figure 3.12. M. HhaI 
recognises the palindromic sequence 5'---GCGC---3' and methylates the inner 
cytosine to produce 5'---GmCGC---3'. The three dimensional structure of M. HhaI 
and implications for functions are described in Chapter One. The gene encoding 
M. HhaI was obtained from Dr. Geoffrey Wilson (New England Biolabs) and was 
sub-cloned into two different vectors (pGEX-KG and pLITMUS-28) to improve 
expression and to facilitate purification (Kan, 1999). Both plasmids carrying the 
Hhal Mtase gene were propagated in the E. cola strain DH5a mcrABC- and were 
used in the following experiments. 
The amino acid sequence of M. SPRI and M. HhaI were aligned and are presented in 
figure 3.12 (a). 
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1 ATG ATT GAA ATA AAA GAT AAA CAG CTC ACA GGA TTA CGC TTT ATT GAC 
M I E I K D K Q L T G L R F I D 
49 CTT TTT GCA GGA TTA GGT GGC TTT AGA CTT GCT TTA GAA TCT TGC GGT 
L F A G L G G F R L A L E S C G 
97 GCT GAG TGC GTT TAT TCT AAT GAA TGG GAT AAA TAT GCA CAA GAA GTA 
A E C V Y S N E W D K Y A Q E V 
145 TAT GAG ATG AAT TTT GGT GAA AAG CCT GAG GGC GAC ATT ACC CAA GTA 
Y E M N F G E K P E G D I T Q V 
193 AAT GAG AAA ACC ATT CCT GAT CAC GAC ATT TTA TGT GCA GGG TTT CCG 
N E K T I P D H D I L C A G F P 
241 TGC CAA GCG TTT TCT ATT AGT GGA AAA CAA AAA GGA TTC GAG GAC AGC 
C Q A F S I S G K Q K G F E D S 
289 AGA GGT ACG CTC TTT TTT GAT ATT GCA CGT ATT GTC CGT GAA AAA :.. ... 
R G T L F F D I A R I V R E K K 
337 
--ýý -_ 
- ---r T -"=_ ý..... 
N r... _ vom, v 
Ar; G ý- TCG CAT GAT 
P K V V F M E N V K N F A S H D 
385 AAT GGA AAT ACG TTA GAA GTT GTA AAA AAT ACA ATG AAT GAA TTG GAC 
N G N T L E V V K N T M N E L D 
433 TAT TCT TTT CAT GCT AAA 
Y S F H A K V L N A L D Y G I P 
481 G, _-- AAT GAT CTC AAT 
Q K R E R I Y M I C F R N D L N 
529 ATT CAA AAT TTC CAA TTT CCA AAA CCT TTT GAG CTT AAT ACT TTT GTG 
I Q N F Q F P K P F E L N T F V 
577 AAA GAT TTG TTA TTA CCT GAT AGC GAG GTG GAA CAC TTA GTT ATT GAT 
K D L L L P D S E V E H L V I D 
625 AGA AAA GAT TTG GTA ATG ACA AAC CAA GAA ATT GAG CAA ACA ACC CCC 
R K D L V M T N Q E I E Q T T P 
673 AAA ACA GTT CGA CTT GGT ATT GTA GGA AAA GGT GGG CAA GGA GAA CGA 
K T V R L G I V G K G G Q G E R 
721 ATT TAT AGC ACA AGA GGC ATT GCA ATT ACC TTA TCT GCT TAT GGT GGC 
I Y S T R G I A I T L S A Y G G 
767 GGC ATT TTC GCT AAG ACA GGG GGA TAT TTA GTA AAC GGG AAG ACA CGG 
G I F A K T G G Y L V N G K T R 
817 AAA TTA CAC CCT AGA GAG TGT GCT AGA GTA ATG GGC TAC CCA GAT AGT 
K L H P R E C A R V M G Y P D S 
865 TAT AAA GTC CAC CCG TCA ACC AGC CAA GCA TAT AAA CAA TTT GGT AAC 
Y K V H P S T S Q A Y K Q F G N 
913 TCA GTT GTT ATC AAT GTA CTT CAA TAT ATT GCT TAT AAC ATT GGT TCA 
S V V I N V L Q Y I A Y N I G S 
961 TCA TTA AAT TTC AAA CCA TAT TAA 
S L N F K P Y Stop 
Figure 3.12: Nucleotide and amino acid sequences of M. HhaI. The amino acids present in the six 
highly conserved motifs of C5-Mtases are coloured as follows: Motif I (red), motif IV (brown), motif 
VI (green), motif VIII (light blue), motif IX (pink) and motif X (dark blue). The TRD region between 
motif VIII and IX is shown with underlined amino acids. Data from GenBankT'A/EMBL Data Bank: 
accession number J02677. 
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CHAPTER THREE 
3.2.2: MUTAGENESIS OF WILD TYPE MOTIF IX OF M. HhaI TOWARDS 
M. SPRI 
The consensus sequence of motif IX in C5-Mtases is RXXXXXEXXR. In 
monospecific Mtases this region is moderately conserved whereas in multispecific 
Mtases, motif IX is strongly conserved (Figure 3.5 and Table 3.1). However, our 
mutagenesis experiment on motif IX of multispecific Mtase confirmed that although 
multispecific Mtase have a strongly conserved motif IX, they have the capability to 
accommodate certain mutations. 
We decided to carry out an experiment for mutagenesis of wild type motif IX of 
M. Hha1 in view of the results obtained from the mutagenesis of multispecific Mtase 
M. SPR. As a starting point Ala 280 was chosen which aligns with Phe 386 of 
M. SPRI. To understand the nature of the experiment, a summary of the mutants 
constructed is shown in figure 3.12 (b) and the schematic diagrams are placed at the 
end of the chapter. 
3.2.2.1: Ala 280 Phe mutagenesis in wild type M. HhaI 
The region of M. HhaI targeted for mutation was motif IX-X (as with M. SPRI). Some 
amino acids of this region are strongly conserved, such as Ala 280. Although Ala 
280 in M. HhaI is strongly conserved in other monospecific Mtases, it aligns with Phe 
386 in M. SPRI and this residue was therefore chosen for mutation. In order to 
mutagenise Ala 280 of M. HhaI it was convenient to introduce a new restriction site 
into this region of the gene. Analysis of the sequence of the gene showed that the 
introduction of a new StyI site was possible without changing the amino acid 
sequence. In addition a single base change would also change the codon for alanine 
to phenylalanine. The oligonucleotides NIS 15 and NIS 16 (shown below) were used 
61 
Wild type M. HhaI 
pMSK 12 
Wild type M. HhaI 
Active 
6x His tagged at N-terminus 
pQIS 12 
A 280 P 
Partially active 
Styl site introduced 
pQIS 14 
A 280 P, R 277 L 
Inactive 
Styl site deleted, Xbal site 
introduced 
pQIS 18 
A 280 P, R277 L, F302 A 
Active 
Accl site introduced 
pMSK 7 
Wild type M. Hhal 
Active 
GST fused at N-terminus 
I 
pQIS 11 
A 280 P 
Partially active 
Styl site introduced 
I 
pQIS 13 
A 280 P, R 277 L 
Inactive 
Styl site deleted, Xbal site 
introduced 
I 
pQIS 17 
A 280 P, R 277 L, F 302 A 
Active 
Accl site introduced 
pQIS 21 
A280P, R277L, F302A, 
Y289D 
Inactive 
A1wNI site introduced 
pQIS 20 pQIS 22 
F 302 AY 289 D 
Partially active Inactive 
6x His tagged at N-terminus 6x His tagged at N-terminus 
Key: 
Plasmid Number 
Mutational Position 
Methylation Activity 
Diagnostic Site Introduced 
Figure 3.12 (b): An schematic representation of the formation of mutants of M. HhaL Two constructs 
of M. HhaI one containing GST fusion and the other with 6x histidine tag were simultaneously used for the 
experiment. 
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NIS 15INIS 16 duplex oligonucleotide: 
Styl 
5'-GGAAATTACACCCTAGGGAGTGTTTTAGAGTAATGGGCTAC -3' 
3'-CCTTTAATGTGGGATCCCTCACAAAATCTCATTACCCGATG -5' 
KLHPRECFRVMGY 
NIS 15: 5'-GGAAATTACACCCTAGGGAGTGTTTTAGAGTAATGGGCTAC-3' 
NIS 16: 5'-GTAGCCCATTACTCTAAAACACTCCCTAGGGTGTAATTTCC-3' 
for this mutagenesis experiment. Two templates were used for site directed 
mutagenesis, namely pMSK 7 (wild type M. HhaI in pGEX-4T-3 GST fused) and 
pMSK 12 (wild type M. HhaI in pLITMUS-28 with 6 histidines). 
The resulting constructs were called as pQIS 11 and pQIS 12 as shown in Figure 
3.13. Both mutant constructs pQISI I and pQIS 12 were checked for the presence of 
a new Sty! site and for M. HhaI activities. There is no StyI site in pMSK 7, while 
three Sty! sites exist in pMSK 12. The mutant construct pQIS 11 acquired a new Sty! 
site and was linearised by Styl digestion. pQIS 12 also contained a new Sty! site. The 
1085 bp DNA fragment was cut into two fragments of sizes 887 bp and 198 bp, 
which confirmed the presence of a new restriction site (Figure 3.13). Restriction 
digestion of plasmids with Hhal established that both mutants encode an inactive 
Mtase. However, when plasmids obtained from overnight cultures that were induced 
with 0.1 mM IPTG were analysed, it was observed that the proteins encoded by these 
plasmid possessed partial activity. It is known that even a single alteration may 
change multiple properties of a protein, including its structure, folding pathway, 
flexibility, stability, and enzymatic properties (Coombs and Corey, 1998). The 
availability of a crystal structure of M. Hhal (Cheng et al., 1993) allowed us to have a 
closer look (with the assistance of Dr. G. C. Ford) at the region surrounding these 
residues. It was also instructive to identify the amino acids within the vicinity of 
these residues that constitute motif IX. We analysed the amino acids within a 4.0 A 
radius of each amino acid in motif IX of M. HhaI and these are given in Table 3.1. 
This distance is sufficient to cover interactions such as hydrogen bonds, ionic and 
Van der Waals interactions, and hydrophobic packing. Therefore this analysis 
includes all amino acids, which may be directly disturbed by mutation. From the 
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above analysis it was found that the oxygen of Arg 277 interacts both with the 
nitrogen and the ß carbon of Ala 280. It became apparent that by altering the Ala 280 
to Phe of M. HhaI the interaction between Ala 280 and Arg 277 could well be 
disturbed, perhaps accounting for a partial loss of catalytic activity. Phenylalanine 
carries an aromatic side chain; the volume of which is 190 A3: more than double to 
that of Ala (88.6 A3). It seems that as a consequence of this mutation, the Arg 277 
present in the same alpha helix may be sterically hindered in M. Hhal and as a result 
M. HhaI becomes partially active. 
3.2.2.2: Arg 277 Leu mutagenesis in the mutant Ala 280 Phe of M. Hhal 
Arg 277 appears to be highly conserved in motif IX of mono-specific Mtases (Figure 
3.5 and Table 3.1). Leu is proposed as a possible replacement because it is found in 
all multi-specific Mtases at this position (with the exception of M. 4BssHII). A pair of 
oligonucleotides was synthesised for this mutagenesis experiment, which would lead 
to the replacement of the Arg codon with that of Leu. These oligonucleotides NIS 17 
NIS17INIS18 duplex oligonucleotide 
Xba I 
5'-CGGAAATTACACCCTCTAGAGTGTTTTAGAG-3' 
3'-GCCTTTAATGTGGGAGATCTCACAAAATCTC-5' 
RKLHPLECFR 
NIS 17: 5'-CGGAAATTACACCCTCTAGAGTGTTTTAGAG-3' 
NIS 18: 5'-CTCTAAAACACTCTAGAGGGTGTAATTTCCG-3' 
and NIS 18 (shown below), introduce a unique Xbal site into the gene, for diagnostic 
purpose. In addition, due to this change, the Styl site that had been introduced earlier 
would be deleted (see above). Substitution of Arg 277 with Leu was carried out by 
site directed mutagenesis using pQIS 11 and pQIS 12 as templates (Figure 3.14). 
Site-directed mutagenesis experiments to generate the two new double mutants pQIS 
13 and pQIS 14, were carried out simultaneously and the presence of a new Xbal 
restriction site confirmed the replacement of the arginine codon with that of leucine. 
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When subjected to a restriction analysis with Mal, both the recombinant constructs 
were deduced to be completely inactive and no significant difference was observed 
after overnight growth in the presence of IPTG (Figure 3.14). 
Once again the structure of M. HhaI was examined in more detail in and around 
position 277 and 280, and it was found that phenylalanine at position 302 is in close 
proximity to the side chain of residue 280 where the Ala 280 Phe mutation had been 
introduced. Phe 302 is present in the a-helix running parallel to the a-helix of motif 
IX and its bulky side chain is positioned towards the side chain of Phe 280 in the 
mutant. Therefore, assuming that the two bulky groups of phenylalanine are vying 
for the same space, it was decided to replace the phenylalanine at position 302 with a 
smaller amino acid such as alanine. 
3.2.2.3: Phe 302 Ala mutagenesis in the double mutant Arg 277 Leu, Ala 280 
Phe of M. HhaI 
Sequence of motif X of M. HhaI revealed that Phenylalanine at position 302 is 
located just before the consensus amino acid sequence GNXV. Comparison of 
various mono-specific Mtases sequences showed that Phe 302 of M. HhaI is not 
conserved (Figure 1.4). 
Amino acid sequence of Motif X of M. SPRI and M. Hhal 
M. SPR: YKQAGNSITV 
M. iihsI: YKQFGNSVVI 
302 
When the sequence of M. HhaI was compared with that of M. SPRI in motif X 
(shown above) it was observed that there was an alanine instead of a phenylalanine. 
In order to alter Phe 302 of M. HhaI into Ala two oligonucleotides NIS 19 and NIS 
20 were synthesised. The duplex is shown below, with changes shown in red, and the 
new restriction site AccI (silent mutation) is shown in bold. In addition, a Hincll site 
was deleted in this region, which provided an additional diagnostic test. The 
oligonucleotides are shown below with the mutated bases in red (silent mutation for 
Accl site) and blue for the desired Phe 302 Ala codon change. 
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NIS 19/NIS 20 duplex oligonucleotide 
AccI 
5'-GTTATAAAGTCCACCCGTCTACCAGCCAAGCATATAAACAAGCTGGTAACTCAGTTGTTATC-3' 
3'-CAATATTTCAGGTGGGCAGATGGTCGGTTCGTATATTTGTTCGACCATTGAGTCAACAATAG-5' 
YKVHPSTSQAYKQAGNSVVI 
NIS19: 5'-GTTATAAAGTCCACCCGTCTACCAGCCAAGCATATAAACAAGCTGGTAACTCAGTTGTTATC-3' 
NIS2O: 5'-GATAACAACTGAGTTACCAGCTTGTTTATATGCTTGGCTGGTAGACGGGTGGACTTTATAAC-3' 
Site-directed mutagenesis was carried out to construct a triple mutant of M. Hhal 
using the templates pQIS 13 and pQIS 14. The new mutant constructs now carry 
three mutations: Ala 280 Phe, Arg 277 Leu and Phe 302 Ala (Figure 3.15). The 
mutant pQIS 17 was confirmed on the basis of the loss of a HinclI site. The mutant 
pQIS 18 was confirmed by the presence of a new, unique Acct site (Figure 3.15). 
When the triple mutant plasmids were tested with Hhal for their methylation status, 
it was found that the mutant pQIS 18 expressed a protein that has fully regained 
Mtase activity (Figure 3.15). The mutant construct pQIS 18 was sequenced and was 
found to contain all the expected mutations and no other changes. Part of the 
sequencing analysis showing all the three mutations is shown in Figure 3.16. 
3.2.2.4: Phe 302 Ala mutagenesis in wild type M. HhaI 
The same oligonucleotides NIS 19 and NIS 20 (shown above) were also used for 
constructing the single mutant Phe 302 Ala in wild type M. HhaI to see if this alone 
had any effect on the activity of M. HhaI. The single mutant pQIS 20 was generated 
using pMSK 12 (that encodes wild type M. HhaI) as a template (Figure 3.17). The 
construct pQIS 20 encoded a protein that shows partial activity. Graphical analysis of 
the region surrounding residue Phe 302 revealed that the oxygen atom of Phe is close 
to the s carbon atom of Met 283, in addition to its neighbouring atoms such as Ala 
298, Lys 300 and Asn 304 which may have been disturbed by the substitution and 
this therefore may account for the reduction in catalytic activity of the enzyme. 
3.2.2.5: Tyr 289 Asp mutagenesis in the triple mutant (Arg 277 Leu, Ala 280 
Phe, Phe 302 Ala) of M. HhaI 
It has been observed from the crystal structure of M. HhaI (Cheng et al., 1993) that 
Tyr 289 makes close interaction with the NHl and NH2 groups of Arg 277, in 
addition to other residues such as Leu 21, Asn 52, Pro 286 and Asp 287. Because 
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Figure 3.16: Part of the DNA sequencing analysis chromatogram for pQIS 18 (encoding a triple 
mutant of M. HhaI). (A): Arg 277 Leu (with new Xbal restriction site) and Ala 280 Phe. (B): Phe 302 
Ala with new Accl site. 
(Aý Arg 277 Leu Ala 280 Phe 
11 
(Bý Phe 302 Ala 
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Arg 277 has already been mutated to Leu, it was assumed that there might be a 
positive effect on catalytic activity if Tyr 289 was replaced with an amino acid found 
in M. SPRI. Therefore another mutagenic experiment was designed to change Tyr 
289 (in the triple mutant of M. HhaI, Arg 277 Leu, Ala 280 Phe and Phe 302 Ala) to 
Asp, to determine its effect upon the activity of the enzyme. Two oligonucleotides 
NIS 21/NIS 22 duplex oligonucleotide 
A IwNI 
5'-GGCTACCCAGATTCTGACAAAGTCCACCCGTC-3' 
3'-CC GATGGGTCTAAGACTGTTTCAGGTGGGCAG-5' 
GYPDSDKVHP 
NIS 21: 5'-GGCTACCCAGATTCTGACAAAGTCCACCCGTC-3' 
NIS 22: 5'-GACGGGTGGACTTTGTCAGAATCTGGGTAGCC-3' 
were designed and synthesized for this site-directed mutagenesis experiment. There 
is one AIwNI site already present in the sequence of the triple mutant of M. HhaI 
(encoding for Arg 277 Leu, Ala 280 Phe and Phe 302 Ala) construct number pQIS 
18. Therefore the new construct can easily be detected on the basis of a newly 
introduced A1wNI site. The oligonucleotides NIS 21 and NIS 22 are shown below 
with mutated bases indicated in red (silent mutation for AIwNI site) and blue for the 
desired Tyr 289 Asp codon mutation. 
The mutagenesis experiment was carried out, and the new construct was called pQIS 
21, a quadruple mutant of M. HhaI carrying the following mutations (Arg 277 Leu, 
Ala 280 Phe Tyr 289 Asp and Phe 302 Ala) (Figure 3.18). The authenticity of the 
construct was confirmed first on the basis of a newly introduced A1wNI site (Figure 
3.18). To determine the effect of this mutation upon the activity of the enzyme, the 
recombinant plasmid was challenged with an excess of Hhal. The quadruple mutant 
as determined in this manner was found to be inactive. It appears that the triple 
mutant pQIS 18 (Arg 277 Leu, Ala 280 Phe and Phe 302 Ala) has altered the enzyme 
in terms of regional interactions and structural integrity but this mutation Tyr 289 
Asp has a more pronounced effect on the stability of M. HhaI. The triple mutant 
provides a satisfactory alternative constellation of amino acid side chains for the 
activity of M. HhaI to be retained, but that the fourth mutant in which Tyr 289 is 
substituted by Asp is incompatible with biological activity of the enzyme. 
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For completeness it was important to characterize the Tyr 289 Asp single mutant of 
M. HhaI to see if this mutation alone had any effect on the stability/activity of the 
enzyme. 
3.2.2.6: Tyr 289 Asp mutagenesis of wild type M. HhaI 
The same oligonucleotides NIS 21/NIS 22 that were used for the above experiment 
were used for this mutagenesis (Figure 3.19). The new construct pQIS 21, which is 
wild type M. HhaI in which Tyr 289 is replaced by Asp was verified by the presence 
of an AIwNI site. The activity of the resultant plasmid pQIS 22 was checked by filial 
digestion: the modified Mtase M. HhaI was found to be completely inactive. The 
result shows that this Tyr 289 residue is also critical for catalytic activity. Tyr 289 is 
partially buried in the M. HhaI molecule and the analysis of the crystal structure of 
the enzyme revealed that -OH group of Tyr is hydrogen bonded with Oxygen of Leu 
21 (in the absence of SAM). In addition, Tyr 289 also makes interactions with Pro 
286, Asp 287, Asn 52 and Arg 277. In the presence of SAM, the Tyr 289 makes 
interactions with Pro 286, Leu 21 and Arg 277. Although Tyr 289 is not the core of 
the enzyme but mutation to Asp has a strong adverse effect on catalytic activity. Asp 
is much smaller in size than Tyr and its replacement leaves very large space in the 
middle of the protein and in addition its acidic nature leads to drastic effects that 
render the enzyme inactive. A representation of the mutations introduced into 
M. SPRI and M. HhaI in this study are presented in Figure 3.20. 
3.3: The use of WAVE DHPLC system to analyse the activity of wild 
type and mutant DNA Mtases 
The activity of both wild type and mutant M. HhaI and M. SPRI can be assessed using 
an in vivo methylation protection assay. The methylation protection assay examines 
the ability of methylation by restriction with relevant restriction enzyme to digest the 
plasmid encoding the Mtase (for example, digestion of M. SPRI encoding plasmid 
with HaeIII or MspI). However, there are a number of factors that can limit the 
amount of information that is obtained. 
a) The digestion of the plasmid can only be informative in terms of whether the 
DNA can be digested by a restriction enzyme or not. Although the presence 
of a partially active Mtase in the methylation protection assay can lead to a 
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diagnostically significant DNA fragment smear on the agarose gel, this does 
not give any quantitative measure of the Mtase activity. 
b) With a partially active Mtase there is a trade off between using enough DNA 
to obtain a clear result and using too much (and creating a situation where not 
all of the DNA can be cut by the restriction enzyme). 
c) In addition, if there is any uncut DNA present in the tube because of reduced 
methylation activity of mutant Mtase, it is difficult to visualize that uncut 
DNA because it is present in very small amounts. Therefore, the information 
regarding the reduced level of activity is difficult to extract from the gel 
assays. 
An alternative to gel analysis of the DNA fragments is the use of HPLC. Therefore, 
an experiment was designed to analyse and compare the activity of three different 
mutant Mtases by HPLC, in order to attempt to quantify differences in plasmid 
methylation profiles. 
3.3.1: COMPARISON OF THE ACTIVITY OF MUTANT Mtases USING 
HPLC 
Three mutants with different levels of enzymatic activity (active, partially active and 
inactive) were chosen and their activity was analysed by HPLC. The mutant plasmid 
pQIS 18 that codes for a triple mutant of M. HhaI (Arg 277 Leu, Ala 280 Phe, Phe 
302 Ala) was used as a control for an active enzyme. The mutant construct pQIS 12 
that was constructed by exchanging Ala 280 to Phe and showed partial activity was 
selected as an example of partial active Mtase. The plasmid pQIS 14 (encoding for 
the Ala 280 Phe and Arg 277 Leu in M. HhaI) expressed an inactive enzyme and was 
selected as an example of inactive Mtase. The comparative agarose gel profile for the 
three plasmids pQIS 18, pQIS 14 and pQIS 12 after HhaI cleavage is shown in 
Figure 3.21. 
In order to compare the three plasmids by HPLC, samples were injected onto the 
WAVE system after IHhaI cleavage, using the optimised gradient as described in 
section 2.2.12 (Table 2.6). The resulting chromatograms for the three plasmids were 
overlaid and are shown in Figure 3.22. The digestion profile for pQIS 18 showed that 
it has not been cleaved by the action of Hhal. As a result of this, the intact DNA is 
eluted at the end of elution with in the high acetonitrile wash phase (See the 
chromatogram shown in purple, Figure 3.22). This shows that the plasmid encodes 
an active enzyme and protected against restriction with its cognate restriction enzyme 
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Figure 3.21: Assessment of methyltransferase activity using an Hhal restriction analysis on I% 
Agarose Gel. 
Lane 1: pQIS 18 (Active methyltransferase). 
Lane 2: pQIS 12 (Partially active Mtase). 
Lane 3: pQIS 14 (Inactive Mtase). 
Methylation of the plasm ids Hhal sites prevents digestion by the Hhal restriction en yme. 
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Figure 3.22: Assessment of methyltransferase activity using DHPLC analysis of Hhal restriction 
Blue Trace: pQIS 18 (Active methyltransferase). 
Green Trace: pQIS 12 (Partially active Mtase). 
Red Trace: pQIS 14 (Inactive Mtase). 
The results are consistent with our previous in vivo methylation protection assays analysed on agarose 
gel (see Section 3.1.5 and 3.2.2). The slight increase in base line is due to the increased concentration 
of Acetonitrile. 
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Hhal. HPLC analysis for pQIS 14 separates the DNA fragments in clearly visible 
peaks (See the chromatogram shown in red, Figure 3.22). The peaks in the 
chromatogram clearly indicate that the construct is completely degraded and not 
protected. Therefore the protein encoded by this construct is catalytically inactive. 
HPLC analysis of pQIS 12 showed that it is only partially restricted resulting in the 
appearance of very small amount of peaks. Most of the sample was only eluted at the 
end of HPLC run, indicating a partially active construct (shown in green) (Figure 
3.22). Hence, the difference in the methylation profile is clearly comparable by this 
HPLC analysis. 
3.4: Discussion 
In this chapter the mutagenesis experiments on multi-specific Mtase SPRI and mono- 
specific Mtase HhaI are presented. The summary of the mutagenesis experiments 
with the amino acid sequences of mutant constructs and the observed methylation 
activity is given in Figure 3.23. Mutagenesis experiments were focused on motif IX 
and X to evaluate the structure function relationship of the enzyme in general and the 
TRD region and motif IX in particular. The nucleotide sequences of the mutants are 
also aligned with the sequence of wild type sequence and shown with the mutated 
residues in blue and conserved residues in red. In addition we have attempted to 
correlate and establish the digestion profile of the mutant and wild type Mtases by 
HPLC. 
In the first experiment Phe in M. SPRI was altered to Ala to mimic motif IX of 
M. HhaI. Phe 386 of M. SPRI aligns with Ala 280 of M. HhaI and many other mono- 
specific Mtases and therefore we have chosen to mutate Phe to Ala. This single 
mutation led to a partial loss of M. SPRI activity. The principal difference between 
Phe/Ala is that the former side chain is much bigger than the methyl group of Ala 
(Figure 3.24). 
The crystal structure of M. SPRI has not yet been obtained and therefore we cannot 
predict with any certainty the interaction of any of the amino acid residues in this 
enzyme. However on the basis of information obtained from the crystal structure of 
M. HhaI (Cheng et al., 1993), it is clear that Ala 280 of M. HhaI makes interactions 
with its neighbouring residues. Further analysis of these interactions revealed that 
Ala 280 in M. HhaI makes an interaction with residues 276-278 and 282-285 in the 
presence of DNA. In the absence of DNA, M. HhaI makes interactions with residues 
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Figure 3.24: Comparison of 
amino acid sizes which were 
used for mutagenesis 
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276 and 283-285. It would appear that the replacement of Phe with a much smaller 
hydrophobic amino acid Ala leads to a loss in some of the steric interference, which 
restores methylation capacity of the enzyme. 
The second mutation Ala 390 Gly, did not affect the activity of the enzyme at all, as 
determined by our assays. The larger size of the methyl side chain is therefore not a 
critical factor in the enzyme structure. 
In the third mutagenic experiment (Asp 392 Pro) in M. SPRI, whilst the mass 
difference in the two amino acid residues is very small (Figure 3.24), Asp has an 
acidic side chain whereas Pro is hydrophobic and changes directionality of back bone 
(See Appendix III for amino acid chemistry) but it appears that this amino acid plays 
a less important role in terms of global structural interactions in the enzyme. 
Despite the impressive ability of natural enzymes to catalyse a diverse set of 
reactions, attempts to make even minor modification to substrate specificity and to 
improve catalytic efficiency have proven to be difficult. The function of enzymes is 
not only dependent on the chemical properties of the side chains of the amino acid 
residues that contact substrates and cofactor; it is also influenced by residues distant 
from the active site. Such residues may play a critical role in holding the catalytic 
residues in their required orientations. Charge distribution throughout a whole 
enzyme molecule may facilitate substrate binding by electro statically guiding the 
substrate into the active site. A common example for selective substrate guidance and 
to catalyze the hydrolysis of proteins is the family of serine proteases that are found 
in prokaryotes and Eukaryotes. Despite the fact that proteins folds are quite different, 
the geometric orientations of these are closely similar between families. Thus the 
peptidases of the chymotrypsin, subtilisin and carboxypeptidase C clan have a 
common "catalytic triad" of the three amino acids: Serine (nucleophile), aspartate 
(electrophile), and histidine (base). Chymotrypsin (mammalian digestive enzyme) is 
found in the small intestine and has a similar catalytic site (Stryer, 1995). In this 
enzyme all charged groups are present on the surface of the molecule except for the 
three that play a critical role in catalysis. Serine 195 is adjacent to histidine 57 and 
carboxylate group of aspartate 102, and these residues are buried in the protein and 
form a catalytic triad. Crystallographic studies of complexes of chymotrypsin with 
substrate analogs have shown the location of the site of specific recognition and the 
likely orientation of the susceptible peptide bond. Tryptophan binds to chymotrypsin 
with its indole side chain fitted neatly into a pocket near serine. This deep cleft 
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accounts for the specificity of chymotrypsin for aromatic and other bulky 
hydrophobic side chains. Therefore, it has been difficult to demonstrate the 
importance of residues that are remote from the active site because the number of 
these residues is large and the contribution of each residue is difficult to detect 
individually. In general, it can be concluded from these experiments that there is 
some flexibility in motif IX of M. SPRI and it can tolerate the mutations to amino 
acids residues present at the same position as in mono-specific Mtase M. HhaI. 
The interaction of the TRDs of the variable region in multi-specific Mtases with 
DNA can be assumed to be similar to those described for monospecific Mtases. 
However the unconventional placement of a functional TRD at the N-terminus of 
M. (4)BssHH shows that the interactions between large and small domains and the 
target DNA must be different in this case (Sethmann et al., 1999). It looks that a 
different steric relationship between TRD, DNA and other enzyme regions involved 
in the methylation process must exists in M. (4)BssHII. In view of the established 
three-dimensional structures of Mtases folded into a large (catalytic) and small 
(recognition) domain, it is conceivable that the N-terminal TRD becomes placed at 
the join between these domains in the neighbourhood of the variable region. It is also 
proposed that specific DNA recognition may occur in a similar way as with the 
TRDs of the variable region (Sethmann et al., 1999). This supports the idea that the 
interactions in multi-specific enzymes can be more flexible than in mono-specific 
Mtases. 
In the light of the experiments made in multi-specific Mtase M. SPRI, experiments 
have been designed to mutate mono-specific Mtase M. HhaI. The sequence of 
M. HhaI was mutated from Ala 280 to Phe (as was found in M. SPRI). In the crystal 
structure of mono-specific C5-Mtases M. HhaI (Cheng et al., 1993; Kumar et al., 
1994) and M. HaeIII (Reinisch et al., 1995) motifs I to VIII and X form the large 
domain while the variable region plus motif IX comprise the small domain (Figure 
3.25). This mutagenesis made the enzyme partially active which upon analysis 
revealed that this residue Ala 280 when replaced with a larger amino acid (with 
bulky side chain) Phe, sterically hindered neighbouring residues (Figure 3.26). 
Considering Arg 277 as being disturbed with earlier mutation was mutated into Leu. 
This mutation further worsens the situation and the enzyme became inactive. 
However, when another possible interacting residue Phe 302 was mutated into Ala, it 
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Figure 3.25: Schematic drawing of the secondary structural elements of M. Hhal. The large (amino acids 1-93 and 
amino acids 304-327) and small (amino acids 194-275) domains are marked. Conserved or functionally important 
amino acids are circled. The cofactor S-adenosyl-L-methionine (SAM) binding site, with its interactions with the 
protein, is also shown. The thick dashed lines indicate hydrophobic interactions, and the thin lines indicate 
electrostatic interactions. The red boxes represent the amino acid residues that were changed in the experiment. 
The colours of various motifs are as shown in figure 1.5 (Figure adapted from Cheng et al., 1993). 
Figure 3.26: Tertiary structure of Motif IX of M. Hhal. The protein backbone is shown as a 
worm plot. Colours are shown as in secondary structure of M. Hhal (motif I red; motif IV, yellow; 
motif IX, magenta; and motif X, blue). The DNA is shown as a "ball and stick" representation. 
The side chains of four amino acids which were targeted for mutations are also shown as a Ball 
and Stick representation. 
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restored the activity of the enzyme. We have presented a model for this triple 
mutation (Figure 3.27). From the model it appears that the two helices that are 
parallel to each other and can only accommodate amino acids that do not disfigure its 
orientation. Therefore it is only possible to swap amino acids from motif IX from a 
multi-specific Mtase to mono-specific Mtase and redesign M. HhaI provided that if 
the structure is not distorted. However, further sequence exchanges are incompatible 
between mono-specific and multi-specific Mtases. To conclude from this set of 
experiments I would like to add that these enzymes are clearly superficially related 
but mechanistically/structurally different. A 3D-structure analysis of M. SPRI should 
help to explain these differences in structure / function relationship. 
The analysis of active, partial active and inactive Mtase by HPLC (Figure 3.22) have 
also given a new way of profiling the methylation potential which we have used in 
our future experiments (See Chapter Six). We believe that this technique is more 
reliable and efficient as well as more sensitive than the agarose gel electrophoresis. 
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Figure 3.27: A model for the Triple mutant structure of M. HhaI (A280F, R277L & F302A). 
The wild type M. Hhal protein is shown as yellow ribbon. The residues that were altered are shown 
as "ball and stick" representation with CPK colour atoms. The three mutant side chains are shown 
superimposed on this structure in red ball and stick representation. Other side chains within 4A in 
the wild type molecule are shown in pink wire frame. The whole molecule is shown in the bottom 
right with residues 376-305 coloured yellow in order to locate this region in the overall structure. 
The mutant image was created by Dr. Matthew J. Conroy, using Insight (MSI inc. ) and subsequently 
energy minimised in XPLOR (Br(inger 1992 XPLOR version 3.1: A system for crystallography and 
NMR. Yale University, New Haven). The figure was produced using Molscript (Kraulis (1991) J. 
Appl. Cryst. 24 946-950) and Raster3D, (Merritt & Murphy (1994) Acta Cryst. D50 869-873). 
Schematic diagrams 
showing the plasmid sketches 
with gel pictures 
(Including Figures 3.6,3.13 - 3.15,3.17 - 3.19) 
Gel 1 
G 
acIq 
pQIS 7 
6327 bns 
6.32 kb 
/ GS BamHl 
aclq 
PQIS 8 Sp 
6327 bps 
His-ta /sj'I 
Xbal 
BamHI /G 
acIq 
pQIS 9 
6327 bns 
amHl 
Gel 2 
Figure 3.6: Schematic representation showing the construction of three mutants of M. SPRI (pQIS 8, pQIS 
9 and pQIS 10). The new Fspl restriction site is shown in red. Gel 1: shows 30 µl PCR product generated after 
site-directed mutagenesis (using pQIS 7 as template DNA) and analysed on a I% agarose gel. M: GeneRulerTM I 
kb DNA ladder. Lane 1: PCR product generated after site-directed mutagenesis for pQIS 8.2: PCR product 
generated after site-directed mutagenesis for pQIS 9.3: PCR product generated after site-directed mutagenesis for 
pQIS 10. Mutants plasmid were digested with an excess of Mspl in order to assess Mtase activity and the resulting 
digests analysed on 1% gel. Gel 2: Lane 1 pQIS 8 (F 386 A mutant) Mspl digest. 2: pQIS 9 (A 390 G mutant) 
Mspl digest. 3: pQIS 10 (D 392 P mutant) Mspl digest. M: GeneRulerTM I kb DNA ladder. 4: pQIS 8 (F 386 A 
mutant) Fspl digest. (Three fragments of size 2738,2380, and 1209 bps confirmed the identity of construct pQIS 
8). (Note: For DNA ladder size see Chapter 2, and Appendices). 
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Figure 3.13: Schematic representation showing the construction of pQIS 11 and pQIS 12 (containing 
the gene encoding the Ala 280 Phe mutant of M. HhaI). The new restriction site Styl is shown in red. Gel 
1: Lane 1 PCR product generated during site directed mutagenesis from pMSK 12. Lane 2 PCR product 
generated during site directed mutagenesis 
from pMSK 7. Gel 2: Digestion analysis of products shown 
using Styl restriction enzyme. Lane 1, pQIS 12 cut with Styl . 
(Fragment sizes 2824,887,198 and 27 bp). 
Lane 2: pQIS 11 cut with Styl (linear DNA, 5949 bp). M: GeneRulerTM I kb DNA ladder in both gels. 
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Figure 3.14: Schematic representation of the construction of double mutants (A280F, A277L) 
pQIS 13 and pQIS 14 from pQIS 11 and pQIS 12. New restriction site of Xhal shown in red. 
Mutants were made by site directed mutagenesis (SDM) (See Gel 1). 1: PCR product generated 
during site directed mutagenesis for pQIS 13 2: PCR product generated during site directed 
mutagenesis for pQIS 14. Gel 2: Lane 1: pQIS 13 double mutant (A280F, A277L) Hhal digest. 
(Cleaved DNA, thus encoded enzyme was inactive). 2: pQIS 13 double mutant (A280F, A277L) Xbal 
digest. (Fragment sizes 542 and 5407 bps) 3: pQIS 14 double mutant (A280F, A277L) Hhal digest. 4: 
pQIS 14 double mutant (A280F, A277L) Xbal digest. (Fragment sizes 215,542 and 3179 bps) M: 
GeneRulerTM I kb DNA ladder in both gels. 
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Figure 3.15: Schematic representation of the construction of triple mutants (A280F, A277L & 
F302A) pQIS 17 and pQIS 18 from pQIS 13 and pIS14. New restriction site of Accl shown in red in 
plasmid constructs pQIS 17 and pQIS 18. Mutants were made by site directed mutagenesis (SDM). Gel 1: 
Lane 1 and 2; 30 µl PCR product after SDM for both new constructs. pQIS 17 was confirmed by the 
disappearance of Hincll site. Gel 2 (1.5% agarose gel): Lane M 1: 100 bp DNA ladder. Lane 2: pQIS 17 
cleaved with Hincll (2552,1747,979,671 bp). pQIS 18 was digested with Accl for the presence of unique 
restriction site. Gel 3: Lane 1: pQIS 18 digested with an excess of Hhal for its activity. (Uncut DNA 
reveals that the plasmid encodes for an active Mtase Hhal). Lane 2: pQIS 18 cleaved with Accl (linear 
3936 bp). M: GeneRuler" I kb DNA ladder in all three gels. (For exact sizes of standard 100 bp and I kb 
DNA ladder please see Chapter 2 and Appendices). 
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Figure 3.17: Schematic representation of the construction of pQIS 20 (single mutant Phe 302 Ala) 
using pMSK 12 (which encodes for wild type M. HhaI). Substitution of Phe 302 into Ala in motif IX by 
site directed mutagenesis. The new restriction site of Accl shown in red in the plasmid pQIS 20 map. Gel 
1: Lane 1 PCR product generated during site directed mutagenesis using pMSK 12 as template. Gel 2: 
lane 1 represents the construct pQIS 20 digested with Accl (linear 3936 bp). This digestion verifies the 
formation of pQIS 20. Gel 3 lane 1, pQIS 20 digested with Hhal. (Partial activity is shown by the protein 
encoded by pQIS 20) M: GeneRulerTM I kb DNA ladder in all gels. 
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Figure 3.18: Schematic representation of the construction of quad mutant (Ala 280 Phe, Arg 277 
Leu, Phe 302 Ala, & Try 289 Asp) pQIS 21 from active triple mutant (Ala 280 Phe, Arg 277 Leu 
& Phe 302 Ala) pQIS 18. In plasmid map new restriction site of A1wNI is shown in red. Gel 1: lane 1: 
shows PCR product generated during site directed mutagenesis using pQIS 18 as template. Gel 2: Lane 
1: pQIS 21 cleaved with A1wNl (2342,1594 bp) and verifies the formation of pQIS 21. M: 
GeneRulerTM I kb DNA ladder in both gels. 
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Figure 3.19: Schematic representation of the construction of single mutant pQIS 22 (Tyr 289 
Asp) from wild type M. Hhal (pMSK 12). Substitution of Tyr 289 into Asp in motif IX introduces 
new restriction site of AIwNI shown in red in the plasmid map. Gel 1: lane 1: PCR product 
generated during site directed mutagenesis using pMSK 12 as template. Gel 2: Lane 1: pQIS 22 
cleaved with A1wNI (2342,1594 bp). This digestion verifies the formation of pQIS 22. M: 
GeneRulerrM I kb DNA ladder in both gels. 
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CONSTRUCTION OF CHIMAERAS OF M. HhaI BY 
INSERTION MUTAGENESIS 
4.1: Introduction 
It is known from the crystal structure of M. HhaI that the variable region (amino acids 
171-271) begins as a long stalk on the surface of the protein (Cheng et al., 1993). 
Many experiments have been carried out to explore the structural flexibility of 
methyltransferases (Mtases) (Wilke et al., 1988; Trautner et al., 1988; Walter et al., 
1992; Trautner et al., 1996; Matin, 2000) (see also Chapter 3, section 3.1.2. ) most of 
which focus on the TRD region. Experiments concerning the exchange of TRDs 
regions among multispecific Mtases have shown that chimaeric constructs can be 
made successfully (Balganesh et al., 1987; Trautner et al., 1988; Walter et al., 1992; 
Trautner et al., 1996). These experiments showed the interchange-ability of the core 
structures of different phage enzymes. However, the only case in which the exchange 
of TRDs between the mono and multispecific Mtases has been productive is in the 
chimaeric constructs involving M. (4)BssHhI and the highly related monospecific 
Mtase M. 43TII (Sethmann et al., 1999). In such a situation one should be able to 
delete or add target recognising modules in the variable region, causing either loss or 
the acquisition of novel methylation capacities. In support of this expectation, an 
experiment has been planned to insert various segments from the multispecific Mtase 
M. SPRI into the monospecific M. HhaI that has been modified as described in 
chapter three. 
The appropriate interaction between the large and small domains is essential for C5- 
Mtases to catalyse sequence specific methylation (Sethmann et al., 1999). In 
particular, complementary interactions between the variable region, TRD and motifs 
IX and X appear to be crucial for optimal enzymatic activity. It would seem therefore 
possible that the enzyme could tolerate insertions only if the extra polypeptide is 
placed on the surface of the protein structure without disturbing the "core" 
interactions. 
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4.2: Construction of a Chimaera in which the TRD region of 
M. HhaI has been exchanged with segment from M. SPRI 
Previous work has shown that specificity determinants of the mono-specific Mtases 
are located within the variable region (see Chapter 1). In addition a structural 
correlation exists between conserved motif IX and the variable region (KlimaAauskas 
et al., 1991; Mi and Roberts, 1992). It seems that hybrid Mtases retain greater 
activity when the variable region and the flanking motif IX derive from the same 
parent enzyme. These results suggest that there may be some direct structural 
interactions between the variable region and motif IX (Mi and Roberts, 1992) that 
play a role in catalysis. 
In order to study the degree of tolerance to structural changes and to explore the 
relationship between the variable region and motif IX of M. HhaI, I have carried out a 
series of TRD insertion and exchange experiments. As discussed earlier, in the light 
of the successful TRD swapping experiments between multi-specific Mtases, it was 
hypothesised that the triple mutant plasmid pQIS 18 (Ala 280 Phe, Arg 277 Leu and 
Phe 302 Ala) and the quadruple mutant plasmid pQIS 21 (Ala 280 Phe, Arg 277 Leu, 
Phe 302 Ala and Tyr 289 Asp) might provide more suitable frameworks for TRD 
exchanges between M. HhaI and one of the TRDs from M. SPRI. 
The wild type M. HhaI gene has been used as a "host" for the MspI specific TRD of 
M. SPRI: the resulting construct (pHhaI-TRDM) was catalytically inactive (Matin, 
2000). In this experiment the region encoding the Mspl specific TRD was inserted as 
an XhoI-EcoRI fragment into wild type M. HhaI (Matin, 2000). In the following set 
of experiments mutants of M. HhaI (described in Chapter 3), which mimic motif IX 
of the multi-specific Mtase M. SPRI, were chosen for insertion of those segments 
from M. SPRI shown in Figure 4.1. 
During the course of insertion of segments from M. SPRI it was vital to introduce 
certain restriction sites both in M. SPRI and M. HhaI to facilitate the cloning and for 
the formation of chimaeras. The mutants prepared in this experiment are summarised 
in figure 4.1 (a) and 4.1 (b). The schematic diagrams showing the plasmid sketches 
with gel pictures are placed at the end of the chapter. 
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Wild type M. SPRI 
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Figure 4.1: The approximate size and position of segments from the variable region of wild type 
M. SPRI which were used for cloning into the triple mutant of M. HhaI. Wild type M. SPRI and 
segments from M. SPRI are shown in red. The numbers are the coordinates of amino acids in M. SPRI with 
unique restriction sites. (Some restriction sites were not present in the wild type sequence and were 
generated later, see text for details). The TRD region are described in boxes. Map is not drawn to scale. 
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Figure 4.1 (a): Schematic representation showing the mutants of M. HhaI during the course of 
introduction of new restriction sites for the insertion of various segments from M. SPRI. Wild type 
M. Hhal carries a six histidine tag at its N-terminus. 
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Figure 4.1 (b): Schematic representation showing the mutants of M. SPRI during the course of 
introduction of new restriction sites for the insertion of various segments from M. SPRI into M. HhaL 
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4.2.1: INSERTION OF THE MspI SPECIFIC TRD FROM M. SPRI INTO THE 
M. HhaI TRIPLE MUTANT 
In the first instance plasmid pQIS 18, carrying three mutations (Ala 280 Phe, Arg 
277 Leu and Phe 302 Ala) in M. HhaI was selected for the insertion of an MspI 
specific TRD coding sequence (Segment A, see Figure 4.1) from M. SPRI. It was 
convenient to use the pHhaI-TRDM construct (see above) for swapping the entire 
TRD region, which carries both TRDs (Mspl and Mal) arranged sequentially. 
The enzymes chosen for the cloning of the desired region of DNA from pHhaI- 
TRDM to pQIS 18 were Bc1I and BbsI. Bc1I requires the DNA to be prepared in a 
Dam strain of E. coll. The enzymes Bc1I and BbsI utilize the same buffer but require 
a different temperature for incubation. Therefore the DNA was prepared using the E. 
coli strain GM2163 and was then subjected to sequential restriction digestion with 
Bc1I and BbsI. The experiment is summarised in Figure 4.2. The final construct was 
called pQIS 23 (Triple mutant + MspI TRD) and was identified by restriction 
analysis. The appearance of a new Bg1II site confirmed that the new constructs 
carried the Mspl TRD, along with the Hhal TRD region (Figure 4.2). The sequence 
of M. HhaI DNA showing the deduced amino acid sequence before and after the 
MspI TRD insertion is shown in Figure 4.3. The activity of the mutant enzyme 
encoded by the pQIS 23 was evaluated by HhaI and MspI restriction analysis; it was 
found to be inactive (Figure 4.2). y. 
4.2.2: INSERTION OF THE MspI SPECIFIC TRD FROM M. SPRI INTO THE 
M. Hhal QUADRUPLE MUTANT 
The quadruple mutant of M. HhaI pQIS 21 carrying four mutations (Ala 280 Phe, Arg 
277 Leu, Phe 302 Ala and Tyr 289 Asp) was also chosen for an experiment involving 
the insertion of the MspI TRD coding sequence (Segment A, see Figure 4.1) from the 
M. SPRI gene. The same strategy was used as was carried out for the triple mutant 
pQIS 18 (see above). Bc1I and BbsI were used to create a 3332 bp (vector) DNA 
from pQIS 21, and a 733 bp (insert) DNA from pHhal-TRDM. Recombinant 
plasmids were screened to identify pQIS 24 (quadruple mutant + MspI TRD). The 
starting plasmids pQIS 21 and pHhal-TRDM both have a unique Bg1II site, as shown 
in Figure 4.4. In addition, the inserted MspI specific TRD region also contains XhoI 
and EcoRI sites. Restriction analysis with Xhol, EcoRI and Bg1II confirmed the 
authenticity of the new plasmid pQIS P. Mspl and Mal restriction digestion 
revealed that the new construct pQIS 24yýO, r,, eýniätically inactive (Figure 4.4). 
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A AAA GAT TTG TTA TTA OCT GAT AGC GAG GTG GAA CAC TTA GTT ATT GAT 
_ 193 K D L L L P D S E V E H L V I D 
AGA AAA GAT TTG GTA ATG ACA AAC CAA GAA ATT GAG CAA ACA ACC CCC 
209 R K D L V M T N Q E I E Q T T P 
AAA ACA GTT CGA CTT GGT ATT GTA GGA AAA GGT GGG CAA GGA GAA CGA 
225 K T V R L G I V G K G G Q G E R 
ATT TAT AGC ACA AGA GGC ATT GCA ATT ACC TTA TCT GCT TAT GGT GGC 
241 I Y S T R G I A I T L S A Y G G 
GGC ATT TTC GCT AAG ACA GGG GGA TAT TTA GTA AAC GGG AAG ACA CGG 
257 G I F A K T G G Y L V N G K T R 
AAA TTA CAC CCT AGA GAG TGT GCT AGA GTA ATG GGC TAC CCA GAT AGT 
273 K L H P R E C A R V M G Y P D S 
TAT AAA GTC CAC CCG TCA ACC AGC CAA GCA TAT AAA CAA TTT GGT AAC 
289 Y K V H P S T S Q A Y K Q F G N 
TCA GTT GTT ATC AAT GTA CTT CAA TAT ATT GCT TAT AAC ATT GGT TCA 
305 S V V I N V L Q Y I A Y N I G S 
B GTT GAG TAC TCC AGA AAA AGC GGG CTT GGA CGA GAA CTT GCT GTA TCT 
V E Y S R K S G L G R E L A VS 
CAT ACG CTT TCT GCT TCT GAC TGG AGA GGA TTG AAT AGG AAC CAA AAA 
H T L S A S D W R G L N R N QK 
CAA AAT GCA GTT GTT GAG 
Q N A V V E 
C AAA GAT TTG TTA TTA CCT GAT AGC CTC GAG GTT GAG iAC TCC AG: _. 00 
K D L L L P D S L E V E Y S R K 
TCT CAT ACG CTT TCT GCT TOT 
S G L G R E L A V S H T L S A S 
"O-: C TGG AGA GGA TTG AAT AGG AAC CAA AAA CAA AAT GCA OTT GTT 
D W R G L N R N Q K Q N A V V E 
: 'T ATG GAA TTC GTG GAA CAC TTA GTT ATT GAT AGA AAA GAT TTG GTA 
H M E F V E H L V I D R K D L V 
ATG ACA AAC CAA GAA ATT GAG CAA ACA ACC CCC AAA ACA GTT CGA CTT 
M T N Q E I E Q T T P K T V R L 
GGT ATT GTA GGA AAA GGT GGG CAA GGA GAA CGA ATT TAT AGC ACA AGA 
G I V G K G G Q G E R I Y S T R 
GGC ATT GCA ATT ACC TTA TCT GCT TAT GGT GGC GGC ATT TTC GCT AAG 
G I A I T L S A Y G G G I F A K 
ACA GGG GGA TAT TTA GTA AAC GGG AAG ACA CGG AAA TTA CAC CCT CTA 
T G G Y L V N G K T R K L H P L 
GAG TGT TTT AGA GTA ATG GGC TAC CCA GAT AGT TAT AAA GTC CAC CCG 
E C F R V M G Y P D S Y K V H P 
TCA ACC AGC CAA GCA TAT AAA CAA GCT GGT AAC TCA GTT GTT ATC AAT 
S T S Q A Y K Q A G N S V V I N 
GTA CTT CAA TAT ATT GCT TAT AAC ATT GGT TCA 
V L Q Y I A Y N I G S 
Figure 4.3: Nucleotide and amino acid sequences of, A) "Triple mutant" of M. Hhal, showing the 
variable region, as well as motif IX (purple) and motif X (blue), B) M. SPRI Mspl specific target 
recognition domain (TRD), C) "Triple mutant" of M. Hhal with the Mspl specific TRD from M. SPRI 
gene inserted (the insertion shown in red). Extra amino acids flanking the inserted Mspl specific TRD are 
shown in green. 
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4.3: Replacement experiments in M. HhaI 
4.3.1: REPLACEMENT OF THE M. HhaI TRD WITH M. SPRI TRDs 
As shown by the above experiments, M. HhaI cannot tolerate the insertion of the 
MspI TRD, and this insertion abolishes M. HhaI activity even when motif IX has 
been modified to resemble that of multi-specific Mtase M. SPRI. All the insertions 
described in the present experiment were carried out in the variable region towards 
the C-terminal region of the protein, which is essential for interactions with motif IX. 
It was assumed that because the sequence of motif IX has been modified, and had 
now become more like multi-specific Mtase M. SPRI, it might accommodate a larger 
variable region carrying all three TRDs. Therefore it was decided to swap the TRD 
region in construct pQIS 23 (see above) with the three TRDs of M. SPRI. However, 
from cloning point of view, this was not a straightforward experiment. In order to 
ensure that the cloning sites in the M. HhaI mutant gene are unique, some restriction 
sites must be removed. In addition, similar or compatible sites were required in both 
M. HhaI and M. SPRI genes for error-free swapping. The construct pQIS 23 was used 
first for the abolition of few of the restriction sites from the multiple cloning sites at 
3' end of the M. HhaI gene as follows. 
4.3.1.1: Removal of an 83 bp fragment downstream of the 3'end of the M. HhaI 
gene 
The 3' end of the gene contained in construct pQIS 23 carries part of a multiple 
cloning site, which proved to be a significant hurdle in obtaining the recombinant 
plasmid. Removal of this sequence was achieved by cleavage of the construct pQIS 
23 with Stuf and PstI followed by an end-filling reaction. The linearised 3982 bp 
plasmid was recovered from the gel and the cohesive end generated by Pal was 
converted into a blunt end. This was carried out by using Vent® DNA polymerase. 
This enzyme can be used for filling-in a 5' overhang due to 5'-3' polymerase activity, 
or to "chew back" a 3' overhang via its 3'-5' exonuclease activity to create blunt 
ends. Restriction digestion with Stul yields blunt-ended DNA products. After 
treatment with VentR® DNA polymerase the linear plasmid was purified by phenol 
extraction followed by ethanol precipitation. The DNA was circularised by self- 
ligation. The resultant construct was called pQIS 26 and its identity was confirmed 
on the basis of the disappearance of various restriction sites (Figure 4.5). 
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4.3.1.2: Deletion of Xhol and EcoRI sites downstream of the 3'end of the gene 
encoding M. HhaI 
The Xhol and EcoRI restriction sites that are present at the 3' end of the M. HhaI gene 
were deleted as follows. Two complementary mutagenic oligodeoxynucleotides NIS 
NIS23/ NIS 24 duplex mutagenic oligonucleotide: 
A Xhol /A EcoR1 
5'-TTCAAACCATATGCTCGTGGGATTCCCCTTAAGTGAG-3' 
3'-AAGTTTGGTATACGAGCACCCTAAGGGGAATTCACTC-5' 
FKPYARGIPLK 
NIS23: 5'-TTCAAACCATATGCTCGTGGGATTCCCCTTAAGTGAG-3' 
NIS 24: 5'-CTCACTTAAGGGGAATCCCACGAGCATATGGTTTGAA-3' 
23 and NIS 24 were designed and synthesised (with the mutant base shown in red in 
the primer sequence below). Mutagenesis was achieved using the Quick-Change 
(Stratagene) method and the resultant construct was named pQIS 28 (Figure 4.6). 
The identity of the construct was confirmed by the restriction analysis as shown 
(Figure 4.6). 
4.3.1.3: Construction of M. HhaI lacking a TRD region by the insertion of 
Linker NIS 25/NIS 26 into the variable region 
The next step in this cloning strategy was insertion of a short linker, replacing the 
entire TRD coding region up to the start of the sequence-encoding motif IX that lies 
on an Xhol-Bbsl restriction fragment in pQIS 28. A pair of oligonucleotides were 
designed and synthesized for this purpose. The NIS 25/ NIS 26 linker duplex, which 
was obtained by annealing the two oligonucleotides, has cohesive ends for Xhol and 
Bbsl. The linker also contains unique Sall, PstI, Munl and EcoRI sites (shown below 
in bold or in a different colour for distinction). 
NIS 25/NIS 26 Linker duplex: 
Xhol Sall Pst1 MunI EcoRI Bbsl 
5'-TCGAGCGTCGACCTGCAGCAATTGGAATTCGGAAGACAC-3' 
3'-C GCAGCTGGACGTCGTTAACCTTAAGCCTTCTGTGCCTT-5' 
NIS 25: 5'-TCGAGCGTCGACCTGCAGCAATTGGAATTCGGAAGACAC-3' 
NIS 26: 5'-TTCCGTGTCTTCCGAATTCCAATTGCTGCAGGTCGACGC-3' 
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pQIS 28 was cleaved with Xhol and BbsI to remove a 342 bp fragment encoding the 
variable region and MspI and HhaI TRDs, and, after recovering the larger band 
(3636 bp) from the agarose gel, the MS 25/NIS 26 linker was inserted into this 
vector. Digestion of the mutant constructs with various restriction enzymes 
confirmed the formation of the new construct, which consists of the M. HhaI gene 
without any TRD region (Figure 4.7). The construct was called pQIS 30. 
4.3.1.4: Cloning of the EcoRII, MspI & HaeIII specific TRDs of M. SPRI into the 
M. HhaI triple mutant 
An experiment was planned to see if the triple mutant of M. HhaI (Ala 280 Phe, Arg 
277 Leu and Phe 302 Ala) (which contains a motif IX that is like that of multi- 
specific Mtases) could tolerate an insert (Segment B, consisting of all the three 
TRDs) from multi-specific M. SPRI. The vector DNA was prepared by cleavage of 
pQIS 30 with Sall and EcoRI for the insertion of the TRDs coding sequence. The 
resulting vector DNA (3657 bp) was recovered from an agarose gel. The insert (390 
bp) DNA comprising the three TRD coding sequences prepared by using the same 
restriction enzyme digestion of pQIS 7 (encoding wild type M. SPRI) and was then 
recovered from the gel (Figure 4.8). The insert and the vector DNA were kept for 
ligation and the resulting constructs were analysed by restriction digestion. The Pal 
site that was present in the linker region had now disappeared (because the insertion 
of the sequence encoding three TRDs from M. SPRI does not contain this site). When 
the new molecule was cleaved with MunI it gave a linear DNA fragment of 4.0 kb, 
which also confirmed the presence of the insert. The new construct was called pQIS 
31. Restriction analysis with MspI and HaeIII were used to check the activity of the 
enzyme encoded by recombinant construct pQIS 31. The enzyme encoded by the 
resultant construct was found inactive (Figure 4.8). 
4.3.1.5: Removal of three amino acids to give an exact alignment with the 
consensus motif IX 
The alignment containing the new construct (shown below) revealed that there are 
three extra amino acids Lys, Thr and Arg present because of a slight difference in the 
relative positions of EcoRI site in the two Mtases. Although the last Arg present 
could be equivalent to the conserved Arg, this assumption would change the space 
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between the last TRD (HaeI1I TRD) and motif IX. The data indicate that the amino 
acids beyond the C-terminus of the ensemble of TRDs, although not necessary for 
individual TRD activity, may very well modulate the overall methylation potential of 
these enzymes (Trautner et al., 1996). 
Therefore the next experiment was designed to remove these three amino acids, 
which were Lys, Thr and Arg. It was decided to introduce another EcoRI site after 
three amino acids. Finally the DNA was cut with EcoRl in order to remove the extra 
three codons (followed by self-ligation). 
Name Swigs Prot Sequence 
M. HhaI P05102 LVNGKTI---KLHPR'CIIVM 
M. SPRI P00476 YPKYRI RLTPLCLQ F` D 
pQIS 31 YPKYRIKTRKLHPLCFVM 
Two mutagenic primers MS 27 and NIS 28 were designed to introduce a new EcoRI 
site 9 bp away from the existing EcoRI site. The introduction of a new EcoRI site 
leads to the deletion of a BbsI restriction site, which was used for diagnostic 
purposes. The sequences of the primers and of the duplex are shown below, with the 
mutated bases shown in red. 
NIS 27/ NIS 28 duplex mutagenic oligonucleotide: 
EcoRI EcoRl 
5'-CCAAAATACAGAATTCGGAGAATTCGGAAATTACACCCTC-3' 
3'-GGTTTTATGTCTTAAGCCTCTTAAGCCTTTAATGTGGGAG-5' 
PKYRIRRIRKLHP 
NIS 27: 5'-CCAAAATACAGAATTCGGAGAATTCGGAAATTACACCCTC-3' 
NIS 28: 5'-GAGGGTGTAATTTCCGAATTCTCCGAATTCTGTATTTTGG-3' 
Site-directed mutagenesis was carried out using Pfu polymerase, and the PCR 
product was digested with Dpnl for one hour before being used to transform E. coli 
(Figure 4.9). The resulting constructs were screened by restriction analysis with BbsI. 
The correct construct (numbered pQIS 32) was used for digestion with EcoRI 
followed by religation. 
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The two EcoRI sites in pQIS 32 are 9 bp apart. According to the manufacturer (NEB) 
EcoRI requires one base at the end of a DNA fragment to effect cleavage with an 
efficiency greater than 90% after two hours of incubation. Therefore the DNA was 
incubated with concentrated EcoRI for 6 hours and the products were run on an 
agarose gel in order to recover the linearised DNA fragment (Figure 4.9). The DNA 
was then retained for religation and was then used to transform E. coll. Plasmid DNA 
was prepared from the colonies and the corrected construct was named pQIS 33 
(Figure 4.9). 
4.3.2: CLONING OF AN ORF FROM M. SPRI CONSISTING OF PART OF 
THE VARIABLE REGION AND THREE TRDs INTO THE M. HhaI TRIPLE 
MUTANT 
Although the redesigned motif IX of mono-specific Mtase M. HhaI resembled that of 
the multispecific Mtases and the distance between the TRD region and motif IX had 
been altered, the chimaeric construct was still inactive. Previous data have 
demonstrated that the there is a need to preserve the variable region for enzyme 
activity (Wilke et al., 1988, Trautner et al., 1996). Because we have exchanged the 
TRD region of M. HhaI with that of three specific TRDs of M. SPRI, it was assumed 
that the TRDs of M. SPRI may require their own variable region for activity. 
In the mono specific C5-Mtase M. HhaI, the variable region of some 60 amino acids 
represents part of the large catalytic domain and the connector region to the small 
domain involved in target recognition (Klimasauskas et al., 1994). 
Using this information we decided to insert the ORF for the variable region to a 
limited length of some 65 amino acids from M. SPRI so that it should not exceed the 
size of larger catalytic domain as in the original monospecific Mtase M. HhaI. 
Therefore the final experiment planned was the insertion of the sequence of the 
variable region and the three specific TROs (Segment C, see Figure 4.1) from 
M. SPRI gene into the triple mutant M. HhaI gene. 
4.3.2.1: Introduction of a new XhoI site into the gene encoding wild type 
M. SPRI 
For the cleavage of the sequence of variable region and three TRDs from M. SPR, it 
was essential to generate a new site in pQIS 7 (encoding wild type M. SPR) at the 
appropriate location. It was decided to introduce a XhoI site and to use the XhoI and 
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EcoRI sites for the proposed experiment. Therefore a new XhoI site was introduced 
into the variable region of the M. SPR gene, in order to facilitate subsequent removal 
of the sequence encoding the variable region and the three TRDs by XhoI-EcoRI 
cleavage. Unfortunately it was not possible to introduce a new Xhol site without 
introducing an amino acid change in the open reading frame of M. SPR: Gln 189 Glu. 
A set of mutagenic oligonucleotides; NIS 31 and NIS 32 were designed and 
synthesized as shown below. 
NIS 31/ NIS 32 duplex mutagenic oligonucleotide: 
XhoI/AvaI 
5'-AGAAAGGATATACTCGAGAAAGGGAAACAGAG-3' 
3'-TCTTTCCTATATGAGCTCTTTCCCTTTGTCTC-5' 
RKDILEKGKQ 
NIS 31: 5'-AGAAAGGATATACTCGAGAAAGGGAAACAGAG-3' 
NIS 32: 5'-CTCTGTTTCCCTTTCTCGAGTATATCCTTTCT-3' 
pQIS 34 was obtained from pQIS 7 and carries two Xhol sites and was therefore 
subsequently used for the excision of Xhol/EcoRI fragment for insertion into the 
M. HhaI encoding chimaeric construct pQIS 32 (Figure 4.10). The construct pQIS 34 
encodes wild type M. SPRI containing a new XhoI site in the coding sequence 
specifying the variable region and has one amino acid codon Gln 189, mutated to a 
Glu codon. Since pQIS 34 was protected against cleavage with Mspl (Figure 4.10), it 
was therefore concluded that the protein encoded by pQIS 34 is enzymatically active. 
4.3.2.2: Cloning part of the sequence encoding the variable and TRD regions 
from M. SPRI into the M. HhaI triple mutant gene 
The appropriate vector and insert were prepared by cleavage of pQIS 32 and pQIS 34 
with Xhol and EcoRI. Both the vector DNA (3.6 kb) from pQIS 32 and insert DNA 
(550 bp) from pQIS 34 were recovered from an agarose gel, and were ligated 
together. The resultant construct was called pQIS 35. The presence of the insert was 
confirmed by Xhol/EcoRI double digestion, which yielded an expected 565 bp 
fragment. The activity of the construct was checked by HaeIII and Mspl digestion 
which revealed that the protein encoded by the construct was enzymatically inactive. 
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The bacterial cells carrying the new construct, pQIS 35, were grown in the presence 
of IPTG, and plasmid DNA was recovered. It was checked again to see if the plasmid 
was protected against HaeIII and Mspl digestion. This experiment confirmed that the 
plasmid coded for a protein that was enzymatically inactive (Figure 4.11). 
4.3.3: CLONING OF AN ORF FROM M. SPRI, CONSISTING OF THE 
ENTIRE VARIABLE REGION AND THREE TRDs INTO THE M. Hha1 
TRIPLE MUTANT 
The general architecture of all C5-Mtases is well documented and it has been noted 
that two regions are important for base flipping. One is at the C-terminus of the 
highly conserved catalytic motif, while the second lies in the variable region that is 
responsible for DNA sequence recognition (Roberts, 1995). All variable regions are 
bipartite. They contain at their N-terminal side a very similar sequence of 71 amino 
acids. This sequence is highly conserved among the multi-specific Mtases, and the 
integrity of this sequence must be maintained in order to preserve enzyme activity 
(Trautner et al., 1996). In the mono-specific C5-Mtase M. HhaI, the equivalent region 
of 60 amino acids represents part of a large catalytic domain, as well as the connector 
region to the small domain involved in target recognition (Klimasauskas et al., 
1994). Hence, it is plausible that target recognition by multi-specific Mtases requires 
a 71-conserved amino acid sequence (i. e. not the equivalent region of M. HhaI). It 
was conjectured, furthermore, that if the conserved 71 amino acid sequence of the 
multi-specific Mtase M. SPRI was replaced with the equivalent region of 60 amino 
acids from the mono-specific Mtase M. HhaI, it might restore the activity to the 
enzyme. The next experiment was designed to introduce the conserved 71 amino acid 
sequence of M. SPRI with the three TRDs into the redesigned M. HhaI gene. In pQIS 
7 (which encodes for wild type M. SPRI) there is an existing Pacl site at the start of 
the coding sequence for the variable region. However, there was a need to introduce 
a similar or compatible site at an equivalent position in construct carrying the 
M. HhaI gene. 
4.3.3.1: Introduction of a PacI site into various constructs carrying the M. HhaI 
gene 
It was decided to introduce a Pacl site into pMSK 7 (encoding wild type M. HhaI), 
into pQIS 18 (expressing the redesigned triple mutant of M. HhaI) as well as pQIS 35 
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(in which we have introduced an EcoRI site at an equivalent position to that in the 
gene encoding M. SPRI) (See sections 4.1.5.2 and 4.1.5.3). The mutagenic 
oligonucleotides used for this purpose were NIS 33 and NIS 34 (the new restriction 
site is shown below in bold, with the mutation in red). 
NIS 33/ NIS 34 duplex mutagenic oligonucleotide: 
Pa cI 
5'-GATTTGTTTTCGCAATGATTTAATTAATCAAAATTTCCAATTTCC-3' 
3'-CTAAACAAAAGCGTTACTAAATTAATTAGTTTTAAAGGTTAAAGG-5' 
ICFRNDLINQNFQF 
NIS 33: 5'-GATTTGTTTTCGCAATGATTTAATTAATCAAAATTTCCAATTTCC-3' 
NIS 34: 5'-GGAAATTGGAAATTTTGATTAATTAAATCATTGCGAAAACAAATC-3' 
Three plasmids: pMSK 12, pQIS 18 and pQIS 35 were used as templates for site- 
directed mutagenesis to introduce the Pad site and to effect two codon changes: Asn 
176 Ile and Ile 177 Asn (Figure 4.12). The constructs were checked by restriction 
analysis, and numbered pQIS 36, pQIS 37 and pQIS 38 (as shown in Figure 4.12). 
The protein coded by the construct pQIS 36 (a mutant of wild type M. HhaI (Asn 176 
Ile and Ile 177 Asn)) retains enzymatic activity since the pQIS 36 is not cleaved by 
HhaI. The construct pQIS 37 was generated from pQIS 18 (encoding the redesigned 
triple mutant of M. HhaI) and was found to express an inactive Mtase; it appears that 
the Asn 176 Ile and Ile 177 Asn mutations inactivate the triple mutant of M. HhaI 
(pQIS 18). The third construct pQIS 38 was inactive, as expected, because the 
template DNA pQIS 35 was inactive. This experiment indicated that there may be a 
initial interaction between motif IX and the variable region in M. HhaI. This 
inference is based on the observation that when the redesigned motif IX (active in the 
triple mutant state) is used for mutation (Asn 176 Ile and Ile 177 Asn) in the variable 
region, it is unable to methylate. 
The analysis of the crystal structure of M. HhaI for Asn-Ile at position 176-177 
revealed that these two amino acids reside at the surface of the protein at the starting 
curl of the variable loop region (see Figure 4.21). Although these two amino acids 
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two triplets, involving the Pro-Cys region and the Thr-Leu residues that are found in 
the TRD which lies in the small domain, on the other side of the cleft (Cheng et al., 
1993). The side-chain nitrogen of Asn 120 forms a hydrogen bond to the backbone 
oxygen of residue 79 next to Pro 80. Glu 119 also interacts with Arg 165 through ion 
pairing. A number of hydrogen bonds link the large and small domains through 
amino acids 160-163 and the region around Thr250-Leu251 (Cheng et al., 1993). 
Because the overall architecture of this set of enzymes (C5-Mtases) is so well 
conserved, it is highly likely that they will all have similar structures and will use the 
same catalytic mechanism (Roberts, 1995). However, it is likely that the physical 
interactions between the conserved dipeptide T (L, V, I) found in the TRD region 
and the core catalytic domain will be arranged in a different way in multi-specific 
Mtases because of the presence of multiple TRDs. Based on this assumption, we 
once again decided to carry out another set of experiments that involve the transfer of 
a region starting from motif VI and ending at the TRDs (from the multi-specific 
Mtase M. SPRI). The region before motif VI contains the invariant triplet G1u119- 
Asnl20-Vall21 (ENV) in M. HhaI and M. SPRI were aligned to find a suitable place 
for the introduction of a unique site, which would facilitate exchange of the desired 
region. The alignment is shown below with the conserved residues shown in red. 
Alignment of M. Hhal and M. SPRI in motif VI 
116 
M. HhuI: REKKPKV 
I 
FMENVKNFASHDNGN 
M. SPRI: KEKQPKFFVFENVKGLINHDKGN 
1 
112 
In insertion mutagenesis experiments, two problems are often encountered, and this 
was the case in planning a strategy for exchanging segments of M. SPRI and M. Hhal. 
For example, in this experiment the only suitable unique restriction site present in 
both plasmids was Apal, which can be introduced at codons Val 116 and Phe 117 of 
M. HhaI and in M. SPRI at codons Phe 112, Phe 113 and Val 114. This is a drawback, 
as the resulting site generates a mutation in itself but at the same time provides an 
opportunity to study the individual mutations. Therefore, it was decided to introduce 
an ApaI site in both genes, complete the fragment exchange and, if required restore 
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the original codons by mutation to maintain the structural integrity of the protein. 
The second problem that we faced was the maintenance of the reading frame with 
respect to the newly introduced restriction sites. The ORF of M. Hhal is in a different 
frame to that of M. SPRI, and this had to be taken into consideration. 
4.3.4.1: Introduction of a new Apal site into the gene encoding M. SPRI 
The mutagenic oligonucleotides designed and synthesized for the introduction of this 
Apal site were NIS 35 and NIS 36 (as shown below, with the mutated bases shown in 
red). This mutagenesis experiment led to the following changes: Phe 112 Leu, Phe 
113 Gly and Val 114 Pro. It was decided to study these mutations using two plasmids 
as templates, which are as follows. 
A: Wild type M. SPRI (encoded by construct number pQIS 7) (See Section 3.1.1). 
B: Mutant M. SPRI F386A (encoded by construct number pQIS 8) (See Section 
3.1.4.1). 
NIS 35/ NIS 36 duplex mutagenic oligonucleotide: 
ApaI 
5'-CAAAGCAACCAAAGTTGGGCCCTTTTGAAAATGTTAAAG-3' 
3'-GTTTCGTTGGTTTCAACCCGGGAAAACTTTTACAATTTC-5' 
KQPKLGPFENVK 
NIS 35: 5'-CAAAGCAACCAAAGTTGGGCCCTTTTGAAAATGTTAAAG-3' 
NIS 36: 5'-CTTTAACATTTTCAAAAGGGCCCAACTTTGGTTGCTTTG-3' 
(A): Introduction of an ApaI site in pQIS 7 
The construct carrying the wild type M. SPRI gene (pQIS 7) was used as the template 
for the Phe 112 Leu, Phe 113 Gly and Val 114 Pro mutagenesis experiment and the 
resulting construct was verified by Apal digestion. pQIS 7 contains a unique ApaI 
site: by this experiment a second site was introduced. Upon restriction digestion with 
Apal, two fragments were obtained of the correct size (3962+2365 bps), which 
confirmed that the mutagenesis had been successful. The new construct, pQIS 45, 
upon restriction digestion with Apal and EcoRI yielded a 787 bp fragment, which 
also confirmed its authenticity. The plasmid was checked for the activity of the 
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encoded mutant enzyme by MspI restriction analysis. Once again it was found that 
the protein encoded by the mutated protein of M. SPRI was inactive (Figure 4.14). 
(B): Introduction of an Apal site into pQIS 8 
The construct pQIS 8 (encoding the Phe 386 Ala mutant of M. SPRI) was used as a 
template for the site-directed mutagenesis experiment, for the introduction of the new 
Apal site. The resulting construct, when digested with Apal yielded two fragments of 
DNA (3962+2365 bps), which confirmed that the plasmid carried a new ApaI site 
(Figure 4.14). The new construct was called pQIS 46 (a Phe 386 Ala mutant of 
M. SPRI which also now carried other mutations Phe 112 Leu, Phe 113 Gly and Val 
114 Pro in the region just before the ENV region (motif VI)). When the methylation 
potential of the mutant protein was measured, it was observed that the protein was 
enzymatically inactive (Figure 4.14). 
4.3.4.2: Introduction of a new Apal site into the gene encoding M. HhaI 
For mutagenesis and introduction of a new site into the gene encoding M. HhaI (and 
its mutant constructs) oligonucleotides NIS 37 and NIS 38 were designed and are as 
shown below with the base changes shown in red. This mutation experiment led to 
changes of two amino acid residues (from the wild type M. Hhal) namely Val 116 
Gly and Phe 117 Pro. 
NIS 37/ NIS 38 duplex mutagenic oligonucleotide: 
Apa I 
5'-AAAAAACCTAAAGTGGGCCCTATGGAAAATGTG-3' 
3'-TTTTTTGGATTTCACCCGGGATACCTTTTACAC-5' 
KKPKVGPMENV 
NIS 37: 5'-AAAAAACCTAAAGTGGGCCCTATGGAAAATGTG-3' 
NIS 38: 5'-CACATTTTCCATAGGGCCCACTTTAGGTTTTTT-3' 
The methyltransferase Hhal-carrying constructs selected for these experiments were 
as follows. 
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A: pMSK 12 (encoding for wild type M. HhaI) 
B: pQIS 18 (encoding for redesigned triple mutant of M. HhaI) 
C: pQIS 36 (encoding for Asn 176 Ile, Ile 177 Asn mutant of M. HhaI) 
A: Introduction of a new Apal site into pMSK 12 
The substitutions Changes Val 116 Gly and Phe 117 Pro were carried out using site- 
directed mutagenesis (for the synthesis of new construct pQIS 41). pQIS 41 was 
identified by the presence of a unique ApaI site, digestion with which produced 
linearised plasmid (Figure 4.15). The mutations Val 116 Gly and Phe 117 Pro caused 
the encoded protein to be enzymatically inactive (Figure 4.15). 
B: Introduction of a new Apal site into pQIS 18 
Using oligonucleotides NIS 37 and NIS 38, a site-directed mutagenesis experiment 
was carried out on pQIS 18 and the resulting new construct, pQIS 42 was checked 
for the presence of this new ApaI site. Restriction analysis confirmed the identity of 
the new construct pQIS 42 (Figure 4.15). Mal degraded the plasmid, demonstrated 
that the plasmid is not protected and therefore encodes an inactive Mtase (Figure 
4.15). 
C: Introduction of a new Apal site into pQIS 36 
pQIS 36 was also used as template DNA for the introduction of mutations Val 116 
Gly and Phe 117 Pro. The identity of the resulting construct pQIS 43 was confirmed 
on the basis of the presence of the unique Apal site. pQIS 43 was checked for 
susceptibility to Hhal and was found to encode an inactive enzyme (Figure 4.15). 
D: Introduction of motif VI, the variable regions and the TRDs region from 
M. SPRI into the M. HhaI triple mutant 
This experiment was performed in two steps. In the first step the insert (segment E, 
see Figure 4.1) from construct pQIS 45 (encoding M. SPRI), which had been 
recovered by cleavage with ApaI and EcoRI, was ligated with the vector generated 
from pQIS 41 (cut with same two enzymes (See Figure 4.15)). The identity of the 
resulting construct pQIS 47 (Figure 4.16) was confirmed by restriction analysis, and 
then, using AIwNI and EcoRI restriction enzymes, the missing sequence encoding the 
C-terminal part of the triple mutant enzyme M. HhaI (region containing motif IX and 
motif X) was swapped from pQIS 40. The final construct pQIS 48 (Figure 4.16) now 
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possessed a larger coding region of M. SPRI and includes conserved motif VI (ENV 
region) and all three TRDs up to the start of motif IX, flanked by the redesigned 
triple mutant of M. HhaI. The identity of this construct was confirmed by restriction 
analysis, as shown in Figure 4.16. The activity of the encoded mutant Mtase was also 
checked by M. spl digestion of the plasmid and it was found that the protein encoded 
by the gene is inactive (Figure 4.16). However, this was to be expected because the 
mutation introduced by the extra Apal site had already inactivated the enzyme (See 
section above). Therefore, as planned earlier, it was necessary to restore the original 
amino acid codons to see if this could make any difference to the methylation 
capability of the enzyme. 
E: Restoration of original codon of motif VI in the chimaeric construct encoded 
by pQIS 48 
The sequence of the chimaeric construct pQIS 48 was aligned with that of wild type 
M. HhaI and M. SPRI, and on examination it was decided to mutate the Gly into Val 
and Pro into Phe (to maintain the amino acids up to this point similar to that of 
M. HhaI). Mutagenic primers designed for site-directed mutagenesis were NIS 41 and 
NIS 42, as shown below (with the changed bases shown in bold and red). 
Alignment of M. HhaI, M. SPRI and chimaeric construct pQIS 48 in motif VI 
M. HhaI: RERKPKVVFMENVKNFASHDNGN 
M. SPRI: KEKQPKFFVFENVKGLINHDKGN 
pQIS 48: REKKPKVGPFENVKGLINHDKGN 
NIS 41/ NIS 42 duplex mutagenic oligonucleotide: 
AApaI site 
51-GAAAAAAAACCTAAAGTGGTCTTTTTTGAAAATGTTAAAGGG-3' 
3'-CTTTTTTTTGGATTTCACCAGAAAAAACTTTTACAATTTCCC-5' 
EKKPKVVFFENVKG 
NIS 41: 5'-GAAAAAAAACCTAAAGTGGTCTTTTTTGAAAATGTTAAAGGG-3' 
NIS 42: 5'-CCCTTTAACATTTTCAAAAAAGACCACTTTAGGTTTTTTTTC-3' 
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These primers were designed to mutate the Gly-Pro dipeptide into Phe-Val, and to 
abolish the ApaI site. Site-directed mutagenesis-generated plasmids were prepared 
and characterised and it was found that the ApaI site had been deleted. The construct 
was named pQIS 52, as shown in Figure 4.17. However, the enzyme generated by 
the encoded protein was still inactive (Figure 4.17). 
4.3.4.3: Introduction of motif VI, the variable regions and the TRDs region from 
M. SPRI into wild type M. Hha1 
A: Deletion of the EcoRI site from pMSK 12 (encoding the wild type M. HhaI) 
To achieve this objective an experiment was designed in which the existing EcoRI 
site would be deleted from the wild type M. HhaI gene, and a second EcoRI site 
introduced before the sequence encoding motif IX. Since an EcoRI site exists outside 
the ORF of M. HhaI (pMSK12) it was deleted by cleavage with EcoRI followed by 
treatment with VentR® DNA polymerase to make the DNA blunt-ended (see section 
4.1.4.1). Blunt-ended DNA was self-ligated and a construct with a deleted EcoRI site 
was obtained. The construct was named pQIS 49 (wild type M. HhaI gene without an 
EcoRI site). The construct expressed protein, which subsequently protected the 
plasmid against Hhal cleavage (Figure 4.18). 
B: Introduction of an Apal site in pQIS 49 
The oligonucleotides used for mutagenesis and introduction of the Apal site in pQIS 
49 (wild type M. HhaI with deleted EcoRI site) were NIS 37 and NIS 38 (See Section 
4.1.7.2). A Site-directed mutagenesis experiment with wild type pQIS 49 was carried 
out to introduce changes: Val 116 Gly and Phe 117 Pro produced the new construct 
pQIS 50. pQIS 50 was characterised on the basis of its newly acquired unique Apal 
site (Figure 4.18). The changes Val 116 Gly and Phe 117 Pro rendered the encoded 
protein enzymatically inactive (Figure 4.18). 
C: Introduction of an EcoRI site into pQIS 50 (Val 116 Gly and Phe 117 Pro 
mutant of M. HhaI gene) 
pQIS 50 was used as the template for the introduction of an EcoRI site (at the start of 
the sequence encoding motif IX, at an equivalent position to that in M. SPRI) using 
the mutagenic primers shown below, with changes shown in red. 
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NIS 43 / NIS 44 duplex mutagenic oligonucleotide: 
EcoRI 
5'-TATTTAGTAAACGGGAGAATTCGGAAATTACACCCTAG-3' 
3'-ATAAATCATTTGCCCTCTTAAGCCTTTAATGTGGGATC-5' 
YLVNGRIRKLH2 
NIS 43: 5'-TATTTAGTAAACGGGAGAATTCGGAAATTACACCCTAG-3' 
NIS 44: 5'-CTAGGGTGTAATTTCCGAATTCTCCCGTTTACTAAATA-3' 
Two changes were engineered using site-directed mutagenesis namely Lys 270 Arg 
and Thr 271 Ile. The construct pQIS 51 was made and was shown to contain both 
ApaI and EcoRI sites. pQIS 51 was found to encode inactive protein: the construct 
was not protected from Hhal digestion (Figure 4.18). pQIS 51 was now suitable for a 
desired swap of the coding region from M. SPRI (Motif VI to the start of motif IX). 
D: Cloning of an ApaI-EcoRI gene fragment from the M. SPRI gene into the 
wild type M. HhaI gene 
in this experiment an insert (Segment E, see Figure 4.1) from construct pQIS 45 
(encoding M. SPRI) was recovered by cleavage with ApaI and EcoRl and was then 
ligated with the vector generated from pQIS 51 (already cut with same two 
enzymes). The resulting construct pQIS 53 (4267 bps) contained wild type M. HhaI 
expressing an inserted region from M. SPRI (from motif VI to the end of the TRDs) 
and this was confirmed on the basis of restriction analysis (Figure 4.19). The protein 
encoded by the construct pQIS 53 was found to be enzymatically inactive. 
E: Restoration of the original codon of motif VI in the chimaeric construct 
encoded by pQIS 53 
The chimaeric construct pQIS 53 encoded a similar motif VI sequence to that of 
pQIS 48. Therefore a similar experiment was designed to mutate Gly into Val and 
Pro into Phe. Mutagenic primers NIS 41 and NIS 42 (section 4.1.7.4), which had 
been previously used to mutate Gly-Pro residues into Val-Phe residues and to delete 
the Apal site, were again used for site-directed mutagenesis. The new construct pQIS 
54 was prepared (which encodes wild-type M. HhaI sequence from motif VI to the 
end of the TRDs from M. SPRI) (Figure 4.19). However, when the activity of the 
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protein encoded by the construct pQIS 54 was measured, it was found that it was 
enzymatically inactive. 
4.3.5: THE RELATIONSHIP BETWEEN THE VARIABLE REGION AND 
MOTIF IX OF WILD TYPE M. HhaI 
4.3.5.1: Introduction of an EcoRI site into pQIS 49 
Plasmid pQIS 49 (encoding wild type M. HhaI) in which the existing EcoRI site had 
been abolished (Section 4.1.7.5: A) was used to engineer two changes, namely Lys 
270 Arg and Thr 271 Ile using site-directed mutagenesis. This mutagenesis 
experiment introduces an EcoRI site at a position equivalent to the EcoRI site in 
M. SPRI. The primers NIS 43 and NIS 44 (Section 4.1.7.5: C) were used for this 
mutagenesis experiment. The mutant construct pQIS 55 (K270R, T271I) was 
identified by the presence of a unique EcoRI restriction site (Figure 4.20). However 
these changes affected the activity of the encoded M. HhaI. It was observed that the 
methylation activity of the mutant enzyme encoded by pQIS 55 was reduced (Figure 
4.20). 
4.3.5.2: Introduction of PacI site into pQIS 55 
pQIS 55 (containing the K270R and T271I mutations (and an EcoRI site)) was used 
as the template for Asn 176 Ile and Ile 177 Asn mutagenesis (for the introduction of 
a Pacl site). The primers NIS 33 and NIS 34 (section 4.3.3.1) were used for this 
experiment. The resulting construct, pHhaI-EcoRI-Pacl, was tested for the activity of 
the encoded protein. It was found that it had lost enzymatic activity and thus the 
plasmid was not protected against HhaI cleavage (Figure 4.20). 
This experiment supports our previous observation (for the formation of pQIS 37) 
that if mutations are carried out in motif IX and the TRD region simultaneously, 
methylation activity is lost (Section 4.3.3.1). This shows a clear relationship between 
the two regions and supports previous author's findings (Mi and Roberts, 1992). 
4.4: Discussion 
In all C5-DNA Mtases from prokaryotes and eukaryotes, a set of conserved amino 
acid sequence elements are associated with general enzymatic functions. These 
sequence elements are arranged in canonical order. Crystallographic studies on two 
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bacterial Mtases have shown that general enzymatic functions such as cofactor 
(SAM) binding and catalysis are provided by a large "catalytic" domain formed 
primarily by the N-terminal part of the enzyme, (motifs I-VIII) in conjunction with 
motif X. The second, smaller "recognition" domain of the Mtases is composed of the 
central variable region containing the target recognition domain(s) (TRDs) and part 
of the C-terminal motifs IX and X (Klimagauskas et al., 1994; Reinisch et al., 1995). 
The specificity of methylation is achieved by the selective recognition of defined 
DNA target sequences, within which methylation occurs by the TRDs (Trautner et 
al., 1996). The integrity of the small domain, providing a correct interplay between 
the variable TRD region and the conserved motifs IX and X, appears to be crucial for 
the enzymatic activity. This assumption followed experiments in which chimaeric 
monospecific Mtases were analysed. Activity of such chimaeric Mtases was only 
observed when the entire small domains (variable region, TRD and motif IX-X) were 
exchanged, whereas an exchange of only the variable region or only motif IX-X 
resulted in inactive enzymes (Mi and Roberts, 1992). 
On the other hand, Walter et al., (1992) have demonstrated the modular character of 
multispecific Mtases by deleting, rearranging and exchanging several TRDs. It has 
been shown that target recognition is independent of a particular TRD or core 
sequence context. It is also documented that multispecific Mtases can accommodate 
inert material of non-Mtase origin within their variable region without losing their 
activity (Walter et al., 1992, Matin, 2000). This suggests that the enzyme core 
sequences preceding or following it form separable functional domains. 
The enzyme M. HhaI regained activity after redesigning of motif IX by the 
introduction of three point mutations and it was thought that these changes may be 
sufficient to enable functional exchange of TRDs between a mono- and a multi- 
specific Mtase. The variable region in M. HhaI starts from amino acid 171 and lies on 
the surface of protein (Figure 4.21) spanning about 100 amino acids (Cheng et al., 
1993). Experiments were carried out in the loop at the N-terminus of the variable 
region of M. HhaI in the hope that a functional Mtase that would be re-targeted to 
alternative DNA sequences. The MspI specific TRD sequence from M. SPRI was 
inserted preceding the Mal TRD sequence at amino acid number 201-205 in both 
triple and quadruple mutants of M. HhaI. Both mutants mimic motifs IX-X of the 
multispecific Mtase, M. SPRI. However, both chimaeric construct pQIS 23 and pQIS 
24 encoded inactive enzymes. 
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Figure 4.21: Ribbon diagram of M. HhaI coloured by motif as shown in Figure 1.6. The location of 
insertions is indicated with an arrow which is amino acid 201 as described in Figure 4.3. The image was 
created by Dr. Matthew J. Conroy. The figure was produced using Molscript (Kraulis (1991) J. Appl. Cryst. 
24 946-950) and Raster3D, (Merritt & Murphy (1994) Acta Cryst. D50 869-873). (Figure from Cheng et al., 
1993, pdb code: I hmy ). 
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A second approach was adopted initially by exchanging the TRD of Hhal with that 
of M. SPRI. A series of other cloning experiments that included the exchange of the 
variable and the TRDs region of M. SPRI in M. HhaI followed this exchange strategy. 
From these insertion and exchange experiments (summarised in Figure 4.22 and 
4.23) it became clear that it was difficult to convert a mono-specific Mtase into a 
multi-specific Mtase. 
Various mutagenesis experiments in selected mutants and the wild type forms of 
both M. HhaI and M. SPRI were also carried out to determine the effect of individual 
and multiple mutations on the catalytic activity of the corresponding enzymes. A 
summary of mutations introduced in M. SPRI and M. HhaI are given in Figure 4.24. It 
has been observed that mutation in the variable region at or near the N-terminus of 
either M. SPRI or M. HhaI (construct pQIS 34 and pQIS 36) is tolerated by both 
Mtases. However, when pQIS 18 (encoding the triple mutant of M. HhaI) was used as 
template for the construction of pQIS 37, it was observed that the encoded enzyme 
had lost its ability to methylate. Another similar example can be seen where pQIS 55 
was used to construct pHhaI-EcoRI-PacI. Although, the Mtase expressed from pQIS 
55 already possesses a reduced level of enzyme activity, it is completely inactive 
when further mutations were introduced at the beginning of the variable region. This 
clearly confirms that close coupling of the variable region and motif IX of 
monospecific Mtase Hhal exists as observed by Mi and Roberts (1992). 
It has also been observed that the loop of the variable region in monospecific 
M. HhaI, which starts from amino acid number 171, is not flexible and cannot 
support the insertion of polypeptide of any length. 
In these experiments it has proved not possible to replace a mono-specific TRD 
region with that of a multispecific Mtase and in order for a multi-specific TRD to 
work in the framework of a monospecific Mtase a deeper understanding of the 
structure-function relationship of these enzymes is required. From this set of 
experiments it can be concluded that these enzymes are clearly superficially related 
but exhibit mechanistic and structural differences. A 3D-structure analysis of 
M. SPRI will be invaluable in attempting to explain these differences. 
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Figure 4.23: Schematic presentation of approximate size and position of inserts in the variable region of 
wild type and redesigned triple mutant of M. HhaI. Wild type M. SPR and the insert from M. SPR are shown in 
red. The positions of amino acids where mutations 
have been carried out for the introduction of unique 
restriction sites have been shown with amino acid residue number in M. SPR. The TRD region are shown in 
boxes. Wild type M. Hhal is shown in green and redesigned M. HhaI in blue. The map is not drawn to scale. 
Construct No Description 
pQIS 34: Single point mutation for the introduction ofXhol site in 
rý; 
pQIS 7 encoding for wild type M. SPRI. 
pQIS 45: Triple mutant with the introduction ofApaI site in pQIS 7 
Q encoding for wild type M. SPRI. 
Cb 
II 
II 
II 
pQIS 46: Triple mutant with the introduction of ApaI site in pQIS 8 
encoding for single mutant of M. SPRI. 
pQIS 36: Double mutant with the introduction of Pacl site in 
construct encoding for wild type M. Hhal. 
pQIS 37: Double mutant with the introduction of Pacl site in mutant 
construct pQIS 36 encoding for triple mutant of M. Hhal. 
pQIS 41/pQIS 50: Double mutant with the introduction ofApal site 
in construct encoding wild type M. Hhal. 
pQIS 42: Double mutant with the introduction of Apal site in pQIS 
V4 , ý,, y 
18 encoding for triple mutant of M. Hhal. 
II 
ý 
pQIS 43: Double mutant with the introduction of Apal site in pQIS 
36 encoding for double mutant of M. Hhal. A§r 
I pQIS 51: Double mutant with the introduction of EcoRl site in pQIS 
50 encoding for double mutant of M. Hhal. 
pQIS 55: Double mutant with the introduction of EcoRl site in wild 
type M. Hhal. 
ti 
pHhaI-EcoRl-Pacl: Double mutant with the introduction of Pacl 
site in construct pQIS 55 encoding for double mutant of M. IIhul. 
Figure 4.24: Summary of mutant constructs made by point mutations. The map of mutants constructs 
made in M. SPRI gene are shown in red and in M. Hhal gene are shown in blue. A brief description of the 
constructs and the activity of encoded protein by these construct is shown in right hand panel. The protein 
encoded by the constructs pQIS 
34 and pQIS 36 is active. The protein encoded by the constructs pQIS 55 is 
partial active The protein encoded by all the other constructs was inactive. The map is not according to scale. 
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Figure 4.2: Schematic representation of the construction of pQIS 23. The TRW from Mspl was 
cloned into pQIS 18 (encoding the Ala 280 Phe, Arg 277 Leu & Phe 302 Ala mutations). New 
restriction sites BglIJ, Xhol and EcoR! are shown in red. Gel shows a restriction analysis of the new 
construct pQIS 23. Lane 1: pQIS 23 digested with Mspl. (Since the plasmid Mspl sites are 
unmethylated, pQIS 23 cannot code for an active methyltransferase). Lane 2: pQIS 23 digested with 
Bglll. (it verifies the presence of another Bg1II site, fragment size are 3144 and 921 bps) Lane 3: 
pQIS 18 digested with Bg1I1. (Linear DNA, 3936 bps). M: GeneRulerTM I kb DNA ladder. (For 
GeneRulerTM 1 kb DNA ladder size, see Chapter Two and appendices). Map is not drawn to scale. 
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Figure 4.4: Schematic representation of the construction of pQIS 24. The MspI specific TRD was 
cloned into pQIS 21 (encoding for Ala 280 Phe, Arg 277 Leu, Tyr 289 Asp & Phe 302 Ala 
mutations). New restriction sites of BglII, Xhol and EcoRI are shown in red. Gel shows a restriction 
analysis of new construct pQIS 24. Lane 1: pQIS 24 digested with Mspl. (Since the plasmid Mspl sites 
are unmethylated, pQIS 24 cannot code for an active methyltransferase). Lane 2: pQIS 24 digested with 
Bg1II. (To verify the presence of another Bg1Il site, fragment size are 3144 and 921 bps) Lane 3: pQIS 
21 cut with Bg1I1. (Linear DNA, 3936 bps). M: GeneRulerT"' I kb DNA ladder. 
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Figure 4.5: Schematic representation of the construction of pQIS 26 (Triple mutant + 
MspI TRD) with deleted multiple cloning site. Gel 1: Lane 1, pQIS 23 cut with Pstl and Stul 
and gel purified. M: GeneRulerTM I kb DNA ladder. Gel 2: Restriction analysis for pQIS 26 to 
verify that the mutiple cloning site has been deleted. Lane 1, Control pQIS 23 digested with 
Pst!. M: GeneRulerTM I kb DNA ladder. 2: pQIS 26 incubated with Pstl (uncut DNA), 3: 
pQIS 26 incubated with Stul (uncut DNA). 4: pQIS 26 digested with A1wNl (Linear DNA 3978 
bps). 5: pQIS 26 incubated with BamHl (uncut DNA). 
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from pQIS 26. Gel 1: Lane 1: PCR product generated after site-directed mutagenesis using 
pQIS 26 as template. Gel 2: Restriction analysis for pQIS 28 to verify that the Xhol and EcoRl 
sites has been deleted. Lane 1: pQIS 28 incubated with EcoRl. (Uncut DNA) 2: pQIS 28 
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Figure 4.7: Schematic representation showing the construction of pQIS 30 (M. HhaI 
without any TRD region). Gel 1: Lane 1: pQIS 28 digested with Xhol and Bbsl (3636+ 342 
bp) (for the gel purification of vector) 2: pQIS 28 digested with AIwNI (linear 3978 bp) M: 
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Figure 4.8: Schematic representation of the construction of pQIS 31 (swapping of M. Hha1 TRD with 
three TRD encoding region "segment B" specific for M. SPRI). 
Gel 1: Lane 1: pQIS 7 digested with EcoRl and Sall to gel recover the insert (fragment size 5937 and 390 bp). 
Gel 2: Lane 1: pQIS 31 digested with Pstl. (Uncut DNA signifies the removal of linker insert). 2: pQIS 31 
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Figure 4.9: Schematic representation of the construction of pQIS 32 & pQIS 33 (M. HhaI with 
corrected motif IX encoding three TRDs specific for M. SPRI). Gel 1: Lane 1: PCR product generated 
after SDM for the introduction of a new EcoRI site 9 bp apart from the existing EcoRl site. Gel 2: Lane 
1: pQIS 32 cut with Bbsl (Uncut DNA, due to abolition of Bbs1 site). Lane 2: pQIS 31 cut with Bbsl and 
Styl. (as control digestion, fragment size 2974 and 1073 bps). Lane 3: pQIS 32 cut with Bbsl and Styl. 
(only Sty! cut and linearized the DNA, 4047 bps). Lane 4: pQIS 32 cut with concentrated EcoRl for gel 
purification and religation to construct pQIS 33. M: GeneRulerTM 1 kb DNA ladder in both gels. 
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Figure 4.10: Schematic representation of the construction of pQIS 34. (This introduces Gin 189 Gin 
mutation in order to introduce a new Xho1 site into wild type sequence of M. SPRI i. e. in pQIS 7). 
Gel 1: Lane 1: Shows the PCR product formed after site directed mutagenesis using pQIS 7 as template. 
Gel 2: Lane 1, pQIS 34 cut with Mspl. (Uncut DNA, construct pQIS 34 encodes for an active Mtase 
enzyme). Lane 2: pQIS 34 cut with 
Xhol and EcoRI. (Fragment size, 5518,565 and 244 bps verifies the 
presence of new Xhol site). 
M: GeneRulerTM I kb DNA ladder in both gels. 
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Figure 4.11: Schematic representation showing the construction of pQIS 35 (by swapping 
Xhol-EcoRl "segment C" from M. SPRI into redesigned triple mutant of M. HhaI). Gel 1, 
Lane 1: pQIS 32 cut with Xhol and EcoRl for the gel purification of vector DNA. (Fragment 
size, 3641,397 and 9 bp). Gel 2: Lane 1, pQIS 35 cut with Xhol and EcoRl. (Fragment sizes, 
3641 and 565 bps). The presence of 565 bp insert confirms the formation of pQIS 35. Gel 3: 
Lane 1, pQIS 35 cut with HaeIII. Lane 2, pQIS 35 cut with Mspl. Digestion with Haelll and 
Mspl showed that the chimaeric protein encoded by construct pQIS 35 is inactive and unable to 
methylate its specific sites. M: GeneRulerTM I kb DNA ladder for all three gels. 
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Figure 4.12: Schematic representation showing the construction of pQIS 36, pQIS 37 & pQIS 38. 
A) Formation of pQIS 36 (encoding for Asn 176 lie and Ile 177 in wild type M. Hhal). B) Formation of pQIS 
37 (encoding for Asn 176 Ile and lie 177 in triple mutant M. Hhal). C) Formation of pQIS 38 (encoding for 
Asn 176 lie and lie 177 in chimaeric construct pQIS 35). Gel 1: Lane 1-3, shows the PCR products generated 
after site directed mutagenesis for three plasmids. Gel 2: Restriction analysis for newly constructed plasm ids 
pQIS 36, pQIS 37 and pQIS 38 that verifies the introduction of new Pacl site. Lane 1, pQIS 36 cut with Pacl 
(linear DNA 3936 bps, indicated the presence of unique restriction site Pacl ). 2: pQIS 37 cut with Pacl (linear 
DNA, 3936 bps) 3: pQIS 38 cut with Pacl. (linear DNA 4206 bps) M: GeneRulerTM 1 kb DNA ladder in both 
gels. 
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Figure 4.13: Schematic representation showing the construction of pQIS 40. This was achieved by 
swapping Pacl-EcoRI "segment D" from M. SPRI into redesigned triple mutant of M. HhaI. Gel 1: Lane 1, 
pQIS 7 cut with PacI and EcoRI (5718 + 609 bp) (to gel purify the 609 bp insert). 2: pQIS 38 cut with 
Pact and EcoRI (3567 + 639 bps) (to gel purify the 3567 bp vector). Gel 2: Lane 1, pQ1S 40 cut with Pacl 
and EcoRI. (Fragment sizes, 3567 and 609 bp) Gel 3: Lane 1, pQIS 40 cut with Xhol (Uncut DNA). 
Abolition of Xhot site confirms the new insert from pQIS 7.2: pQIS 40 cut with Accl. (Fragments sizes, 
3708,460 and 8 bps). Another Acct site is introduced as a result of swapping and also confirmed the 
insertion of "segment D" from M. SPRI. Gel 4: Lane 1, pQIS 40 incubated with Mspl. (Inactive). 2: pQIS 
40 incubated with Haelll. (Inactive). M: GeneRulerTM I kb DNA ladder in all gels. 
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Figure 4.14: Schematic representation showing the construction of pQIS 45 and pQIS 46 (which 
encodes for Phe 112 Leu, Phe 113 Gly and Val 114 Pro mutation in the sequence of wild type 
M. SPRI pQIS 7 and mutant M. SPRI pQIS 8). This mutation also introduces Apal site shown in red. 
Gel 1: Lane 1, pQIS 45 cut with Apal. (Fragment size, 3962 and 2365 bp). 2: pQIS 46 cut with Apal. 
(Fragment size, 3962 and 2365 bp). Gel 2: Lane 1, pQIS 45 cut with Mspl. (Inactive). 2: pQIS 46 cut 
with Mspl. (Inactive) M: GeneRulerTM 1 
kb DNA ladder in both gels. 
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Figure 4.15: Schematic representation showing the construction of pQIS 41,42 and pQIS 43. 
A) Formation of pQIS 41 (which encodes for Val 116 Gly and Phe 117 Pro mutation in wild type M. Hhal). 
B) Formation of pQIS 42 (which encodes for Val 116 Gly and Phe 117 Pro mutation in triple mutant of 
M. Hhal) and C) Formation of pQIS 43 (which encodes for Val 116 Gly and Phe 117 Pro mutation in pQIS 
36). This mutation also introduces Apal site for diagnostic purpose shown in red. Gel 1: Lane 1-3, pQIS 41, 
pQIS 42 and pQIS 43 double digested with Apal and EcoRl. (Fragment sizes 3296 and 640 bps confirms the 
presence of the newly introduced site 
Apal). Gel 2: Lane 1-3, pQIS 41, pQIS 42 and pQIS 43 digested with 
Mal. (the presence of completely degraded DNA indicates that there was no restriction protection and thus the 
encoded enzyme is inactive). M: GeneRulerTM I kb DNA ladder in both gels. 
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Figure 4.16: Schematic representation showing the construction of pQIS 47 and pQIS 48. The final 
chimaeric construct pQIS 48, contains M. SPRI "segment E" (figure 4.1) into the (redesigned triple mutant) 
M. Hhal. Gel 1: shows the digestion of pQIS 45 with Apal and EcoRl to gel purify 787 bp insert sequence. 
(Fragment sizes are 3175,2365 and 787 bps) Gel 2: shows the digestion of pQIS 47 with Apal and EcoRI to 
verify the insert size-(3296 + 787 bps) Gel 3: Lane 1 show the digestion of pQIS 47 with AIwNI and EcoRI to 
recover insert sequence. (Fragment sizes, 2215 and 1868 bps). Lane 2 show the digestion of pQIS 40 with 
AIwNl and EcoRl to recover vector sequence. (Fragment sizes, 2308 and 1868 bps). Gel 4: Lane I shows the 
digestion of pQIS 48 cut with Accl for verification of this construct. (Fragment sizes are 3708,460 and 8 bps). 
Lane 2: pQIS 48 cut with Apal (Linear 4176 bps) for confirmation of this construct. Lane 3: pQIS 48 cut with 
Mspl (Inactive enzyme, DNA completely cleaved). M: GeneRulerTM 1 kb DNA ladder in all gels. 
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Figure 4.17: Schematic representation showing the construction of pQIS 52 from chimaeric construct 
pQIS 48. Gel 1: shows the PCR product generated after SDM using pQIS 
48 as template. Gel 2: shows the 
digestion of pQIS 52 with Apal. (Uncut DNA verifies the abolition of existing Apal site and construction of 
pQIS 52). Gel 3: Lane 
1 shows digestion of pQIS 52 with Mspl. (DNA cleaved, therefore the plasmid encodes 
for inactive enzyme). Lane 2 shows the 
digestion of pQiIS 52 with Haelll. (DNA completely cleaved, thus the 
encoded recombinant protein 
is inactive). M: GeneRuler 1 kb DNA ladder in all three gels. 
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Figure 4.18: Schematic representation showing the construction of pQIS 51 from wild type M. Hhal 
(pMSK 12). 
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Figure 4.19: Schematic representation showing the construction of pQIS 53 and pQIS 54. 
This was achieved by introducing the Apal-EcoRl fragment "segment E" (Figure 1) from 
M. SPR into wild type M. Hhal to generate pQIS 53. Gell, Lane 1: pQIS 53 cut with Apal and 
EcoRI. (Fragment sizes are 3480 abd 787 bps). Restoration of original codon of motif VI to Val 
and Phe as in M. Hhal generated pQIS 54. Gel 2, Lane 1: pQIS 54 cut with Mspl (Completely 
degraded DNA, Inactive chimaeric Mtase is encoded). Lane 2: pQIS 54 cut with Haelll 
(Completely digested DNA, inactive Mtase). Lane 3: pQIS 54 cut with Apal. (Uncut DNA 
confirms the deletion of Apal site). 
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Figure 4.20: Schematic representation showing the construction of pQIS 55 and pHhal-EcoRl-Pact. 
pQIS 55 is M. Hhal that encodes 
for K270R, T2711 mutation and pHhal-EcoRl-Pact encodes for K270R, 
T2711 +N 1761,1177N mutation. Gel 1: shows the PCR product generated after SDM. Ge12: Lane I shows 
digestion of pQIS 55 cut with EcoRl. (Linear band verifying the introduction of new EcoRI site and 
formation of new construct pQIS 55). 2: pQIS 49 cut with Hhal. (Uncut DNA thus encoded protein is 
active). 3: pQIS 55 cut with Hhal. (Partial protection, thus encoded protein activity is reduced). M: 
GeneRulerTM I kb DNA ladder in both gels. 
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5.1: Introduction 
All prokaryotic DNA C-5 Mtases possess a common structural organisation. 
Comparison of the amino acid sequences of this class of enzymes has shown the 
presence of some highly conserved regions within a large background of seemingly 
unrelated sequences (Posfai et al., 1984). It is reasonable to hypothesize that the 
conserved regions in such sequences represent sub-domains, which are involved in 
equivalent general biochemical steps in the methylation reaction in all such enzymes. 
Behrens et al. (1987) compared the primary structure of M. pl is with the amino acid 
sequences of two other multi-specific DNA Mtases from the temperate Bacillus 
subtilis bacteriophages SPR and cp3T. From this analysis, it was proposed that 
several regions with sequence diversity evoke specificity-recognising domains. 
Lauster et al. (1989) concluded that four homologous regions occur in the same order 
within the core of 11 prokaryotic enzymes, and designated them as core elements 
(CEs) I, II, III and IV (reading from the NH2 terminus to COOH terminus). Motifs I- 
X, containing an invariant amino acid sequence, are found in the same order in all 
enzymes of this class except AquI (Posfai et al, 1989). Among these ten conserved 
motifs there are six most strongly conserved motifs (I, IV, VI, VIII, IX & X) shown 
in Figure 5.1. These motifs form a rigid structural framework separated by a flexible 
connecting loop region (Cheng et al., 1993). Therefore it has long been proposed that 
the conserved sequences are involved in the biochemical steps of the methylation 
reaction while the variable region represents the target recognition domains. 
Attempts to construct functional chimaeric enzymes were found to be successful 
after the introduction of unique restriction sites at equivalent locations within the 
gene encoding the two multi-specific methyltransferase M. SPRI and M. cp3T, 
followed by the swapping of these regions (Balganesh et at., 1987). The chimacric 
constructs were found to express a Mtase with an activity comparable to that of the 
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Figure 5.1: Schematic representation of the primary structure of mono and multispecific 
methyltransferases. Six of the most strongly conserved structural motifs of the methyltransferases (I, 
IV, VI, VIII, IX & X) are shown. Colour scheme is as shown in Figure 1.2. Target recognition 
sequences (TRDs) for both multispecific MTase SPR and Hhal are shown with the cytosine that can 
be methylated is underlined. 
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parental M. SPRI, and to that of M. cp3T. These experiments revealed the 
compatibility of the core elements of different bacteriophage enzymes. Target 
recognising domains from the Mtases SPR and (p3T have also been combined with 
those of Alls to give enzymes with novel combinations of target recognition 
properties (Trautner et al. 1988). However, all these experiments were carried out on 
these closely related Bacillus subtilis bacteriophage Mtases. 
In spite of the conservation between C5-DNA Mtases, M. HhaI & M. SPRI have a 
different recognition sequence, and therefore different specificities. We have 
attempted to convert mono-specific Mtase into multi-specific Mtase in two steps. In 
the first step, this was attempted by changing motif IX of a mono-specific Mtase to 
resemble that of M. SPRI (a multi-specific Mtase), and this experiment was 
successful. This was believed to be necessary as direct structural interactions 
between the variable region and motif IX have been proposed (Mi and Roberts 
1992). This conclusion is also confirmed by the mutagenesis experiments described 
here, in which mutation was engineered in motif IX followed by the creation of 
another mutation in the variable region; these changes make the enzyme inactive (see 
Chapter 4, section 4.3.5). In the second set of experiments attempts were made to 
insert the TRDs of M. SPRI and its amino-terminal flanking region in a range of 
constructs that extend to motif V. However, the redesigned M. HhaI would not 
tolerate any polypeptide insertion and consequently lost methylation activity. From 
these data two possible conclusions were drawn: the first was that the redesign of 
motif IX was sub-optimal. Secondly the structure of this mono-specific Mtase 
M. HhaI is not flexible enough to tolerate any insertions in the TRD region, in 
contrast to multi-specific Mtase M. SPRI, which can tolerate such insertions in the 
variable region (Walter et al., 1992; Matin, 2000). To determine whether the mono- 
specific Mtase M. HhaI is flexible or not, we carried out motif exchange experiments 
and to see whether M. HhaI and M. SPRI can accept motifs from each other. 
Aims 
The initial aim for this experiment was to determine whether the conserved motifs I- 
IV is interchangeable between multi-specific and mono-specific Mtases as has been 
observed for bacteriophage Mtases (Balganesh et al., 1987). It was hoped that this 
would reveal whether there was any compatibility at all between a mono- and 
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multispecific Mtase that would lead to accommodation of a region carrying motif-I 
and motif I-IV from Mtase M. HhaI within M. SPRI, and vice versa. 
5.2: Engineering of chimaeric constructs by motif swapping 
5.2.1: EXPERIMENTAL DESIGN 
Motif swapping of M. HhaI and M. SPRI was carried out sequentially: 
The first engineered protein contained an exchange of motif I, and the second 
construct contained the region from motif I to motif IV. Finally reciprocal chimaeras 
were constructed. 
For swapping the motifs there were certain limitations; the main constraints were 
i. The restriction site(s) introduced into each gene had to be unique site. 
ii. Mutagenesis had to be neutral both with respect to the reading frame of the 
gene and the amino acid sequence of parental enzymes. 
iii. The open reading frame (ORF) for the two plasmids had to be conserved. 
All of these limitations were considered and restriction sites were chosen at 
appropriate locations for the swap of motifs as described in the following section. 
5.2.2: REPLACEMENT OF MOTIF I OF M. HhaI WITH MOTIF I OF 
M. SPRI AND VICE VERSA 
The primary structures of two enzymes M. HhaI and M. SPRI were aligned from 
motif I to motif IV (shown in Figure 5.2). A stretch of 13 amino acid residues is also 
shown below in which the conserved amino acid residue Glu of motif II is shown in 
red. It was decided to introduce a NruI restriction enzyme site into the gene encoding 
M. HhaI just before the conserved codon for Glu, by mutating Asn at position 39 into 
Arg. The decision to change the uncharged polar residue Asn at position 39 into a 
charged (basic) hydrophilic residue did not represent an ideal solution. However, 
since there was no choice it was decided to mutate the Arg amino acid residue back 
to the original Asn amino acid if required, after the desired swap had been 
completed. 
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1 33 50 
SPR: MGRLRVMSLFSGIGAFEAALRNIGVGYELVGFSEIDKYAVKSFCAIHNVD 
HhaI: MIEIKDKQLTGLRFIDLFAGLGGFRLALESCGA ECVYSNEWDKYA QEVYEMNFG 
1 39 54 
51 100 
EQLNFGDVSKIDKKKLPEFDLLVGGSPCQSFSVAGHRKGFEDTRGTLFFQ 
EKPE GDITQVNEKTIPDHDILCAGFPCQAFSISGKQKGFEDSRGTLFFD 
55 t 103 
Figure 5.2: Alignment of M. SPR and M. HhaI amino acid sequences from motif I to motif IV. 
The conserved amino acids are shown in red. Arrows represent the point where the gene was 
cleaved. 
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34 39 46 
M. HhaI: ECVYSNEWDKYAQ 
M. SPRI: ELVGFSEIDKYAV 
28 33 40 
5.2.2.1: Introduction of a unique Nrul site into pQIS 64 (which encodes wild 
type M. HhaI) 
In M. HhaI amino acid residue Asn 39 was chosen for mutation into Arg (for the 
introduction of a Nrul site). Two mutagenic oligonucleotides NIS 51 and NIS 52 
were synthesized for this codon change as shown below, with the mutation shown in 
red. 
NIS 51 / NIS 52 duplex mutagenic oligonucleotide: 
NrUI 
5'-GCTGAGTGCGTTTATTCTCGCGAATGGGATAAATATGC-3' 
3'-CGACTCACGCAAATAAGAGCGCTTACCCTATTTATACG-5' 
AECVYSREWDKY 
NIS 51: 5'-GCTGAGTGCGTTTATTCTCGCGAATGGGATAAATATGC-3' 
NIS52: 5'-GCATATTTATCCCATTCGCGAGAATAAACGCACTCAGC-3' 
The primers NIS 51 and NIS 52 were used for site-directed mutagenesis and pQIS 64 
was used as the template DNA. The correct construct formed was identified by the 
presence of a new Nrul site (Figure 5.3, and related figures for the plasmids sketches 
with gel diagrams are placed at the end of the chapter). The plasmid encoding the 
mutant M. HhaI (Asn 39 Arg) was called pQIS 74 and the protein encoded by this 
mutant was found to be inactive. The region specific interactions of Asn 39 were 
analysed in the structural model of M. HhaI. This residue is close to the Oxygen of 
Asp 16, the Nitrogen of Phe 18, the Nitrogen of Ala 19 and the Oxygen of Gly 59 
(Cheng et al., 1993). The distance between these residues was less than 3.0 A. It has 
also been noted that residues Asp 16, Phe 18, Ala 19 are present in ß1 and 132 sheets, 
and run parallel to the position of Asn 39. In addition, Gly 59, which is present in the 
helix B that runs across the P1 and ß2 sheets. Electrostatic interactions or hydrogen 
bonds also exist between S-adenosylmethionine (SAM) and Glu 40 and surrounding 
residues (Cheng et al., 1993). It seems that the disturbance of these analogous 
interactions has caused a major destabilisation of the enzyme core structure, 
rendering the enzyme inactive. 
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5.2.2.2: Introduction of Nrul site in pQIS 7 (which encodes wild type M. SPRI) 
In M. SPRI the serine residue at position 33 was chosen for mutation into Arg; the 
aim being to introduce a unique Nru1 site into the gene. The oligonucleotides used 
for the mutation were NIS 53 and NIS 54. In this mutagenesis experiment, two bases 
were changed as shown below in red. 
NIS 53 / NIS 54 duplex mutagenic oligonucleotide: 
Nrul 
5'-GAGCTGGTTGGTTTTCGCGAGATTGATAAATATGCC-3' 
3'-CTCGACCAACCAAAAGCGCTCTAACTATTTATACGG-5' 
ELVGFREIDKYA 
NIS 53: 5' -GAGCTGGTTGGTTTTCGCGAGATTGATAAATATGCC-3' 
NIS 54: 5' -GGCATATTTATCAATCTCGCGAAAACCAACCAGCTC-3' 
The template DNA used for this experiment was pQIS 7 and the construct generated 
as a result was pQIS 76. The identity of the new construct was confirmed by the 
presence of a new unique Nrul site (Figure 5.4). When tested for its activity, it was 
revealed that the protein encoded by the mutant of M. SPRI (Ser 33 Arg) had lost its 
ability to methylate (Figure 5.4). It appears that the instability in the enzyme core 
structure, which might be similar to that found in M. Hhul may occur here as well, 
and may therefore explain the enzyme's inactivity. 
5.2.2.3: Exchange of motif I from M. HhaI the corresponding region in M. SPRI 
The plasmids pQIS 74 and pQIS 76 were cleaved with Apal and Nrul, and the insert 
and vector DNA were recovered from the gel as shown in Figure 5.5. They were 
ligated prior to transformation of E. coli and the resulting colonies were screened for 
the presence of the constructs carrying the insert from the M. HhaI. Restriction 
analysis with EcoRI confirmed the presence of the insert. There is a single EcoRl site 
in pQIS 76 and pQIS 74 also carries an EcoRI site before the start of M. Hhal gene. 
Therefore, the discovery of the two expected EcoRI fragment sizes confirmed the 
identity of pQIS 78 (Figure 5.5). The activity of the protein encoded by the plasmid 
pQIS 78 was checked by M. spI cleavage and it was shown to be inactive. 
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5.2.2.4: Arg 39 Asn mutagenesis in pQIS 78 (which encode motif I of M. HhaI 
and motif II to X of M. SPRI) 
As noted above the mutation of Asn 39 to Arg leads to inactivation of the enzyme 
during the synthesis of pQIS 74. The Asn 39 lies in the (ßl-aA-02) structural 
segment that forms part of the binding site for SAM contains motif I, which is highly 
conserved among C5-Mtases (Cheng et al., 1993). Therefore, it was decided to 
restore the codon sequence so that it contained the original wild type amino acid. The 
mutagenic primers NIS 55 and NIS 56 were synthesized to engineer this mutation in 
pQIS 78, which also deleted the Nrul site. The sequence of the oligonucleotides is 
shown below with the mutation shown in red and the deleted Nrul restriction site in 
bold. 
NIS 55 and NIS 56 duplex mutagenic oligonucleotide: 
ANrul 
5'-GCTGAGTGCGTTTATTCTAACGAGATTGATAAATATGCCGTC-3' 
3'-CGACTCACGCAAATAAGATTGCTCTAACTATTTATACGGCAG-5' 
AECVYSNEIDKYAV 
NIS 55: 5'-GCTGAGTGCGTTTATTCTAACGAGATTGATAAATATGCCGTC-3' 
NIS56: 5'-GACGGCATATTTATCAATCTCGTTAGAATAAACGCACTCAGC-3' 
Site-directed mutagenesis generated the construct pQIS 82 carrying Arg to Asn 
mutation which was confirmed by the loss of the Nrul site. However, the enzyme did 
not regain methylation activity (Figure 5.6) confirming that the engineered protein 
containing motif I of M. HhaI and motif II to X of M. SPRI is not compatible, and 
unable to perform enzymatic activity. 
5.2.2.5: Exchange of motif I from M. SPRI to M. Mal 
The plasmids pQIS 74 and pQIS 76 were cleaved with Nrul and Xhol, and the insert 
(871 bps) and vector DNA (5054 bps) were recovered from the gel as shown (Figure 
5.7). The fragments were ligated together prior to transformation of E. coli and the 
resulting colonies were screened for the presence of the constructs carrying the insert 
from M. SPRI. 
There is one EcoRI site in M. SPRI before motif IX and M. HhaI also carries an 
EcoRI site before the start codon. The final construct, pQIS 80. has lost both EcoRl 
sites, and this property was used to confirm its identity. Restriction analysis with 
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Nrul/Xho1 also confirmed the presence of a 871 bps insert (Figure 5.7). The activity 
of the protein encoded by the chimeric construct was checked with Hhal cleavage 
and it was found that it was inactive. This experiment confirmed that that the 
engineered protein is incompatible. 
5.2.2.6: Arg 33 Ser mutagenesis in pQIS 80 
In order to maintain the sequence of M. SPRI up to the point of swap, it was decided 
to bring back the original amino acid Ser at position 33. A pair of oligonucleotide 
NIS 57 and NIS 58 was made to engineer this mutation of Arg to Ser in construct 
pQIS 80 and to delete Nrul site. The sequence of oligonucleotide is shown below 
with the mutation shown in red and the deleted Nrul site in bold. 
NIS 57 and NIS 58 duplex mutagenic oligonucleotide: 
ANr uI 
5'-GAGCTGGTTGGTTTTAGCGAATGGGATAAATATGCAC-3' 
3'-CTCGACCAACCAAAATCGCTTACCCTATTTATACGTG-5' 
ELVGFSEWDKYA 
NIS 57: 5'-GAGCTGGTTGGTTTTAGCGAATGGGATAAATATGCAC-3' 
NIS 58: 5'-GTGCATATTTATCCCATTCGCTAAAACCAACCAGCTC-3' 
The mutagenesis experiment generated pQIS 83 with one amino acid changed (Arg 
to Ser) and with the Nrul restriction site abolished (Figure 5.8). The chimaera (which 
contained motif I of M. SPRI and Motif II and onward from M. HhaI) was found to be 
inactive. 
5.2.3: REPLACEMENT OF MOTIF I-IV OF M. HhaI WITH MOTIF I-IV OF 
M. SPRI AND VICE VERSA 
The second experiment planned was to generate a pair of chimaeras by fusion 
between two Mtases M. HhaI and M. SPRI containing motif I-IV of one and the rest 
of the molecule from the other. A Kpnl restriction site already exists in plasmid pQIS 
64 (which contain sequence of wild type M. HhaI). It was decided to use this site as a 
fusion point to construct the planned chimaeras. However, there is a need to create a 
similar site at same position in the plasmid pQIS 7 carrying the M. SPRI gene. The 
primary structure of M. HhaI and M. SPRI is shown in Figure 5.2 and an arrow 
represents the point of interchange. 
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5.2.3.1: Introduction of a Kpn1 site into pQIS 7 
The primers used for the introduction of Kpnl site in pQIS 7 (containing the 
sequence for wild type M. SPRI) are shown below. This represents a silent mutation 
and the resulting construct pQIS 72 encodes an active Mtase enzyme M. SPRI (Figure 
5.9). The construct pQIS 72 was confirmed by the presence of unique KpnI site. 
NIS 47 and NIS 48 duplex mutagenic oligonucleotide: 
KpnI 
5'-GAAGATACAAGAGGTACCTTGTTTTTTCAATACG-3' 
3'-CTTCTATGTTCTCCATGGAACAAAAAAGTTATGC -5' 
NIS 47: 5' -GAAGATACAAGAGGTACCTTGTTTTTTCAATACG-3' 
NIS 48: 5' -CGTATTGAAAAAACAAGGTACCTCTTGTATCTTC-3' 
5.2.3.2: Swapping of motif I-IV from M. Hhal to M. SPRI 
Ligation of vector (5258 bps) generated from pQIS 64 (encoding wild type M. HhaI) 
with the insert (1084 bps) from pQIS 72 (encoding wild type M. SPRI) both of which 
had been cut with Kpn1 and Xhol and gel purified (Figure 5.9). The new construct 
pQIS 79, that is a chimaera of two Mtases M. HhaI and M. SPRI now contains motif 
I-IV of M. HhaI and V-X from M. SPRI (Figure 5.10). 
5.2.3.3: Swapping of motif I-IV from M. SPRI to M. HhaI 
Ligation of pQIS 72 (wild type M. SPRI) (5243 bps) with the insert from pQIS 64 
(wild type M. HhaI) (691 bps) both cut with KpnI and Xhol and recovered from the 
gel (Figure 5.10). The construct pQIS 81 is a chimaera of the two Mtases M. Hhal 
and M. SPRI encoding for motif I-IV of M. SPRI and V-X from M. Hhal (Figure 
5.11). The graphic representation summarising all of the constructs made in this 
motif exchange experiment is given in Figure 5.12. 
Although mutagenesis experiment that includes point mutations (chapter three), 
insertion mutagenesis (chapter four) and exchange of regions (chapter five) the 
enzyme remains inactive, it was not clear whether the enzyme had also lost the 
sequence specific binding function of the inserted TRD. Surface Plasmon Resonance 
(SPR) experiments were designed to address this question. Surface Plasmon 
Resonance (SPR) allows a direct comparison to be made between the binding affinity 
for the DNA of wild type and mutant Mtases. 
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A) pQIS 78 
B) pQIS 79 
C) pQIS 80 
D) pQIS 81 
E) pQIS 82 
F) pQIS 83 
Figure 5.12: Summary of the chimaeric constructs made in this chapter. 
A) Motif I of M. Hhal fused with motifs 11 -X of M. SPR. 
B) Motifs I- IV of M. Hhal fused with motifs V-X of M. SPR. 
C) Motif I of M. SPR fused with motifs II -X of M. Hha1. 
D) Motifs I- IV of M. SPR fused with motifs V-X of M. Hhal. 
E) Motif I of M. Hhal fused with motifs 11 -X of M. SPR (restored Asn 39). 
F) Motif I of M. SPR fused with motifs II -X of M. Hhal (restored Ser 33). 
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5.3: Surface Plasmon Resonance (SPR) 
5.3.1: INTRODUCTION 
SPR is an optical technique that detects refractive index changes at the surface of a 
sensor chip. In fact, Surface Plasmon Resonance (SPR) is a technique that can be 
used for the measurement of biomolecular interactions in real time, with no labelling 
of the molecules necessary. SPR is an optical phenomenon that occurs when light 
illuminates a thin conducting film under specific conditions, which can best be 
described by first understanding the principle of total internal reflection (TIR). TIR 
occurs at an interface between non-absorbing media. When a light beam propagating 
in a medium of higher refractive index meets an interface at a medium of lower 
refractive index at an angle of incidence above a critical angle, the light is totally 
reflected at the interface and propagates back into the high refractive index medium. 
When TIR occurs an electromagnetic evanescent wave travels from the interface into 
the lower refractive index medium. If the interface is coated in a thin layer of 
conducting material such as a metal of suitable thickness, SPR can arise (Figure 
5.13). In a metallic solid, the plasma consists of a `gas' of free electrons. Plasma 
oscillations that propagate at the interface of a metal and a dielectric medium are 
called Surface Plasmons (SPs). In an SPR sensor, light is coupled resonantly into 
electric oscillations, or surface plasmons, at a metal surface. Such oscillations give 
rise to a non-propagating evanescent wave, which extends from the metal surface 
into the sample solution, decaying exponentially as a function of distance. 
Macromolecular complexes formed at the metal-liquid interface, resulting in a 
change in refractive index of the liquid media at the interface, perturb the evanescent 
wave and alter the propagation characteristics of the plasmons. Changes in the 
propagation characteristics of the plasmons in turn alter the characteristics of the 
internally reflected light. Such changes are ultimately detected and quantified. In 
general, increasing the bio-layer thickness, results in an increase in the resonance 
angle. The thicker the bio-layer on the conductive film surface, the greater the SPRI 
minimum shifts to higher angles. This shift in angle is shown on the sensorgram of 
the BIACORE® apparatus as a change in the response signal, and the larger the 
change in angle, the greater will be the response signal. 
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Figure 5.13: Surface Plasmon Resonance (SPR) Detection System. 
The polarized light is focused into a wedge-shaped beam providing a continuous interval of light wavevectors 
kX. This covers the working range for the plasma wavevector ksp during biomolecular interaction analysis. An 
increased sample concentration in the surface coating of the sensor chip causes a corresponding increase in 
refractive index which alters the angle of incidence required to create the SPR phenomenon (the SPR angle). 
This SPR angle is monitored as a change in the detector position for the reflected intensity dip (from Ito 11). By 
monitoring the SPR-angle as a function of time the kinetic events in the surface can be displayed in a 
sensorgram. (Figure adapted from BIACORE BlAtechnology Note 107). 
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5.3.2: BIACORE SYSTEM 
One of today's frontlines in biology is to investigate macromolecular interactions in 
a quantitative way. Such analysis using BIACORE® instruments has been established 
as a powerful technique. The BIACORE® system is a biosensor instrument 
employing surface plasmon resonance detection for molecular interaction analysis. 
The first commercial biosensor was first developed in 1990 by BIACORE Inc. 
formally Pharmacia Biosensors (Myszka, 1997). This system monitors the refractive 
index change as a molecule interacts at the sensor surface. The signals generated are 
recorded in arbitrary response units (RU). While BIACORE instruments are 
routinely used for kinetic measurements and for the determination of binding 
constants, the immobilization of a ligand onto the sensor chip surface has to be 
individually optimised for every system. In the basic design of a SPR biosensor- 
based experiment, one reactant, which is often called the ligand, is attached to the 
sensor surface. The other reactant, which is referred to as the analyte, flows past this 
surface in solution. When the analyte (A) and the ligand (B) interact to form a 
complex (AB), a response is generated (Myszka, 1997). Schematic diagram of the 
molecular interactions that occur at the sensor surface are shown in Figure 5.14. As 
the binding responses occur in real time, it is possible to obtain kinetic information 
about the interaction. 
A real-time sensorgram provide two kinds of information (BlAtechnoloogy 
Handbook, 1994): (a) the rate of interactions (association, dissociation or both) 
providing a kinetic rate constant and (b) analyte concentration. It is important to note 
that the SPRI detection systems signal is related to the change in surface 
concentration of the analyte. Therefore it depends on the molecular weight of the 
analyte and the valence of the interaction. A higher molecular weight analyte will 
give a proportionally larger response. 
5.3.2.1: Stoichiometric Determination 
The following equations can be used on the assumption that the relationship between 
response and mass is the same for both ligand and analyte (1000 RU = Ing/mm2 for 
protein). 
Ligand sites (pmole/mm2) x ligand response/ ligand molecular weight x valence 
Where valence is the number of analyte molecules, which can bind to the ligand (i. e. 
2: 1 stoichiometry has a valence of 2) substituting ligand sites for analyte molecules. 
R. = Analyte MW / ligand MW x ligand response x valence 
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Figure 5.14: A schematic representation showing molecular interactions at the biosensor surface. 
The ligand B is attached to the surface via a flexible linker. During the association phase, analyte (A,, ) is 
flowed past the surface. km is the mass transport coefficient used to describe the diffusion of analyte through 
the unstirred solvent layer. ka and Kd are the intrinsic reaction rate constants, which describe the formation 
of (AB) complex. Figure adapted from Myszka (1997). 
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Where R,,, ax is the maximum binding capacity of the surface 
ligand for this analyte in 
RU. 
5.3.2.2: General Rate equation 
The on and off rates for binary complex formation are described by 
A+B AB 
k, i 
Association rate 
d[A]3]/dt = ka [A][B] 
Dissociation rate 
-d[AB]dt = kd [AB] 
At equilibrium, dissociation rates and association rates are equal, therefore: 
kd /ka= KD (the equilibrium (affinity) dissociation constant) 
or 
k, /kd = KA (the equilibrium (affinity) association constant) 
The equilibrium constant defines the balance between a complex made up of the 
bound and the free components at equilibrium, while the rate constants define how 
fast the interaction occurs. An interaction is fully characterised in kinetic terms only 
when both rate constants and equilibrium constants are determined. If one rate 
constant and the equilibrium constant can be measured, the other rate constant can be 
deduced (alternatively, the equilibrium constant can be calculated from measured 
rate constants). 
Typical ranges of parameters for equilibrium and rate constants measurable with 
BIACORE® are shown in the following table. An important feature is that because 
SPR is sensitive to molecular mass, there is a lower limit (200 Da) for detection 
(Karlsson and Stahlberg, 1995). 
Equilibrium constant KD 10-4_ 10-M 
Association rate constant Ka 10 -10 M' s 
Dissociation rate constant Kd 10 -10' 
Temperature range 4- 40°C 
Minimum molecular weight 200 Da 
Flow rates 1- 100 Al min 
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In kinetic experiments, a major parameter that must be controlled is the diffusion of 
the analyte across the sensor surface, where it will interact with the ligand. This 
diffusion can cause mass transport limitations that compromise the determination of 
rate constants for fast binding reactions. These effects can be minimised by using 
low amounts of ligand bound to the surface (<15ORU) and high flow rates (>20 µl 
min'). At the same time a similar problem appears for the opposite situation, if the 
analyte is not transported away from the surface quickly enough, it may re-bind 
thereby slowing the apparent dissociation process. Another important aspect to 
consider when designing a BIACORE experiment is the use of a reference surface on 
which no ligand is immobilised. This removes instrument artefacts, such as matrix 
effects and non-specific binding. However, in this study preliminary comparisons are 
made between wild type and mutants (which only differ in one or two amino acids), 
and detailed kinetics analysis was not involved, it was not necessary to use small 
amounts of ligand or high flow rates. 
5.3.2.3: Analysis of Binding Data 
For the establishment of reliable kinetic parameters in an SPR experiment it is 
important to carry out a number of experiments simultaneously. Any response curve 
can be described by the sum of two or more integrated rate equations and therefore 
there is not enough information in a single response curve to discriminate between 
different binding mechanisms. However, it has been demonstrated that fitting 
association and dissociation phases from a series of analyte concentrations (global) 
analysis can be used to discriminate between different reaction mechanisms 
(Myszka, 1997). 
5.3.2.4: Aims 
Whilst DNA Mtases do not exhibit the same level of affinity in non-catalytic 
recognition of their target sites, they still bind with sufficiently high affinity to be 
investigated by surface plasmon resonance (Kan, 1999; Matin, 2000). In this 
experiment it was proposed to explore nucleic acid-protein interactions using surface 
plasmon resonance, which provides a convenient means of analysing complex 
formation at the surface of the BIACORE® chip. The interactions between 
recombinant wild type and mutant proteins with synthetic oligonucleotides carrying 
the recognition sequence for the protein were studied. 
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5.3.3: IN VITRO TRANSLATION OF WILD TYPE AND MUTANT M. HhaI 
It was decided to express protein from plasmids carrying the wild type and mutant 
M. HhaI gene. However, considering the number of mutants it was thought 
convenient to express the proteins in vitro. The cell free system originally devised by 
Zubay (1973) exploits DNA fragments, plasmids or isolated genes, which are 
transcribed by the endogenous RNA polymerase of the bacterial extract coupled with 
translation of the transcript by ribosomes. Specific proteins synthesised can then be 
assayed by their enzymatic or their biological activity. The E. colfT7 S30 extract 
system for circular DNA from Promega offers a single tube, coupled 
transcription/translation system. The E. coliT7 S30 extract system also simplifies the 
process and reduces the time required to obtain in vitro translation results (Promega 
Technical Bulletin No 219). It has been reported that protein translated in vitro by E. 
cobT7 S30 extract system can synthesize up to several hundred micrograms of 
protein (Davis et al., 1998). Therefore the protein expressed in this way is sufficient 
for the study of DNA-protein interactions using the BIACORE® system. The E. 
col: T7 S30 extract system can be used for transcription and translation of genes 
cloned downstream from the T7 RNA polymerase promoter and therefore, it was 
necessary to transfer all the mutant constructs from the original plasmid to a plasmid 
with a T7 promoter. The pET system is the most powerful system yet developed for 
the cloning and expression of recombinant proteins in E. coli (Novagen Catalogue 
1998-99). 
It was therefore necessary to swap all the wild type and mutant constructs from 
previous constructs into pET-22b. In the first experiment the wild type M. HhaI was 
transferred from pMSK 7 to pET-22b. After that, selected mutants of M. Hhal were 
swapped into pET-22b. 
5.3.3.1: Transfer of the wild type M. HhaI gene from pMSK-7 to pET-22b 
The wild type M. HhaI gene (derived from pMSK 7) was cleaved by EcoRI and XhoI 
and recovered from an agarose gel. It was ligated into gel-purified pET-22b, which 
was pre-cut with the EcoRI and XhoI. Those transformants arising from E. cola 
DH5a mcr , 
derived from the ligation mixture, were screened for the presence of the 
M. HhaI gene. The resulting construct pQIS 56 contained the wild-type M. HhaI gene 
in an appropriate reading frame and is under the influence of the bacteriophage T7 
promoter. In addition, the expressed protein will have a six-histidine tag attached at 
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the C-terminus. However, it was not possible to check the activity of the construct 
pQIS 56 simply by challenging the plasmid with Mal because DH5a mcr E. coli 
cells lack the T7 RNA polymerase gene. The target gene was therefore virtually 
"off' in vivo and did not express the M. HhaI enzyme. The activity of M. HhaI was 
checked by the mcr response of E. coli cells BL 21 (DE3). BL21 (DE3) is the most 
widely used host strain that is a lysogen of XDE3, and therefore carries a 
chromosomal copy of the T7 RNA polymerase gene under control of the lacUVS 
promoter. The genes cloned in pET plasmid are under the control of strong 
bacteriophage T7 transcription and translation signals, which provide a source of T7 
RNA polymerase in the host cells induces expression. Once it had been established, 
that the construct contained the correct insert, the recombinant expression plasmid 
was transferred into an expression host containing a chromosomal copy of the T7 
RNA polymerase gene under lacUV5 control, and expression was induced. However 
owing to the presence of the active Mtase gene, hydrolysis of the methylated plasmid 
takes place because of the mcr+ genotype of BL21(DE3), and as a result no colonies 
appear on transformation plates. 
After the wild type M. HhaI had been transferred into pET-22b, it was convenient to 
swap the mutants into pET-22b. The selected constructs made in pET 22b were 
translated in vitro (See Chapter Two) and the protein expressed was used for 
BIACORE® SPR experiments. Quantification of protein was necessary in order to 
ensure equivalent amounts of protein were used in all binding assays. It had been 
observed that the quantification using NTA chip in the BIACORE® 2000 was not a 
good choice, as poor quality binding was observed at the NTA surface. It has been 
reported that stable binding can be obtained for a monomeric hexahistidine peptide 
but not for monomeric His-tagged proteins (Nieba et al., 1997). Proteins with only 
one His-tag only bind very weakly to the Nie+-NTA surface at neutral p11. In 
conclusion, the only limitation is that one His tag on a monomeric protein is usually 
not sufficient for stable binding, except in special cases (Nieba et al., 1997). 
As an alternative assay, in vitro methylation of DNA by wild type M. HhaI expressed 
in vitro was carried out to see whether the protein was expressed at sufficient level to 
detect activity. The assay is described in material and methods (Chapter Two). 
Typically 10 µl of in vitro expressed protein was incubated with 25 j il of IMAC resin 
(50% bed volume) (for binding of M. HhaI with beads) for one hour. The beads were 
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then centrifuged, washed once with Mtase buffer, and were then used to catalyse the 
methylation of 600 ng (2 µl) X DNA in the presence of 5 µl Mtase buffer (described 
in section 3.1.7.1) supplemented with 100 µM of SAM overnight, at 37°C. After this 
time, the contents of the tube were centrifuged and the supernatant was transferred 
into another tube. The reaction was stopped by addition of NEM followed by the 
addition of HhaI buffer and the restriction enzyme followed by a further incubation 
for one hour. Two control experiments were also carried out in parallel to this 
experiment. The first used a purified DNA methyltransferase as a positive control 
and the second used luciferase expressed in vitro as a negative control. At the end of 
the reaction the products were analysed on a 1% agarose gel (Figure 5.15). It was 
observed that in vitro expressed M. HhaI could methylate ? DNA so that it was 
completely protected from Mal restriction (Figure 5.15). We can see a slight smear 
(see lane one) compared to the positive control (see lane three), which is single band 
of a, DNA, which could be due to the presence of various other proteins present in 
the lysate which were not removed by a single washing. It was also observed in this 
experiment that one to two hours incubation was not sufficient (data not shown) for 
the in vitro translated product to complete the methylation reaction. It appears that 
the either the protein yield is very low in this experiment or the presence of other 
proteins affect the methylation reaction. 
In order to improve the quality of the data the selected constructs have been 
"normalised" by sub cloning them into pET-22b as GST fusions. The constructs were 
made and checked for their activity (by transformation of E. coli BL21 (DE3)) via 
the mcr response. Table 5.1 summarises the properties of parent plasmid and the new 
constructs made in pET-22b. It was decided to carry out an in vitro translation for 
wild type M. HhaI as a GST fusion and to check its encoded protein by in vitro 
methylation protection assay as was carried out with IMAC resin (explained above). 
The only difference this time was glutathione agarose beads instead of IMAC resin. 
The result (Figure 5.16) showed that the encoded protein by pQIS 65 is catalytically 
active and protection of X DNA was observed against restriction with Mal. 
5.3.3.2: Preparation of CM5 chip 
The quantification of recombinant fusion protein was carried out using a GST 
capture kit (Biacore). The GST capture kit provides site directed immobilization of 
GST fusion proteins through capture on immobilized Goat anti-GST antibody at the 
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Figure 5.15: In vitro methylation protection by wild type M. Hhal expressed in vitro. The Gel above 
shows an alternative assay for in vitro methylation protection of lambda DNA by in vitro expressed 
M. Hhal. Lane 1: 600 ng of X DNA incubated with in vitro translated M. Hhal followed by restriction 
with Hhal (Protected X DNA without cleavage). Lane 2: Negative control. 600 ng of ? DNA incubated 
with luciferase followed by restriction with Hhal. (No protection, X DNA completely cleaved). Lane 3: 
600 ng of A. DNA incubated with in vivo expressed and purified M. Hhul followed by restriction with 
Hhal (Protected A. DNA, no cleavage). M: GeneRuler'M I kb DNA ladder. (See Chapter Two and 
appendices for the DNA marker ladder size). 
Figure 5.16: In vitro methylation protection by wild type M. Hhal expressed in vitro. The Gel above 
shows an alternative assay for in vitro methylation protection of lambda DNA by in vitro expressed 
M. Hhal purified by glutathion agarose beads. M: GeneRuler"" I kb DNA ladder. Lane 1: 400 ng of X 
DNA incubated with in vitro translated M. Hhal followed by restriction with Hhul (Protected A DNA 
without cleavage). Lane 2: Negative control. 400 ng of A DNA incubated with luciferase followed by 
restriction with Hhal. (No protection, k DNA completely cleaved). Lane 3: 400 ng of X DNA incubated 
with in vivo expressed and purified M. Hhal followed by restriction with Hhul (Protected A DNA, no 
cleavage). 4.400 ng A DNA restricted with Hhal (negative control, A DNA completely cleaved). (See 
Chapter Two and appendices for the DNA marker ladder size). 
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Table 5.1: Summary and properties of the new constructs made in pET-22b 
Description Parent In vivo New Mcr+ 
construct methylation construct in response 
protection pET 22b 
response on gel 
1 Wild type pMSK 7 Active pQIS 65 Active 
M. HhaI 
2 Single mutant pQIS 12 Partial Active pQIS 66 Inactive 
(A280F) 
3 Double mutant pQIS 14 Inactive pQIS 67 Inactive 
(A280F, R277L) 
4 Triple mutant pQIS 18 Active pQIS 68 Active 
(A280F, R277L, 
F302A) 
5 Double mutant pQIS 55 Partial Active pQIS 69 Active 
(K270R, T2711) I 
-j 
surface of a CM5 chip. These types of chips were prepared manually in the 
laboratory. Anti-GST was first diluted to 30 µg/m1 in coupling solution (10 mM Na- 
acetate, pH 5.0), and immobilised onto a CM5 sensor chip using the amine coupling 
method. This method involves activation of the carboxyl groups on the matrix by the 
addition of a mixture (1: 1) of succinimide (NHS, N"hydroxysuccinimide, 11.5 
mg/ml) and carbodiimide (EDC, N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide 
hydrochloride, 75 mg/ml) to form active esters which react with amine groups on the 
ligand (anti-GST) to form a covalent bond. After ligand coupling, ethanolamine is 
added to deactivate the remaining active esters (see Figure 5.17). After the successful 
coupling of the antibody, it was equilibrated with 1x PBS (140 mm NaCl, 2.7 mm 
KCI, 10 mM Na2HPO4,1.8 mM KH2PO4, pH 7.3). Following were the observations 
during preparation of CM5 chip. 
Description Relative Response (RU) 
1 Non activated surface 0 
2 Activation with NHS/EDC 137.4 
T Injection of anti-GST 4164.2 
4 Deactivation with ethanolamine -329.3 
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Figure 5.17: A) Graphic representation of Coupling of anti-GST on the surface of CMS chip. The 
interactions relating to each part of the sensorgram are shown above and also explained below, more 
information is given in the text. 1) Base line showing non-activated carboxyl groups of the 
carboxymethylated dextran layer; 2) Activation of the carboxyl groups on the matrix by adding a mixture 
of carbodiimide (EDC) and succinimide (NHS) to form active esters that can react spontaneously with 
amine groups on the ligand; 3) After activation; 4) Coupling of ligand: Goat anti GST IgG is covalently 
bound; 5) Buffer washes away loosely associated ligand; 6) Residual active esters are deactivated with 
ethanolamine; 7) Difference in 3 and 7 reflects the amount immobilized. B) Chemistry of reactions taking 
place on the surface of the CMS sensor chip during ligand immobilization. a) Non-activated carboxyl 
groups on the surface of the chip b) Some carboxyl groups are activated with NHS/EDC. c) IgG is 
covalently bound d) Residual active esters are deactivated with ethanolamine. 
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The CM5 sensor chip is now ready for co-eluting GST by injecting onto the surface 
of the sensor chip. A range of recombinant GST (Schistosoma japonicum) dilutions 
from 4 ng/µl to 100 ng/µl was used for the preparation of a calibration curve. 
The plasmids listed in Table 5.1 were used to direct in vitro translation and the in 
vitro translated proteins were then first quantified. In this step, typically 2,5 and 10 
µl of in vitro expressed protein diluted with 1X methyltransferase buffer up to a final 
volume of 50 µl were injected at a flow rate of 5 µ1 per minute on to the surface of 
CM5 sensor chip. Response curves obtained were used for the determination of 
unknown concentration of in vitro expressed recombinant proteins. 
5.3.3.3: Analysis of the M. HhaI binary complex with DNA 
An experiment was designed to analyse the wild type M. HhaI and some selected 
mutants (shown in the Table 5.1) for binary complex formation with an 
oligodeoxynucleotide containing the HhaI recognition site using surface plasmon 
resonance. In order to do so, Biotinylated DNA sequence/oligonucleotides specific 
for binding to HhaI, HaeIII and Mspl specific sites were designed and synthesized of 
Name of Feature Sequence 
Oligonucleotide 
Al = 5'BHH Top Biotinylated oligo for Hhal 5'-BGAATGCTACAGTATCGTGCGCTCA 
with (GCGC) recognition CGTACAACATCCAG-3' 
sequence 
A2 = 3'HHM Bottom oligo for Al 5'-CTGGATGTTGTACGTGAGMGCACG 
ATACTGTAGCATTC-3' 
A13 = 5'BSP Top Biotinylated oligo for MspI 5'-BGAATGCTACAGTATCGTCCGGTCA 
with (CCGG) recognition CGTACAACATCCAG-3' 
sequence 
ASP2 = 3'SPM Bottom oligo for A13 5'-CTGGATGTTGTACGTGAMCGGACG 
ATACTGTAGCATTC-3' 
A14 = 5'BHA Top Biotinylated oligo for HaeIll 5'-BGAATGCTACAGTATCGTGGCCTCA 
with (GGCC) recognition CGTACAACATCCAG-3' 
sequence 
BHA2 = 3'HAM Bottom oligo for A14 5'-CTGGATGTTGTACGTGAGGMCACG 
ATACTGTAGCATTC-3' 
B= Biotinylated 
M= 5' Methylcytosine 
Table 5.2: List of oligonucleotides used as ligands for binding experiments with 
SA chip of BIACORE 
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equivalent length differing by a single base pair at the target site (See Table 5.2). 
Only the top oligonucleotide was 5'-biotinylated. The sequences detailed in Table 
5.2 comprise one recognition site after annealing and mimic the natural substrates. 
In the M. HhaI: DNA binding analysis using SPR, two types of controls must be 
considered, the first one is the non-specific binding between the in vitro protein and 
the ligand. This can be determined by using a non-Mtase protein, translated in the 
same way as the other proteins were translated such as luciferase. Luciferase is used 
to check whether the kit has worked efficiently and to determine the level of non- 
specific binding of the extract to the ligand. The second control required is an 
estimation of the non-specific binding of proteins to the SA chip. This was achieved 
by using the blank flow cell that contains streptavidin without DNA. 
An SA sensor chip was normalised with Bianormalising solution (40% W/W 
glycerol in water) to compensate for the variations in reflectance characteristics 
between different sensor chips. It was then washed with 1M NaCl in 50 mM NaOH 
prior to the assay. The biotinylated substrate (800 nM) was prepared in 
methyltransferase buffer (50 mM Tris-HCI, pH 8.5,50 mM NaCl, 10 mM 
dithiothreitol), and immobilised in molar excess on the surface of the SA sensor chip 
utilising the streptavidin-biotin interaction. Flow cell 1 was kept blank, with no pre- 
attached oligonucleotide. Flow cell 2 contained immobilised biotinylated Mal 
binding site-specific oligonucleotide. Flow cell 3 contained an immobilised 
biotinylated MspI binding site-specific oligonucleotide (in order to measure non- 
specific interactions). 
The protein under investigation was passed over the "flow cells" of the SA chip in 
equimolar concentration to initiate the molecular interaction. The injection flow rate 
was set at 5 µUmin in order to achieve maximum binding in the shortest period of 
time. Enzyme-substrate binding was detected soon after the enzyme solution was 
injected. Response curves show steady state formation of enzyme substrate complex. 
When enzyme-substrate coupling had reached a maximum value, and the enzyme 
solution injection was terminated, the sensor chip surface was flushed thoroughly 
with an excess of HhaI methyltransferase buffer. The molecular interactions in the 
form of response units for variants of Hhal was recorded for blank (flow cell 1), 
HhaI specific (flow cell 2) and non-specific (flow cell 3). 
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The DNA binding affinity of the GST-M. HhaI wild type and its mutant variants were 
compared by SPR. Interestingly the association phase is almost the same for all 
mutants and wild type M. HhaI. 
All experiments were carried out at 25°C. Wild type and mutant protein were 
injected over substrate in a total injection volume of 2Oµ1. The background resulting 
from non-specific binding of the enzyme to a blank flow cell was subtracted from the 
data before analysis, which was performed using the Bia-evaluation program. The 
results are presented in table below and shown in Figure 5.18. 
Description Construct number Rmax (RU) 
I Wild type M. HhaI pQIS 65 966 
2 Single mutant (A280F) pQIS 66 883 
3 Double mutant (A280F, R277L) pQIS 67 930 
4 Triple mutant (A280F, R277L, F302A) pQIS 68 936 
5 Double mutant (K270R, T2711) pQIS 69 889 
The result showed that there is no significant difference in the association properties 
of mutants with that of wild type of M. HhaI. Although the mutants showed different 
methylation profile by in vitro protection assay, these results indicate that the DNA 
recognition is unaffected by these mutations. 
5.4: Discussion 
It has been established for the monospecific and multispecific Mtases that the 
variable region is wholly responsible for the selection of DNA sequences to be 
methylated (Wilke et al., 1988; Mi and Roberts, 1992; Trautner et al., 1996). We 
have attempted to dissect the variable region of M. HhaI by mutational analysis (see 
chapter three and four) and by constructing various hybrids by insertion of segments 
from multispecific Mtase M. SPRI (chapter four) to establish the relationship between 
variable region and motif IX of M. HhaI. We managed to redesign motif IX of 
M. HhaI that mimics to multispecific Mtase M. SPRI. However, all other attempts to 
exchange the monospecific variable region with the TRDs of M. SPRI were 
unsuccessful. A list of all the mutant constructs made in this study, by the codon 
changes at single or multiple sites in M. SPRI is given in Table 5.3. Table 5.4 
summarises the mutant made at single or multiple sites in M. HhaI. 
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Figure 5.18: Biacore analysis of the interaction between an Hhal binding site-specific oligonucleotide 
and variant of the Hhal methyltransferase. The results showed in figure A-F represents molecular 
interactions as follows. The protein under investigations were passed over three "flow cells" of the Biacore 
chip and interactions were measured and shown for each flow cell as labelled. Flow cell I was a blank 
(without substrate) with a no pre-attached oligonucleotide. Flow cell 2 contained an immobilized 
biotinylated Hhal binding site specific oligonucleotide. Flow cell 3 contained an immobilized biotinylated 
Mspl binding site-specific oligonucleotide (in order to measure non specific interactions). After subtracting 
the effects due to non-specific interactions, the chromatograms were overlaid and are shown in panel G. 
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Table 5.3: Summary of mutant constructs made in M. SPRI gene 
Construct Mutation Description Activity 
pQIS 8 Phe386Ala Single point mutation with the introduction of Partial 
Fspl site 
pQIS 9 Ala390Gly Single point mutation Active 
pQIS 10 Asp392Pro Single point mutation Active 
pQIS 34 G1nl89Glu Single point mutation with the introduction of Active 
Xhol site 
pQIS 45 Phell2Leu Triple mutant with the introduction ofApal site Inactive 
Phe 113 Gly 
Vall 14Pro 
pQIS 46 Phel l2Leu Quadruple mutant with the introduction ofApal Inactive 
Phell3Gly site 
Vail 14Pro 
Phe386Ala 
pQIS 76 Ser33Arg Single point mutation with the introduction of Inactive 
NruI site 
Table 5.4: Summary of mutant constructs made in M. HhaI gene 
Construct Mutation Description Activity 
pQIS 11/ A1a28OPhe Single point mutation with the introduction of Partial 
pQIS 12 Styl site 
pQIS IN Arg277Leu Double mutation with the introduction of Xbal Inactive 
pQIS 14 A1a28OPhe site and deletion of StyI site 
pQIS 17/ Arg277Leu Triple mutation with the introduction of AccI Active 
pQIS 18 A1a28OPhe site and deletion of HincII site 
Phe302A1a 
pQIS 20 Phe302Ala Single point mutation with the introduction of Partial 
AccI site 
pQIS 21 Arg277Leu Quadruple mutation with the introduction of Inactive 
Ala280Phe A1wNI site 
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Tyr289Asp 
Phe302Ala 
pQIS 22 Tyr289Asp Single point mutation with the introduction of 
Inactive 
A1wNI site 
pQIS 36 Asnl761le Double mutant with the introduction of PacI 
Active 
Ile 177Asn site 
pQIS 37 Asnl761le Double mutation with the introduction of Pacl 
Inactive 
I1e177Asn site in triple mutant of M. HhaI gene encoded 
Arg277Leu by pQIS 18 
Ala280Phe 
Phe302Ala 
pQIS 41/ Vall 16G1y Double mutant with the introduction of ApaI Inactive 
pQIS 50 Phell7Pro site 
pQIS 42 Vall16G1y Double mutant with the introduction of Apal Inactive 
PheI17Pro site in triple mutant of M. Hhal gene encoded 
Arg277Leu by pQIS 18 
Ala280Phe 
Phe302Ala 
pQIS 43 Vall 16G1y Double mutant with the introduction of Apal Inactive 
Phel l7Pro site in double mutant of M. HhaI gene encoded 
Asn1761le by pQIS 36 
Ilel77Asn 
pQIS 51 Vall16G1y Double mutant with the introduction of EcoRI Inactive 
Phe117Pro site in double mutant of M. HhaI gene encoded 
Lys270Arg by pQIS 50 
Thr2711ie 
pQIS 55 Lys270Arg Double point mutation with the introduction of Partial 
Thr2711le EcoRI site 
pQIS 74 Asn39Arg Single point mutation with the introduction of Inactive 
NruI site 
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As a final attempt to check the flexibility of monospecific Mtase M. HhaI an 
experiment was carried out to exchange motifs in M. HhaI and M. SPRI. During this 
experiment site directed mutagenesis was also carried out to generate new restriction 
sites. Furthermore, protein expressed using in vitro transcription/translation was used 
for biochemical experiments including an in vitro methylation protection assay. The 
experiment leading to real time binding interactions between variants of M. HhaI and 
double stranded oligonucleotides has also been discussed. 
The Asn 39 Arg mutagenesis in wild type M. HhaI made the enzyme catalytically 
inactive. It has been found from the analysis of crystal structure of M. HhaI (Cheng et 
al., 1993) that Asn 39 makes close contacts with oxygen of Asp 16 and nitrogen of 
both Phe and Ala at amino acids position 18 and 19 in the presence of SAM. In the 
presence of DNA Asn 39 is found to make contacts to SAH and the oxygen of Gly 
59 in addition to the contacts already stated in the presence of SAM. Asn is 
uncharged polar amino acid while Arg is positively charged amino acid. Introduction 
of a positively charged amino acid in the hydrophobic core structure of protein leads 
to an adverse structural arrangement. Molecular modelling software was used to 
predict the altered position of Arg 39 in M. HhaI and it appears that the side chain of 
Arg could well point towards SAM/SAH because of the orientation of the backbone 
of the protein. Therefore, this destabilization of the enzyme mass result in the activity 
of the enzyme being lost. A tentative model for the Asn 39 Arg mutation is shown in 
Figure 5.19. 
The codon for Arg 39 has been exchanged with the codons for Asn in the protein 
encoded by construct pQIS 78. However, the activity of the encoded protein has not 
been restored. Although the contacts of Asn 39 with amino acids towards N-terminal 
end of the enzyme have been restored, however the hydrogen bond between Gly 59 
and Asn 39 do not exists any more because of the exchange of sequence from the 
M. SPRI gene. Therefore, the restoration of methylation capacity of hybrid enzyme is 
not achieved. In the same manner, I believe that similar situation should have been 
arisen with M. SPRI and restoration of codons for Ser 33 in construct pQIS 80 did not 
encode an active chimaeric Mtase. 
Among the hybrid Mtases that we prepared (Chapter Five) none of them showed 
Mtase activity. This could be due to a lower level of expression of hybrid genes or 
some inherent instability in the protein products. This was tested by expression of 
protein on a small scale in 5 ml culture from each of the hybrid Mtases and then 
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Figure 5.19: A model for the Asn 39 Arg in the structure of M. Hhal. SAH, Asn 39 and the modelled 
mutant Arg are shown in ball-and-stick with CPK coloured atoms and green and red sticks respectively. 
The Arg side chain comes very close to the SAH co-factor, the positive charge possibly affecting binding. 
The longer side chain of the Arg may cause steric problems as can be seen in the diagram where it clashes 
with a short helical region. Some secondary structure elements have been removed in this diagram for 
clarity. The image was created by Dr. Matthew J. Conroy. The figure was produced using Molscript 
(Kraulis (1991) J. Appl. Cryst. 24 946-950) and Raster3D, (Merritt & Murphy (1994) Aria ('r v. c(. I)50 
869-873). 
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subjecting a crude cell extract to SDS PAGE. Four chimaeric constructs (i. e. pQIS 
79, pQIS 81, pQIS 82 and pQIS 83) were induced for the expression of hybrid 
protein. In all cases, following induction, the hybrid proteins were clearly visible and 
the amounts were comparable to those of the wild type Mtases (Figure 5.20). This 
indicated that poor expression was not the cause of inactive protein. Therefore it is 
assumed that due to exchange of motifs between two different types of Mtases, the 
protein instability has occurred. This suggests that there may be some direct 
structural interactions between various regions within each class of Mtases. 
In vitro translated wild type enzyme were shown to be competent in a methylation 
protection assay. The aim of these in vitro transcription/translation experiments was 
to establish whether the mutants retained some degree of structural integrity, as 
indicated by the retention of DNA recognition capacity. It was concluded from the 
experiments in which binary complex formation was monitored between the variants 
of M. HhaI enzyme and oligonucleotides, that there is no detectable sequence- 
specific difference in DNA association. The first step in DNA methylation is binding 
of DNA with the Mtase. The TRD region is mainly responsible for the recognition of 
the specific target site, which is then followed by sequence specific methylation. All 
the mutants of M. HhaI tested for DNA recognition carry mutations in or around 
motif IX. Different mutants that were enzymatically active, partially active and 
inactive all exhibited similar association profiles with the specific oligonucleotide. 
This suggests that motif IX plays a role in general stability of the enzyme core 
, structure 
but have less role in the recognition of DNA sequences. 
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Figure 5.20: Protein expression for the chimaeric constructs pQIS 79, pQIS 81, pQIS 82 and pQIS 83. 
PAG}. analysis after the protein induction and small scale extraction for the chimaeric constructs. Hie gel 
confirms that the protein is intact without any truncation and can be expressed by induction. M is broad 
range protein molecular weight marker as shown in chapter two and appendix in both gels. the lane order 
is as follows. 
Gel 1: 
pQIS 79 Soluble fraction 
pOIS 79 Pallet fraction 
pQIS 81 Soluble fraction 
pQIS 81 Pallet fraction 
Gel 2: 
pOIS 82 Soluble fraction 
pQIS 82 Pallet fraction 
pQIS 83 Soluble fraction 
pQIS 83 Pallet fraction 
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Figure 5.3: Schematic representation showing the construction of pQIS 74 (mutant of M. Hhal 
encoding for Asn 39 Arg). The newly 
introduced Nrul site is shown in red. Gel I shows the PCR 
product generated after site-directed mutagenesis. M: GeneRulerTM I kb DNA ladder. Gel 2, Lane 1: 
pQIS 74 digested with Hhal (The DNA is not protected from restriction digestion indicating that an 
inactive protein is encoded by this plasmid). Lane 2: Control pQIS 64 cut with Nrul (Uncut DNA shows 
that Nrul site does not exist in this plasmid) Lane 3: pQIS 74 cut with Nrul to verify the identity of the 
new construct. (Linear DNA due to unique Nrul site confines the formation of pQIS 74). M: 
GeneRulerTM I kb DNA ladder. 
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Figure 5.4: Schematic representation showing the construction of pQIS 
76 which encodes for Ser 33 
Arg codon in M. SPRI. The newly 
introduced Nrul site is shown in red. Gel 1 shows the PCR product 
generated after site-directed mutagenesis. 
Gel 2, Lane 1: pQIS 76 digested with Haelll (The DNA is not 
protected from restriction 
digestion indicating that an inactive protein is encoded by this plasmid). Lane 2. 
pQIS 76 digested with 
Nrul for verification of the identity of new construct. (DNA has been linearised due 
to the presence of unique 
Nrul site). M: GeneRulerTM I kb DNA ladder in both gels. 
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Figure 5.5: Schematic representation showing the construction of pQIS 78 (chimaera of M. SPRI and 
M. Hha1). Gel 1 shows the digestion of pQIS 74 and pQIS 76 to gel purify the vector and insert DNA for 
the construction of pQIS 78. Lane 1: pQ1S 74 digested with Apal and Nrul. (Fragment sizes are 3796 and 
2153 bps). Lane 2: pQIS 76 digested with Apal and Nrul. (Fragment sizes are 4204 and 2123 bps). Gel 2: 
Lane 1: pQIS 78 cut with Mspl for activity check. (The DNA is not protected from restriction digestion 
indicating that an inactive protein is encoded by this plasmid). Lane 2: pQIS 78 cut with EcoRl for the 
identity of verification of new construct. (Fragment sizes are 5203 and 1154 bps). M: GeneRulerI'm 1 kb 
DNA ladder in both gels. 
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Figure 5.6: Schematic representation showing the construction of pQIS 82 (chimaera of M. SPRI and 
M. HhuI). This construct is equivalent to pQIS 78 made earlier but with the restoration of original codon 
sequence of Asn of M. Hhal by SDM at the fusion point of M. Hhal and M. SPRI sequence. Gel I shows 
the generation of PCR product after SDM. Gel 2: Lane 1: pQIS 78 cut with Nrul as control digestion. 
(Linear DNA). Lane 2: pQIS 82 digested with Nrul. (Uncut DNA signifies that the mutagenesis has been 
successful and Nrul site has been abolished). Lane 3: pQIS 82 cut with Mspl for activity check. (The 
DNA is not protected from restriction digestion indicating that an inactive protein is encoded by this 
plasmid). M: GeneRulerTM I kb DNA ladder in both gels. 
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Figure 5.7: Schematic representation showing the construction of chimaeric construct pQIS 80 which 
contains sequence of motif I of M. SPR and the sequence of motif II-X of M. Hhal. Gel 1: Lane I shows 
the digestion of pQIS 76 with Nrul and Xhol. (Fragment sizes are 5054 and 1273 bps). Lane 2: pQIS 74 cut 
with Nntl and Xhol. (Fragment sizes are 5078 and 871 bps). Gel 2: Lane 1: pQIS 80 cut with Nrul and 
Xhol. (Fragment sizes are 5054 and 871 bps). Lane 2: pQIS 80 cut with BamHI and Xhol. (Fragment sizes 
are 4951 and 974 bps). M: GeneRuler' I kb DNA ladder in both gels. 
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Figure 5.8: Schematic representation showing the construction of pQIS 83 (Chimaera of M. SPRI 
and M. Hha1). This construct is equivalent to pQIS 80 made earlier but now restore the original codon 
sequence of Ser of M. SPRI by SDM at the fusion point of M. SPRI and M. Hhal sequence. Gel I shows the 
generation of PCR product after SDM. Gel 2: Lane 1: pQIS 83 cut with Nrul (Uncut DNA signifies that 
the mutagenesis has been successful and Nrul site has been abolished). Lane 2: pQIS 83 cut with Mspl for 
activity check. (The DNA is not protected from restriction digestion indicating that an inactive protein is 
encoded by this plasmid). M: GeneRulerl I kb DNA ladder in both gels. 
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Figure 5.9: Schematic representation showing the construction of pQIS 72 which encodes for wild 
type M. SPRI. Gel 1 shows the PCR product generated (after site-directed mutagenesis for the 
introduction of unique Kpnl site, silent mutation). Gel 2, Lane 1: pQIS 72 digested with Mspl (The 
DNA is protected from restriction digestion indicating that an active protein is encoded by this 
plasmid). Lane 2: pQIS 72 cut with HaeIII (The DNA is protected from restriction digestion indicating 
that an active protein is encoded by this plasmid). Lane 3: pQIS 72 cut with Kpnl to verify the new 
construct. (Linear DNA due to unique Kpnl site confirms the formation of pQIS 72). M: GeneRuler iM 
I kb DNA ladder in both gels. 
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Figure 5.10: Schematic representation showing the construction of pQIS 79. Gel 1 shows the 
restricted DNA fragments for the recovery through gel. Lane 1: pQIS 64 cut with Kpnl and Xhol to 
extract the 5258 bps vector. Lane 2: pQIS 72 cut with Kpnl and Xhol to gel extract the 1084 bp insert. 
Gel 2, Lane 1: pQIS 79 digested with Mspl (The DNA is not protected from restriction digestion 
indicating that an inactive protein is encoded by this plasmid). Lane 2: pQIS 79 cut with Hhul (The 
DNA is cleaved indicating that an inactive protein is encoded by this plasmid). Lane 3: pQIS 79 cut 
with EcoRl to verify the new construct. (Fragment sizes are 1145 and 5197 bps). Lane 4: pQIS 79 cut 
with Kpnl and Xhol to verify the new construct. (Fragment sizes are 1084 and 55258 bps). M: 
GeneRulerTM I kb DNA ladder in both gels. 
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Figure 5.11: Schematic representation showing the construction of pQIS 81. The insert and vector 
DNA fragments for this ligation were recovered from the gel I shown in figure 5.10. Gel 1, Lane 1: 
pQIS 81 digested with Mspl (The DNA is not protected from restriction digestion indicating that an 
inactive protein is encoded by this chimaeric construct). Lane 2: pQIS 81 cut with Hhal (The DNA is 
cleaved indicating that an inactive protein is encoded by this construct). Lane 3: pQIS 81 cut with Kpnl 
and Xhol to verify the new construct. (Fragment sizes are 691 and 5243 bps). Lane 4: pQIS 81 cut with 
EcoRI to verify the new construct (uncut DNA, no EcoRl site ). M: GeneRulerTM I kb DNA ladder. 
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DEVELOPMENT OF A "BACTERIAL TWO-HYBRID 
SYSTEM" BASED ON THE REVERSIBLE ASSEMBLY 
OF AN ENGINEERED FORM OF M. SPRI 
6.1: The Two-Hybrid System 
6.1.1: INTRODUCTION 
Two-hybrid systems are based on a genetic method that uses transcriptional activity 
as an indirect measure of protein-protein interaction (Phizicky and Fields, 1995). It 
relies on the modular nature of many site specific Transcriptional Activators which 
typically consist of a DNA Binding Domain (X) (targets the activator to the gene that 
will be expressed) and a Transcriptional Activation domain (Y) (contacts other 
proteins of transcriptional machinery to enable Transcription to occur) (Phizicky and 
Fields, 1995; Drees, 1999). In the Two-Hybrid system the two domains of the 
activator need not be covalently linked and can be brought together by the interaction 
of two proteins (Phizicky and Fields, 1995). 
This system requires two chimaeric proteins to be constructed: 
1. DNA binding domain fused to some protein (X) 
2. Transcription activation domain fused to some protein (Y) 
These two hybrids are expressed in a cell containing one or more reporter genes. If 
protein X and Y interact, they create a functional transcriptional activator by bringing 
the activation domain into close proximity with the DNA-binding domain. This can 
be detected by expression of the reporter gene (Phizicky and Fields, 1995) (Figure 
6.1). 
The Yeast Two-Hybrid system has been used . extensively since 
its original 
description almost 10 years ago to identify protein-protein interactions (Drees, 1999). 
Many modifications have been introduced in the original Two-Hybrid system to 
expand the range of possible investigation of macromolecular interactions (Drecs, 
1999). These powerful genetic selection methods are proving useful in protcomic 
projects aimed at generating macromolecular interaction maps. 
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Figure 6.1: A simplified model for the current basis of the yeast two hybrid system (Fields, 1989). 
A: In the absence of interacting partner, the two domains are unable to come close enough to activate the 
reporter gene. B: The partners 1 and 2 promote the interaction of activation domain and binding domain and 
as a result of this, activation of a reporter gene (ß-galactosidase in the above example) takes place and this 
can be easily detected using the chromophore X-Gal in the growth medium ("blue colonies"). 
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The Two-Hybrid system has certain advantages over conventional methods for 
studying protein-protein interactions, such as co-immuno-precipitation, co- 
fractionation and affinity chromatography. In this system, there is no need to purify 
any of the candidate proteins or produce antibodies. No prior knowledge of protein 
function is required. It has ultimate flexibility for enabling the detection of 
completely novel sets of interacting proteins. This system can be used for testing 
interactions of pairs of proteins, groups of proteins in pair wise combination or entire 
libraries of genes against either individual proteins or against another library. 
Furthermore, the nucleotide sequences of those clones that are defined as positive in 
a two hybrid screens can be readily obtained by recovering the corresponding 
plasmids. 
Gene regulatory proteins generally bind to specific DNA sequences. Several DNA 
binding motifs have been described and transcription factors often are classified 
according to the type of DNA binding domain they contain e. g. Helix-Turn Helix, 
C2H2 Zinc Finger, and Homeodomain (Nelson and Cox, 2000). Such regulatory 
proteins contain domains not only for DNA binding but also for protein-protein 
interaction. Several well-defined structural domains have been described that are 
devoted to the interactions required for dimer formation, which is generally a 
prerequisite for DNA binding. Like DNA-binding motifs, these structural motifs, 
which promote oligomer formation, contain characteristic consensus sequences such 
as the Leucine Zipper motif and the basic Helix-Loop Helix motif (Nelson and Cox, 
2000). 
6.1.2: LEUCINE ZIPPER PROTEINS 
One protein motif whose function can be measured effectively using the Two-Hybrid 
system is the "leucine zipper". The leucine zipper is a structure that mediates the 
function of several eukaryotic gene regulatory proteins. The zipper consists of a 
periodic repetition of leucine residues at approximately every seventh position, and 
regions containing them typically span 8 turns of alpha helix (Landschulz, 1988). 
Initially it was thought that the Leu residues interdigitated and hence they were 
named "zippers". Now it is known that the leucine side chains that extend from one 
helix interact with those from a similar helix, hence facilitating dimerisation in the 
form of a coiled-coil (Nelson and Cox, 2000). Leucine zippers are present in many 
gene regulatory proteins, and examples include the CREB proteins, JunJAP 1 
transcription factors, fos oncogene and fos-related proteins, C-myc, L-myc and N. 
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myc oncogenes, and so on. Leucine zipper proteins can be divided into several 
families on the basis of the properties of polypeptide region adjacent to the zipper. 
One such leucine zipper family contains a region of dense positive charge 
immediately adjacent to the amino terminus of the zipper domain (Figure 6.2). This 
family is generally referred as the B-zip family, which can be further subdivided into 
the two sub-families according to observed degree of similarity between amino acids 
in the leucine zipper and basic region (Kerppola and Curran, 1991): 
A: The Fos related subfamily e. g. Fos, FosB, Fral, Fra2 etc. 
B: The Jun related subfamily e. g. Jun, JunB, JunD etc. 
At present in the SWISSPROT database roughly 100 of the 10000 human protein 
sequences listed contain a potential leucine zipper motif, and of these about one third 
are described as "potential" or putative leucine zippers. Computer modelling studies 
have shown that it is difficult to predict the presence of an active leucine zipper from 
sequence data alone (Bonnberg-Bauer et al., 1998); it was pointed out in this 
particular study that of 3398 sequences predicted to contain leucine zippers or 
containing a leucine repeat frame, only 408 could be unequivocally identified as 
leucine zippers. Therefore it can be seen that a rapid functional test is needed for the 
study of leucine zippers in genome research. 
6.1.3: THE YEAST TWO-HYBRID SYSTEM 
It is apparent that many functions in the cell are performed by multi-component 
protein systems (Blundell and Srinivasan, 1996; Alberts; 1998). In addition, a 
number of complete genome sequences (for example, from Saccharomyces 
cerevisiae, Drosophila melanogaster and Escherichia coil) contain open reading 
frames that have not been completely characterised (Uetz et al., 2000; Hodgkin, 
2000). A complete understanding of functional genomics (also known as "the 
physiology of cells") involve identifying how gene products interact in carrying out 
their biochemical functions. 
A potentially useful test for protein-protein interactions is the S. cerevislae Two- 
Hybrid approach (Fields and Song, 1989; Phizicky and Fields, 1995; Bartel and 
Fields, 1997). This has been characterized and modified by several groups, and is 
available in various commercial forms (Uetz et al., 2000; Gietz et al., 1997). Cells 
provide the apparatus of a biochemical assay for the partners in a potential protein- 
protein interaction, sometimes known as "bait" and "prey". Since each cell in a 
library can contain a different pair of bait and prey, in theory a large number of pair 
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Figure 6.2: 
(A) Structural model for leucine zipper. 
(B) Crystal structure of leucine zipper complexed with DNA (PDB code Idgc). I)NA is 
shown as a "ball and stick" model and two helices of the interacting leucine zipper proteins 
are shown in green, with the leucines shown in yellow. The image was created by Dr. 
Matthew J. Conroy. The figure was produced using Molscript (Kraulis (1991) 
. 
1.4ppl. 
Cryst. 24 946-950) and Raster3D, (Merritt & Murphy (1994) Aclu ('ryst. D50 869-873). 
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wise interactions can be examined on comparatively few agar plates with appropriate 
selections or screens. Reviews are available that describe the use, interpretation, and 
pitfalls of two hybrid experiments in S. cerevisiae, and it has been predicted that this 
type of assay will provide a high throughput system that might be needed for 
automated screening for the all of the protein-protein interactions encoded by a 
genome (Hu et al., 2000, Colas and Brent, 1998). 
6.1.4: THE NEED FOR A BACTERIAL TWO HYBRID SYSTEM 
In the past few years the genomes of C elegans, Escherichia coli and S. cerevisiae 
have been sequenced (The C. elegans Sequencing Consortium, 1998; Blattner et al., 
1997; Hu et al., 2000). The sequence of the human genome has also been completed 
recently and initial sequencing and analysis of the human genome has been released 
(International human genome sequencing consortium, 2001). The crucial challenge 
for biologists in the future will be to make sense of this information, much of which 
will encode protein sequences. To fully understand the function of proteins in living 
cells, a detailed knowledge of their structures and their role will be required. Despite 
the widespread use of the yeast two-hybrid system, there are certain limitations in 
handling yeast and there are reasons why similar genetic assays in E. coli would be 
useful. It is more convenient to use prokaryotes, which are scientifically "friendly" to 
molecular biologists and biotechnologists. A great advantage of E. colt is that the 
speed with which large numbers of interactions could be tested owing to relatively 
greater efficiency of transformation of bacteria over yeast. The development of a 
user-friendly system with increased speed of analysis represents an interesting 
challenge that has important commercial implications. E. coil grows faster than yeast 
and, with present methods, can be transformed with higher efficiency, allowing 
better coverage in library-based screens. In addition, since the cloning steps in yeast 
often involve passing libraries through E. coli hosts, using E. coil would remove a 
step from each cycle in a high throughput-screening programme. The smaller 
genome complexity and greater evolutionary distance from higher eukaryotes mean 
that E. coli systems should not generate as many false positives and negatives due to 
interactions between endogenous proteins and eukaryotic baits and prey as found in 
S. cerevisiae. With respect to drug screening, another potential advantage is that the 
cell envelope of E. coli seems to be somewhat more permeable to small molecules 
than the cell wall of yeast. Finally, yeast two hybrid systems require nuclear 
localization of the hybrid proteins and the presence of localization signals for other 
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cellular compartments could prevent bait or prey from reaching the nucleus, a 
problem that should not occur in E. coli. 
6.1.5: AIMS 
The main aim of this experiment is to develop a two-hybrid system for E. coli 
drawing on a knowledge of the structural features of C5-DNA Mtases, which can be 
used to positively identify leucine zipper encoding genes originating from genomic 
libraries, which may eventually provide the basis for a more general system for the 
analysis of protein-protein interactions. 
6.2: The use of M. SPRI as the core of a bacterial two hybrid system 
6.2.1: INTRODUCTION 
It has been observed that individually inactive N- and C-terminal encoding parts of 
the M. BspRI gene can complement each other, resulting in specific, in vivo 
methylation of DNA (Posfai et al., 1991). The DNA encoding the N- and C-terminal 
parts of this enzyme have been cloned in compatible plasmids which have then been 
used to co-transform E. coll. Both non-overlapping and partially overlapping 
fragments were found to be capable of complementation. If the detachment position 
occurred in motif VIII or C-terminal to it, the resultant enzyme showed no activity, 
but if the C-terminal part was longer than this, the resulting proteins were active or 
partially active (Posfai et al., 1991). 
A similar example was observed when a clinically isolated Escherichia cola strain 
HK31 was found to possess a gene encoding the EcoHK31I restriction modification 
system (Lee et al., 1995). M. EcoHK31I consists of two polypeptides a and ß with 
sizes 309 and 176 amino acids respectively. All the conserved motifs in C5-Mtases 
can be found in polypeptide a except motif IX that is present in polypeptide ß (Lee 
et al., 1995). This group reconstituted a functional M. EcoHK311 by fusing 
polypeptides a (all the elements in the structure of C5 Mtases apart from motif IX) 
and (motif IX) together. Polypeptide a and ß were separately synthesized in a T7- 
promoter controlled over-expression system and in vitro methylation occurred only 
when the two extracts were mixed. This experiment confirms that the two 
polypeptides are required for methylation (Lee et al., 1995). 
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Another such variant type, M. AquI is also known to complement for its full 
methylase activity from two partly overlapping ORFs of 248 and 139 codons 
(Karreman and Waard, 1990). 
It has also been established that it is possible to insert genetic material into the gene 
encoding the cytosine-specific DNA methyltransferase M. MspI whilst still retaining 
activity of the gene product (Walter et al., 1992; Matin, 2000). The tolerance of 
M. SPRI to polypeptide insertions has been evaluated and it has been found that the 
variable region of M. SPRI can accommodate an insert of varying lengths (Matin, 
2000). The target recognition domain for MspI, (Mspl TRD), from M. SPRI was 
replaced with a polylinker region. This new plasmid was named pSPR(X) and is 
refractory to HaeIII restriction (Matin, 2000). 
We have also observed during the creation of new restriction sites in the M. SPRI 
gene that when a Kanamycin cassette (approximately 1.25 kb in size) was inserted in 
the variable region, it changed the open reading frame (ORF) of the gene thereby 
splitting the encoded protein into two polypeptides. This might have made the Mtase 
gene inactive, but it did not (data not shown). The plasmid was not cleaved by HaeIII 
because the two encoded polypeptides probably re-assembled to produce an active 
enzyme. Based on these experiments it was hypothesised that two separate 
polypeptides from the N- and C-terminal parts of M. SPRI could produce an active 
enzyme by complementation, if by some means they could be brought close to each 
other. The present work takes this approach a stage further in that it is shown that it 
is possible to "cut" the gene of the multispecific methyltransferase M. SPRI into two 
parts, to fuse each part to a DNA segment coding for a leucine zipper motif, and 
then, on expression of the genes, to produce a fully functional enzyme whose 
structural domains are "held together" by leucine zipper motifs. Therefore the 
M. SPRI enzyme can work as a hetero-dimer, that is to say, the two halves of the 
enzyme can be expressed separately and the two peptides will reconstitute to produce 
methylation activity in vivo. 
6.2.2: CLONING OF TWO FRAGMENT OF THE M. SPRI GENE 
ENCODING THE N- AND C-TERMINAL DOMAINS INTO COMPATIBLE 
PLASMIDS 
In order to develop a co-expression system, an experiment was designed to clone the 
N-terminal and C-terminal encoding fragments of M. SPRI into two compatible 
plasmids, and to express the recombinant proteins to test the above hypothesis. It was 
123 
CHAPTER SIX 
convenient to use pSPR(X) (see above) for cloning the two regions into two 
compatible plasmids owing to the presence of a linker region in the central coding 
region of the gene containing several unique restriction sites. 
In general, unrelated plasmids are compatible because their replication systems are 
different enough for them not to be able to co-exist in E. coll. A compatible partner 
plasmid in the co-expression system requires a different on to prevent segregation 
and ultimate loss of one plasmid in culture (Johnston et al., 2000 and references 
therein). In addition, the other requirements include a different antibiotic resistance 
gene for selection and most importantly, a variety of unique restriction sites that are 
shared with other plasmid for efficient cloning (Johnston et al., 2000). We have 
chosen pACYC184 (Chang and Cohen, 1978) as second vector to be used for co- 
expression. The pSPR(X) / pACYC 184 co-expression vectors were found 
convenient as two vector bacterial co-expression system The plasmid pSPR(X) 
derived from pGEXKG-2T (Guan and Dixon, 1991) originally carry ColEl replicon 
and is fully compatible with those plasmids that carry p15A replicon such as plasmid 
pACYC 184 (MBI Fermentas catalogue, 2000-2001). 
The cloning steps needed to make the system as explained above are as follows. All 
the diagrams pertaining to the sketches and gel pictures for the new constructs are 
placed at the end of the chapter. 
6.2.2.1: Construction of pQIS 84 in which the "linker" is replaced by a sequence 
encoding a leucine zipper 
The aim of this experiment was to insert a leucine zipper region in place of the 
"linker" in M. SPRI encoded by pSPR(X). The leucine zipper chosen for this 
experiment was from the human transcription factor CCAAT/Enhancer Binding 
Protein Alpha (CEBA HUMAN), and has the amino acid sequence shown below 
(also shown in Appendix IV) (Landschulz et al., 1988). For simplicity I will use 
numbering of leucine zipper sequence encoded amino acids starting from first 
leucine as number one and onward as shown with the sequence below. 
A pair of complementary oligodeoxynucleotides, NIS 59 and NIS 60 were 
synthesised to create the appropriately coding DNA duplex. Two restriction sites 
were incorporated into the oligonucleotides to produce Xhol and EcoRI "ends" for 
subsequent cloning in pSPR(X) (shown in bold and red). The oligonucleotides were 
annealed, and the resulting double-stranded DNA duplex was cloned as a XhoI. 
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EcoRI fragment between the XhoI and EcoRI sites in the SPRI polylinker of 
pSPR(X). The cloning of the leucine zipper gene also introduced a unique NruI site 
into the plasmid pSPR(X), and this restriction site was subsequently used to diagnose 
the success of the cloning experiment. The resulting plasmid was named pQIS 84 
and coded for an active form of M. SPRI (Figure 6.3). 
NIS 59/60: Leucine zipper C/EBP duplex oligonucleotide 
Xhol 
5'-TCGAGTTGAC TAGTGACAAT GACCGCCTGC GCAAACGCGT 
3'-CAACTG ATCACTGTTA CTGGCGGACG CGTTTGCGCA 
ELTSDNDRLRKR 
123456789 10 11 
Nrul 
GGAACAGCTG AGTCGCGAAC TGGACACGCT GCGGGGCATC 
CCTTGTCGAC TCAGCGCTTG ACCTGTGCGA CGCCCCGTAG 
VEQLSRELDTLRGI 
12 13 14 15 16 17 18 19 20 21 21 22 23 24 
EcoRl 
TTCCGCCAGC TGG-3' 
AAGGCGGTCG ACCTTAA-5' 
FRQL 
25 26 27 28 
NIS 59: Leucine zipper C/EBP top strand oligo 
Xhol 
5'-TCGAGTTGACTAGTGACAATGACCGCCTGCGCAAACGCGTGGAA 
Nrul 
CAGCTGAGTCGCGAACTGGACACGCTGCGGGGCATCTTCCGCCAGCTGG-3' 
NIS 60: Leucine zipper C/EBP bottom strand oligo 
EcoRI Nrul 
5'-AATTCCAGCTGGCGGAAGATGCCCCGCAGCGTGTCCAGTTCGCGA 
CTCAGCTGTTCCACGCGTTTGCGCAGGCGGTCATTGTCACTAGTCAAC-3' 
6.2.2.2: Construction of pQIS 98 (pMETC-LZ) containing sequences encoding 
for leucine zipper followed by HaeIII TRD and motif IX-X of M. SPRI 
As was mentioned earlier, wild type M. SPRI has a structure that consists of 10 well- 
conserved motifs surrounding a variable region containing the EcoRI1, M. spI and 
Hae1II TRDs (Behrens et al., 1987; Wilke et al., 1988; Posfai et al., 1989: Lauster et 
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al., 1989). The aim of this cloning experiment was to remove the nucleotide 
sequence encoding motifs I to VIII and the EcoRII TRD from the M. SPRI gene in 
pQIS 84. 
The region coding for M. SPRI motifs I to VIII and the EcoRII TRD lies between 
bases 936-1820 in the plasmid pQIS 84, and these were removed from the pQIS 84 
plasmid as a BamHI-Bg1II fragment. (The Bg1II site is present in the "SPR 
polylinker" described above. ) The remaining plasmid, which contained a gene fusion 
consisting of GST, the leucine zipper, the HaeIII TRD and SPRI motifs IX and X, 
was re-circularised by ligation. The resulting plasmid was named pMETC-LZ (pQIS 
98) (Figure 6.3). 
6.2.2.3: Construction of three plasmids (encoding sequences for M. SPRI with 
leucine zipper, wild type M. SPRI and motif I-VIII of M. SPR with leucine 
zipper) in pACYC 184 
The aim of these experiments was to construct three plasmids in pACYC 184 as 
follows. The first one comprised DNA sequence encoding M. SPRI containing an 
insert encoding a leucine zipper, in pACYC 184, equivalent to pQIS 84. The second 
construct contained the sequence of wild type M. SPRI in pACYC184. The third 
construct contained motifs I to VIII, the EcoRII TRD and leucine zipper region 
sequences, in cloning vector pACYC184. 
The construction of these plasmids is described below. For this set of experiments 
the cloning vector pACYC184 was used (Gene bank accession number X06403, 
New England Biolabs (UK) Ltd., Hitchin, Herts). pACYC 184 contains a tetracycline 
resistance gene (bases 1581-2771) which contains within it two unique restriction 
sites, namely BamHI (position 1870) and Nrul (position 2467). It has a pl5A origin 
of replication and is a low copy number plasmid. 
(A) Construction of pQIS 92 containing sequence of M. SPRI with Icucine zipper 
insert sequence in pACYC 184 
pACYC 184 was linearised by a BamHI / NruI double digest and the DNA fragment 
consisting of the central portion of the tetracycline resistance gene (599 bp fragment) 
was discarded. The 3646 bps fragment was recovered from the gel. 
126 
CHAPTER SIX 
Plasmid pQIS 84 (described earlier) was then linearised with a BamHI / Ec11361 
double digest. Ec1136II recognises the site GAGTCTC, and is an isoschizomer of 
Sacl (MBI Fermentas, Amherst NY). This enzyme also generates blunt-ended DNA, 
which can be joined with NruI (also a blunt-end generating restriction enzyme). This 
produced a 1382bp (BamHI / Ec1136I ended) fragment, which was then ligated into 
the BamHI / NruI linearised pACYC 184 plasmid, producing final plasmid pQIS 92 
(containing the M. SPRI I-VIII/EcoRII TRD, leucine zipper region, MspI TRD, motif 
IX-X of M. SPRI) in pACYC 184 (Figure 6.4). The construct pQIS 92 was confirmed 
by restriction analysis with Ncol and EcoRV. There is no site for Ncol in pQIS 84 
and this unique site is present only in the chloramphenicol gene in pACYC 184. 
EcoRV generated fragments from pQIS 92 also match with the expected fragments. 
When tested for in vivo methylation potential by restriction with HaeIII, it was 
revealed that the plasmid was partially protected. This can be partly explained by the 
fact that the Mtase gene is expressed from a plasmid with a p15A origin of 
replication and this has a low copy number, which results in reduced "gene dosage", 
and therefore partial methylation protection is observed. It was decided to check the 
Mcr response by transformation of E. coli strain DH5a. When used to transform E. 
coli strain DH5a, no colonies appeared, thus indicating that the Mtase is still active. 
Therefore, it was also decided to clone wild type M. SPRI sequence in pACYC 184 to 
see if the wild type has similar methylation potential while in a low copy number 
plasmid. This will also remove any doubts concerning the use of M. SPRI which 
carries an insert encoding a leucine zipper (in the TRD region) did not reduce the 
methylation activity. 
(B) Construction of plasmid pQIS 99 encoding wild type M. SPRI sequence in 
pACYC 184 
This experiment was designed to maintain wild type M. SPRI in pACYC 184. The 
construct pQIS 92 (see above) was cleaved with KpnI and MunI and the resulting 
vector (4182 bps) was ligated with the KpnI and MunI cleaved insert (846 bps) 
already cleaved from wild type M. SPRI (construct pQIS 72, see chapter four) and 
recovered from the gel (Figure 6.4). The final construct pQIS 99 now contains a 
complete M. SPRI sequence cloned in pACYC 184. However, when checked with 
MspI and HaeIII, it was found that the enzyme encoded by the plasmid was partially 
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active. It appears that the level of expression of the enzyme was not efficient to 
provide full protection. 
(C) Construction of plasmid pQIS 100 encoding sequences of M. SPRI from 
motif I-VIII (N-Terminal fragment) and leucine zipper in pACYC 184 
Using a BamHI / StuI double digest the genes coding for the SPRI motifs I-VIII, the 
EcoRII TRD region and the sequence encoding for leucine zipper (see above) were 
cut from plasmid pQIS 92 to give a 1009 bp DNA fragment. The pACYC 184 
plasmid was again linearised with a BamHI / Nrul double digest and the DNA 
fragment consisting of the central portion of the tetracycline resistance gene 
discarded (597 bp fragment). The 1009 bp BamHI / StuI ended fragment was then 
ligated into BamHI / Nrul linearised pACYC 184 (3646 bps), producing plasmid 
pQIS 100. The construct was confirmed by restriction analysis with KpnI. The 
plasmid pACYC 184 does not contain a KpnI site but the recombinant plasmid pQIS 
100 does. Another double digestion with BamHI and Xhol also confirmed the 
presence of the correct insert (Figure 6.5). 
6.2.2.4: Construction of pQIS 101 by the deletion of the EcoRI restriction site 
from pQIS 100 
Since it was intended that experiments would be carried out in which the sequence 
encoding leucine zipper in pQIS 100 would be replaced by other sequences (such as 
mutant leucine zippers, see below), and since the leucine zipper coding sequence was 
cloned as an EcoRI-XhoI fragment, it was necessary to remove a second EcoRI site 
from within the chloramphenicol resistance gene in the plasmid. (The second EcoRI 
site is at position 1 in both the pACYC184 and pQIS 100 plasmids. ) To do so, a pair 
of complementary oligodeoxynucleotides NIS 63 and NIS 64 (35bp) were 
synthesised which removed the EcoRI restriction site, using the Quick-change 
method (Stratagene). 
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EcoRI 
Wild type sequence: 5' -CTTTCATTGCCATACGGAATTCCGGATGAGCATTC-3' 
NIS 63: 5'-CTTTCATTGCCATACGAAATTCCGGATGAGCATTC-3' 
NIS 64: 5'-GAATGCTCATCCGGAATTTCGTATGGCAATGAAAG-3' 
This was a silent mutagenesis and the sequence of amino acid residues was not 
changed by this mutation. In fact, the chloramphenicol gene is in a complementary 
direction and the change in codon from TTC to TTT did not alter the phenylalanine 
residue as shown (see primer NIS 64 with mutation shown in red). The resulting 
plasmid was named pQIS 101. The digestion of the plasmid with EcoRl makes it 
linear. The construct was further confirmed by restriction digestion with various 
enzymes as shown in Figure 6.6. 
6.2.2.5: Introduction of another ATG (start codon) after the BamIII site in 
pMETN-LZ (pQIS 101) 
Originally the M. SPRI gene had been cloned as a GST fusion. The N-terminal 
sequence of M. SPRI containing motifs I-VIII and the EcoRII TRD region were 
cloned into pACYC 184 as a BamHI / Stul fragment, without the GST open reading 
frame. During this cloning experiment the open reading frame of M. SPRI was lost 
and the nearest ATG start codon was at base pair position 1894 instead of base pair 
number 1870 in all constructs made in pACYC 184. The original and the new 
sequence of amino acids are aligned and shown below. 
Original sequence in wild type M. SPR: MGKLRVMSLFSGIGA 
Present sequence after cloning in pACYC 184: MSLFSGIGA 
It was decided to introduce another start codon ATG at the correct position so that a 
complete sequence of M. SPRI at the N-terminal region would be translated. A 
forward primer NIS 77 was designed to amplify a segment of the M. SPRI gene with 
a start codon corresponding to the position of the first methionine. In addition to the 
BamHI site another site for NcoI was introduced for diagnostic purposes. The new 
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start codon ATG is shown in red whereas the original ORF is shown blue. The 
reverse primer MS 73 starts from the EcoRI site within the leucine zipper-coding 
region. The sequences of the primers are as shown below with the restriction sites 
shown in bold. 
Sequence of oligonucleotides used for introduction of a start codon in constructs 
in pACYC 184 
BamHI /NcoI 
NIS 77: 5' -GCGCGGATCCATGGGTAAACTACGTGTAATG-3' 
RGSMGKLRVM 
EcoRI 
NIS 73: 5' -GCGCGAATTCCAGCTGGCGGAAGATGC-3' 
Using pQIS 101 as a template and primers NIS 77 and NIS 73 a PCR experiment 
was carried out (using Pfu polymerase) to generate a 999 bp fragment. The PCR 
product was recovered from the gel and restriction digested with BamHI and EcoRI 
to create sticky ends. The vector DNA was also prepared by cleavage of pQIS 101 
with BamIR and EcoRI and recovered from the gel. Both the vector and insert DNA 
were ligated to produce a final construct pMETN-LZ (pQIS 101-N). The construct 
pMETN-LZ was confirmed by restriction analysis with NcoI (Figure 6.7). 
6.2.3: IN VIVO COMPLEMENTATION OF N. AND C-TERMINAL 
FRAGMENTS OF M. SPRI 
The two constructs pMETC-LZ and pMETN-LZ were used (in equimolar 
concentrations) to co-transform competent cells of the Mcr+ strain of E. coli D115a, 
and were plated on media supplemented with ampicillin and chloramphenicol. The 
same cells were also plated out on single antibiotic plates containing either ampicillin 
or chloramphenicol to determine the transformation efficiency of the cells for 
individual constructs. A control experiment was also carried out in parallel using a 
construct (p19nh) containing the C-terminal fragment of M. SPRI without any leucine 
zipper coding sequence attached at the end of the gene. In each experiment the 
competent DH5acells gave a transformation efficiency of 2107 per pg of 
pLITMUS28 DNA. 
In this experiment M. SPRI was expressed from two plasmids by expressing the gene 
encoding 'motifs I-VIII from one plasmid and that encoding motifs IX-X from 
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another compatible plasmid. The genes coding for either the N-terminal or for the C- 
terminal regions of M. SPRI were fused with the gene encoding the dimerisation 
domain of leucine zipper. This enabled both motifs, after their expression in E. coli, 
to drive dimerisation of the expressed polypeptide, thereby forming an active Mtase. 
Co-transformation of pMETC-LZ and pMETN-LZ resulted in the formation of no 
colonies on double antibiotic plates (see Table below and Figure 6.8). However, in a 
control experiment where one plasmid did not contain the leucine zipper region, 
there was no observable dimerisation and therefore many colonies were formed on 
the double antibiotic plate. A proposed model for the in vivo complementation of 
Mtase M. SPRI is shown in Figure 6.9. 
Bait (pMETN based Prey (pMETC Observation 
plasmi based plasmid) 
1 pQIS 100 (pMETN-LZ) pQIS 98 Active Mtase (No colonies on 
(METC-LZ Amp+Cm plate) 
2 pQIS 101N (pMETN- pQIS 98 Active Mtase (No colonies on 
LZ, with corrected start (pMETC-LZ) Amp+Cm plate) 
codon) 
3 pQIS LOIN (pMETN- p19nh (pMETC, Inactive Mtase (Many colonies 
LZ, with corrected start no leucine zipper) on Amp+Cm plate, approx. 
codon) 800-1000 
Aller the initial success of the above complementation experiment involving the N- 
and C-terminal fragments of M. SPRI in vivo I set out to design a robust prokaryotic 
two-hybrid system. 
The first problem to consider is that the interaction of the two halves of the Mtase 
enzyme leads to the formation of no transformants and therefore the system should 
be considered as a reverse two-hybrid system. It was also necessary to establish 
whether the abolition of the leucine zipper interaction did competitively abolish 
M. SPRI activity. 
Finally, experiments are described to address whether a selection of known 
interacting proteins can also bring the two peptides of Mtase M. SPRI close enough to 
make the enzyme active. 
6.2.4: CONSTRUCTION OF PLASMIDS CONTAINING SEQUENCES FOR 
YEAST INTERACTING PROTEINS MLC1P AND IQGAP 
It is known that budding yeast IQGAP-like protein, Cykl/Igg1p, has multiple roles in 
the assembly and contraction of the actomysin ring. Shannon and Li (2000) have 
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Figure 6.8: Results from the E. coli assay after co-transformation of pMETC-LZ and pMETN-LL. 
Agar media plates supplemented with (Al) Ampicillin and Chloramphenicol (A2) Chloramphenicol and 
(A3) Ampicillin. These experiments show the results of plasmid co-transformation into a nu"r+ mcthylation- 
intolerant DH5a E. coli strain. A lack of bacterial colonies in plate Al indicates that M. SPR-mediated 
methylation of the plasmid has occurred. The presence of colonies on plate A2 indicates that the cells 
harbour pMETN-LZ. The cells which acquired plasmid pMETC-LZ alone appear on plate A3. 
2 
GST C 
" 
METC-LZ 
e zipper restores 
e function by bringing 
peptides together. 
Figure 6.9: A proposed model of the leucine zipper mediated assembly of an active M. SPRI 
from METC-LZ and METN-LZ. When plasmid pMETN-LZ (containing sequence of block I-VIII 
of M. SPRI fused with Leucine zipper) and plasmid pMETC-LZ (containing sequence of Leucine 
zipper and block IX-X of SPR) are co-transformed, an active methyltransferase can be identified by 
an mcr+ host response, in the form of no colonies, on plates containing Ampicillin and 
Chloramphenicol (see figure 6.8). 
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shown that Mlc 1p binds with the IQ motifs of Cyk l /Iggp 1 and have presented 
evidence that this interaction recruits Cyk 1 /Iqg lp to the bud neck. They 
demonstrated that Mlc 1p is important for the assembly of the actomysin ring in 
budding yeast and that this function is mediated through interaction with 
Cyk l /Iqg l p. Boyne et al. (2000) have also reported that Mlc 1 functions to recruit 
Iqg Ip and in turn actin to the actomyosin ring and that it is also required for Myo 1p 
function during ring contraction. An experiment was designed to test the interaction 
of these two proteins i. e. N-terminal fragment of Iqg 1p and Mlc I by using the Mtase 
two-hybrid system. 
6.2.4.1: Construction of pQIS 103 containing the ORF of Mid in pMETN-LZ 
by replacing the leucine zipper containing sequence 
For the amplification of the Mlc 1 gene sequence, two oligodeoxynucleotides QY I 
and QY 2 were synthesized. The forward primer QY I containing a XhoI site 
whereas the reverse primer QY 2 contained an EcoRI site (shown below) in order to 
facilitate the subsequent cloning of the gene in pMETN-LZ plasmid. 
QY 1 and QY 2: Forward and reverse primer for Amplification of Micl gene 
Xhol 
QY1: 5'-GGCCCTCGAGATGTCAGCCACCAGAGCCAATAAAG-3' 
EcoRI 
QY2: 5'-GGCCGAATTCTCATTGTCTCAAAACATCTCGATGAACTTC-3' 
The Mlcl gene sequence, known to contain 450 bp was amplified from yeast 
genomic DNA (a kind gift from Dr. Clive Price). The amplified PCR product (450 
bps) was cleaved with Xhol and EcoRI (to generate sticky ends) before ligation with 
pMETN-LZ that was precut (for excision of the leucine zipper coding sequence) and 
gel purified with the same enzymes. The final construct that contained Mlc 1 gene 
was confirmed by restriction analysis. There is no StuI site in the parent plasmid: but 
this site is present in the Mlclgene. Following Stul digestion a linear DNA molecule 
confirmed the presence of the inserted sequence. Xhol and EcoRI digestion of the 
construct pQIS 103 also resulted in excision of a 450 bp fragment, which confirmed 
insertion of the Me 1 gene (Figure 6.10). 
132 
ATGGCTGATCAACTGACAGAAGAGGAGATTGCAGAGTTCAAAGAGGCTTTTTCT 
MADQLTEEEIAEFKEAFS 
CTGTTTGACAAGGATGGTGATGGTACCATCACTACAAAGGAGTTGGGTACTGTGATGCGT 
LFDKDGDGTITTKELGTVMR 
TCTCTTGGTCAGAACCCGACAGAAGCAGAATTACAGGACATGATCAACGAAGTCGACGCT 
SLGQNPTEAELQDMINEVDA 
GATGGCAACGGCACAATTGACTTCCCAGAGTTTCTGACAATGATGGCGCGCAAAATGAAA 
DGNGTIDFPEFLTMMARKMK 
GATACAGATAGCGAAGAAATTCGTGAAGCGTTCCGTGTGTTTGACAAGGATGGTAACGGT 
DTDSEEIREAFRVFDKDGNG 
TACATTTCTGCTGCAGAACTTCGTCATGTGATGACAAACCTTGGTGAGAAGCTGACAGAT 
YISAAELRHVMTNLGEKLTD 
GAAGAAGTTGATATGATTCGTGAAGCAGACATCGATGGTGATGGTCAAGTAAACTATGAA 
EEVDMIREADIDGDGQVNYE 
GAGTTTGTACAGATGATGACAGCGAAGTAA 
EFVQMMTAK STOP 
Figure 6.12: DNA and amino acid sequence of human calmodulin. 
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6.2.4.2: Construction of pQIS 104 containing the ORF of Iqglp in pMETC-LZ 
by replacing the sequence encoding a leucine zipper 
The Iqg lp gene sequence was also amplified by PCR using two 
oligodeoxynucleotides QY 3 and QY 4. The forward primer QY 3 containing a Xhol 
site whereas the reverse primer QY 4 contained an EcoRI site (shown below) in 
order to facilitate the subsequent cloning of the gene in pMETC-LZ plasmid. 
QY 3 and QY 4: Forward and reverse primer for amplification of IqgI gene 
Xhol 
QY 3: 5'-GGCCCTCGAGGGATCCATGACAGCATATTCAGGCTCT-3' 
EcoRI 
QY 4: 5'-GGCCGAATTCGTCGACTTCTGGCTCTTTCAAATACAGC-3' 
The 2.5 kb N-terminal fragment of Iqg lp gene was amplified from yeast genomic 
DNA (Figure 6.11). However, when digested with XhoI and EcoRl to mobilise the 
PCR product, the presence of an internal EcoRI site was observed: two fragments of 
1.5 and 1.0 kb approximately were produced. I therefore cloned the two fragments 
sequentially. In the first step the 1.5 kB XhoI/EcoRI fragment was cloned into 
pMETC-LZ by replacing the leucine zipper coding sequence and the product was 
identified by restriction analysis. The 1.0 kB EcoRl fragment was then inserted into 
pQIS 102 to produce pQIS 104 as shown in Figure 6.11. The correct orientation of 1 
kb fragment was confirmed by restriction digestion by restriction digestion with 
BamHI and Sall: digestion with EcoRI and Xhol confirmed this conclusion. 
6.2.4.3: In vivo complementation of N- and C-terminal fragments of M. SPRI 
The two constructs pQIS 103 and pQIS 104 were used (in equimolar concentrations) 
to co-transform competent cells of E. coli DH5a. No complementation was 
observed: there were many colonies on double antibiotic plates. 
6.2.5: CONSTRUCTION OF PLASMIDS ENCODING CALMODULIN AND 
CALMODULING BINDING PROTEINS 
Calcium is a well-established second messenger (Corcoran and Means, 2001). The 
calcium receptor calmodulin (CaM) is involved in many changes through its effects 
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on a variety of CaM-binding proteins. Among these, the multifunctional Ca 2+ / 
calmodulin-dependent kinases (CaMKs) are notable for their effects on components 
of transcription complexes, directly connecting Ca2+ with changes in gene expression 
(Corcoran and Means, 2001). 
The crystal structure of calmodulin complexed with a calmodulin-binding peptide (a 
synthetic peptide based on the Gallus gallus (chicken) (KMLS_CHICK/P l 1799 in 
Swiss-Prot)) from Smooth Muscle Myosin Light Chain Kinase (smMLCK) is 
available (PDB code lcdl)(Meador et al., 1992). The calmodulin cDNA sequence 
and primary structure are shown in Figure 6.12. The structure of a 
calmodulin: peptide complex is presented in Figure 6.13. 
The aim of this cloning experiment was to insert the human calmodulin gene (as bait) 
in place of the leucine zipper in pMETC-LZ, and a potential calmodulin-binding 
region (RS20) of chicken myosin light-chain kinase (MLCK) gene (as prey) in place 
of the leucine zipper in pMETN-LZ. Co-transformation was subsequently used to 
test whether the two proteins could promote assembly of the separate N- and C- 
termini of M. SPRI to create an active Mtase enzyme response. 
6.2.5.1: Construction of pQIS 113 containing the ORF of calmodulin binding 
peptide in pMETN-LZ by replacing the leucine zipper ORF 
A pair of complementary oligodeoxynucleotides, NIS 71 and NIS 72 (85 bps) were 
synthesised to create the calmodulin-binding peptide RS20 coding sequence. The 
sequence of the oligonucleotide with the amino acid sequence of the corresponding 
peptide is shown below. Four extra amino acids towards the N-terminus and two 
extra amino acids towards the C-terminus from the original sequence were added in 
order to facilitate the formation of the helix of calmodulin binding polypeptide by 
providing a short linker for fusion with Mtase N- or C-terminus fragments. The Xhol 
and EcoRI restriction sites for cloning into pMETN-LZ are shown in red. A 
restriction site for Ncol was added for diagnostic purposes without changing the 
amino acid codon and is shown in bold. 
134 
Figure 6.13: Calmodulin (CaM) complexed with a synthetic peptide from smooth muscle Myosin 
Light Chain Kinase (MLCK) (PDB code lcdl). The CaM domain is shown in red and blue. ('a'' 
ions are shown as white spheres whereas the smMLCK CaM binding peptide is shown in yellow. 
Hydrophobic residues of smMLCK which bind into the CaM binding pocket are shown in wire frame. 
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NIS 71 / NIS 72 duplex oligodeoxynucleotides: 
Xhol 
5'-TCGAGAAATATATGGCCAGAAGAAAATGGCAGAAAACAGGCCATGCTGTCCGAGCA 
3'-CTTTATATACCGGTCTTCTTTTACCGTCTTTTGTCCGGTACGACAGGCTCGT 
EKYMARRKWQKTGHAVRA 
Ncol EcoRI 
ATAGGAAGACTGTCATCCATGGCAATGG-3' 
TATCCTTCTGACAGTAGGTACCGTTACCTTAA-5' 
IGRLSSMAM 
NIS 71: 
5'-TCGAGAAATATATGGCCAGAAGAAAATGGCAGAAAACAGGCCATGCTGTCCGAGCA 
ATAGGAAGACTGTCATCCATGGCAATGG-3' 
NIS 72: 
5'-AATTCCATTGCCATGGATGACAGTCTTCCTATTGCTCGGACAGCATGGCCTGTTTTC 
TGCCATTTTCTTCTGGCCATATATTTC-3' 
The oliogonucleotides NIS 71 and NIS 72 were annealed to give an 85 bp duplex 
fragment with XhoI and EcoRI ends, and this was ligated into pMETN-LZ. which 
had already been cleaved with XhoI and EcoRI to allow the replacement of the 
leucine zipper open reading frame. The identity of pQIS 113 was confirmed by 
restriction digestion with Ncol. The duplex oligonucleotide contained two Ncol sites 
whereas the plasmid pMETN-LZ contained one Ncol site. The resulting fragments 
were of an expected size (Figure 6.14). 
6.2.5.2: Construction of pQIS 114R containing sequence of calmodulin in 
pMETC-LZ by replacing sequence of leucine zipper 
The Calmodulin gene was obtained from Prof. John Waltho (University of 
Sheffield). For the amplification of calmodulin gene, a pair of complementary 
oligodeoxynucleotides NIS 74 and NIS 76 were synthesized, which carry Xhol and 
EcoRI sites for subsequent cloning in pMETN-LZ or pMETC-LZ plasmids (shown 
below). 
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NIS 74 and NIS 76 Forward and reverse primers for amplification of calmodulin 
Xhol Bcll 
NIS74: 5'-GCGCCTCGAGATGGCTGATCAACTGACAGAAGAG-3' 
EcoRI 
NIS76: 5'-GCGCGAATTCCTTCGCTGTCATCATCTGTACAAAC-3' 
NIS 74 and NIS 76 (34 and 35bp) were used to amplify the gene from a plasmid 
containing a calmodulin gene. The PCR product (Figure 6.15) was purified and 
cleaved with Xhol and EcoRJ to generate sticky ends. This gave a 447 bp fragment, 
which was then ligated into pMETC-LZ (Figure 6.15). The final product pQIS 114R 
now carried an insert of approximately 450 bps in size and this was confirmed by 
restriction digestion with Xhol and EcoRI (Figure 6.15). 
6.2.5.3: In vivo Complementation of the N- and C-terminal fragments of 
M. SPRI fused to calmodulin and a calmodulin recognising peptide 
The next step after construction of the two plasmids that carried (a) calmodulin and 
(b) calmodulin binding peptide fused to the N- and C-terminus fragments of M. SPRI 
respectively, was to express them in vivo in E. coli DH5a. Therefore the two 
plasmids were used in equimolar amounts to co-transform E. coli DH5a. However, 
on an antibiotic plate containing ampicillin and chloramphenicol growth of colonies 
were observed. This indicated that in vivo complementation of M. SPRI had not taken 
place. The observations recorded were as follows. 
S. No Bait (pMETN based 
plasmid) 
Prey (pMETC based 
plasmid) 
Observation 
1 pQIS 113 (CaM peptide) pQIS 114R (CaM) Inactive Mtase (Many 
colonies on Amp+Cm 
plate) 
2 pQIS 113 (CaM peptide) pQIS 98 (pMETC-LZ) Inactive Mtase (Many 
colonies on Amp +Cm 
late 
A negative control experiment was performed in parallel using pQIS 98 (carrying 
sequences encoding a leucine zipper and motif IX-X of M. SPRI) and pQIS 113 
(carrying sequences encoding motif I-VIII of M. SPRI and a calmodulin binding 
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peptide). The length of the sequence encoding leucine zipper (93 bps) is almost 
equivalent as that of calmodulin peptide (85 bps). The idea was to examine the two 
fusion protein having similar molecular weight but without any known interactions 
as negative control. The result of this co-transformation was as expected: 
complementation was not observed and consequently many colonies were obtained 
on double antibiotic plates. 
In order to establish whether Ca +2 ions are required for binding of peptide with 
calmodulin, another experiment was carried out by growing colonies picked from a 
double antibiotic plate in a5 ml culture containing ampicillin and chloramphenicol in 
the presence of varying amount of CaC12. Four colonies picked from double 
antibiotic plates were transferred into four tubes containing 5 ml LB, ampicillin. 
chloramphenicol and CaC12 with 1 mM, 5 mM, 10 mM and 0.0 mM in each tube. 
The cells were grown for 6-8 hours to observe any difference in growth. There was 
no significant difference in growth in all four cultures. Miniprep DNA prepared from 
the culture was cleaved with Xhol to linearize the plasmid before analysis on agarose 
gel, and this showed that both plasmids were present in the culture. In another 
experiment, co-transformation was carried out and the cells were plated onto agar 
media plates containing 1 mM CaC12. The appearance of colonies on a double 
antibiotic plate confirmed that the proteins encoded by the two plasmids did not 
complement in vivo and the presence of calcium had no effect. 
6.2.6: ANALYSIS OF THE ASSEMBLY OF M. SPRI DRIVEN BY MUTANT 
LEUCINE ZIPPERS 
In order to investigate the role of long amino acid side chains on the ability of 
leucine zipper peptides to interact, two experiments were carried out. 
1. The conserved Asparagine at position 5 was substituted by Lysine 
2. The conserved Leucine at position 8 was substituted by Proline 
6.2.6.1: Construction of pQIS 115 containing a mutant (Asn 5 Lys) leucine 
zipper motif in pMETN-LZ 
Complementary oligodeoxynucleotides, NIS 80 and NIS 81 were used to introduce a 
site-directed change (Asn 5 Lys) into the leucine zipper ORF in pMETN-LZ using 
the Quick-Change method (Stratagene). One base pair change from AAT to AAA 
changed the Asn codon to that specifying Lys. A new C lal restriction site was also 
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introduced in order to facilitate screening for the mutant. The presence of this C1aI 
site does not alter the final amino acid sequence. The sequences of oligonucleotides 
are shown below, with the new restriction site shown in boldface and the mutation in 
red. 
NIS 80 / NIS 81 duplex oligonucleotide: 
CIaI 
5'-GTTGACTAGTGACAAAGATCGATTGCGCAAACGCGTGG-3' 
3'-CAACTGATCACTGTTTCTAGCTAACGCGTTTGCGCACC-5' 
LTSDKDRLRKRV 
CIaI 
NIS80: 5'-GTTGACTAGTGACAAAGATCGATTGCGCAAACGCGTGG-3' 
Clal 
NIS81: 5'-CCACGCGTTTGCGCAATCGATCTTTGTCACTAGTCAAC-3' 
The resulting construct was named pQIS 115 and encoded the N-terminus of M. SPRI 
fused to the Asn 5 Lys mutant leucine zipper. Colonies were screened for plasmids 
containing an additional Clal site (Figure 6.16). 
6.2.6.2: Construction of pQIS 116 encoding the Leu 8 Pro mutant leucine zipper 
Complementary oligodeoxynucleotides NIS 82 and NIS 83 (36 bp) were used to 
introduce site-directed changes into pMETN-LZ using the Quick-Change method 
(Stratagene). The sequence of primers is shown below with a single base mutation 
from CTG to CCG (to change leucine into proline) and another silent mutation (CGC 
to CG(: ) to generate the SacII restriction site. 
NIS 82 / NIS 83 duplex oligonucleotide: 
SacII 
5'-AGTGACAATGACCGCCCGCGGAAACGCGTGGAACAG-3' 
3'-TCACTGTTACTGGCGGGCGCCTTTGCGCACCTTGTC-5' 
SDNDRPRKRVEQ 
SacII 
NIS 82: 5'-AGTGACAATGACCGCCCGCGGAAACGCGTGGAACAG-3' 
Sac! I 
NIS83: 5'-CTGTTCCACGCGTTTCCGCGGGCGGTCATTGTCACT-3' 
139 
CHAPTER SIX 
The resulting plasmids were screened by restriction digestion. The oligonucleotides 
used for mutagenesis for Leu 8 Pro contained a SacII site to be used for diagnostic 
purposes. pMETN-LZ already contained one SacII site whereas the final construct 
(pQIS 116) now contained two SacII sites. The cleavage pattern obtained by a 
restriction digest analysis of the new construct pQIS 116 confirmed the presence of 
mutation (Figure 6.17). 
6.2.6.3: Construction of pQIS 117 containing sequence encoding the Leu 8 Pro 
leucine zipper mutant 
The mutagenic complementary oligodeoxynucleotides NIS 82 and NIS 83 (36 bp) 
synthesized earlier (see above) were used to carry out the site-directed change of 
leucine to proline in pMETC-LZ using the Quick-Change method (Stratagene). The 
new construct pQIS 117 also attained a unique SacII site that was not present in its 
parent plasmid pMETC-LZ (Figure 6.18). 
6.2.6.4: In vivo Complementation of N- and C-terminal fragments of M. SPRI 
using a mutated leucine zipper motif 
The next experiment after construction of the three mutant plasmids pQIS 115 
(pMETN-LZ Asn 5 Lys), pQIS 116 (pMETN-LZ-Leu 8 Pro), and pQIS 117 
(pMETC-LZ Leu 8 Pro) was one to test in vivo complementation. Co-transformation 
was carried out in different combinations to measure the Mcr response. The results of 
these experiments are shown in the table below. 
S. No Bait (pMETN based Prey (pMETC based Observation 
plasmid) lasmid 
1 pQIS 115 (Mn 5 Lys pQIS 98 (pMETC-LZ) Active Mtasc (No 
mutant) colonies on Amp+Cm 
plate) 
2 pQIS 116 (Leu 8 Pro pQIS 98 (pMETC-LZ) Active Mtase (No 
mutant) colonies on Amp+Cm 
plate) 
3 pQIS LOIN (pMETN-LZ) pQIS 117 (Leu 8 Pro Active Mtase (No 
mutant) colonies on Amp+Cm 
plate) 
4- pQIS 116 (Leu 8 Pro pQIS 117 (Leu 8 Pro Active Mtase (No 
mutant) mutant) colonies on Amp+Cm 
late 
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The set of results from the co-transformation experiments (see table above) 
demonstrated that the complementation of N- and C-terminal fragments in vivo led to 
the formation of an active methyltransferase. As a result there were no colonies on 
double antibiotic plates. When the results from another two co-transformations 
experiments were obtained it was confirmed that the Leu 8 Pro mutant had not lost 
the ability to promote assembly of an active Mtase. A fourth co-transformation 
experiment also gave the same result. 
Mutational analysis of leucine zippers have shown that alteration of one of the 
leucine residues in the zipper motif is generally tolerated except when it is replaced 
by a proline, which introduces a kink into the a-helix, or by a charged amino acid, 
which disrupts the hydrophobic spine (Kouzarides and Ziff, 1988; Gentz et al., 
1989). It has also been reported that the simultaneous substitution of leucines at 
either the amino- or the carboxy terminus of both the Fos and Jun leucine zippers has 
a less deleterious effect than the substitution of leucines at the amino terminus of one 
and the carboxy terminus of the other zipper (Gentz et al., 1989). According to the 
results of Schuermann et al. (1989) it appears that all of the five leucines participate 
in the interaction with Jun, but that the different leucine residues have different 
functional importance. We have mutated the second leucine in the series (from N- 
terminal) and it could be argued that the resulting successful complementation is due 
to the compensation of the mutation by the adjacent leucine residues. It is also 
probably true that the mutation did not prevent the two N- and C- terminal fragments 
interacting to make an active Mtase. In other words the sensitivity of the experiment 
is probably good enough to be used for other experiments. However, it was necessary 
to measure the level of association of the leucine zipper motifs by measuring the 
methylation potential of the resulting Mtase. 
We decided to carry out in vivo methylation assays by growing two plasmids in mcr 
cells and then digestion with HaeIII followed by agarose gel analysis and analysis by 
WaveTM. This has been described in section 6.3. 
6.2.7: CONSTRUCTION OF PLASMIDS CONTAINING SEQUENCES FOR 
WBP1 AND OST! 
It was decided to carry out another experiment using a pair of known interacting 
yeast protein (WBPI and OSTI). Yeast genomic DNA was obtained from Dr. Clive 
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Price (University of Sheffield). The WBP1 and OST1 sequences were amplified 
from genomic DNA using PCR. 
6.2.7.1: Construction of pQIS 118 containing sequence encoding for WBP1 
For the amplification of the WBP1 gene, two oligodeoxynucleotides NIS 86 and NIS 
87 were synthesized. The forward primer NIS 86 containing a Xhol site whereas the 
reverse primer NIS 87 contained a MfeI site (shown below) in order to allow the 
subsequent cloning of the gene in pMETC-LZ plasmids. MfeI is an isoschizomer of 
MunI and the site generated by this enzyme is compatible for ligation with DNA cut 
with EcoRI. This was essential as the sequence of WBP1 carried an internal EcoRI 
site. The WBP1 sequence is estimated to be 1293 bps. The sequence of amino acids 
of WBP1 is shown in Appendix IV. 
NIS 86 and NIS 87 Forward and reverse primers for the amplification of WBP1 
Xhol 
NIS 86: 5'-GCGCCTCGAGATGCGGACCGATTGGAATTT-3' 
Mfel 
NIS87: 5'-GCGCCAATTGGTTTGTTTTTTTGAATGTTT-3' 
Pfu polymerase was used for the amplification of DNA sequence from yeast genomic 
DNA and the size of WBP1 PCR product was checked by running an aliquot on an 
agarose gel. The PCR product was purified by passing through a Mobispin column 
and was then subjected to restriction analysis using Xhol and Munl. The resulting 
DNA was heated at 65°C for 20 minutes before ligation to the vector pMETC-LZ 
that had been precut with XhoI and EcoRI. The colonies appearing as a result of 
transformation to E. coli were screened for the correct insertion of the 1293 bp DNA 
fragment with various restriction enzymes such as XhoI/EcoRI, Bam!! I, 
XhoI/Ec1I136 and Xbal and shown in Figure 6.19. 
XhoIlEcoRl should generate a 1032 bp fragment because WBPI has been cloned as a 
Xhol/Mural fragment and therefore the original EcoRI site was lost. The resulting 
fragment is shorter because of the presence of the internal EcoRI site. A restriction 
digestion analysis also confirmed the presence of the correct insert (Figure 6.19). 
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6.2.7.2: Construction of pQIS 119 containing sequence encoding for OST1 
OST1/YJL002C gene sequence was amplified by using two oligodeoxynucleotides 
NIS 84 and MS 85 (shown below). The forward primer NIS 84 contained Xhol site 
and reverse primer contained an EcoRI sites in order to allow subsequent cloning in 
pMETN-LZ. The sequence of OST1 was estimated to be 1431 bps. The sequence of 
amino acids for OST1 is shown in Appendix IV. 
NIS 84 and NIS 85 Forward and reverse primers for the amplification of OST! 
Xhol 
NI584: 5'-GCGCCTCGAGATGAGGCAGGTTTGGTTCTC-3' 
EcoRI 
NIS85: 5'-GCGCGAATTCTCAGTTAGTTACGTTCATGT-3' 
Pfu polymerase was used for the amplification of DNA sequence from yeast genomic 
DNA and the size of the OST1 PCR product was checked by running an aliquot on 
an agarose gel. The PCR product was purified by passing through a Mobispin 
column and was then cut with Xhol and MunI. The resulting DNA was heated at 
65°C for 20 minutes before ligation to the vector pMETC-LZ that had been precut 
with Xhol. The colonies appearing as a result of transformation were screened for the 
correct insertion of 1431 bp DNA fragment. Restriction analysis with Muni, 
KpnI/Munl, BamHl/EcoRI, Xhol/EcoRI confirmed the presence of correct insert 
(Figure 6.20). 
6.2.7.3: In vivo Complementation of N- and C-terminal fragments of M. SPRI 
with WBP1 and OST1 
After construction of these two plasmids they were tested for complementation as 
before. 
S. No Bait (pMETN based Prey (pMETC based Observation 
plasmid) plasmid) 
1 pQIS 119 (OST1) pQIS 118 (WBP1) Inactive Mtase (Many 
colonies on Amp+Cm 
late 
The summary of all constructs made so far and the results of co-transformation are 
presented in Table 6.1. 
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Table 6.1 Summary of transformation experiments based on mcr response (for 
the complementation of N- and C-terminal fragments in bacterial two-hybrid 
system). The transformation efficiency of E. coli DH5a mcr+ was always X107 or 
>107. 
Bait (pMETN Prey (pMETC Observation 
based plasmid) based plasmid) 
1 pQIS WIN pQIS 98 (pMETC- Active Mtase (No colonies on 
(pMETN-LZ) LZ) Amp + Cm plate) 
2 pQIS LOIN p19nh (Motif IX-X Inactive Mtase (Many colonies 
(pMETN-LZ) without LZ) on Amp + Cm plate) 
3 pQIS 113 pQIS 98 Inactive Mtase (Many colonies 
(CaM peptide) (pMETC-LZ) on Amp + Cm plate) 
4 pQIS 104 pQIS 103 Inactive Mtase (Many colonies 
(yeast gene) (yeast gene) on Amp + Cm plate) 
5 pQIS 113 pQIS 114R Inactive Mtase (Many colonies 
(CaM peptide) (CaM) on Amp + Cm plate) 
6 pQIS 115 pQIS 98 Active Mtase (No colonies on 
(Asn 5 Lys mutant) (pMETC-LZ) Amp + Cm plate) 
7 pQIS 116 pQIS 117 Active Mtase (No colonies on 
(Leu 8 Pro mutant) (Leu 8 Pro mutant) Amp + Cm plate) 
8 pQIS 119 pQIS 118 Inactive Mtase (Many colonies 
(OST! ) (WBP1) on Amp + Cm plate) 
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6.3: Comparison of Methylation potential by three different methods 
So far the bacterial two-hybrid hypothesis has been tested by co-transformation and 
sequential transformation in parallel and the observations were recorded in the form 
of presence or absence of bacterial colonies. Sequential transformation was carried 
out for each combination as shown in the summary Table 6.1. In sequential 
transformations the bacteria carrying one plasmid were made competent to accept 
another plasmid. In this study, to keep the experiment procedures constant, we have 
always first transformed bacteria with a low copy number plasmid i. e. originating 
from pACYC 184 (pMETN-series plasmids). Then the second plasmid was used to 
transform bacteria and the results were recorded as active or inactive due to the Mcr 
response of Escherichia coli DHSa. However, to find out more regarding the level of 
interactions in leucine zippers or interacting proteins, it was decided to carry out in 
vivo methylation protection assays (as described in Chapter Two). Escherichla cola 
DH5a mcr harbouring plasmids for analysis were grown on plates supplemented 
with two antibiotics i. e. ampicillin and chloramphenicol. The DNA was extracted, 
purified and the identity of both plasmids was confirmed by restriction analysis with 
EcoRI or XhoI, after which the DNA was cut with HaellI in order to analyse its 
methylation status. An aliquot of reaction mixture (10 µl) for each restriction 
digestion was analysed on agarose gels (Figure 6.21). The remaining 10 pl of the 
reaction mixture was used for the analysis by DHPLC. 
The result of the restriction protection assay for all the two-hybrid plasmids, analysed 
on an agarose gel are shown in Figure 6.21. The DHPLC analysis after restriction 
with` HaelII for all two-hybrid plasmids was also analysed and the resulting 
chromatograms are shown in Figure 6.22. The summary for the two-hybrid 
experiment compared by three different means is presented in Table 6.2. A visual 
rating of (+ and -) (active and inactive respectively) was provisionally assigned to 
these results from visual interpretation of the gel and DHPLC traces. 
The data obtained from the DHPLC analysis were subsequently manipulated further 
to extract more information. The traces obtained by DHPLC were overlaid in order 
to identify uncut DNA (retention time, 15 minutes and later) (Figure 6.23). A visible 
fraction of uncut DNA persists in the case of the plasmids encoding active Mtascs 
(see chromatograms for A, C and E). In addition there is some uncut DNA found in 
the chromatogram F (see red profile). It could be due to the presence of larger 
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Figure 6.21: Two hybrid plasmid restriction protection assay: Plasmids DNA after recovery from E. 
coli DH5a mcr were restricted with Xhol to confirm the presence of both Bait and Prey plasmids, and 
with Huelll to establish the digestion profile. The lane order (in 1% agarose gel) is as follows; 
1. GeneRulerTm I kb DNA ladder. 
2. pQIS 101N (W/T LZ) + pQIS 98 (W/T LZ) cut with Xhol 
3. pQIS 101 N (W/T LZ) + pQIS 98 (W/T LZ) cut with HaeI11 
4. pQIS 113 (CaM pep) + pQIS 98 (W/T LZ) cut with Xhol 
5. pQIS 113 (CaM pep) + pQIS 98 (W/T LZ) cut with Haelll 
6. pQIS 1 15 (Asn 5 Lys) + pQIS 98 (W/T LZ) cut with Xhol 
7. pQIS 115 (Asn 5 Lys) + pQIS 98 (W/T LZ) cut with HaelII 
8. pQIS 1 13 (CaM Pep) + pQIS 114 (CaM) cut with Xhol 
9. pQIS 113 (CaM Pep) + pQIS 114 (CaM) cut with Haelll 
10. pQIS 116 (Leu 8 Pro) + pQIS 117 (Leu 8 Pro) cut with Xhol 
1I. pQIS 116 (Leu 8 Pro) + pQIS 117 (Leu 8 Pro) cut with Haelll 
12. pQIS 119 (OSTI) + pQIS 118 (WBPI) cut with Xhol 
13. pQIS 119 (OST1) + pQIS 118 (WBPI) cut with HueIII 
14. GeneRuler FMI kb DNA ladder. 
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Figure 6.23: The overlaid chromatogram of two-hybrid plasmid restriction protection assay 
analysed by DHPLC shown after 15 minutes of retention time. Plasm ids DNA after recovery from E. 
coli DH5cc mcr were restricted with Haelll to establish the digestion profile. The order is as follows; 
A. pQIS LOIN (W/T LZ) + pQIS 98 (W/T LZ) cut with Haelll 
B. pQIS 113 (CaM pep) + pQIS 98 (W/T LZ) cut with HaelIl 
C. pQIS 115 (Asn 5 Lys) + pQIS 98 (W/T LZ) cut with HaeIII 
D. pQIS 113 (CaM Pep) + pQIS 114 (CaM) cut with HaelIl 
E. pQIS 116 (Leu 8 Pro) + pQIS 117 (Leu 8 Pro) cut with HaeI1I 
F. pQIS 119 (OST I) + pQIS 118 (WBPI) cut with HaeI1l 
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Table 6.2: Summary of the Joint Results obtained by co-transformations, 
restriction protection and by DHPLC A visual rating of (+ and -) (active and 
inactive) has been assigned for these results after viewing the gel and DHPLC traces. 
Bait Prey Mcr Restriction DHPLC 
(pMETN) (pMETC) response Protection on gel profile 
A pQIS 101n pQIS 98 
(WIT LZ) (W/T LZ) Active +++ +++ 
B pQIS 113 pQIS 98 
(CaM pep) (WIT LZ) Inactive + - 
C pQIS 115 pQIS 98 
(N 5 K) (W/T LZ) Active + + 
D pQIS 113 pQIS 114 
(CaM Pep) (CaM) Inactive - - 
E pQIS 116 pQIS 117 
(L 8 P) (L 8 P) Active ++ ++ 
F pQIS 119 pQIS 118 
(OST1) (WBP1) Inactive + ++ 
restriction fragments in these constructs (Appendix V). There might be a possibility 
that a weak interaction of yeast Wbpl and Ostl protein would lead to this kind of 
result. At the moment I cannot speculate on any reason for this result. 
6.3.2: Nucleotide sequence analysis of the Mtase genes used in the two-hybrid 
experiments 
Twelve primers were designed that facilitated the nucleotide sequencing of the 
complete 5' or 3' terminal sequence of the Mtases M. SPRI gene including the 
inserted sequence of interacting protein. The sequences of primers THI-TH12 that 
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were used for sequencing reactions are shown in Table 6.3. The primers used for 
sequencing against each construct are given in Table 6.4. 
Table 6.3: Sequence of Primers used for sequencing two-hybrid plasmids 
Primer Number Sequence 5' - 3' Length 
THl AGGGCTGGCAAGCCACGTT 19 bp 
TH 2 CAGATGATGACAGCGAAGG 19 bp 
TH3 CCAGGTGCTGTTCCGAAT 18 bp 
TH 4 TGCGGTTCATTCACATGCG 19 bp 
TH5 CGTTACGACTTCCTCTGT 18 bp 
TH 6 CCAGTCCTGCTCGCTTCG 18 bp 
TH 7 TAGGGAGCGACTTTACAT 18 bp 
TH8 GACGACAATAGACGTGTC 18 bp 
TH 9 GTTTATTCCCACAATGCCC 19 bp 
TH1O AACGGCCCACCGGACACT 18 bp 
TH11 CAGAATTGACCTAGAGCTG 19 bp 
TH12 GAGAGGGACTGAAAATTGCAG 21'bp 
Table 6.4: Two-hybrid plasmids and Primers used for them 
Construct No Gene length to be sequenced 
(in bps) 
Primers used 
1 pQIS 98 478 THI 
2 pQIS 101 999 TH6, TH7 
3 pQIS 113 990 TH6, TH7 
4 pQIS 114 832 TH I, TH2 
5 pQIS 115 999 TH6, TH7 
6 pQIS 116 999 TH6, TH7 
7 pQIS 117 478 TH1 
8 pQIS 118 1681 TH1, TH3, TH4, TH5 
9 pQIS 119 2343 TH6, TH7, TH8, TH9, TH IT 
10 pSPR(X) 1315 TH1, TH11, TH12 
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6.4: Discussion 
As we pass into the post-genomic era, our attention naturally shifts to the products of 
the genomes that have been solved i. e. proteins. While the initial focus of this new 
age will be the description of the three dimensional-structure of all these gene 
products, not far behind must be the determination of how all of these proteins 
integrate to produce generalised phenotypes. The general principals for both genetic 
and biochemical tests for protein-protein interactions have been reviewed by 
Phizicky and Fields (1995). Genetic assays are thought of as analogous to 
biochemical assays (Hu et al., 2000). The yeast two-hybrid system represents a 
powerful in vivo approach to analyse interactions between macromolecules and to 
screen for polypeptides that bind to a given "bait" protein (Field and Song, 1989). 
Bacterial equivalents to the yeast two-hybrid system have not been developed until 
recently (Karimova et al., 1998; also reviewed by Hu et al., 2000). In this chapter we 
describe a novel bacterial two-hybrid system that allows easy in vivo screening of 
functional interactions between two proteins. The two-hybrid system that we have set 
up is based on the reconstitution of an active multi-specific Mtase M. SPRI. It takes 
advantage of the modular structure of M. SPRI, which has perhaps a similar two 
domain structural organisation to that of monospecific Mtases Mal, and Haeffl. The 
multi-specific Mtases are characterised by an unprecedented structural plasticity 
(Walter et al., 1992). We have used individually inactive N- and C-terminal 
containing segments of M. SPRI (detached at the MspI specific TRD region) to 
complement and form an active enzyme with the help of an appended leucine zipper 
motif. 
Two compatible plasmids were constructed each carrying the ORFs of the N- or C- 
terminal components of M. SPRI fused to a leucine zipper motif. When expressed 
separately in E. cola, these polypeptides do not assemble into an active enzyme 
unless the interacting polypeptides are genetically fused to these fragments. In the 
bacterial two-hybrid system, interaction between the two chimaeric proteins results 
in functional complementation between the two fragments and restoration of 
enzymatic activity. The resulting active Mtase triggers the E. cola resident mcr gene 
that challenges the growth of colonies by biological restriction of methylated DNA. 
A functional methyltransferase is revealed by a positive mcr host response, in the 
form abolition of plasmid transformants. 
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The experiments described in this chapter have demonstrated that a leucine zipper 
can mediate the formation of a heterodimer of the multi-specific methyltransferase 
(M. SPRI). The 28 amino acid leucine zipper motif of C/EBP dimerizes with high 
affinity. Leucine zipper proteins exist in an alpha helical conformation and the dimer 
interface of a leucine zipper is formed by the interaction of the side chains of the 
residues at the a, d, e, and g position of the (abcdefg)n heptad repeat (Zeng et al., 
1997). In a control experiment using the bacterial two-hybrid system it was found 
that the deletion of the leucine zipper domain is sufficient to abolish M. SPRI 
assembly. It has therefore been shown that this bacterial two-hybrid system is 
capable of "reporting" on the interactions between small peptides (such as, for 
example the C/EBP leucine zipper). 
I have extended this analysis and studied the interactions between two yeast proteins 
namely mlc 1p and the N-terminal fragment of Iqg l p. In this case however, no 
interaction was observed. It was thought that this might represent a limitation of the 
bacterial system. However, when a similar experiment was carried out with yeast 
two-hybrid system, using the same two proteins, no interaction was recorded 
(Personal communication, Boyne, J). When a full-length Iqgl protein (172.729 kDa 
in size instead of 98.744 kDa) added to mlcl, an interaction was detected by co- 
immuno-precipitation (Boyne et al., 2000). 
In addition, I investigated whether point mutations in a leucine zipper could abolish 
the homodimer formation. It was found that such point mutation(s) did not affect 
dimerisation, since no colonies were obtained on multiple antibiotic plates arising 
from complementation of the expressed fragments of M. SPRI. Kouzarides and Ziff 
(1988) have reported that the mutation of individual leucine(s) in the leucine zipper 
protein fos, do not affect complex formation with Jun. 
Therefore either these mutations have not affected the binding properties at all or it 
might be possible that the mutation has reduced the binding properties. If it is the 
later case, the significance of these relatively small changes in binding activity is 
difficult to judge. Therefore we can claim that the system is powerful enough to 
detect even weak interaction, or alternatively it is not capable of distinguishing 
between strong and weak interactions by microbiological means. 
I have also tried using the bacterial two-hybrid system to analyse the dimerisation 
capacity of a calmodulin-binding peptide with calmodulin. The interaction between 
calmodulin and the calmodulin-binding peptide is well documented. However, I did 
148 
CHAPTER SIX 
not find any evidence for interactions using this bacterial two-hybrid system. In 
addition experiments were performed to study the interactions between two yeast 
membrane proteins Wbp1 and Ostl. The Saccharomyces cerevisiae 
oligosaccharyltransferasese (OST) is a protein complex composed of six 
polypeptides (Kelleher and Gilmore, 1994). Oligosaccharyltransferases of this type 
catalyse the transfer of a high mannose oligosaccharide from a lipid linked 
oligosaccharide donor onto an Asn acceptor site within Asn-X-Ser/Thr consensus 
motifs in newly synthesised proteins. This Asn linked glycosylation of proteins via 
OST, takes place in the lumen of the endoplasmic reticulum. In native rough 
microsomal membranes, components of the OST complex are in close proximity to 
membrane-bound ribosomes, since they can be chemically cross-linked to the 60S 
ribosomal subunit. Mammalian OST48L and RIL are homologous to yeast Ostl and 
Wbpl and have been shown to interact by a yeast two-hybrid approach and by 
biochemical assays (Fu et al., 1997). In this work yeast Wbpl and Ostl did not show 
an interaction using the bacterial two-hybrid system. Such inconsistencies between 
the genetic and biochemical methods make it essential that all putative interactions 
are verified by more than on method. However it is unclear why this experiment 
failed but it could be due to various factors including the basic differences in E. coli 
and yeast. The other possible reasons might be interference of large protein with 
Mtase, poor folding, susceptibility to proteolysis or the inappropriate ratio of 
expression of the two proteins. Living cells need globular proteins in correct 
quantities at appropriate times. It is therefore as important to be able easily to 
degrade these proteins, as it is to be able to synthesise them. Globular proteins in 
living cells usually have a rather rapid turnover and their native states have therefore 
evolved to be only marginally stable (Branden and Tooze, 1999). Hence, there could 
be a possibility that very large proteins (especially membrane proteins) could not be 
used for interaction studies by this bacterial two-hybrid assay. Further experiments 
on bacterial two-hybrid system are currently underway in our lab. 
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Figure 6.3: Schematic representation showing the construction of pMETC-LZ (pQIS 98) encoding a 
leucine zipper fused to motif IX and X of M. SPRI. Gel 1: Lane 1: pQIS 84 incubated with Haelll. (DNA is 
protected by Haelll restriction digestion indicating that an active protein is encoded by this plasmid). Lane 2: 
pQIS 84 digested with Nrul. (Linear DNA 
digested with Nrul verifies the insertion of linker and formation pQIS 
84). Gel 2: Lane 1 pQIS 84 digested with BamHl and Bglll. This procedure was used in order to excise the N- 
terminal M. SPR fragment containing motif 1-Vill. (Fragment sizes are 5434 and 894 bps) Gel 3: Lane 1 pQIS 
98/pMETC-LZ digested with BamHl. Uncut DNA indicated the loss of BamHl site. Lane 2 pQIS 98/pMETC-LZ 
digested with Xhol and Sacl (fragments sizes are 4956 and 478 bp). M: GeneRulerTM I kb DNA ladder in all 
gels. 
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Figure 6.4: Schematic representation showing the construction of pQIS 92 and pQIS 99. The construct 
pQIS 92 encodes for a version of M. SPRI in which the Mspl TRD is replaced with a leucine zipper region. 
The construct pQIS 99 represents wild type M. SPRI gene cloned into the plasmid pACYC 184. Gel 1: Lane 
1: pQIS 92 digested with Haelll (showing partial protection). Lane 2: pQIS 92 digested with Ncol. (Linear 
DNA fragment). There is no Ncol site in pQIS 84 whereas pACYC 184 contains one Ncol site. Lane 3: 
pQIS 92 digested with EcoRV. (Fragments of sizes 4625 and 403 bps). One EcoRV site is present in 
M. SPRI whereas the other is in pACYC 184 and the fragments yielded are as expected. Gel 2: Lane I pQIS 
92 digested with BamHl and Muni. (Fragments sizes are 1138 and 3890 bp). Lane 2: pQIS 99 cut with 
BamHl and Munl (Fragments sizes are 1087 and 3890). A comparison of the difference in size of the lower 
bands in lane I and 2 illustrates the difference between pQIS 92 and pQIS 99. M: GeneRuleri'M I kb DNA 
ladder in both gels. 
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Figure 6.5: Schematic representation showing the construction of pQIS 100. This results in a 
construct which encodes motif I-VIII of M. SPRI fused with the leucine zipper region. Gel 1: pQIS 100 
cut with Kpnl (for the verification of the construct). The M. SPRI gene contain a unique Kpnl site and 
therefore the plasmid pQIS 100 has been linearised. M: GeneRulerTM 1 kb DNA ladder. 
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Figure 6.6: Schematic representation showing the construction of pQIS 101. Gel 1: PCR product 
generated after site-directed mutagenesis. Gel 2: lane 1 pQIS 101 digested with EcoRI. (Linear DNA). 
Lane 2: pQIS 101 digested with KpnI (Linear DNA). Lane 3: pQIS 101 cut with BamHl and Xhol. 
(Fragment sizes 3749 and 906 bps). Lane 4: pQIS 101 cut with BamHl and EcoRI. (Fragment sizes 3656 
and 999 bps). M: GeneRulerTM I kb DNA ladder in both gels. 
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Figure 6.7: Schematic representation showing the construction of pMETN-LZ (pQIS 101N) (with 
corrected start codon). Gel 1: Lane 1 shows the generation of 999 bp PCR product. (Using primers NIS 77 
and NIS 73). Gel 2: Lane 1: pQIS LOIN cut with Ncol. (Fragment sizes 2174 and 2481) (pQIS LOIN 
contains a corrected start codon and a new Ncol site). Lane 2: pQIS 101 cut with Ncol. (Linear DNA). M: 
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Figure 6.10: A Schematic representation showing the construction of pQIS 103. This plasmid 
encodes a protein composed of the Micl gene from yeast fused to motif I-Vill from M. SPRI. Gel 1: 
shows the 450 bps NO fragment generated by PCR. Gel 2: Lane 1: pQIS 103 cut with Stul. (linear 
DNA, 5018 bps). Lane 2: pQIS 103 cut with Xhol and EcoRI. (Fragment sizes 4562 and 456 bps). M: 
GeneRulerTM I kb DNA ladder in both gels. 
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protein composed of the Igglpl gene from yeast fused to motif IX-X from M. SPRI. Gel 1: Lane I shows the 
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are 5353 and 2565 bps). Lane 2: pQIS 104 cut with Xhol. (Linear DNA 7.9 kb size). Lane 3: pQIS 104 cut with 
EcoRl. (Fragment sizes are 6830 and 1088 bps). M: GeneRulerTM I kb DNA ladder in both gels. 
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Figure 6.14: Schematic representation showing the construction of pQIS 113. This plasmid 
contains motif I-VIII of M. SPR fused with the Calmodulin Binding Peptide sequence. The 
oligonucleotide contain a Ncol site and there is an existing Ncol site in the plasmid. Gel 1: Upon 
restriction the plasmid generated two fragments (3149 + 1497 bps) which confirmed the identity of the 
new construct. M: GeneRulerTM 1 kb DNA ladder. 
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Figure 6.15: Schematic representation showing the construction of pQIS 114l which 
encodes a calmodulin gene fused with motif IX-. 'C 
from M. SPRI. Gel 1 (1.5 % agarose): 
Lane 1 447 bps fragment generated by PCR. Lane 2: 
100 bp DNA ladder. Gel 2: Lane 1 shows 
the restriction digestion of pQIS 114R by Xhol and 
EC°RI which generated a 450 bp fragment 
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Figure 6.16: Schematic representation showing the construction of pQIS 115. This plasmid contains 
the gene for a C/EBP leucine zipper with a Asn 5 Lys mutation). Gel 1 shows the restriction digestion of 
pQIS 115 with C1aI. The resulting fragments 3375 and 1280 bps confirmed the identity of the new 
construct. M: GeneRulerTM 1 kb DNA ladder. 
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Figure 6.17: Schematic representation showing the construction of pQIS 116. This plasmid 
contains the gene for a C/EBP leucine zipper with a Leu 8 Pro mutation). The plasmid DNA was cut 
with restriction enzyme SacII to confirm the identity of newly introduced mutation. Gel 1 shows the 
restriction digestion of pQIS 116 with Sac1I. The resulting fragments 2684 and 1971 bps confirmed the 
identity of the new construct. M: GeneRulerTM I kb DNA ladder. 
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Figure 6.18: Schematic representation showing the construction of pQIS 117. This plasmid 
contains the gene for a C/EBP leucine zipper with a Leu 8 Pro mutation). Gel 1 shows the digestion of 
pQIS 117 with Sacll. Linear DNA fragment of 5.4 kb confirmed the identity of newly introduced 
mutation and formation of new construct. M: GeneRulerTm I kb DNA ladder. 
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Figure 6.19: Schematic representation showing the construction of pQIS 11& This plasmid contains a yeast 
gene which encodes WBPI and fused with the sequence of motif IX-X of M. SPRI. Gel 1: Lane 1 shows the 
1293 bps WBPI fragment generated by PCR. Gel 2: Lane 1: 1293 bp PCR product as control DNA. Lane 2: 
pQIS 118 cut with Xhol and EcoRI (Fragment sizes 5605 and 1032 bps). (A smaller insert size due to internal 
EcoRI site. Compare lane 1 and lane 2). Lane 3: pQIS 118 cut with BamHI. Linear DNA. (BamHl site is present 
only in WBP1 gene). lane 4: pQIS 118 cut with Xhol and Ec11136. (Fragment sizes 4958 and 1679 bps). Lane 
5: pQIS 118 cut with Xbal. (Uncut DNA, blocked by ovelapping dam methylation). M: GeneRulerTM I kb DNA 
ladder in both gels. 
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Figure 6.20: Schematic representation showing the construction of pQIS 119. This plasmid contains a 
yeast gene which encodes OST1 fused with the sequence of motif I-VIII of M. SPRI. Gel 1: Lane I shows the 
1431 bps OSTI fragment generated by PCR. Gel 2: Lane 1: pQIS 119 cut with Muni yielded linear DNA. 
(Muni site is present only in OSTI gene). Lane 2: pQIS 119 cut with Kpn1 and Muni (Fragment sizes 4718 
and 1281 bps). Lane 3: pQIS 119 cut with BamHI and EcoRI. (Fragment sizes 3656 and 2343 bps). Lane 4: 
pQIS 119 cut with Stul yielded linear DNA. (Stul site is present only in OSTI gene). M: GeneRulerTM I kb 
DNA ladder in both gels. 
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7.1: GENERAL DISCUSSION 
C5-DNA Mtases are found in a range of organisms and catalyse the transfer of a 
methyl group from the co-factor SAM to the C5 position of a specific cytosine within 
DNA. Sequence comparisons of multispecific phage-encoded C5-Mtases has led to 
the identification of contiguous overlapping domains that are responsible for the 
recognition of specific DNA sites. These regions of the polypeptide chain are termed 
target-recognition domains (TRDs). The cytosine-specific Mtase M. SPRI from 
Bacillus subtilis bacteriophage contains three TRDs which methylate DNA sites 
recognised by the restriction enzymes EcoRII, Mspl and HaeIII (Trautner et al., 
1988). M. SPRI has a structure consisting of 10 well-conserved motifs surrounding 
the variable region containing the TRDs. 
Crystallographic studies on two mono-specific bacterial Mtases have shown that 
general enzymatic functions such as cofactor (SAM) binding and catalysis are 
provided by a large "catalytic" domain formed by the N-terminal part of the enzyme, 
which includes the conserved motifs I-VIII. The second smaller "recognition" 
domain of the Mtases is composed of the central variable region containing the 
target-recognising domain(s) (TRDs) and part of the C-terminal motifs IX and X 
(Klima§auskas et al., 1994; Reinisch et al., 1995). Motif X forms one of the bridges 
between the two domains. In the monospecific Mtases, studies of hybrids between 
two Mtases of different specificities, have demonstrated that there may be some 
direct structural interactions between the variable region and motif IX. The integrity 
of the small domain, provides a suitable interface between the variable, TRD- 
containing region and the conserved motifs IX and X, and appears to be crucial for 
enzymatic activity (Mi and Roberts, 1992). 
The experiments presented in this thesis describe the introduction and analysis of 
mutations into two C5-DNA Mtases, M. SPR and M. HhaI. M. HhaI was chosen 
owing to our knowledge of its structure. The main aim of this mutational study was 
to dissect the internal relationship of the small domain comprising variable region 
and motif IX. 
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In the first phase of the experimental work (chapter 3) three individual point 
mutations were engineered into the sequence of M. SPRI in motif IX, in order to 
mimic motif IX of mono-specific Mtases. The protein encoded by the Phe 386 Ala 
mutant of M. SPRI gave partial activity. Analysis of the kinetics of covalent complex 
formation (Pinerbasi et al., 1998) has shown that such mutants exhibit a delay in the 
initial phase of covalent complex formation, but after prolonged incubation, the 
extent of covalent complex formation appeared very similar to the wild type. The 
altered kinetic properties observed may be explained by altered conformational 
properties of the mutant or a modification of one or more chemical steps. While the 
M. SPRI Phe 386 Ala mutant features a decrease in methylation activity, a similar 
trend of reduced activity was observed when a similar mutation was carried out in 
M. HhaI i. e. Ala 280 Phe mutant. The crystallographic data from M. HhaI (Cheng et 
al., 1993) revealed the networks of interactions of surrounding amino acids. From 
such analysis it became apparent that by altering the Ala 280 Phe, its neighbouring 
amino acids were perturbed (Figure 3.26 and 3.27) and as a result M. HhaI exhibited 
reduced active. Using a rational approach for mutagenising M. Hhal, a series of 
subsequent amino acids substitution were introduced systematically in order to 
simulate the properties of motif IX and X of multispecific Mtase. Finally a triple 
mutant of M. HhaI was generated that had regained the enzymatic activity, which was 
initially lost. 
With this active multispecific like M. HhaI mutant in hand it was tempting to 
generate a chimaeric Mtase combining a TRD from M. SPRI. Insertion mutagenesis 
experiments in the triple mutant of M. HhaI were carried out in the variable region of 
M. HhaI by inserting the MspI specific TRD from M. SPRI. In addition, a number of 
DNA fragments and ORFs were inserted from the variable region and TRDs of 
multispecific M. SPRI in the triple mutant of M. HhaI, in such a way that the reading 
frame of M. Hhal remained intact (chapter 4). In another series of experiment, 
chimaeras were constructed by the exchange of motifs between wild type M. SPRI 
and M. HhaI. Unfortunately none of these constructs encoded an active enzyme 
(chapter 5). 
During this exercise certain other mutations were also engineered in the sequence of 
wild type of M. SPRI and M. HhaI for the introduction of various restriction sites at 
different locations. The sequence of MSPRI and M. HhaI was aligned and the 
mutants are summarised in Figure 7.1. In M. HhaI, the activity of the double mutant 
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NI176/177IN was undisturbed. However, the activity of the enzyme encoded by the 
double mutant KT270/271RI was considerably reduced. The mutation that was 
introduced into the variable region, illustrated the high flexibility in this region of 
M. HhaI: the latter mutant had reduced activity. Here I should point out the level of 
reduced activity of different mutants observed in this study. Although protein 
expression and purification was not carried out for all mutants (as it was not the aim 
of the study), in vivo methylation protection assay revealed that there are different 
levels of reduced methylation potential which is apparent from close observation of 
restriction profiles on gels. Generally, point mutations in motif IX and X render 
M. HhaI partially active with the exception of one that makes it inactive (Figure 7.1). 
In this study M. SPRI mutations in motif IX are tolerated with one exception that 
makes it partial active (Figure 7.1). However data suggests that generally mutations 
in this region are not tolerated and produce class I mutants, in which the general 
methylation capacity of the Mtases is reduced or destroyed (Wilke et al., 1988). 
Trautner et al., (1996) also indicated that amino acids beyond the C-terminus of the 
ensemble of TRDs, although not necessary for individual TRD activity, may very 
well modulate the overall methylation potential of these enzymes. This clearly shows 
that motif IX and X have more important role in the structure of mono-specific 
M. HhaI. 
The basis of losing the methylation potential 
The methylation capacity of an enzyme can be disrupted by a single point mutation. 
This is however, dependent on the position of mutation and its interaction with either 
the catalytic region or the target recognition domain. Residues that are remote from 
the active site in the primary structure of a protein may play an important role (Oue 
et al., 1999). 
Mutational analysis of C5 Mtases has revealed that a spectrum of activity exists 
ranging from fully active to inactive. In between, the term partially active is defined 
by plasmids that show some resistance to restriction. For any given mutant that 
exhibits `partial' activity it is possible that the enzyme is fully active, but rapidly 
degrades in vivo, or that the enzyme turns over at a reduced rate owing to some 
catalytic or substrate binding defect. A partially active mutant is defined here by the 
characteristic restriction pattern obtained when the plasmid encoding the mutant is 
exposed to the cognate restriction enzyme. For example wild type M. SPRI when 
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expressed in a plasmid, will be refractory to digestion with MspI and HaeIII, an 
inactive mutant will fail to methylate the plasmid and digestion with either MspI or 
HaeIII leads to complete cleavage at all sites. A partially active mutant either leads to 
a cleavage at a limited number of sites or due to the reduced methylation potential of 
mutant protein. It is difficult to determine the reason for partial protection without a 
detailed analysis of the kinetic properties of the purified mutant enzymes. 
In this study it is also observed that the mono-specific Mtase loses catalytic activity 
due to insertion of large sequences, conflicting with the flexible nature of multi- 
specific Mtases as observed by Walter et al., (1992). One possible explanation is that 
the mere enlargement of TRDs of the variable region by insertion of the Mspl 
specific TRD would exceed a limit of TRD tolerated by the variable region and 
would hence interfere with the proper function of the protein. Alternatively when the 
MspI specific TRD was inserted, it might have impaired the activity of the 
neighbouring HhaI TRD, as observed in the chimera encoded by pQIS23 and pQIS 
24. In another experiment when three TRDs of M. SPRI were inserted, once again the 
enlargement of the TRD of the variable region takes place. This shows that although 
the construct encoded by pQIS 18 mimics the multispecific Mtase M. SPRI it is still 
unable to tolerate extra polypeptide in the variable region. 
Two-hybrid system based on an engineered form of M. SPRI 
An emerging field for the analysis of biological systems is the study of the complete 
protein complement of the genome, the 'proteome'. There are several complementary 
tools available for proteome analysis including 2D protein electrophoresis and mass 
spectrometry. In addition, two-hybrid technology has also been shown to be helpful 
in defining protein-protein interactions. These technologies provide a wealth of 
information that is useful in discovery-based science. However, there are some key 
limitations of these approaches and new technology is required to be able to fully 
integrate proteomic information with information obtained about DNA sequence, 
mRNA profiles and metabolite concentrations into effective models of biological 
systems. 
The principle of two-hybrid technology is based on the interaction of two chimaeric 
("hybrid") components (Fields and Song, Nature, 1989). In their version of the 
system, hybrid 1, "the bait", is composed of a protein fused to a DNA-binding 
domain that specifically binds to the promoter of a reporter gene. Hybrid 2, "the 
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prey", is composed of a polypeptide fused to an "activation domain" which recruits 
the transcription machinery of the yeast cell. If a functional, transcription complex is 
reconstituted which drives the expression of a reporter gene, a specific gene whose 
expression (direct two-hybrid methods), or inhibition (reverse two-hybrid methods), 
reveals the existence of a protein-protein interaction. Using molecular tools and high- 
throughput screening procedures based on two-hybrid interaction systems, it is 
possible to identify protein-protein interactions to build protein interaction maps and 
thereby derive dedicated bioinformatic databases. 
Bacterial two-hybrid system 
A bacterial two-hybrid system would offer significant advantages over eukaryotic 
alternatives owing to rapid cell growth rates, efficient expression of heterologous 
proteins and higher permeability of the cells to small molecules as potential 
inhibitors of protein-protein interactions. New systems that utilise bacteria for two- 
hybrid analyses are emerging (Karimova et al., 1998). This genetic test is based on 
the reconstitution, in an Escherichia coli cya strain, of a signal transduction pathway 
that takes advantage of the positive control exerted by cAMP. Two putative 
interacting proteins are genetically fused to two complementary fragments, T25 and 
T18, which constitute the catalytic domain of Bordetella pertussis adenylate cyclase. 
Association of the two-hybrid proteins results in functional complementation 
between T25 and T18 fragments and leads to cAMP synthesis. Cyclic AMP then 
triggers transcriptional activation of catabolic operons, such as lactose or maltose 
that yields a characteristic phenotype. 
Benefits of bacterial two-hybrid system 
Despite the widespread use of the yeast two-hybrid system, there are reasons why 
similar genetic assays in E. coli would be useful. One advantage of an E. coli system 
is that the speed with which large numbers of interactions can be tested could be 
increased, a commercially important consideration. E. cola grows faster than yeast 
and, with present methods, can be transformed with higher efficiency, allowing 
better coverage in library based screens. In addition, since the cloning steps in yeast 
often involve passing libraries through E. coil hosts, using E. coli would remove a 
step from each cycle in a high throughput-screening programme. The smaller 
genome complexity and greater evolutionary distance from higher eukaryotes mean 
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that E. coli systems should not generate as many false positives and negatives due to 
interactions between endogenous proteins and eukaryotic baits and preys as S. 
cerevisiae systems do. With respect to drug screening, another potential advantage is 
that the cell envelope of E. coli seems to be somewhat more permeable to small 
molecules than the cell wall of yeast. Finally, yeast two hybrid systems require 
nuclear localization of the hybrid proteins and the presence of localization signals for 
other cellular compartments could prevent bait or prey from reaching the nucleus, a 
problem that should not occur in E. coll. 
Leucine zipper proteins 
One protein motif whose function can be measured effectively using the Two-Hybrid 
system is the "leucine zipper". The leucine zipper is a structure that is believed to 
mediate the function of several eukaryotic gene regulatory proteins. The zipper 
consists of a periodic repetition of leucine residues at approximately every seventh 
position, and regions containing them typically span 8 turns of alpha helix (Hurst 
1994). Initially it was thought that the Leu residues interdigitated and hence they 
were named "zippers". Now it is known that the leucine side chains that extend from 
one helix interact with those from a similar helix, hence facilitating dimerisation in 
the form of a coiled-coil (Nelson and Cox 2000). 
A rapid functional test has been described in this study for the evaluation of protein- 
protein interactions utilising bacteria instead of yeast. The system is based on the 
construction of an artificial heterodimeric Mtase M. SPRI, and its in vivo assembly 
through dimerisation as explained in chapter six. By using an mcr+ E. coil strain that 
loses its plasmid-conferred antibiotic resistance in the presence of an active M. SPRI, 
it is possible to positively identify interacting protein "bait-prey" pairs. 
A superficial search through the SWISSPROT protein database reveals at least 22 
human genes that are listed as containing "putative" leucine zippers (Table 7.1). 
There are about 71 human leucine zippers that are "verified" in SWISSPROT, and 
there are about 9000 human proteins of all types listed in SWISSPROT to date. 
Therefore out of the total human proteome there may be hundreds of "controversial' 
leucine zippers that we might be able to verify using out leucine zipper E. cols 
system. 
In those cases where the two-hybrid data are borderline, mathematical analysis 
helped resolve the results after the plasmids had been digested with HaeIII and 
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analysed on DHPLC. Therefore, this biochemical analysis that includes the use of the 
DHPLC may facilitate the measurement of the strength of interaction of the bait and 
prey proteins. 
Table 7.1: List and amino acid sequence of potential leucine zipper domains 
found in human protein through Swiss-Prot sequence database. 
Human 
Protein 
Primary 
Accession 
Number 
"Putative" leucine zippers 
Leucine 
zipper 
LxxxxxxLxxxxxxLxxxxxxLxxxxxxL 
ATF4 P18848 LTGECKELEKKNEALKERADSLAKEIQYL 
BIK 013323 LLALLLLLALLLPLLSGGLHLL 
HTF4 Q99081 LYSRDTGLPGCQSSLLRQDLGL 
ITF2 P15884 LHSLQSRIEDRLERLDDAIHVL 
M3K9 P80192 LRAKEKELRTWEEELTRAALQQKNQ and 
LRRREQELAEREIDILERELNI 
M3KA Q02779 IQHMFDDLRTKEKELRSREEELLR and 
LRRREQELAEREMDIVERELHL 
MAFG 015525 LQQEVEKLASENASMKLELDALRSKYEAL 
MYCL P12524 LVGAEKRMATEKRQLRCRQQQLQKRIAYL 
MYCN P04198 LQAEEHQEKEKLQARQQQLLLL 
MYC P01106 LISEEDLLRKRREQLKHKLEQL 
NEFA P80303 LKEYENIIALQENELKKKADELQKQKEELQRQHDQL 
NEM-, 4O Q9Y6K9 LAEKKELLQEQLEQLQREYSKL 
NPT2 Q06495 LAVGLILLAGSLVLLCTCLILL 
CBI 0Q 2818 LRRFEEELAAREAELNAKAQRLSQETEALGRSQGRLEAKKREL 
RPB6 P41584 LEGETDPLLIAMKELKARKIPIIIRRYLPDGSYEDWGVDELII`FD 
SRE1 P36956 LQHSNQKLKQENLSLRTAVHKS 
SRE2 Q12772 LQQVNHKLRQENMVLKLANQKN 
TFEB P19484 LENHSRRLEMTNKQLWLRIQEL 
USF1 P22415 LQLDNDVLRQQVEDLKNKNLLL 
USF2 Q15853 LQMDNELLRQQIEELKNENALL 
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Pitfalls and potential limitations 
One disadvantage of this bacterial two-hybrid system is that the interaction of protein 
"bait-prey" pairs results in the death of the E. coli strain used for the test; in other 
words this is a "reverse" two-hybrid system. This means that it is not possible to 
recover the DNA that codes for a successful "prey" for identification. This is 
particularly important when trying to "fish" for novel "prey" genes from genomic 
libraries. 
Therefore an E. coli based system that allows the recovery of "prey" genes in the 
same way as conventional yeast two-hybrid systems, is needed to complement the 
reverse M. SPRI system. 
7.2: FUTURE WORK 
I believe that the bacterial two-hybrid project needs refinement. There is a need to 
establish those conditions under which well defined interactions (both strong and 
weak) takes place. In addition a positive selection for homodimerization is desirable. 
A model has been proposed for making the reverse two-hybrid system a positive one 
and is summarised in Figure 7.2; this involves obtaining a temperature sensitive 
mutation in the Mtase. It has been possible to generate a temperature sensitive 
mutant of M. SPRI using site directed mutagenesis (Trautner, personal 
communication). In the same manner a temperature sensitive mcr system could be 
generated. A temperature sensitive M. SPRI or mcr system of E. coli could be used to 
create a positive bacterial two-hybrid system. Temperature sensitive enzyme is 
known to be active at 30°C and inactive at 42°C. When colonies from master plate 
are replica plated and grown at two different temperatures, Mtase being inactive at 
42°C, all transformants will grow. However at 30°C only the inactive Mtase-carrying 
transformants will develop colonies. Therefore missing colonies in 30°C plate are the 
hits: they carry the interacting partners (proteins), which ultimately bring the two 
halves of Mtase (N- and C-terminal of M. SPRI) close enough to express Mtase 
activity. The missing colonies can be amplified from 42°C plate. These hits therefore 
carry clones with interacting gene products. However, at the moment this system 
may be adopted as a general tool to identify and characterise various types of known 
interactions. There is also a need to determine whether this system could be used to 
identify interacting proteins among an excess of non-interacting ones e. g. screening 
of libraries etc. 
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Figure 7.2: A proposed model for the generation of a temperature sensitive M. SPRI, and its use in a 
two-hybrid experiment. It is possible to generate temperature-sensitive mutants of the M. SPRI using site- 
directed mutagenesis (Trautner, personal communication). A temperature sensitive M. SPRI could be used to 
create a two-hybrid system as shown schematically above. Temperature sensitive enzyme M. SPRI is known 
to be active at 30°C and inactive at 42°C. When colonies from master plate will be allowed to grow at two 
different temperatures, Mtase being inactive at 42°C, all transformants will grow. However at 30°C only the 
inactive Mtase carrying transformants will develop colonies. Therefore, missing colonies in 30°C plate are 
the hits: they carry the interacting partners (proteins) which ultimately bring the two halves of Mtase (N- and 
C-terminal of M. SPRI) close enough to express Mtase activity. The missing colonies can be amplified from 
42°C plate. These hits therefore carry clones with interacting gene products. 
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Appendix I 
GeneRuler" "' I kb and 100 bp DNA LADDER 
ragment Base Pairs I )NA 
1 10.000 20 ng 
2 8.000 24 ne 
4 6.000 30 nie 
5 5.000 30 ng 
6 4.000 40 nag 
7 3,500 51 ng 
8 3.000 154.5 ng 
9 2.500 33.5 ng 
10 2,000 35 ng, 
11 1,500 24.5 ng 
12 1,000 10 ng 
12 750 16.5 ng 
13 500 14.5 ng 
14 250 16.5 ne 
Fragment [lase Pairs DNA Mass 
1 1.500 46 ng 
2 1,200 37 ng 
3 1.000 91 ng 
4 900 27 ng 
5 800 24 ng 
6 700 21 ng 
7 600 18 ng 
8 500 91 ng 
9 400 37 ng 
10 300 27 ng 
11 200 24 nu 
12 100 55ng 
Base Pairs 
1,500 
1,200 
1,089 
900 
800 
100 
6011 
Soo 
400 
lli 
? (Il 
1(1 
fdlflll_ 
, iIim 
=. 1 II Ill 
41 MO 
jtI II_I 
:i iý ii i 
; in 
111' IO 
7511 
Electrophoretic molecular weight standards for DNA fragments separated on agarose. 
(a) GcneRulerTM lkb DNA Ladder (MWI) (14 fragments) with 0.5µg loading on l. 0°/ß agarose gel and 
the (b) 100 bp ladder (Mill) (12 fragments) analysed on 1.8.0% agarose gel. The approximate DNA 
mass has also been tabulated above for each fragment. (Data adapted from Mill Iýcrmentas). 
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PROTEIN BROAD RANGE MARKER 
Fragment Protein 
I Myosin 
2 MBP-ß-galactosidase 
3 b-galactosidase 
4 Phosphorylase b 
5 Serum albumin 
6 Glutamic dehydrogenase 
7 MBP2 
8 Lactose dehydrogenase 
9 Triose phosphate isomerase 
10 Trypsin inhibitor 
11 Lysozyme 
12 Aprotinin 
13 Insulin A, B chain 
Source 
rabbit muscle 
E. coli 
E. coli 
rabbit muscle 
bovine 
bovine liver 
E. coli 
porcine muscle 
rabbit muscle 
soybean 
chicken egg white 
bovine lung 
bovine pancreas 
. ý-. w 2 
ei- 4 
tiom 5 
6 
IM- 
m -- 7 
d. n. f" 
8 
u9 
I0 
Calculated 
MW (Da) 
212,000 
158,194 
116,351 
97,184 
66,409 
55,561 
42,710 
36,487 
26,625 
(20,040-20,167) 
14,313 
6,517 
(2,340-3,400) 
It is a mixture of purified proteins with known amino acid sequences. They are 
resolved to 13 sharp bands when analysed by SDS-PAGE and stained with 
Coomassie Blue R-250. Protein bands numbered 1-10 are visible in this gel. Two 
bands (BSA, MW 66.4 kDa and triphosphate isomerase, MW 26.6 kDA) are at 
double intensity to serve as reference point. MBP is abbreviation for maltose binding 
protein (NEB, 1999 Catalogue). 
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Appendix IV 
Sequences of proteins used for testing dimer formation in two hybrid 
experiments 
Plasmids Sequence of test protein 
pQIS 84 (pSPR-LZ) LEI. TSDNDRI, RKRVEQLSRELDTLRGIFRQLEF 
No of amino acids: 33 
Molecular weight: 4047.5 
Plasmids carrying C-terminal 
region sequence of M. SPR (motif 
IX-X) 
pQIS 98 or pMETC (LZ) LEL. TSDNDRLRKRVEQLSRELDTLRGIFRQLEF 
No of amino acids: 33 
Molecular weight: 4047.5 
pQIS 114R or pMETC (Calmodulin) LEMADQLTEEEIAEFKEAFSLFDKDGDGTITTKELG 
No of amino acids: 151 TVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEF 
Molecular weight: 17098.9 LTMMARKMKDTDSEEIREAFRVFDKDGNGYISAAE 
LRHVMTNLGEKLTDEEVDMIREADIDGDGQVNYEE 
FVQMMTAKEF 
pMETC (N-terminal fragmentof lggl) LEGSMTAYSGSPSKPGNNNSYLNRYVENLGTNVTP 
yeast PLRPQSSSKINSSLNIASPSHLKTKTSASNSSATILSK 
No of amino acids 861 KVESSVSKLKPSLPNKLVGKYTVDLSNYSKIELRYY 
Molecular weight: 98744.6 EFLCRVSEVKIWIEAVIEEALPSEIELCVGDSLRNGV 
FLAKLTQRINPDLTTV I FPAGDKLQFKHTQNINAFFG 
LVEHVGVPDSFRFELQDLYNKKNIPQVFETLHILISM 
INKKWPGKTPALTNVSGQISFTKEEIAACKKAWPRI 
RDFKSLGTNINTAPASPEEPKEKRSGLIKDFNKFERP 
NIPVEEILITPRKNITDANCSDFSNTPSPYNEAPKMSN 
LDVVVEKRKFTPIEPSLLGPTPSLEYSPIKNKSLSYYS 
PTI SKYLTYDTEFYTRRSRAREEDLNYYQTFKYSPS 
HYSPMRRERMTEEQFLEKVVQLQNICRGVNTRFNL 
YIQKRLLNLFEQDILRFQACLRGNKFRVLSSMYLPIR 
RAKIDVPHVEAIQSRIKGSRIRYKYDKLKFTLSRFSC 
TVELLQAYCRSKLLKTTVNTKLNDIEISHYPLTKLQ 
SYMRASY VRKKVMSLNTKLNDERESI MKFSAII RG 
NVVRCSEDAILSAVHDVHKENISKLQSLIRGIFTRSC 
LASIIYSLGKENCNIIQLSACIRGNAVRHKVQSLFAP 
ENNLSETVHDLQGLVRGILVRYTLDLVDDIVEYNN 
LALFQAFSRGALVRESLDQKSSFYKRNVRSVIMIQS 
WIRKSLQRSAYLELLDCPNPSLWAVKKFVHLLNGT 
ATIEEVQNQLESCQASLDSENMKKERLLKSI RQQLN 
INGVLDKFGLLKDKDHELGISDSTIPKSKYQKYEKL 
FYMLQVDPSYWKLLYLKEPEVDEF 
pQIS 117 or pMETC (LZ-Leu 8 Pro) LELTSDNDRPRKRVEQLSRELDTL. RGIFRQI. EF 
No of amino acids: 33 
Molecular weight: 4031.5 
APPENDICES 
pQIS 1 18 or pMETC (WBP1) LEMRTDWNFFFCILLQAIFVVGTQTSRTLVLYDQST 
No of amino acids: 435 EPLEEYSVYLKDLEQRNYKLEYLDINSTSTTVDLYD 
Molecular weight: 49966.3 KEQRLFDNIIVFPTKGGKNLARQIPVKQLIKFFENEG 
NILCMSSPGAVPNTIRLFLNELGIYPSPKGHVIRDYF 
SPSSEELVVSSNHLLNKYVYNARKSEDFVFGESSAA 
LLENEQIVPILNAPRTSFTESKGKCNSWTSGSQGFLV 
VGFQNLNNARLVWIGSSDFLKNKNQDSNQEFAKEL 
LKWTFNEKSVIKSVHAVHSHADGTSYDEEPYKIKD 
KVIYSVGFSEWNGEEWLPHIADDIQFELRQVDPYYR 
LTLSPSGNDSETQYYTTGEFILPDRHGVFTFLTDYR 
KIGLSFTTDKDVKAIRHLANDEYPRSWEISNSWVYI 
SAICGVIVAWIFFVVSFVTTSSVGKKLETFKKTNQF 
RG 
Plasmids carrying N-terminal region 
sequence of M. SPR (motif I-VIII ) 
pQIS LOIN or pMETN (LZ) LEI. TSDNDRLRKRVEQLSRELDTLRGIFRQLEF 
No of amino acids: 33 
Molecular weight: 4047.5 
pMETN (MLC I yeast gene) LEMSATRANKDIFTLFDKKGQGAIAKDSLGDYLRA 
No of amino acids: 153 IGYNPTNQLVQDIINADSSLRDASSLTLDQITGLIEV 
Molecular weight: 16963 NEKELDATTKAKTEDFVKAFQVFDKESTGKVSVGD 
LRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYK 
KFIEDVLRQEF 
pQIS 113 or pMETN (Myosin Light LEKYMARRKWQKTGHAVRAIGRLSSMAMEF 
Chain Kinase peptide (MLCK) for 
Calmodulin) 
No of amino acids: 30 
Molecular weight: 3553.2 
pQIS 115 or pMETN (LZ-Asn 6 Lys) LEI, TSDKDRLRKRVEQI. SRELDTLRGIFRQLEF 
No of amino acids: 33 
Molecular weight: 4047.5 
pQIS 116 or pMETN (LZ-Leu 8 Pro) LELTSDNDRPRKRVEQLSRELDTL. RGIFRQLEF 
No of amino acids: 33 
Molecular weight: 4061.6 
pQIS 119 or pMETN (OSTI) LEMRQVWFSWIVGLFLCFFNVSSAAQYEPPATWEN 
No of amino acids: 480 VDYKRTIDVSNAYISETIEITIKNIASEPATEYFTAFES 
Molecular weight: 54590.4 GI FSKVSFFSAYFTNEATFLNSQLLANSTTAPGDDGE 
SEIRYGIIQFPNAISPQEEVSLVIKSFYNTVGIPYPEHV 
GMSEEQHLLWETNRLPLSAYDTKKASFTLIGSSSFE 
EYHPPNDESLLGKANGNSFEFGPWEDIPRFSSNETL 
AIVYSHNAPLNQVVNLRRDIWLSHWASTIQFEEYYE 
LTNKAAKLSKGFSRLELMKQIQTQNMRQTHFVTVL 
DMLLPEGATDHYFTDLVGLVSTSHAERDHFFI RPRF 
PIFGGWNYNFTVGWTNKLSDFLHVSSGSDEKFVASI 
PILNGPPDTVYDNVELSVFLPEGAEIFDIDSPVPFTN 
VSIETQKSYFDLNKGHVKLTFSYRNLISQVANGQVL 
IKYDYPKSSFFKKPLSIACYIFTALMGVFVLKTLNM 
NVTNEF 
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The expected DNA fragments sizes (shown in base pairs) from two-hybrids 
plasmids. The sizes shown in black are generated from pMETN-oriented plasmid 
and the one shown in red are originated from pMETC plasmid. The combinations of 
plasmids shown in series A to F are same as explained in text. 
A B C D E F 
pQIS 101n/ 
pQIS 98 
(W/T LZ) 
pQIS 113 
(CaM 
peptide)/ 
pQIS 98 
WIT LZ 
pQIS 115/ 
pQIS 98 
(W/T LZ) 
pQIS 113 
(CaM 
peptide)/ 
pQIS 114 
Cam 
pQIS 116 (L 
8 P)I pQIS 
117 
(L 8 P) 
pQIS 119 
(Ostl)/ pQIS 
118 (WBP1) 
8, 8, 8, 8, 8, 8, 
11,18 11,18 11,18 11,18 11,18 11,18 
25 25 
43,45 43,45 43,45 43,45 43,45 43,45 
57 57 57 57 57 56,57 
72 72 
80,87 80,87 80,87 80,87 80,87 80,87 
98 98 98 98 98 98 
102 102 102 102 102 101,102 
117 117 117 117 117 117 
123 123 123 123 123 
135 135 135 135 135 130,135,139 
155 155 155 155 155 155 
169 169 169 169 169 162,169 
173 173 173 173 173 173,177 
184,185 184,185 184,185 184,185 184,185 184,185 
200,203 200,203 200,203 200,203 200,203 200,20', 
213 213 213 213 213 213,213 
222 222 222 222 222 222 
255 255 255 255 255 255 
267 267 267 267 267 267 
287 287 287 287 287 287 
308 
326 326 326 326 326 326 
337 337 337 337 337 337 
346 346 346 346 346 346 
355 355 355 355 355 355 
369 369 369 369 369 369 
392,395 392,395 392,395 392,395 392,395 392,395 
434 434 434 434 434 434 
458 458 458 458 458 458 
484 484 484 484 484 484 
539 
563 563 563 563 563 563 
587 587 587 587 587 587 
653 653 653 653 653 653 
662 662 
768 768 768 
1045 
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Sequence of Oligonucleotides used in this study 
Name Sequence 5'--- 3' Brief Description 
NIS 7 TATGTTAATAAAGAATCTGAACATCATCATCATCATCA Top oligo (linker) for histidine 
TTAATCTAGATC tag with new XbaI site before 
Xhol 
NIS 8 TAGATCTAGATTAATGATGATGATGATGATGTTCAGAT Bottom oligo (linker) for 
TCTTTATTAACA histidine tag with new XbaI 
site before XhoI 
NIS 9 CCGTTAGAGTGCGCAAGGCTACAGGC Top oligo for site directed 
mutagenesis of F 386 A in 
M. SPRI 
NIS 10 GCCTGTAGCCTTGCGCACTCTAACGG Bottom oligo for site directed 
mutagenesis of F 386 A in 
M. SPRI 
NIS 11 GCTTTAGGCTACAGGGTTTTGATGACGAAG Top oligo for site directed 
mutagenesis of A 390 G in 
M. SPRI 
NIS 12 CTTCGTCATCAAAACCCTGTAGCCTAAAGC Bottom oligo for site directed 
mutagenesis of A 390 G in 
M. SPRI 
KIN 13 GGCTACAGGCTTTTCCGGACGAAGATTTTG Top oligo for site directed 
mutagenesis of D 392 P in 
M. SPRI 
NIS 1 44 CAAAATCTTCGTCCGGAAAAGCCTGTAGCC Bottom oligo for site directed 
mutagenesis of D 392 P in 
M. SPRI 
NIS 15 GGAAATTACACCCTAGGGAGTGTTTTAGAGTAATGGGC Top oligo for site directed 
TAC mutagenesis of A 280 F in 
M. Hhal (Styl site) 
NIS 16 GTAGCCCATTACTCTAAAACACTCCCTAGGGTGTAATT Bottom oligo for site directed 
TCC mutagenesis of A 280 F in 
M. Hhal (Styl site) 
NIS 17 CGGAAATTACACCCTCTAGAGTGTTTTAGA Top oligo for site directed 
mutagenesis of R 277 L in 
M. Hhal (Xhal site) 
NIS 18 TCTAAAACACTCTAGAGGGTGTAATTTCCG Bottom oligo for site directed 
mutagenesis of R 277 L in 
M. Hhal (Xbal site) 
NIS 19 GTTATAAAGTCCACCCGTCTACCAGCCAAGCATATAAA Top oligo for site directed 
CAAGCTGGTAACTCAGTTGTTATC mutagenesis of F 302 A in 
MHhal (Acct site) 
NIS 20 GATAACAACTGAGTTACCAGCTTGTTTATATGCTTGGC Bottom oligo for site directed 
TGGTAGACGGGTGGACTTTATAAC mutagenesis of F 302 A in 
- 
M. Hhal (Acct site) 
S2 1 NI GGCTACCCAGATTCTGACAAAGTCCACCCGTC Top oligo for site directed 
mutagenesis of Y 289 D in 
M. Hhal (A1wNI site) 
NIS 22 GACGGGTGGACTTTGTCAGAATCTGGGTAGCC Bottom oligo for site directed 
mutagenesis of Y 289 D in 
MHhal (AlwNI site) 
NIS 23 TTCAAACCATATGCTCGTGGGATTCCCCCTAAGTGAG Top oligo to delete EcoRl & 
Xhol site at the end of M. Hhal 
(in pQIS26/27) 
NIS 24 CTCACTTAAGGGGAATCCCACGAGCATATGGTTTGAA Complementary to NIS 23 to 
delete EcoRl & Xhol site at 
the end of M. Hhal (in pQIS 
APPENDICES 
26/27) 
NIS 25 TCGAGCGTCGACCTGCAGCAATTGGAATTCGGAAGACA Linker top oligo designed to 
C fit in pQIS 28/29 @ Xhol/Bbsl 
to facilitate the subcloning of 
TRDs of SPR in M. Hhal. 
NIS 26 TTCCGTGTCTTCCGAATTCCAATTGCTGCAGGTCGACG Linker bottom oligo designed 
C to fit in pQ1S 28/29 @ 
Xhol/Bbsl to facilitate the 
subcloning of TRDs of SPR in 
M. Hhal. 
NIS 27 CCAAAATACAGAATTCGGAGAATTCGGAAATTACACCC Primer designed to introduce 
TCTAG another EcoRl site 9 bp before 
existing EcoRI site. 
NIS 28 CTAGAGGGTGTAATTTCCGAATTCTCCGAATTCTGTAT Bottom oligo to NIS 27 
TTTGG (EcoRI site) 
NIS 31 AGAAAGGATATACTCGAGAAAGGGAAACAGAG Top oligo for for site directed 
mutagenesis of Q 189 E in 
M. SPRI (Xhol site) 
NIS 32 CTCTGTTTCCCTTTCTCGAGTATATCCTTTCT Bottom oligo for site directed 
mutagenesis of Q 189 E in 
M. SPRI (Xhol site) 
NIS 33 GATTTGTTTTCGCAATGATTTAATTAATCAAAATTTCC Top oligo for site directed 
AATTTCC mutagenesis of NI 176/177 IN 
in M. Hhal (Pact site) 
NIS 34 GGAAATTGGAAATTTTGATTAATTAAATCATTGCGAAA Bottom oligo for site directed 
ACAAATC mutagenesis of NI 176/177 IN 
in M. HhaI (Pacl site) 
NIS 35 CAAAGCAACCAAAGTTGGGCCCTTTTGAAAATGTTAAA Top oligo for for site directed 
G mutagenesis of FFV 
112/113/114 LGP in M. SPRI 
(Apal site) 
NIS 36 CTTTAACATTTTCAAAAGGGCCCAACTTTGGTTGCTTT Bottom oligo for site directed 
G mutagenesis of FFV 
112/113/114 LGP in M. SPRI 
(Apal site) 
NIS 37 AAAAAACCTAAAGTGGGCCCTATGGAAAATGTG Top oligo for site directed 
mutagenesis of VF 116/117 
GP in M. Hhal (Apal site) 
NIS 38 CACATTTTCCATAGGGCCCACTTTAGGTTTTTT Bottom oligo for site directed 
mutagenesis of VF 116/117 
GP in M. Hhal (A pal site) 
NIS 41 GAAAAAAAACCTAAAGTGGTCTTTTTTGAAAATGTTAA Top oligo for site directed 
AGGG mutagenesis of GP 116/ 117 
VF in chimaeric construct 
(deleted Apal site) 
NIS 42 CCCTTTAACATTTTCAAAAAAGACCACTTTAGGTTTTT Bottom oligo for site directed 
TTTC mutagenesis of GP 116/117 
VF in chimaeric construct 
(deleted Apal site) 
NIS 43 TATTTAGTAAACGGGAGAATTCGGAAATTACACCCTAG Top oligo for site directed 
mutagenesis of KT 270/271 RI 
in M. Hhal (EcoRI site) 
NIS 44 CTAGGGTGTAATTTCCGAATTCTCCCGTTTACTAAATA Bottom oligo for site directed 
mutagenesis of KT 270/271 RI 
in M. Hhal (EcoRI site) 
NIS 47 GAAGATACAAGAGGTACCTTGTTTTTTCAATACG Top oligo for site directed 
mutagenesis in M. SPRI 
(Silent, KpnI site) 
NIS 48 CGTATTGAAAAAACAAGGTACCTCTTGTATCTTC Bottom oligo for site directed 
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mutagenesis in M. SPRI 
(Silent, Kpnl site) 
NIS 51 GCTGAGTGCGTTTATTCTCGCGAATGGGATAAATATGC Top oligo for site directed 
mutagenesis of N 39 R in 
M. Hhal (Nrul site) 
NIS 52 GCATATTTATCCCATTCGCGAGAATAAACGCACTCAGC Bottom oligo for site directed 
mutagenesis of N 39 R in 
M Hhal (Nrul site) 
NIS 53 GAGCTGGTTGGTTTTCGCGAGATTGATAAATATGCC Top oligo for site directed 
mutagenesis of S 33 R in 
M. SPRI (Nrul site) 
NIS 54 GGCATATTTATCAATCTCGCGAAAACCAACCAGCTC Bottom oligo for site directed 
mutagenesis of S 33 R in 
M. SPRI (Nrul site) 
NIS 55 GCTGAGTGCGTTTATTCTAACGAGATTGATAAATATGC Top oligo for site directed 
CGTC mutagenesis of R 39 N in 
chimaeric construct (deleted 
Nrul site) 
NIS 56 GACGGCATATTTATCAATCTCGTTAGAATAAACGCACT Bottom oligo for site directed 
CAGC mutagenesis of R 39 N in 
chimaeric construct (deleted 
Nrul site) 
NIS 57 GAGCTGGTTGGTTTTAGCGAATGGGATAAATATGCAC Top oligo for site directed 
mutagenesis of R 33 S in 
chimaeric construct (deleted 
Nrul site) 
NIS 58 GTGCATATTTATCCCATTCGCTAAAACCAACCAGCTC Bottom oligo for site directed 
mutagenesis of R 39 S in 
chimaeric construct (deleted 
Nrul site) 
NIS 59 TCGAGTTGACTAGTGACAATGACCGCCTGCGCAAACGC Leucine zipper coding 
GTGGAACAGCTGAGTCGCGAAC sequence, top oligonucleotide 
NIS 60 TCAGCTGTTCCACGCGTTTGCGCAGGCGGTCATTGTCA Leucine zipper coding 
CTAGTCAAC sequence, bottom 
oligonucleotide 
NIS 63 CTTTCATTGCCATACGAAATTCCGGATGAGCATTC Top oligo to delete extra 
EcoRl site from pQIS 100 
NIS 64 GAATGCTCATCCGGAATTTCGTATGGCAATGAAAG Bottom oligo to delete extra 
EcoRl site from pQIS 100 
NIS 71 TCGAGAAATATATGGCCAGAAGAAAATGGCAGAAAACA Calmodulin binding peptide 
GGCCATGCTGTCCGAGCAATAGGAAGACTGTCATCCAT coding sequence, top oligo 
GGCAATGG 
NIS 7 22 GGACAGCATGGCCTGTTTTCTGCCATTTTCTTCTGGCC Calmodulin binding peptide 
ATATATTTC coding sequence, bottom oligo 
NIS 73 GCGCGAATTCCAGCTGGCGGAAGATGC Reverse primer from EcoRl 
site in leucine zipper-coding 
reg ion 
NIS 74 GCGCCTCGAGATGGCTGATCAACTGACAGAAGAG Forward primer for 
amplification of Calmodulin 
gene (Xhol site) 
NIS 76 GCGCGAATTCCTTCGCTGTCATCATCTGTACAAAC Reverse primer for the 
amplification of Calmodulin 
gene (EcoRl site) 
NIS 77 GCGCGGATCCATGGGTAAACTACGTGTAATG Forward primer to correct the 
start codon of M. SPRI in 
_- pACYC 
184 MIS 880 GTTGACTAGTGACAAAGATCGATTGCGCAAACGCGTGG Top oligo for site directed 
mutagenesis N5K in leucine 
zipper ORF (Clal site) 
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NIS 81 CCACGCGTTTGCGCAATCGATCTTTGTCACTAGTCAAC Bottom oligo for site directed 
mutagenesis N5K in leucine 
zipper ORF (Clal site) 
NIS 82 AGTGACAATGACCGCCCGCGGAAACGCGTGGAACAG Top oligo for site directed 
mutagenesis L8P in leucine 
zipper ORF (Sacll site) 
NIS 83 CTGTTCCACGCGTTTCCGCGGGCGGTCATTGTCACT Bottom oligo for site directed 
mutagenesis L8P in leucine 
zipper ORF (Sacll site) 
NIS 84 GCGCCTCGAGATGAGGCAGGTTTGGTTCTC Forward primer for 
amplification of yeast OST I 
gene (Xhol site) 
NIS 85 GCGCGAATTCTCAGTTAGTTACGTTCATGT Reverse primer for the 
amplification of yeast OST 1 
gene (EcoRI site) 
NIS 86 GCGCCTCGAGATGCGGACCGATTGGAATTT Forward primer for 
amplification of yeast WBPI 
gene (Xhol site) 
NIS 87 GCGCCAATTGGTTTGTTTTTTTGAATGTTT Reverse primer for the 
amplification of yeast WBP 1 
gene (EcoRl site) 
QY I GGCCCTCGAGATGTCAGCCACCAGAGCCAATAAAG Forward primer to amplify 
Mlcl gene sequence from 
yeast genomic DNA 
QY 2 GGCCGAATTCTCATTGTCTCAAAACATCTCGATGAACT Reverse primer to amplify 
TC MicI gene sequence from 
yeast genomic DNA 
QY 3 GGCCCTCGAGGGATCCATGACAGCATATTCAGGCTCT Forward primer to amplify 
IggI gene sequence from yeast 
genomic DNA 
QY 4 GGCCGAATTCGTCGACTTCTGGCTCTTTCAAATACAGC Forward primer to amplify 
Iqg 1 gene sequence from yeast 
genomic DNA 
IP I ACGAATTCCCATATGATTGAAATAAAAGAT Oligo at the beginning of HhaI 
with EcoRl and NdeI site 
IP 4 AGGGGCTATGCCCCTTTCGTCGACATATGGTTTGAAAT Oligo at the end of Hhal with 
TTAA Sail and Ndet site 
ABF 27 GTGTTGGCCGGTGTCGGGGCG Reverse primer for sequencing 
SPR C-terminal region 
ABF19 GCGCGGATCCTTGGGTAAACTCCGGGTAATG Forward primer of M. SPR 
containing BamHI and MspI 
sites used for sequencing 
Note: Oligonucleotides are abbreviated as oligo and the restriction sites are shown 
red and bold where appropriate. 
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Appendix VII 
List of 52 prokaryotic methyltransferases 
Swiss-prot/ Name Organism 
TrEMBL ID 
P05102 M. HhaI Haemophilus haemolyticus 
P11876 DCM OR MEC Escherichia coil 
Q57983 MJ0563 Methanococcus jannaschii 
Q58600 MJ1200 Methanococcus jannaschii 
P31974 M. AIuI Arthrobacter luteus 
P34882 M. AquI a subunit Synechococcus sp 
P34905 M. BbvI Bacillus brevis 
P13906 M. Bsprl Bacillus sphaericus 
P10283 M. BepI Brevibacterium epidermidis 
P25262 M. HgiBI Herpetosiphon aurantiacus 
P43420 M. Bsp6I Bacillus sp Plasmid pXH13 
P19888 M. BanI Bacillus aneurinolyticus 
P09389 M. Sp1I Bacteriophage SP-beta 
P17044 M. BsuFI Bacillus subtilis 
P05795 M. +3TI Bacillus subtilis, and Bacteriophage phi-3T 
P06530 M. BsuRI Bacillus sublilis 
P09915 M. p11SI Bacteriophage rho-lls 
P00476 M. SprI Bacteriophage SPR 
P36216 M. CviJI Chlorella virus IL-3A (CV-ILJA) 
P25263 M. HgiCI Herpetosiphon aurantiacus 
P25264 M. HgiCJI Herpetosiphon aurantlacus 
P05302 M. DdeI Desulfovibrio desulfuricans 
P24600 M. HgiDI Herpelosiphon aurantiacus 
P25265 M. HgiDII Herpetosiphon aurantiacus 
P50185 M. DsaV Dactylococcopsis salina 
P45000 H11041 Haemophilus influenzae 
P25266 M. HgiEI Herpetosiphon aurantiacus 
P05101 M. EcoRII Escherichia coli 
P50196 M. Eco4711 Escherichia coal 
P34906 M. FnuDI Fusobacterium nucleatum 
P25282 M. HgaI-1 Haemophilus gallinarum 
P25283 M. HgaI-2 Haemophilus gallinarum 
P15446 M. HpaII Haemophilus parainfluenzae 
P20589 M. HaeIII Haemophilus aegyptius 
P50192 M. HphI(C) Haemophilus parahaemolyticus 
P29567 M. MthTI Methanobacterium thermoformicicum 
P11408 M. MspI Moraxella sp 
P50188 M. NaeI Nocardia aerocolonigenes 
P50182 M. NIaIV Neisseria lactamica 
P08455 M. NgoPII Neisserla gonorrhoeae 
P31033 M. NgoMI Neisserla gonorrhoeae 
P24581 M. NIaX Neisseria lactamica 
P34879 M. SsoII Shigella sonnet 
P16668 M. Sau3AI Staphylococcus aureus 
P23737 M. Sau961 Staphylococcus aureus 
P34877 M. ScrFIA Lactococcus lactis (subsp. cremoris) 
P34878 M. ScrFIB Lactococcus lactis (subsp. cremoris) 
P09795 M. SinI Salmonella infantis 
P15840 M. SssI Spiroplasma sp. (strain MQ-1) 
P52311 M. XorII Xanthomonas oryzae 
S61228 M. BssHU Bacillus stearothermophilus 
JQ1019 M. H2I Bacteriophage 112 
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Appendix VIII 
List of 16 eukaryotic methyltransferases 
SWISS-prot/ Gene & Organism 
TrEMBL ID 
P05102 Mal methyltransferase 
Q27746 Cytosine-specific methyltransferase from Paracentrotus lividus (common sea 
urchin) 
048867 Cytosine-specific methyltransferase from Daucus carota (carrot) 
049889 Cytosine-specific methyltransferase from Lycopersicon esculentum (tomato) 
065343 Cytosine-specific methyltransferase from Zea mays (maize) 
023273 Cytosine-specific methyltransferase from Arabidopsis thaliana (mouse-ear 
cress) 
048866 Cytosine-specific methyltransferase from Daucus carota (carrot) 
Q9Z33) Cytosine-specific methyltransferase from Rattus ratlus (black rat) 
Q92072 Cytosine-specific methyltransferase from Gallus gallus (chicken) 
P79922 Cytosine-specific methyltransferase from Xenopus laevis (african clawed frog) 
Q171ID9 Cytosine-specific methyltransferase from Brachydanio rerio (zebrafish) 
P13864 Cytosine-5-methyltransferase (M. Mmul) from Mus musculus (mouse) 
P40999 DNA Methyltransferase PMT1(M. SpomI) Schizosaccharomyces pombe (fission 
yeast) 
P34881 Cytosine-5-methyltransferase from Arabidopsis thallana (mouse-ear cress) 
P26358 Cytosine-5-methyltransferase M. HsaI (DNMT1) from Homo sapiens (human) 
014717 Putative DNA methyltransferase DNMT2 from Homo sapiens (human) 
Q9W6K7 De novo DNA methyltransferase 3 DNMT3 (Fragment) from Brachydanlo rerio 
(zebrafish) 
